Query psy12044
Match_columns 767
No_of_seqs 561 out of 3323
Neff 7.5
Searched_HMMs 46136
Date Fri Aug 16 17:11:19 2013
Command hhsearch -i /work/01045/syshi/Psyhhblits/psy12044.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/12044hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG4194|consensus 100.0 1.2E-31 2.6E-36 291.4 6.9 324 30-356 271-611 (873)
2 KOG4237|consensus 100.0 2.8E-29 6.1E-34 263.2 7.8 239 11-254 30-404 (498)
3 PLN00113 leucine-rich repeat r 99.9 7.2E-22 1.6E-26 245.6 20.0 174 31-207 383-560 (968)
4 KOG4194|consensus 99.8 3.8E-21 8.3E-26 210.1 7.8 316 33-360 298-709 (873)
5 PLN00113 leucine-rich repeat r 99.6 6.4E-15 1.4E-19 183.5 11.8 156 49-206 140-296 (968)
6 KOG4237|consensus 99.5 1.5E-15 3.3E-20 160.4 -2.4 196 53-254 50-247 (498)
7 KOG0444|consensus 99.5 8.7E-15 1.9E-19 161.3 0.4 185 31-219 106-297 (1255)
8 KOG0617|consensus 99.4 3.6E-15 7.7E-20 141.6 -4.0 154 48-207 32-186 (264)
9 KOG0617|consensus 99.4 4.8E-15 1E-19 140.7 -3.8 171 32-208 37-213 (264)
10 KOG0444|consensus 99.4 4.9E-14 1.1E-18 155.4 -1.1 162 42-207 94-258 (1255)
11 KOG0472|consensus 99.3 2.2E-14 4.8E-19 151.8 -5.9 150 50-207 161-310 (565)
12 PRK15387 E3 ubiquitin-protein 99.3 4.4E-12 9.5E-17 150.3 11.0 161 21-207 195-355 (788)
13 KOG0472|consensus 99.3 8.7E-14 1.9E-18 147.4 -4.5 170 32-208 118-289 (565)
14 KOG0618|consensus 99.3 1.2E-13 2.6E-18 159.3 -4.6 181 21-206 282-488 (1081)
15 PRK15370 E3 ubiquitin-protein 99.3 1.2E-11 2.5E-16 147.4 10.9 161 29-208 179-339 (754)
16 PRK15370 E3 ubiquitin-protein 99.2 1.4E-11 3E-16 146.7 9.4 159 30-207 201-359 (754)
17 PRK15387 E3 ubiquitin-protein 99.2 1.9E-11 4.1E-16 145.0 9.5 158 32-209 286-460 (788)
18 PLN03150 hypothetical protein; 99.2 5.9E-11 1.3E-15 140.2 12.0 110 100-209 419-530 (623)
19 KOG0618|consensus 99.0 8.7E-12 1.9E-16 144.2 -4.4 164 46-212 238-448 (1081)
20 PF14580 LRR_9: Leucine-rich r 99.0 2E-10 4.3E-15 113.3 3.3 106 50-160 20-126 (175)
21 PLN03150 hypothetical protein; 99.0 1.3E-09 2.7E-14 129.1 9.6 106 78-183 421-527 (623)
22 KOG0532|consensus 98.9 6.5E-11 1.4E-15 130.8 -4.3 165 33-206 55-223 (722)
23 KOG1259|consensus 98.9 2.8E-10 6.2E-15 116.9 -0.8 132 74-211 283-416 (490)
24 PF14580 LRR_9: Leucine-rich r 98.9 1.9E-09 4.1E-14 106.4 4.8 111 95-209 15-128 (175)
25 cd00116 LRR_RI Leucine-rich re 98.8 7.7E-10 1.7E-14 119.7 1.7 157 49-207 51-234 (319)
26 KOG0532|consensus 98.8 1.5E-10 3.2E-15 128.0 -4.1 169 31-208 78-248 (722)
27 cd00116 LRR_RI Leucine-rich re 98.8 1.3E-09 2.9E-14 117.9 1.9 159 48-208 80-264 (319)
28 PLN03210 Resistant to P. syrin 98.8 5.6E-08 1.2E-12 123.1 14.2 148 48-206 588-737 (1153)
29 PLN03210 Resistant to P. syrin 98.7 6.5E-08 1.4E-12 122.5 14.5 98 32-133 593-691 (1153)
30 KOG1259|consensus 98.7 2E-09 4.3E-14 110.9 0.2 137 93-246 278-414 (490)
31 PF13855 LRR_8: Leucine rich r 98.7 1.6E-08 3.4E-13 82.1 4.2 59 124-182 2-60 (61)
32 COG4886 Leucine-rich repeat (L 98.7 1.4E-08 3.1E-13 113.8 4.7 151 50-207 117-290 (394)
33 cd05762 Ig8_MLCK Eighth immuno 98.6 1E-07 2.2E-12 85.4 6.4 91 259-359 5-95 (98)
34 cd05851 Ig3_Contactin-1 Third 98.6 9.3E-08 2E-12 83.7 5.7 82 259-354 6-87 (88)
35 KOG1187|consensus 98.5 2.3E-08 5.1E-13 110.5 1.6 69 427-504 61-130 (361)
36 KOG3207|consensus 98.5 3.4E-08 7.4E-13 106.8 1.5 159 48-207 145-314 (505)
37 cd05745 Ig3_Peroxidasin Third 98.5 1.5E-07 3.3E-12 79.4 5.1 73 268-353 1-73 (74)
38 cd04975 Ig4_SCFR_like Fourth i 98.5 3.8E-07 8.3E-12 82.0 7.7 89 262-355 11-100 (101)
39 cd05863 Ig2_VEGFR-3 Second imm 98.4 2.2E-07 4.7E-12 77.0 4.8 66 272-355 1-66 (67)
40 KOG1859|consensus 98.4 5.2E-09 1.1E-13 118.5 -6.6 128 76-209 165-294 (1096)
41 COG4886 Leucine-rich repeat (L 98.4 1.2E-07 2.6E-12 106.3 4.1 149 53-208 97-246 (394)
42 cd05852 Ig5_Contactin-1 Fifth 98.4 2.8E-07 6E-12 77.8 4.9 72 269-353 1-72 (73)
43 cd05735 Ig8_DSCAM Eight immuno 98.4 6.7E-07 1.5E-11 78.3 7.5 83 269-357 1-84 (88)
44 cd05892 Ig_Myotilin_C C-termin 98.4 4.5E-07 9.7E-12 76.9 5.6 74 272-353 1-74 (75)
45 cd05737 Ig_Myomesin_like_C C-t 98.4 4.2E-07 9.1E-12 80.2 5.7 83 262-353 9-91 (92)
46 cd05728 Ig4_Contactin-2-like F 98.4 6.1E-07 1.3E-11 77.9 5.8 79 261-353 6-84 (85)
47 cd05855 Ig_TrkB_d5 Fifth domai 98.3 9.4E-07 2E-11 75.7 6.4 76 273-353 2-77 (79)
48 cd05859 Ig4_PDGFR-alpha Fourth 98.3 7.4E-07 1.6E-11 80.2 6.0 87 263-355 12-100 (101)
49 cd05894 Ig_C5_MyBP-C C5 immuno 98.3 1E-06 2.3E-11 76.8 6.8 82 263-353 4-85 (86)
50 cd05867 Ig4_L1-CAM_like Fourth 98.3 7.1E-07 1.5E-11 75.7 5.4 75 269-354 1-75 (76)
51 cd04972 Ig_TrkABC_d4 Fourth do 98.3 9.8E-07 2.1E-11 77.4 6.3 81 263-353 9-89 (90)
52 cd05730 Ig3_NCAM-1_like Third 98.3 1E-06 2.2E-11 78.0 6.3 83 263-356 12-94 (95)
53 cd04974 Ig3_FGFR Third immunog 98.3 1.5E-06 3.2E-11 76.4 7.1 85 269-354 1-89 (90)
54 cd04968 Ig3_Contactin_like Thi 98.3 1E-06 2.2E-11 76.9 5.8 80 261-354 8-87 (88)
55 cd05869 Ig5_NCAM-1 Fifth immun 98.3 1.3E-06 2.9E-11 77.8 6.5 83 266-353 14-96 (97)
56 cd05854 Ig6_Contactin-2 Sixth 98.3 1.3E-06 2.8E-11 76.0 6.3 80 271-356 2-83 (85)
57 KOG3207|consensus 98.3 1.1E-07 2.5E-12 102.8 -0.6 159 48-207 171-339 (505)
58 cd05868 Ig4_NrCAM Fourth immun 98.3 8.6E-07 1.9E-11 75.3 4.8 75 269-354 1-75 (76)
59 cd05732 Ig5_NCAM-1_like Fifth 98.3 1.5E-06 3.2E-11 77.0 6.6 87 262-353 9-95 (96)
60 cd05747 Ig5_Titin_like M5, fif 98.3 1.4E-06 3E-11 76.8 6.2 87 256-352 5-91 (92)
61 cd05893 Ig_Palladin_C C-termin 98.3 1E-06 2.3E-11 74.7 5.2 74 272-353 1-74 (75)
62 PF07679 I-set: Immunoglobulin 98.3 7.9E-07 1.7E-11 77.5 4.4 85 260-354 6-90 (90)
63 cd05876 Ig3_L1-CAM Third immun 98.3 1E-06 2.3E-11 73.7 4.6 70 272-354 1-70 (71)
64 cd05857 Ig2_FGFR Second immuno 98.3 1.6E-06 3.4E-11 75.0 5.8 80 265-353 5-84 (85)
65 cd04976 Ig2_VEGFR Second immun 98.3 1.1E-06 2.3E-11 73.7 4.6 70 272-355 1-70 (71)
66 cd05723 Ig4_Neogenin Fourth im 98.3 1.2E-06 2.5E-11 73.4 4.7 69 272-353 2-70 (71)
67 cd04978 Ig4_L1-NrCAM_like Four 98.2 1.4E-06 3.1E-11 73.4 5.1 75 269-354 1-75 (76)
68 cd04969 Ig5_Contactin_like Fif 98.2 1.4E-06 3E-11 73.3 4.9 72 269-353 1-72 (73)
69 cd05870 Ig5_NCAM-2 Fifth immun 98.2 3.2E-06 6.9E-11 75.5 7.6 87 262-353 9-97 (98)
70 KOG0531|consensus 98.2 2.9E-07 6.2E-12 104.1 0.7 150 49-208 72-222 (414)
71 cd04971 Ig_TrKABC_d5 Fifth dom 98.2 2.8E-06 6E-11 73.2 6.6 77 274-353 3-79 (81)
72 cd05864 Ig2_VEGFR-2 Second imm 98.2 1.4E-06 2.9E-11 72.9 4.5 68 273-355 2-69 (70)
73 KOG4579|consensus 98.2 7.6E-08 1.7E-12 89.1 -3.3 133 77-211 29-163 (177)
74 cd05744 Ig_Myotilin_C_like Imm 98.2 1.9E-06 4.1E-11 73.0 5.2 74 272-353 1-74 (75)
75 cd05856 Ig2_FGFRL1-like Second 98.2 2.1E-06 4.5E-11 73.4 5.4 77 264-352 4-80 (82)
76 cd05725 Ig3_Robo Third immunog 98.2 1.7E-06 3.7E-11 71.8 4.6 68 272-353 1-68 (69)
77 cd05748 Ig_Titin_like Immunogl 98.2 2E-06 4.3E-11 72.4 5.0 72 272-353 2-73 (74)
78 cd05865 Ig1_NCAM-1 First immun 98.2 2.5E-06 5.5E-11 76.0 5.7 84 263-354 9-95 (96)
79 cd05891 Ig_M-protein_C C-termi 98.2 2.4E-06 5.1E-11 75.5 5.4 83 262-353 9-91 (92)
80 cd05746 Ig4_Peroxidasin Fourth 98.2 2E-06 4.4E-11 71.5 4.6 68 272-352 1-68 (69)
81 cd05731 Ig3_L1-CAM_like Third 98.2 2.2E-06 4.7E-11 71.3 4.4 70 272-354 1-70 (71)
82 cd05760 Ig2_PTK7 Second immuno 98.1 3.8E-06 8.3E-11 71.5 5.8 72 272-354 1-72 (77)
83 cd05743 Ig_Perlecan_D2_like Im 98.1 2.2E-06 4.7E-11 73.1 4.3 74 269-352 1-74 (78)
84 cd07693 Ig1_Robo First immunog 98.1 7.8E-06 1.7E-10 72.4 7.9 94 257-353 4-98 (100)
85 cd05739 Ig3_RPTP_IIa_LAR_like 98.1 3.7E-06 8E-11 70.1 5.3 67 269-351 1-67 (69)
86 cd05758 Ig5_KIRREL3-like Fifth 98.1 9.2E-06 2E-10 72.5 8.0 86 262-352 9-97 (98)
87 cd05764 Ig_2 Subgroup of the i 98.1 3.8E-06 8.2E-11 70.6 5.2 72 269-353 1-73 (74)
88 cd05765 Ig_3 Subgroup of the i 98.1 4.4E-06 9.5E-11 71.3 5.6 80 269-353 1-80 (81)
89 cd05763 Ig_1 Subgroup of the i 98.1 4.7E-06 1E-10 70.4 5.6 74 272-354 1-74 (75)
90 cd05858 Ig3_FGFR-2 Third immun 98.1 5E-06 1.1E-10 73.0 6.0 81 269-354 1-89 (90)
91 cd05740 Ig_CEACAM_D4 Fourth im 98.1 5.7E-06 1.2E-10 72.9 6.3 75 260-348 9-83 (91)
92 KOG0531|consensus 98.1 5.4E-07 1.2E-11 101.9 -0.4 150 48-207 94-245 (414)
93 cd05726 Ig4_Robo Fhird immunog 98.1 7.3E-06 1.6E-10 71.9 6.9 82 269-356 1-83 (90)
94 cd04970 Ig6_Contactin_like Six 98.1 4.8E-06 1E-10 72.1 5.6 80 271-356 2-83 (85)
95 KOG1909|consensus 98.1 6.5E-07 1.4E-11 94.7 0.1 136 49-184 92-254 (382)
96 cd05853 Ig6_Contactin-4 Sixth 98.1 4.7E-06 1E-10 72.4 5.3 80 271-356 2-83 (85)
97 KOG1859|consensus 98.0 1.3E-07 2.7E-12 107.6 -6.7 128 50-185 165-293 (1096)
98 cd04973 Ig1_FGFR First immunog 98.0 8.8E-06 1.9E-10 69.6 5.6 75 263-352 3-77 (79)
99 cd05742 Ig1_VEGFR_like First i 98.0 7.9E-06 1.7E-10 70.6 5.3 80 269-353 1-82 (84)
100 cd05773 Ig8_hNephrin_like Eigh 98.0 1.7E-05 3.7E-10 72.3 7.5 84 268-356 22-106 (109)
101 cd05724 Ig2_Robo Second immuno 97.9 2E-05 4.4E-10 68.0 6.7 75 262-348 4-79 (86)
102 TIGR00864 PCC polycystin catio 97.9 4.4E-06 9.5E-11 108.0 3.2 78 177-254 1-81 (2740)
103 KOG1644|consensus 97.9 1.1E-05 2.3E-10 79.8 5.0 81 53-138 23-103 (233)
104 cd05736 Ig2_Follistatin_like S 97.9 2.2E-05 4.7E-10 66.4 5.9 73 273-355 2-74 (76)
105 cd05738 Ig2_RPTP_IIa_LAR_like 97.9 2.1E-05 4.6E-10 66.3 5.5 64 272-346 1-64 (74)
106 cd07702 Ig2_VEGFR-1 Second imm 97.9 1.6E-05 3.5E-10 66.8 4.6 67 273-352 2-68 (72)
107 cd05861 Ig1_PDGFR-alphabeta Fr 97.9 3.6E-05 7.8E-10 66.7 6.7 70 269-344 1-70 (84)
108 cd05898 Ig5_KIRREL3 Fifth immu 97.9 4.9E-05 1.1E-09 67.9 7.6 89 259-352 6-97 (98)
109 cd04977 Ig1_NCAM-1_like First 97.9 2.1E-05 4.6E-10 69.4 5.3 74 262-345 8-82 (92)
110 cd05749 Ig2_Tyro3_like Second 97.9 2.9E-05 6.3E-10 66.9 5.9 70 261-348 5-75 (81)
111 cd05848 Ig1_Contactin-5 First 97.8 2.3E-05 5E-10 69.5 5.3 69 268-348 18-87 (94)
112 cd05750 Ig_Pro_neuregulin Immu 97.8 2.4E-05 5.2E-10 65.7 4.9 71 273-350 2-73 (75)
113 cd05756 Ig1_IL1R_like First im 97.8 3.4E-05 7.3E-10 68.5 6.0 81 263-353 8-93 (94)
114 cd05866 Ig1_NCAM-2 First immun 97.8 2.8E-05 6E-10 68.7 5.4 75 262-347 8-83 (92)
115 cd05850 Ig1_Contactin-2 First 97.8 4.2E-05 9.1E-10 67.7 6.3 68 269-348 19-87 (94)
116 cd05722 Ig1_Neogenin First imm 97.8 5E-05 1.1E-09 67.2 6.6 74 263-347 8-87 (95)
117 cd05849 Ig1_Contactin-1 First 97.8 3.7E-05 8.1E-10 68.0 5.4 67 269-348 19-86 (93)
118 KOG4579|consensus 97.8 2.6E-06 5.5E-11 79.2 -2.2 132 50-184 28-159 (177)
119 cd05734 Ig7_DSCAM Seventh immu 97.8 5.2E-05 1.1E-09 64.7 6.0 70 272-347 1-71 (79)
120 cd05729 Ig2_FGFR_like Second i 97.7 6.8E-05 1.5E-09 64.2 6.1 80 265-353 5-84 (85)
121 cd05733 Ig6_L1-CAM_like Sixth 97.7 5.3E-05 1.2E-09 64.4 4.9 67 272-348 1-71 (77)
122 cd05754 Ig3_Perlecan_like Thir 97.7 6E-05 1.3E-09 65.2 5.1 75 261-351 8-83 (85)
123 cd05874 Ig6_NrCAM Sixth immuno 97.6 7.3E-05 1.6E-09 63.6 5.1 67 272-348 1-71 (77)
124 cd05882 Ig1_Necl-1 First (N-te 97.6 0.00011 2.5E-09 65.2 6.1 79 261-341 4-83 (95)
125 PF13306 LRR_5: Leucine rich r 97.6 0.00016 3.4E-09 67.3 7.0 109 74-188 11-119 (129)
126 PF13306 LRR_5: Leucine rich r 97.6 0.00016 3.4E-09 67.4 7.0 117 49-173 12-128 (129)
127 KOG1644|consensus 97.6 8.9E-05 1.9E-09 73.5 5.3 123 78-204 22-150 (233)
128 cd05752 Ig1_FcgammaR_like Frst 97.6 0.00017 3.7E-09 61.6 6.1 62 260-342 6-68 (78)
129 cd04967 Ig1_Contactin First Ig 97.5 0.00014 3.1E-09 63.8 5.8 69 268-348 18-87 (91)
130 cd05895 Ig_Pro_neuregulin-1 Im 97.5 0.00011 2.4E-09 62.1 4.8 71 273-349 2-73 (76)
131 KOG4658|consensus 97.5 6E-05 1.3E-09 92.0 4.0 139 39-182 512-653 (889)
132 KOG1026|consensus 97.5 0.0002 4.4E-09 84.0 8.1 118 169-290 107-228 (774)
133 KOG4658|consensus 97.5 6.3E-05 1.4E-09 91.8 4.1 140 37-179 532-676 (889)
134 cd05757 Ig2_IL1R_like Second i 97.5 0.00028 6.1E-09 62.3 6.8 79 264-356 5-88 (92)
135 cd07701 Ig1_Necl-3 First (N-te 97.5 0.0002 4.4E-09 63.6 5.5 79 261-342 4-84 (95)
136 cd05875 Ig6_hNeurofascin_like 97.4 0.00016 3.5E-09 61.5 4.6 67 272-348 1-71 (77)
137 PF12799 LRR_4: Leucine Rich r 97.4 0.00016 3.6E-09 54.5 3.7 39 148-187 2-40 (44)
138 cd05862 Ig1_VEGFR First immuno 97.3 0.00042 9.2E-09 60.3 6.1 82 269-354 1-84 (86)
139 KOG1909|consensus 97.3 6.2E-05 1.3E-09 80.1 0.5 189 10-207 83-311 (382)
140 KOG3513|consensus 97.3 0.00056 1.2E-08 82.6 8.3 92 255-357 332-423 (1051)
141 smart00408 IGc2 Immunoglobulin 97.3 0.00045 9.7E-09 54.5 5.3 63 268-344 1-63 (63)
142 cd05873 Ig_Sema4D_like Immunog 97.3 0.00044 9.4E-09 60.4 5.5 67 262-342 4-70 (87)
143 cd04979 Ig_Semaphorin_C Immuno 97.3 0.00045 9.8E-09 60.3 5.7 72 262-344 4-75 (89)
144 PF12799 LRR_4: Leucine Rich r 97.3 0.00017 3.7E-09 54.4 2.5 35 77-112 3-37 (44)
145 cd05717 Ig1_Necl-1-3_like Firs 97.3 0.00067 1.4E-08 60.0 6.6 81 261-343 4-85 (95)
146 cd05860 Ig4_SCFR Fourth immuno 97.2 0.0012 2.6E-08 59.0 7.6 87 263-354 12-99 (101)
147 cd07690 Ig1_CD4 First immunogl 97.2 0.00052 1.1E-08 60.8 4.9 81 265-345 3-90 (94)
148 KOG3653|consensus 97.2 0.00035 7.6E-09 77.0 4.5 26 448-473 215-240 (534)
149 PRK15386 type III secretion pr 97.1 0.0017 3.7E-08 72.2 9.1 133 49-205 52-188 (426)
150 cd05753 Ig2_FcgammaR_like Seco 97.1 0.00079 1.7E-08 58.2 5.2 64 265-346 10-74 (83)
151 KOG3665|consensus 97.1 0.0003 6.5E-09 83.9 3.2 133 49-184 122-263 (699)
152 PRK15386 type III secretion pr 97.0 0.0022 4.8E-08 71.3 9.1 131 31-184 55-190 (426)
153 KOG1025|consensus 97.0 0.00026 5.7E-09 82.4 1.6 27 447-473 700-732 (1177)
154 KOG2982|consensus 97.0 0.0004 8.6E-09 72.5 2.3 43 171-213 199-243 (418)
155 cd05845 Ig2_L1-CAM_like Second 97.0 0.0015 3.3E-08 57.9 5.7 72 262-345 11-84 (95)
156 cd05871 Ig_Semaphorin_classIII 96.9 0.0022 4.9E-08 56.4 6.1 81 264-353 6-87 (91)
157 KOG2739|consensus 96.9 0.00043 9.3E-09 71.3 1.7 85 74-160 42-129 (260)
158 KOG0196|consensus 96.9 0.00063 1.4E-08 79.1 3.0 74 428-504 607-704 (996)
159 KOG3513|consensus 96.9 0.0017 3.6E-08 78.6 6.6 80 264-356 436-515 (1051)
160 KOG2120|consensus 96.8 6.3E-05 1.4E-09 78.3 -5.0 86 50-137 186-274 (419)
161 smart00082 LRRCT Leucine rich 96.8 0.00042 9.1E-09 53.8 0.7 49 204-253 1-50 (51)
162 smart00410 IG_like Immunoglobu 96.8 0.0065 1.4E-07 50.7 8.1 77 264-350 4-81 (86)
163 smart00409 IG Immunoglobulin. 96.8 0.0065 1.4E-07 50.7 8.1 77 264-350 4-81 (86)
164 cd05727 Ig2_Contactin-2-like S 96.8 0.0019 4.1E-08 57.4 4.8 73 264-346 13-86 (96)
165 PF13895 Ig_2: Immunoglobulin 96.6 0.0014 3.1E-08 54.9 2.7 61 264-344 9-69 (80)
166 COG5238 RNA1 Ran GTPase-activa 96.6 0.0017 3.6E-08 67.2 3.5 161 48-208 29-228 (388)
167 PF00047 ig: Immunoglobulin do 96.6 0.0013 2.7E-08 53.3 2.1 63 269-339 1-64 (64)
168 KOG2123|consensus 96.6 0.00012 2.6E-09 75.6 -4.9 100 74-177 18-123 (388)
169 cd05759 Ig2_KIRREL3-like Secon 96.5 0.011 2.3E-07 50.7 7.8 75 272-352 2-78 (82)
170 PF01462 LRRNT: Leucine rich r 96.5 0.0015 3.3E-08 44.1 1.9 28 17-48 1-28 (28)
171 PHA02785 IL-beta-binding prote 96.5 0.0061 1.3E-07 66.8 7.6 82 262-345 228-317 (326)
172 KOG4221|consensus 96.5 0.0044 9.6E-08 75.0 6.8 88 259-358 242-329 (1381)
173 KOG2982|consensus 96.5 0.0037 8E-08 65.5 5.1 106 53-159 49-158 (418)
174 KOG2739|consensus 96.5 0.0012 2.7E-08 68.0 1.6 89 95-185 39-130 (260)
175 cd05713 Ig_MOG_like Immunoglob 96.4 0.0074 1.6E-07 53.7 6.0 36 318-353 63-98 (100)
176 smart00013 LRRNT Leucine rich 96.3 0.004 8.8E-08 43.8 3.0 31 17-51 1-31 (33)
177 cd05879 Ig_P0 Immunoglobulin ( 96.2 0.016 3.5E-07 53.5 7.7 89 263-352 7-112 (116)
178 COG5238 RNA1 Ran GTPase-activa 96.2 0.0031 6.7E-08 65.3 3.0 191 9-208 82-317 (388)
179 KOG3665|consensus 96.1 0.003 6.4E-08 75.6 2.7 131 75-207 122-263 (699)
180 cd05897 Ig2_IL1R2_like Second 96.1 0.016 3.4E-07 51.5 6.4 75 265-350 6-85 (95)
181 PF13927 Ig_3: Immunoglobulin 96.1 0.0032 6.9E-08 51.9 1.9 57 272-341 18-75 (75)
182 PHA02826 IL-1 receptor-like pr 96.0 0.01 2.2E-07 61.5 5.9 68 264-343 139-211 (227)
183 cd05881 Ig1_Necl-2 First (N-te 96.0 0.011 2.3E-07 52.5 5.1 79 261-341 4-83 (95)
184 cd05714 Ig_CSPGs_LP Immunoglob 95.9 0.016 3.4E-07 52.3 5.7 86 269-354 2-102 (106)
185 KOG2123|consensus 95.8 0.00066 1.4E-08 70.3 -4.0 82 98-183 18-100 (388)
186 cd05885 Ig2_Necl-4 Second immu 95.8 0.052 1.1E-06 46.6 8.1 68 272-347 2-70 (80)
187 cd05900 Ig_Aggrecan Immunoglob 95.8 0.027 5.8E-07 51.6 6.7 86 268-353 1-107 (112)
188 cd05877 Ig_LP_like Immunoglobu 95.7 0.022 4.7E-07 51.3 6.1 86 268-355 1-103 (106)
189 PHA02826 IL-1 receptor-like pr 95.7 0.014 2.9E-07 60.5 5.0 91 263-354 31-132 (227)
190 cd05872 Ig_Sema4B_like Immunog 95.7 0.029 6.4E-07 48.7 6.2 64 262-340 4-67 (85)
191 cd04983 IgV_TCR_alpha_like Imm 95.7 0.018 3.9E-07 51.9 5.2 82 261-343 5-93 (109)
192 KOG2052|consensus 95.6 0.0046 1E-07 68.0 1.4 25 449-473 217-241 (513)
193 cd05880 Ig_EVA1 Immunoglobulin 95.5 0.03 6.4E-07 51.5 6.2 84 261-345 5-104 (115)
194 PHA02785 IL-beta-binding prote 95.4 0.025 5.5E-07 61.9 6.0 78 266-358 38-120 (326)
195 cd05899 IgV_TCR_beta Immunoglo 95.3 0.023 4.9E-07 51.6 4.4 80 261-343 5-95 (110)
196 cd05878 Ig_Aggrecan_like Immun 95.2 0.047 1E-06 49.8 6.3 86 269-354 2-106 (110)
197 cd05896 Ig1_IL1RAPL-1_like Fir 95.2 0.052 1.1E-06 48.8 6.2 80 264-350 10-100 (104)
198 cd05751 Ig1_LILRB1_like First 95.2 0.043 9.2E-07 48.1 5.7 64 265-342 12-75 (91)
199 cd05715 Ig_P0-like Immunoglobu 95.1 0.078 1.7E-06 48.7 7.6 84 262-346 6-106 (116)
200 cd05718 Ig1_PVR_like First imm 95.0 0.055 1.2E-06 47.7 6.1 36 318-353 60-96 (98)
201 cd05741 Ig_CEACAM_D1_like Firs 95.0 0.027 5.9E-07 49.0 4.0 76 269-344 1-81 (92)
202 cd05888 Ig1_Nectin-4_like Frst 94.9 0.082 1.8E-06 47.2 7.0 35 318-352 62-97 (100)
203 KOG0593|consensus 94.9 0.014 3E-07 61.5 2.0 56 449-504 8-75 (396)
204 cd00098 IgC Immunoglobulin Con 94.6 0.078 1.7E-06 46.4 6.0 74 268-345 12-87 (95)
205 cd05775 Ig_SLAM-CD84_like_N N- 94.6 0.038 8.2E-07 49.1 4.0 79 268-346 3-87 (97)
206 KOG2120|consensus 94.4 0.0065 1.4E-07 63.7 -1.8 152 49-204 210-373 (419)
207 cd05886 Ig1_Nectin-1_like Firs 94.3 0.12 2.6E-06 46.3 6.5 37 318-354 61-98 (99)
208 cd05902 Ig_Neurocan Immunoglob 94.3 0.11 2.4E-06 47.4 6.3 86 269-354 2-106 (110)
209 cd00099 IgV Immunoglobulin var 94.1 0.051 1.1E-06 48.4 3.7 79 265-344 2-91 (105)
210 cd05774 Ig_CEACAM_D1 First imm 94.1 0.068 1.5E-06 48.4 4.4 80 264-343 8-93 (105)
211 cd04980 IgV_L_kappa Immunoglob 93.7 0.089 1.9E-06 47.3 4.4 78 261-341 7-92 (106)
212 cd05901 Ig_Versican Immunoglob 93.6 0.24 5.1E-06 45.7 7.1 41 314-354 73-113 (117)
213 KOG4221|consensus 93.6 0.043 9.3E-07 66.9 2.7 90 255-357 329-418 (1381)
214 cd04984 IgV_L_lambda Immunoglo 93.4 0.12 2.6E-06 45.8 4.8 74 265-341 2-84 (98)
215 cd05846 Ig1_MRC-OX-2_like Firs 93.4 0.21 4.6E-06 44.2 6.4 83 269-353 1-95 (97)
216 cd04982 IgV_TCR_gamma Immunogl 93.2 0.12 2.6E-06 47.3 4.6 81 260-341 4-98 (116)
217 cd05761 Ig2_Necl-1-4_like Seco 93.1 0.39 8.5E-06 41.1 7.4 69 272-346 2-71 (82)
218 cd05887 Ig1_Nectin-3_like Firs 93.1 0.27 5.9E-06 43.7 6.5 82 271-354 2-95 (96)
219 KOG0663|consensus 92.7 0.042 9.1E-07 58.7 0.9 60 441-500 74-145 (419)
220 cd00096 Ig Immunoglobulin doma 92.7 0.36 7.8E-06 37.6 6.2 65 273-343 2-66 (74)
221 PHA02987 Ig domain OX-2-like p 92.6 0.32 6.9E-06 48.2 6.7 91 263-355 24-122 (189)
222 cd06624 STKc_ASK Catalytic dom 92.5 0.068 1.5E-06 55.9 2.1 36 436-473 3-40 (268)
223 cd05716 Ig_pIgR Immunoglobulin 92.5 0.34 7.4E-06 42.7 6.3 78 264-342 2-86 (98)
224 cd07706 IgV_TCR_delta Immunogl 92.1 0.18 3.9E-06 46.1 4.1 81 261-342 6-94 (116)
225 PF07686 V-set: Immunoglobulin 91.8 0.096 2.1E-06 46.8 1.9 81 261-342 8-101 (114)
226 cd07705 Ig2_Necl-1 Second immu 91.7 0.66 1.4E-05 39.9 7.0 69 272-346 2-72 (83)
227 PLN03224 probable serine/threo 91.7 0.096 2.1E-06 60.7 2.2 21 443-463 145-165 (507)
228 PF04478 Mid2: Mid2 like cell 91.6 0.093 2E-06 49.9 1.7 30 372-401 48-78 (154)
229 KOG0193|consensus 91.0 0.13 2.8E-06 59.0 2.4 57 431-504 389-447 (678)
230 PF01102 Glycophorin_A: Glycop 91.0 0.075 1.6E-06 49.1 0.3 31 374-404 65-95 (122)
231 cd05147 RIO1_euk RIO kinase fa 90.6 0.17 3.6E-06 50.9 2.4 25 450-474 4-29 (190)
232 KOG0595|consensus 90.1 0.17 3.7E-06 55.5 2.2 30 444-473 11-42 (429)
233 cd05711 Ig_FcalphaRI Immunoglo 90.1 0.63 1.4E-05 41.0 5.5 66 264-340 10-75 (94)
234 KOG4222|consensus 90.1 0.36 7.7E-06 59.0 4.9 90 255-357 226-315 (1281)
235 KOG0597|consensus 90.0 0.13 2.8E-06 58.5 1.2 30 444-473 3-34 (808)
236 cd07694 Ig2_CD4 Second immunog 90.0 0.83 1.8E-05 39.7 5.8 61 265-341 10-72 (88)
237 PF08693 SKG6: Transmembrane a 89.9 0.36 7.9E-06 35.3 3.0 27 372-398 11-37 (40)
238 PLN03225 Serine/threonine-prot 89.6 0.17 3.8E-06 59.6 2.0 33 443-475 132-170 (566)
239 cd05884 Ig2_Necl-3 Second immu 89.6 0.9 2E-05 39.1 5.9 69 272-345 2-71 (83)
240 KOG0659|consensus 89.4 0.21 4.6E-06 52.0 2.1 24 450-473 9-34 (318)
241 PF08374 Protocadherin: Protoc 89.4 0.37 7.9E-06 48.4 3.7 28 369-396 34-61 (221)
242 cd07837 STKc_CdkB_plant Cataly 89.3 0.17 3.6E-06 53.8 1.4 31 443-473 1-33 (295)
243 cd05712 Ig_Siglec_N Immunoglob 89.2 0.95 2.1E-05 41.7 6.2 80 261-341 6-101 (119)
244 PF08205 C2-set_2: CD80-like C 89.0 0.45 9.7E-06 41.1 3.7 71 269-344 14-85 (89)
245 cd07879 STKc_p38delta_MAPK13 C 88.9 0.26 5.6E-06 54.0 2.5 43 431-473 1-47 (342)
246 cd05631 STKc_GRK4 Catalytic do 88.8 0.23 4.9E-06 52.7 1.9 29 445-473 2-32 (285)
247 cd05144 RIO2_C RIO kinase fami 88.8 0.4 8.6E-06 48.2 3.6 29 445-473 17-46 (198)
248 PTZ00382 Variant-specific surf 88.7 0.25 5.5E-06 43.9 1.8 29 372-400 65-93 (96)
249 PF00560 LRR_1: Leucine Rich R 88.7 0.22 4.8E-06 31.5 1.1 13 149-161 2-14 (22)
250 PF13504 LRR_7: Leucine rich r 88.5 0.27 5.9E-06 29.1 1.3 16 172-187 2-17 (17)
251 KOG0658|consensus 88.5 0.26 5.7E-06 53.4 2.1 29 445-473 26-56 (364)
252 KOG0574|consensus 88.1 0.16 3.4E-06 53.5 0.2 25 449-473 39-65 (502)
253 cd05720 Ig_CD8_alpha Immunoglo 88.1 0.62 1.4E-05 41.8 4.0 75 265-340 2-89 (104)
254 PTZ00284 protein kinase; Provi 88.1 0.18 4E-06 57.9 0.7 39 434-474 122-162 (467)
255 KOG0662|consensus 88.0 0.23 5.1E-06 48.6 1.2 25 449-473 8-34 (292)
256 cd05145 RIO1_like RIO kinase f 87.9 0.36 7.8E-06 48.3 2.6 24 450-473 4-28 (190)
257 cd06617 PKc_MKK3_6 Catalytic d 87.7 0.32 6.9E-06 51.2 2.2 30 444-473 2-33 (283)
258 KOG0201|consensus 87.6 0.33 7.1E-06 53.8 2.2 30 444-473 14-45 (467)
259 cd05119 RIO RIO kinase family, 87.6 0.36 7.9E-06 47.6 2.4 25 449-473 3-28 (187)
260 PRK09188 serine/threonine prot 87.5 0.36 7.8E-06 53.7 2.6 31 443-473 18-51 (365)
261 cd05615 STKc_cPKC_alpha Cataly 87.4 0.33 7.1E-06 52.7 2.2 29 445-473 2-32 (323)
262 cd05883 Ig2_Necl-2 Second immu 87.3 1.8 3.9E-05 37.3 6.2 65 272-344 2-68 (82)
263 cd06639 STKc_myosinIIIB Cataly 87.3 0.25 5.4E-06 52.4 1.1 41 431-473 12-54 (291)
264 cd05771 IgC_Tapasin_R Tapasin- 87.0 1.8 3.8E-05 41.0 6.7 77 267-343 51-131 (139)
265 PF15102 TMEM154: TMEM154 prot 87.0 0.45 9.7E-06 45.1 2.5 23 381-403 66-88 (146)
266 KOG0594|consensus 87.0 0.4 8.7E-06 51.7 2.4 25 449-473 17-43 (323)
267 cd05889 Ig1_DNAM-1_like First 86.9 1.6 3.4E-05 38.9 5.8 29 318-346 58-87 (96)
268 smart00407 IGc1 Immunoglobulin 86.6 1.9 4.2E-05 36.0 6.0 67 272-342 2-70 (75)
269 KOG0600|consensus 86.6 0.37 8E-06 54.3 2.0 54 445-500 119-186 (560)
270 cd06638 STKc_myosinIIIA Cataly 86.6 0.32 7E-06 51.3 1.5 42 430-473 7-50 (286)
271 smart00369 LRR_TYP Leucine-ric 86.6 0.48 1E-05 31.0 1.8 21 99-119 2-22 (26)
272 smart00370 LRR Leucine-rich re 86.6 0.48 1E-05 31.0 1.8 21 99-119 2-22 (26)
273 cd05599 STKc_NDR_like Catalyti 86.1 0.41 8.9E-06 52.7 2.1 30 444-473 2-33 (364)
274 cd07853 STKc_NLK Catalytic dom 86.0 0.52 1.1E-05 52.2 2.9 30 444-473 1-32 (372)
275 cd05632 STKc_GRK5 Catalytic do 85.8 0.43 9.4E-06 50.6 2.0 28 446-473 3-32 (285)
276 KOG4308|consensus 85.6 0.028 6.1E-07 64.5 -7.7 134 51-184 89-246 (478)
277 cd06637 STKc_TNIK Catalytic do 85.6 0.31 6.7E-06 50.9 0.7 32 443-474 6-39 (272)
278 cd05592 STKc_nPKC_theta_delta 85.4 0.56 1.2E-05 50.7 2.6 24 450-473 2-27 (316)
279 KOG1166|consensus 85.2 0.39 8.4E-06 59.1 1.4 31 443-473 698-729 (974)
280 cd05616 STKc_cPKC_beta Catalyt 85.1 0.51 1.1E-05 51.2 2.2 29 445-473 2-32 (323)
281 KOG4222|consensus 85.1 1.6 3.6E-05 53.5 6.4 94 257-355 318-411 (1281)
282 cd07846 STKc_CDKL2_3 Catalytic 85.1 0.33 7.2E-06 51.1 0.7 30 444-473 2-33 (286)
283 KOG0661|consensus 85.0 0.38 8.1E-06 53.9 1.0 51 450-500 17-79 (538)
284 cd07871 STKc_PCTAIRE3 Catalyti 84.9 0.56 1.2E-05 49.8 2.4 31 443-473 5-37 (288)
285 cd05612 STKc_PRKX_like Catalyt 84.7 0.63 1.4E-05 49.5 2.7 30 444-473 2-33 (291)
286 PHA02882 putative serine/threo 84.7 0.57 1.2E-05 50.0 2.3 30 444-473 13-47 (294)
287 cd05108 PTKc_EGFR Catalytic do 84.6 0.57 1.2E-05 50.5 2.3 31 443-473 7-43 (316)
288 cd05626 STKc_LATS2 Catalytic d 84.5 0.55 1.2E-05 52.3 2.1 29 445-473 3-33 (381)
289 KOG4236|consensus 84.2 0.47 1E-05 53.7 1.4 54 444-505 566-623 (888)
290 cd07845 STKc_CDK10 Catalytic d 84.2 0.6 1.3E-05 50.0 2.2 32 442-473 6-39 (309)
291 smart00370 LRR Leucine-rich re 84.0 0.84 1.8E-05 29.9 2.0 16 149-164 4-19 (26)
292 smart00369 LRR_TYP Leucine-ric 84.0 0.84 1.8E-05 29.9 2.0 16 149-164 4-19 (26)
293 cd07860 STKc_CDK2_3 Catalytic 83.9 0.5 1.1E-05 49.7 1.4 30 444-473 1-32 (284)
294 cd04981 IgV_H Immunoglobulin ( 83.7 1.4 3.1E-05 40.5 4.2 78 263-341 6-97 (117)
295 cd05619 STKc_nPKC_theta Cataly 83.7 0.72 1.6E-05 49.9 2.6 24 450-473 2-27 (316)
296 cd07700 IgV_CD8_beta Immunoglo 83.6 1.4 3E-05 39.8 3.9 75 265-340 2-92 (107)
297 cd05605 STKc_GRK4_like Catalyt 83.4 0.67 1.4E-05 49.1 2.1 29 445-473 2-32 (285)
298 cd07848 STKc_CDKL5 Catalytic d 83.3 0.68 1.5E-05 48.8 2.2 30 444-473 2-33 (287)
299 cd05601 STKc_CRIK Catalytic do 83.3 0.65 1.4E-05 50.4 2.0 30 444-473 2-33 (330)
300 cd05591 STKc_nPKC_epsilon Cata 83.3 0.78 1.7E-05 49.6 2.6 24 450-473 2-27 (321)
301 cd05575 STKc_SGK Catalytic dom 83.1 0.79 1.7E-05 49.6 2.6 24 450-473 2-27 (323)
302 PTZ00036 glycogen synthase kin 83.0 0.58 1.3E-05 53.4 1.6 31 443-473 66-98 (440)
303 smart00406 IGv Immunoglobulin 83.0 1 2.2E-05 37.4 2.7 22 317-338 59-80 (81)
304 cd05618 STKc_aPKC_iota Catalyt 82.9 0.81 1.7E-05 49.8 2.6 25 449-473 1-27 (329)
305 cd05603 STKc_SGK2 Catalytic do 82.9 0.81 1.8E-05 49.5 2.6 24 450-473 2-27 (321)
306 cd05571 STKc_PKB Catalytic dom 82.8 0.83 1.8E-05 49.5 2.6 24 450-473 2-27 (323)
307 cd06651 STKc_MEKK3 Catalytic d 82.8 0.98 2.1E-05 47.1 3.1 31 443-473 2-34 (266)
308 PF13504 LRR_7: Leucine rich r 82.7 0.77 1.7E-05 27.2 1.2 10 101-110 3-12 (17)
309 cd05604 STKc_SGK3 Catalytic do 82.5 0.87 1.9E-05 49.4 2.6 24 450-473 2-27 (325)
310 cd05629 STKc_NDR_like_fungal C 82.5 0.78 1.7E-05 50.9 2.3 30 444-473 2-33 (377)
311 cd05590 STKc_nPKC_eta Catalyti 82.5 0.87 1.9E-05 49.3 2.6 24 450-473 2-27 (320)
312 cd05085 PTKc_Fer Catalytic dom 82.4 0.91 2E-05 46.7 2.6 24 450-473 2-26 (250)
313 cd05624 STKc_MRCK_beta Catalyt 82.4 0.75 1.6E-05 50.1 2.1 30 444-473 2-33 (331)
314 cd05573 STKc_ROCK_NDR_like Cat 82.4 0.72 1.6E-05 50.4 1.9 30 444-473 2-33 (350)
315 cd05587 STKc_cPKC Catalytic do 82.3 0.76 1.6E-05 49.8 2.1 29 445-473 2-32 (324)
316 cd07872 STKc_PCTAIRE2 Catalyti 82.3 0.76 1.6E-05 49.3 2.1 31 443-473 6-38 (309)
317 KOG0473|consensus 82.3 0.067 1.5E-06 54.5 -5.6 83 123-207 42-124 (326)
318 cd05595 STKc_PKB_beta Catalyti 82.2 0.89 1.9E-05 49.3 2.6 24 450-473 2-27 (323)
319 PLN00034 mitogen-activated pro 82.2 0.66 1.4E-05 51.0 1.5 27 447-473 78-106 (353)
320 cd05628 STKc_NDR1 Catalytic do 82.2 0.81 1.8E-05 50.5 2.3 30 444-473 2-33 (363)
321 PTZ00283 serine/threonine prot 82.2 0.55 1.2E-05 54.5 1.0 31 443-473 32-64 (496)
322 KOG0577|consensus 82.0 0.43 9.4E-06 54.7 0.0 55 445-503 28-84 (948)
323 PF00069 Pkinase: Protein kina 81.9 0.75 1.6E-05 47.4 1.8 25 449-473 5-31 (260)
324 cd05620 STKc_nPKC_delta Cataly 81.7 0.97 2.1E-05 48.9 2.6 24 450-473 2-27 (316)
325 cd05608 STKc_GRK1 Catalytic do 81.7 0.97 2.1E-05 47.8 2.5 23 451-473 1-25 (280)
326 cd06652 STKc_MEKK2 Catalytic d 81.6 0.91 2E-05 47.2 2.3 31 443-473 2-34 (265)
327 cd05084 PTKc_Fes Catalytic dom 81.6 1 2.2E-05 46.4 2.6 46 450-502 2-50 (252)
328 cd07862 STKc_CDK6 Catalytic do 81.5 1.1 2.3E-05 47.5 2.8 29 445-473 3-34 (290)
329 cd05625 STKc_LATS1 Catalytic d 81.5 0.8 1.7E-05 50.9 2.0 30 444-473 2-33 (382)
330 cd07877 STKc_p38alpha_MAPK14 C 81.5 0.87 1.9E-05 49.9 2.2 40 432-473 8-49 (345)
331 PHA03376 BARF1; Provisional 81.5 4.7 0.0001 40.1 6.9 81 263-346 20-113 (221)
332 cd05570 STKc_PKC Catalytic dom 81.5 1 2.2E-05 48.7 2.6 24 450-473 2-27 (318)
333 cd05755 Ig2_ICAM-1_like Second 81.5 3.9 8.5E-05 36.7 5.9 72 265-345 12-87 (100)
334 cd05586 STKc_Sck1_like Catalyt 81.4 0.98 2.1E-05 49.0 2.5 23 451-473 1-25 (330)
335 KOG0591|consensus 81.4 0.62 1.4E-05 49.0 0.9 124 450-586 26-179 (375)
336 cd06636 STKc_MAP4K4_6 Catalyti 81.4 0.91 2E-05 47.8 2.2 40 432-473 7-48 (282)
337 cd05597 STKc_DMPK_like Catalyt 81.3 0.89 1.9E-05 49.5 2.1 29 445-473 3-33 (331)
338 cd05771 IgC_Tapasin_R Tapasin- 81.2 1.1 2.3E-05 42.4 2.4 36 321-356 2-37 (139)
339 cd05630 STKc_GRK6 Catalytic do 81.2 0.96 2.1E-05 48.0 2.3 29 445-473 2-32 (285)
340 KOG1006|consensus 81.1 0.64 1.4E-05 48.6 0.8 24 450-473 71-96 (361)
341 cd07863 STKc_CDK4 Catalytic do 81.0 0.93 2E-05 47.8 2.1 27 447-473 4-32 (288)
342 cd05585 STKc_YPK1_like Catalyt 81.0 1 2.2E-05 48.5 2.5 23 451-473 1-25 (312)
343 cd05627 STKc_NDR2 Catalytic do 80.9 0.9 2E-05 50.1 2.1 30 444-473 2-33 (360)
344 cd05588 STKc_aPKC Catalytic do 80.9 1.1 2.3E-05 48.8 2.6 24 450-473 2-27 (329)
345 cd05593 STKc_PKB_gamma Catalyt 80.8 1.1 2.3E-05 48.8 2.6 25 449-473 1-27 (328)
346 cd05772 IgC_SIRP Signal-regula 80.8 7.4 0.00016 35.5 7.7 70 267-343 19-92 (111)
347 cd05633 STKc_GRK3 Catalytic do 80.7 1.1 2.4E-05 47.4 2.6 24 450-473 1-26 (279)
348 cd05607 STKc_GRK7 Catalytic do 80.6 1.1 2.4E-05 47.2 2.6 23 451-473 1-25 (277)
349 cd07835 STKc_CDK1_like Catalyt 80.6 0.8 1.7E-05 48.1 1.5 53 447-504 3-57 (283)
350 cd08224 STKc_Nek6_Nek7 Catalyt 80.6 1.1 2.5E-05 46.3 2.6 58 443-504 2-61 (267)
351 cd07878 STKc_p38beta_MAPK11 Ca 80.6 1.3 2.8E-05 48.3 3.2 31 443-473 15-47 (343)
352 cd05622 STKc_ROCK1 Catalytic d 80.5 0.76 1.6E-05 51.1 1.3 37 435-473 37-75 (371)
353 cd05623 STKc_MRCK_alpha Cataly 80.4 0.98 2.1E-05 49.2 2.1 30 444-473 2-33 (332)
354 cd07869 STKc_PFTAIRE1 Catalyti 80.3 1 2.3E-05 48.1 2.2 31 443-473 5-37 (303)
355 cd06632 STKc_MEKK1_plant Catal 80.2 1.4 3E-05 45.3 3.1 28 446-473 3-32 (258)
356 cd05039 PTKc_Csk_like Catalyti 80.2 1.2 2.6E-05 46.0 2.6 31 443-473 6-36 (256)
357 cd06646 STKc_MAP4K5 Catalytic 80.1 1.1 2.4E-05 46.6 2.3 30 444-473 10-41 (267)
358 cd05600 STKc_Sid2p_Dbf2p Catal 80.1 0.96 2.1E-05 49.2 1.9 29 445-473 3-33 (333)
359 cd05033 PTKc_EphR Catalytic do 79.8 1.1 2.4E-05 46.7 2.1 31 443-473 4-39 (266)
360 cd05596 STKc_ROCK Catalytic do 79.7 0.58 1.3E-05 52.0 0.0 31 443-473 43-75 (370)
361 cd07698 IgC_MHC_I_alpha3 Class 79.6 4.7 0.0001 35.3 5.8 68 269-343 14-83 (93)
362 cd06629 STKc_MAPKKK_Bck1_like 79.6 1.2 2.5E-05 46.5 2.3 26 448-473 6-33 (272)
363 cd07847 STKc_CDKL1_4 Catalytic 79.6 0.8 1.7E-05 48.1 1.0 30 444-473 2-33 (286)
364 PTZ00263 protein kinase A cata 79.5 0.89 1.9E-05 49.5 1.4 31 443-473 18-50 (329)
365 cd08228 STKc_Nek6 Catalytic do 79.5 1.4 2.9E-05 45.9 2.8 58 443-504 2-61 (267)
366 cd05602 STKc_SGK1 Catalytic do 79.5 1.3 2.8E-05 48.0 2.6 24 450-473 2-27 (325)
367 KOG4250|consensus 79.4 0.66 1.4E-05 54.4 0.4 30 447-477 18-49 (732)
368 cd05621 STKc_ROCK2 Catalytic d 79.2 0.88 1.9E-05 50.6 1.3 31 443-473 43-75 (370)
369 cd07864 STKc_CDK12 Catalytic d 79.0 1.2 2.6E-05 47.3 2.1 31 443-473 7-39 (302)
370 cd05067 PTKc_Lck_Blk Catalytic 78.9 1.1 2.4E-05 46.4 1.9 29 445-473 8-37 (260)
371 KOG0575|consensus 78.9 1.3 2.8E-05 51.2 2.4 29 445-473 20-50 (592)
372 cd05606 STKc_beta_ARK Catalyti 78.8 1.4 3E-05 46.5 2.6 24 450-473 1-26 (278)
373 cd06641 STKc_MST3 Catalytic do 78.7 1.3 2.8E-05 46.5 2.3 29 445-473 6-36 (277)
374 cd05617 STKc_aPKC_zeta Catalyt 78.7 1.4 3E-05 47.9 2.6 24 450-473 2-27 (327)
375 cd07839 STKc_CDK5 Catalytic do 78.6 1.2 2.5E-05 46.9 1.9 26 448-473 5-32 (284)
376 cd07836 STKc_Pho85 Catalytic d 78.6 1.3 2.9E-05 46.4 2.3 30 444-473 1-32 (284)
377 cd06616 PKc_MKK4 Catalytic dom 78.5 0.93 2E-05 47.8 1.1 30 444-473 5-36 (288)
378 cd05043 PTK_Ryk Pseudokinase d 78.4 1.1 2.4E-05 47.0 1.7 31 443-473 6-42 (280)
379 cd05063 PTKc_EphR_A2 Catalytic 78.3 1.2 2.5E-05 46.5 1.8 31 443-473 5-40 (268)
380 cd05594 STKc_PKB_alpha Catalyt 78.3 1.4 3.1E-05 47.7 2.6 24 450-473 2-27 (325)
381 cd07844 STKc_PCTAIRE_like Cata 78.2 1.3 2.7E-05 46.9 2.1 31 443-473 5-37 (291)
382 cd08229 STKc_Nek7 Catalytic do 78.2 1.3 2.7E-05 46.1 2.0 31 443-473 2-34 (267)
383 cd07870 STKc_PFTAIRE2 Catalyti 78.2 1.2 2.5E-05 47.2 1.8 31 443-473 5-37 (291)
384 cd07856 STKc_Sty1_Hog1 Catalyt 78.2 0.94 2E-05 49.3 1.1 36 436-473 5-42 (328)
385 cd06630 STKc_MEKK1 Catalytic d 77.7 1.7 3.8E-05 45.0 2.9 30 444-473 1-32 (268)
386 cd05719 Ig2_PVR_like Second im 77.6 12 0.00026 33.1 7.8 67 271-345 17-84 (95)
387 cd05109 PTKc_HER2 Catalytic do 77.6 1.4 2.9E-05 46.4 2.1 31 443-473 7-43 (279)
388 PF01034 Syndecan: Syndecan do 77.6 0.73 1.6E-05 37.3 -0.0 13 372-384 12-24 (64)
389 cd05034 PTKc_Src_like Catalyti 77.5 1.4 3.1E-05 45.6 2.2 31 443-473 6-37 (261)
390 cd06625 STKc_MEKK3_like Cataly 77.4 1.8 3.9E-05 44.8 2.9 31 443-473 2-34 (263)
391 KOG0473|consensus 77.4 0.07 1.5E-06 54.4 -7.2 89 93-184 36-124 (326)
392 KOG0605|consensus 77.1 1.6 3.4E-05 49.7 2.4 33 441-473 139-173 (550)
393 cd07849 STKc_ERK1_2_like Catal 77.0 1.3 2.8E-05 48.2 1.8 32 443-474 5-38 (336)
394 PHA02633 hypothetical protein; 77.0 3.5 7.7E-05 33.3 3.7 40 319-358 17-56 (63)
395 cd05598 STKc_LATS Catalytic do 76.9 1.5 3.2E-05 48.7 2.2 29 445-473 3-33 (376)
396 KOG1163|consensus 76.8 1.1 2.4E-05 46.2 1.0 160 433-616 8-188 (341)
397 KOG1095|consensus 76.6 0.51 1.1E-05 58.2 -1.6 50 449-504 698-754 (1025)
398 cd06610 STKc_OSR1_SPAK Catalyt 76.6 1.8 3.9E-05 44.7 2.6 30 444-473 2-33 (267)
399 cd05103 PTKc_VEGFR2 Catalytic 76.6 1.5 3.3E-05 48.0 2.1 30 444-473 8-44 (343)
400 PLN00009 cyclin-dependent kina 76.5 1.5 3.4E-05 46.3 2.2 56 443-503 2-59 (294)
401 cd05581 STKc_PDK1 Catalytic do 76.5 1.7 3.7E-05 45.3 2.4 30 444-473 2-33 (280)
402 PF12877 DUF3827: Domain of un 76.5 2 4.3E-05 49.9 3.0 33 366-398 263-295 (684)
403 cd07868 STKc_CDK8 Catalytic do 76.4 2 4.3E-05 46.1 3.0 25 449-473 7-35 (317)
404 cd05589 STKc_PKN Catalytic dom 76.3 1.5 3.2E-05 47.5 2.0 25 449-473 5-31 (324)
405 cd06917 STKc_NAK1_like Catalyt 76.1 1.8 3.8E-05 45.3 2.4 30 444-473 2-33 (277)
406 cd05072 PTKc_Lyn Catalytic dom 76.1 1.3 2.9E-05 45.8 1.5 30 444-473 7-37 (261)
407 cd07843 STKc_CDC2L1 Catalytic 76.0 1.4 3.1E-05 46.6 1.7 31 443-473 5-37 (293)
408 cd06650 PKc_MEK1 Catalytic dom 76.0 1.8 3.9E-05 47.2 2.5 31 443-473 5-37 (333)
409 cd06649 PKc_MEK2 Catalytic dom 75.7 1.7 3.6E-05 47.3 2.2 55 443-503 5-61 (331)
410 KOG0192|consensus 75.7 1.8 4E-05 48.0 2.5 48 450-504 48-98 (362)
411 cd05102 PTKc_VEGFR3 Catalytic 75.7 1.1 2.3E-05 48.8 0.6 31 443-473 7-44 (338)
412 cd08225 STKc_Nek5 Catalytic do 75.6 1.6 3.5E-05 44.8 2.0 29 445-473 2-32 (257)
413 PF13908 Shisa: Wnt and FGF in 75.6 2.1 4.5E-05 42.6 2.6 14 372-385 78-91 (179)
414 cd06653 STKc_MEKK3_like_1 Cata 75.5 1.9 4.1E-05 44.9 2.5 31 443-473 2-34 (264)
415 cd05068 PTKc_Frk_like Catalyti 75.3 1.6 3.5E-05 45.2 1.9 31 443-473 6-37 (261)
416 cd06615 PKc_MEK Catalytic doma 75.2 1.9 4.1E-05 46.2 2.5 30 444-473 2-33 (308)
417 cd05104 PTKc_Kit Catalytic dom 75.1 1.5 3.2E-05 48.8 1.6 31 443-473 35-72 (375)
418 cd06631 STKc_YSK4 Catalytic do 75.0 2.3 5E-05 44.1 3.0 56 448-504 5-61 (265)
419 KOG3864|consensus 75.0 0.54 1.2E-05 47.2 -1.7 33 147-179 151-184 (221)
420 cd07867 STKc_CDC2L6 Catalytic 74.8 2 4.3E-05 46.0 2.4 25 449-473 7-35 (317)
421 KOG1035|consensus 74.8 0.81 1.8E-05 56.7 -0.6 31 443-473 479-511 (1351)
422 cd07841 STKc_CDK7 Catalytic do 74.8 2 4.4E-05 45.5 2.5 29 445-473 2-32 (298)
423 cd07880 STKc_p38gamma_MAPK12 C 74.7 1.7 3.7E-05 47.6 1.9 31 443-473 15-47 (343)
424 PF02480 Herpes_gE: Alphaherpe 74.7 1.8 3.9E-05 49.3 2.1 20 321-340 270-289 (439)
425 cd07876 STKc_JNK2 Catalytic do 74.6 1.5 3.4E-05 48.1 1.6 31 443-473 21-53 (359)
426 KOG4308|consensus 74.6 0.09 1.9E-06 60.5 -8.4 131 77-207 89-246 (478)
427 cd05111 PTK_HER3 Pseudokinase 74.5 2 4.2E-05 45.3 2.3 25 444-468 8-34 (279)
428 cd07873 STKc_PCTAIRE1 Catalyti 74.4 1.8 3.9E-05 46.1 2.0 31 443-473 6-38 (301)
429 PF14575 EphA2_TM: Ephrin type 74.3 0.68 1.5E-05 39.2 -1.0 16 430-447 56-71 (75)
430 cd07865 STKc_CDK9 Catalytic do 74.3 1.6 3.5E-05 46.3 1.6 31 443-473 12-44 (310)
431 cd06606 STKc_MAPKKK Catalytic 74.2 2.1 4.6E-05 43.7 2.4 29 445-473 2-32 (260)
432 TIGR03724 arch_bud32 Kae1-asso 74.2 1.9 4.2E-05 42.9 2.0 24 450-473 1-24 (199)
433 PTZ00024 cyclin-dependent prot 74.1 2.2 4.7E-05 46.4 2.6 25 449-473 15-41 (335)
434 PRK13184 pknD serine/threonine 74.1 1.8 3.9E-05 53.6 2.1 31 443-473 2-34 (932)
435 cd06609 STKc_MST3_like Catalyt 74.0 2.1 4.5E-05 44.8 2.3 30 444-473 2-33 (274)
436 KOG0580|consensus 73.9 2.6 5.6E-05 43.6 2.8 32 442-473 21-54 (281)
437 cd08529 STKc_FA2-like Catalyti 73.9 2.1 4.5E-05 44.0 2.3 29 445-473 2-32 (256)
438 cd07859 STKc_TDY_MAPK_plant Ca 73.7 2.2 4.7E-05 46.2 2.4 25 449-473 6-32 (338)
439 cd05057 PTKc_EGFR_like Catalyt 73.6 1.6 3.5E-05 45.8 1.4 53 445-503 9-67 (279)
440 cd07830 STKc_MAK_like Catalyti 73.3 2.3 5E-05 44.5 2.5 26 448-473 4-31 (283)
441 cd07875 STKc_JNK1 Catalytic do 73.3 2 4.3E-05 47.4 2.1 31 443-473 24-56 (364)
442 cd05768 IgC_CH4 CH4 domain (fo 73.1 5.8 0.00013 35.6 4.7 74 268-342 15-90 (102)
443 cd06623 PKc_MAPKK_plant_like C 73.1 2.5 5.4E-05 43.6 2.6 31 443-473 1-33 (264)
444 KOG0194|consensus 73.1 2.2 4.8E-05 48.8 2.4 49 449-501 163-217 (474)
445 cd05073 PTKc_Hck Catalytic dom 72.7 2.1 4.5E-05 44.5 1.9 30 444-473 7-37 (260)
446 cd05116 PTKc_Syk Catalytic dom 72.7 2.6 5.7E-05 43.6 2.7 24 450-473 2-29 (257)
447 cd05114 PTKc_Tec_Rlk Catalytic 72.7 1.8 3.8E-05 44.8 1.4 29 445-473 6-35 (256)
448 PHA03209 serine/threonine kina 72.6 2.1 4.6E-05 47.1 2.1 31 443-473 66-98 (357)
449 cd05577 STKc_GRK Catalytic dom 72.6 2.5 5.4E-05 44.3 2.5 23 451-473 1-25 (277)
450 cd05064 PTKc_EphR_A10 Catalyti 72.6 1.8 4E-05 45.1 1.5 30 444-473 6-40 (266)
451 cd05088 PTKc_Tie2 Catalytic do 72.4 2.1 4.6E-05 45.8 1.9 31 443-473 7-41 (303)
452 PF01034 Syndecan: Syndecan do 72.3 1.2 2.5E-05 36.2 -0.1 33 372-404 8-40 (64)
453 PHA02988 hypothetical protein; 72.3 3 6.6E-05 44.2 3.1 63 431-504 15-77 (283)
454 cd07861 STKc_CDK1_euk Catalyti 72.2 2.4 5.1E-05 44.5 2.2 27 447-473 4-32 (285)
455 cd05035 PTKc_Axl_like Catalyti 72.1 3 6.5E-05 43.3 3.0 26 448-473 4-34 (273)
456 cd07854 STKc_MAPK4_6 Catalytic 72.0 2.1 4.6E-05 46.7 1.9 31 443-473 5-37 (342)
457 cd06620 PKc_MAPKK_Byr1_like Ca 72.0 2.4 5.2E-05 44.7 2.2 28 446-473 8-37 (284)
458 cd07833 STKc_CDKL Catalytic do 72.0 2.2 4.8E-05 44.7 2.0 30 444-473 2-33 (288)
459 cd07874 STKc_JNK3 Catalytic do 71.9 2 4.4E-05 47.1 1.7 31 443-473 17-49 (355)
460 KOG1094|consensus 71.8 6.3 0.00014 45.7 5.4 25 449-473 544-569 (807)
461 PF07654 C1-set: Immunoglobuli 71.7 11 0.00025 31.9 6.0 69 268-343 7-77 (83)
462 cd07866 STKc_BUR1 Catalytic do 71.7 2 4.4E-05 45.6 1.6 31 443-473 8-40 (311)
463 PHA03265 envelope glycoprotein 71.7 2 4.4E-05 46.1 1.5 32 375-406 349-380 (402)
464 cd05052 PTKc_Abl Catalytic dom 71.6 1.9 4.1E-05 44.8 1.4 30 444-473 7-38 (263)
465 cd08217 STKc_Nek2 Catalytic do 71.6 2.7 5.9E-05 43.2 2.5 28 446-473 3-32 (265)
466 cd05041 PTKc_Fes_like Catalyti 71.4 2.9 6.4E-05 42.9 2.7 24 450-473 2-26 (251)
467 cd07840 STKc_CDK9_like Catalyt 71.2 2.6 5.7E-05 44.0 2.3 26 448-473 4-31 (287)
468 cd05070 PTKc_Fyn_Yrk Catalytic 71.1 2.4 5.2E-05 43.9 2.0 27 447-473 10-37 (260)
469 PF02009 Rifin_STEVOR: Rifin/s 71.1 1.4 3E-05 47.4 0.1 7 393-399 277-283 (299)
470 cd07855 STKc_ERK5 Catalytic do 71.1 2.6 5.7E-05 45.7 2.3 31 443-473 5-37 (334)
471 PHA03212 serine/threonine kina 70.9 2.4 5.1E-05 47.6 2.0 31 443-473 92-124 (391)
472 cd06635 STKc_TAO1 Catalytic do 70.7 2.5 5.4E-05 45.6 2.0 30 444-473 26-57 (317)
473 cd07699 IgC_L Immunoglobulin C 70.7 11 0.00023 33.7 5.8 72 268-343 16-89 (100)
474 cd06619 PKc_MKK5 Catalytic dom 70.7 3.1 6.8E-05 43.7 2.8 49 448-502 6-56 (279)
475 cd06642 STKc_STK25-YSK1 Cataly 70.6 1.6 3.4E-05 45.8 0.4 27 447-473 8-36 (277)
476 cd07858 STKc_TEY_MAPK_plant Ca 70.5 2.5 5.4E-05 46.0 2.0 31 443-473 5-37 (337)
477 cd05847 IgC_CH2_IgE CH2 domain 70.5 9 0.0002 33.8 5.2 72 269-344 14-87 (94)
478 cd05083 PTKc_Chk Catalytic dom 70.5 1.8 4E-05 44.6 0.9 29 445-473 8-36 (254)
479 TIGR01982 UbiB 2-polyprenylphe 70.5 2.9 6.2E-05 47.8 2.5 29 444-473 119-148 (437)
480 cd05090 PTKc_Ror1 Catalytic do 70.4 2.5 5.5E-05 44.4 2.0 54 444-503 6-65 (283)
481 cd05058 PTKc_Met_Ron Catalytic 70.4 3 6.6E-05 43.1 2.5 25 449-473 1-30 (262)
482 cd05611 STKc_Rim15_like Cataly 70.2 3.1 6.6E-05 43.0 2.5 24 450-473 3-28 (260)
483 cd06656 STKc_PAK3 Catalytic do 70.2 2.8 6.1E-05 44.6 2.3 30 444-473 20-51 (297)
484 cd05578 STKc_Yank1 Catalytic d 69.9 2.7 5.8E-05 43.4 2.0 29 445-473 2-32 (258)
485 cd05050 PTKc_Musk Catalytic do 69.8 2.8 6.1E-05 44.2 2.2 31 443-473 5-42 (288)
486 cd05766 IgC_MHC_II_beta Class 69.7 12 0.00026 32.9 5.8 69 268-343 13-83 (94)
487 cd07831 STKc_MOK Catalytic dom 69.5 3.1 6.8E-05 43.4 2.4 25 449-473 5-31 (282)
488 cd07838 STKc_CDK4_6_like Catal 69.4 2.8 6.2E-05 43.8 2.1 27 447-473 3-31 (287)
489 cd05036 PTKc_ALK_LTK Catalytic 69.4 2.6 5.5E-05 44.3 1.7 31 443-473 6-43 (277)
490 KOG3864|consensus 69.3 0.46 9.9E-06 47.7 -3.6 77 76-156 102-185 (221)
491 cd07703 Ig2_Nectin-2_like Seco 69.3 23 0.00051 31.3 7.5 67 271-345 17-84 (95)
492 cd05112 PTKc_Itk Catalytic dom 69.2 2.7 5.9E-05 43.2 1.9 29 445-473 6-35 (256)
493 cd06607 STKc_TAO Catalytic dom 69.2 3.2 6.9E-05 44.4 2.4 31 443-473 15-47 (307)
494 cd06618 PKc_MKK7 Catalytic dom 69.0 3.3 7.1E-05 44.0 2.5 31 443-473 15-47 (296)
495 cd05053 PTKc_FGFR Catalytic do 69.0 3.1 6.7E-05 43.9 2.3 31 443-473 12-49 (293)
496 cd05770 IgC_beta2m Class I maj 68.9 12 0.00026 33.0 5.6 66 268-341 14-81 (93)
497 cd05087 PTKc_Aatyk1_Aatyk3 Cat 68.9 3.6 7.7E-05 42.9 2.7 24 449-472 1-28 (269)
498 cd05574 STKc_phototropin_like 68.6 3 6.4E-05 44.7 2.1 30 443-472 1-32 (316)
499 cd06605 PKc_MAPKK Catalytic do 68.5 3 6.4E-05 43.2 2.0 31 443-473 1-33 (265)
500 cd05082 PTKc_Csk Catalytic dom 68.5 2.9 6.4E-05 43.1 1.9 32 441-472 4-35 (256)
No 1
>KOG4194|consensus
Probab=99.97 E-value=1.2e-31 Score=291.40 Aligned_cols=324 Identities=26% Similarity=0.401 Sum_probs=264.4
Q ss_pred eeEEEecCCCccccccCC---CCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEc
Q psy12044 30 KQTVECVNKSLITVVEGM---DPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDF 106 (767)
Q Consensus 30 ~~~v~C~~~~L~~iP~~l---~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~L 106 (767)
..+++...+++..+-.+- +..|+.|+||.|.|..+....+.. .++|+.|+|++|+|+.+.++.|..|..|++|+|
T Consensus 271 me~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsf--tqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 271 MEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSF--TQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred cceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhh--cccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 345666666666665433 467788888888888888777764 678888888888888888888888888888888
Q ss_pred cCCCCCCCCCCCCCCCCCCcEEECCCCcCccccc---CCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCcc
Q psy12044 107 SHNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKT---GAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKI 183 (767)
Q Consensus 107 s~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~---~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~L 183 (767)
+.|+|+.+-..+|..+.+|+.|+|++|.|+..+. ..|.+|++|+.|+|.+|+|+.++..+|.++..|+.|||.+|.|
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcc
Confidence 8888888888888889999999999999887664 3578899999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCcccccCCCCCCCchhhhhhhhhhhccCCCCCccCCCCCCCCCCCCCcccccccccccCC----CCCCC
Q psy12044 184 TTISGSNILPTGLHGIDLHHNPWTCDCLLIGLRRWLESTKTPMAIDPICSVPPRLSSVTIKQLSIDELACE----PQITP 259 (767)
Q Consensus 184 t~ip~~~~~~~~L~~L~Ls~N~l~C~c~l~~l~~~l~~~~~~~~~~~~C~~p~~l~g~~i~~l~~~~l~C~----P~i~~ 259 (767)
.+|.+..|....|+.|.+..-.|.|||.+.|+.+|+.....+......|+.|+.+.++.+..++..++.|. |.+..
T Consensus 429 aSIq~nAFe~m~Lk~Lv~nSssflCDCql~Wl~qWl~~~~lq~sv~a~CayPe~Lad~~i~svd~~~lvC~DspkpqI~~ 508 (873)
T KOG4194|consen 429 ASIQPNAFEPMELKELVMNSSSFLCDCQLKWLAQWLYRRKLQSSVIAKCAYPEPLADQSIVSVDTANLVCDDSPKPQIVT 508 (873)
T ss_pred eeecccccccchhhhhhhcccceEEeccHHHHHHHHHhcccccceeeeccCCcccccceeEeechhhceecCCCCcceec
Confidence 99998888877999999999999999999999999999988877888999999999999999999999998 55556
Q ss_pred Cccceeecccccccccccccc--cCCCcEEEeecCeeccCCCcccccccceee----cccCcceeeeEEEEeeeccCCCC
Q psy12044 260 STFYLEIQEGKNVSLLCKVSA--IPEAKITWLFDGVPIQNESMSASESHAVYS----TEEGTEIKKSELLIYNSNIDDNG 333 (767)
Q Consensus 260 ~~~~~~v~~G~~vsL~C~a~g--~P~p~itW~~~g~~l~~~s~~~~~~~~~~~----~~~g~~~~~s~L~I~nvs~sD~G 333 (767)
.+..+....|.++++.|.+.+ .....+.|.++......... .+..+.... ...+..++.+.|++.|+...|+|
T Consensus 509 qPe~~~al~g~nirftC~a~sssasplsi~WR~dnevq~rv~v-ed~a~~~~q~r~~~~~e~~~~~~~L~L~nVt~td~g 587 (873)
T KOG4194|consen 509 QPETVSALIGENIRFTCNAYSSSASPLSIEWRKDNEVQPRVDV-EDFATFLSQNRNGTFGEREEYTAILHLDNVTFTDEG 587 (873)
T ss_pred CchHhhhhhccceEEEEEeccCCCCCceeEeeeccccCcccch-hcchhhhhhhccCccchhhhhhheeeeeeeecccCc
Confidence 666777889999999999987 45668999986653222111 111111111 11334556788999999999999
Q ss_pred ceeEeeccCCCCccc-ceEEEEEe
Q psy12044 334 TFVCVAENQAGSTSS-NYTIRIVL 356 (767)
Q Consensus 334 tY~CvA~N~~G~s~~-s~sL~V~~ 356 (767)
.|.|++.|.+|+..+ .+.+.|..
T Consensus 588 rYQCVvtN~FGStysqk~KltV~~ 611 (873)
T KOG4194|consen 588 RYQCVVTNHFGSTYSQKAKLTVNQ 611 (873)
T ss_pred eEEEEEecccCcchhheeEEEeec
Confidence 999999999999987 46666654
No 2
>KOG4237|consensus
Probab=99.95 E-value=2.8e-29 Score=263.22 Aligned_cols=239 Identities=30% Similarity=0.551 Sum_probs=209.0
Q ss_pred HhhhccCCCCCceecccCCeeEEEecCCCccccccCCCCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCcc
Q psy12044 11 IIKIVSACPTSCICKWKGGKQTVECVNKSLITVVEGMDPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVI 90 (767)
Q Consensus 11 ~~~~~~~CP~~C~C~~~g~~~~v~C~~~~L~~iP~~l~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i 90 (767)
+...+.+||.+|.|+..+ ...|+|++.+|.+||.++|+..+.|+|..|.|+.|++.+|.. +.+|+.|+|++|.|+.|
T Consensus 30 C~~~~~~CP~pC~Cs~~~-g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~--l~~LRrLdLS~N~Is~I 106 (498)
T KOG4237|consen 30 CAHSASACPAPCTCSDVE-GGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKT--LHRLRRLDLSKNNISFI 106 (498)
T ss_pred hhhccccCCCCcccCCCC-CceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccc--hhhhceecccccchhhc
Confidence 444567999999998765 578999999999999999999999999999999999999995 99999999999999999
Q ss_pred CcccccCCCCCCEEEccC-CCCCCCCCCC---------------------------------------------------
Q psy12044 91 DSKAFRGLTNLVDLDFSH-NVLQTVPSDT--------------------------------------------------- 118 (767)
Q Consensus 91 ~p~~f~~L~~L~~L~Ls~-N~Lt~l~p~~--------------------------------------------------- 118 (767)
.|++|.++.+|..|-+-+ |+|+.++.+.
T Consensus 107 ~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~ 186 (498)
T KOG4237|consen 107 APDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQG 186 (498)
T ss_pred ChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccc
Confidence 999999999888776665 8788766332
Q ss_pred --------------------------------------------------------------------------------
Q psy12044 119 -------------------------------------------------------------------------------- 118 (767)
Q Consensus 119 -------------------------------------------------------------------------------- 118 (767)
T Consensus 187 l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP 266 (498)
T KOG4237|consen 187 LAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICP 266 (498)
T ss_pred hhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcCh
Confidence
Q ss_pred ---CCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccccccCCCCC-CC
Q psy12044 119 ---FPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISGSNIL-PT 194 (767)
Q Consensus 119 ---f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~~~~-~~ 194 (767)
|..|++|+.|+|++|+|+.+.+.+|.++..|+.|.|..|+|..+...+|.++..|+.|+|.+|+|+.+.+..|. ..
T Consensus 267 ~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~ 346 (498)
T KOG4237|consen 267 AKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLF 346 (498)
T ss_pred HHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccc
Confidence 22356788888888888888888888888888888888888888888888999999999999999988777664 47
Q ss_pred CcccccCCCCCCCchhhhhhhhhhhccCCCCCccCCCCCCCCCCCCCcccccccccccCC
Q psy12044 195 GLHGIDLHHNPWTCDCLLIGLRRWLESTKTPMAIDPICSVPPRLSSVTIKQLSIDELACE 254 (767)
Q Consensus 195 ~L~~L~Ls~N~l~C~c~l~~l~~~l~~~~~~~~~~~~C~~p~~l~g~~i~~l~~~~l~C~ 254 (767)
+|..|.|-.|||.|+|++.|+..|+++.. ...++.|..|..+++.++.++...++.|.
T Consensus 347 ~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~--~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~ 404 (498)
T KOG4237|consen 347 SLSTLNLLSNPFNCNCRLAWLGEWLRKKS--VVGNPRCQSPGFVRQIPISDVAFGDFRCG 404 (498)
T ss_pred eeeeeehccCcccCccchHHHHHHHhhCC--CCCCCCCCCCchhccccchhccccccccC
Confidence 89999999999999999999999999876 56789999999999999999999999997
No 3
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=99.88 E-value=7.2e-22 Score=245.55 Aligned_cols=174 Identities=19% Similarity=0.150 Sum_probs=144.3
Q ss_pred eEEEecCCCcc-ccccCC--CCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEcc
Q psy12044 31 QTVECVNKSLI-TVVEGM--DPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFS 107 (767)
Q Consensus 31 ~~v~C~~~~L~-~iP~~l--~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls 107 (767)
..++..++.+. .+|..+ .++|+.|+|++|.+++..+..|.. +++|+.|+|++|.+++..+..+..+++|+.|+|+
T Consensus 383 ~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~--l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 460 (968)
T PLN00113 383 FKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK--LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLA 460 (968)
T ss_pred CEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhc--CCCCCEEECcCCcccCccChhhccCCCCcEEECc
Confidence 34555555554 455443 578999999999999888888874 8899999999999999888888889999999999
Q ss_pred CCCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCcccc-c
Q psy12044 108 HNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITT-I 186 (767)
Q Consensus 108 ~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~-i 186 (767)
+|.+.+..|..+ .+.+|+.|+|++|++++..+..|..+++|+.|+|++|.+.+..|..+..+++|+.|+|++|.+++ +
T Consensus 461 ~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 539 (968)
T PLN00113 461 RNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQI 539 (968)
T ss_pred CceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccC
Confidence 999988877765 45889999999999998888888889999999999999998888888889999999999999985 4
Q ss_pred cCCCCCCCCcccccCCCCCCC
Q psy12044 187 SGSNILPTGLHGIDLHHNPWT 207 (767)
Q Consensus 187 p~~~~~~~~L~~L~Ls~N~l~ 207 (767)
|..+..+++|+.|+|++|.+.
T Consensus 540 p~~~~~l~~L~~L~Ls~N~l~ 560 (968)
T PLN00113 540 PASFSEMPVLSQLDLSQNQLS 560 (968)
T ss_pred ChhHhCcccCCEEECCCCccc
Confidence 455556788999999999886
No 4
>KOG4194|consensus
Probab=99.83 E-value=3.8e-21 Score=210.07 Aligned_cols=316 Identities=24% Similarity=0.366 Sum_probs=220.9
Q ss_pred EEecCCCccccc---cCCCCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCC
Q psy12044 33 VECVNKSLITVV---EGMDPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHN 109 (767)
Q Consensus 33 v~C~~~~L~~iP---~~l~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N 109 (767)
++.+.+.+..|- ..+..+|.+|+|+.|+|+.+++..|.. |..|+.|+|+.|+|..+...+|.++.+|+.|||++|
T Consensus 298 L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~--L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N 375 (873)
T KOG4194|consen 298 LDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRV--LSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSN 375 (873)
T ss_pred hccchhhhheeecchhhhcccceeEeccccccccCChhHHHH--HHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCC
Confidence 445555555443 245689999999999999999999984 899999999999999999999999999999999999
Q ss_pred CCCCCCCC---CCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCc----
Q psy12044 110 VLQTVPSD---TFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNK---- 182 (767)
Q Consensus 110 ~Lt~l~p~---~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~---- 182 (767)
.|+..+.+ .|..|++|+.|+|.+|+|..++..+|.++.+|+.|||.+|.|..+.+++|..+ .|+.|.+..-+
T Consensus 376 ~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCD 454 (873)
T KOG4194|consen 376 ELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCD 454 (873)
T ss_pred eEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEe
Confidence 99876543 58889999999999999999999999999999999999999999999999988 88888776432
Q ss_pred --cccccC-------------CCCCCCC---cccccCCCCCCCchhhhhh------------------------------
Q psy12044 183 --ITTISG-------------SNILPTG---LHGIDLHHNPWTCDCLLIG------------------------------ 214 (767)
Q Consensus 183 --Lt~ip~-------------~~~~~~~---L~~L~Ls~N~l~C~c~l~~------------------------------ 214 (767)
|.=++. ....+.. ...+.+.--.|.|+-...+
T Consensus 455 Cql~Wl~qWl~~~~lq~sv~a~CayPe~Lad~~i~svd~~~lvC~DspkpqI~~qPe~~~al~g~nirftC~a~sssasp 534 (873)
T KOG4194|consen 455 CQLKWLAQWLYRRKLQSSVIAKCAYPEPLADQSIVSVDTANLVCDDSPKPQIVTQPETVSALIGENIRFTCNAYSSSASP 534 (873)
T ss_pred ccHHHHHHHHHhcccccceeeeccCCcccccceeEeechhhceecCCCCcceecCchHhhhhhccceEEEEEeccCCCCC
Confidence 211110 0111111 1223334444555411111
Q ss_pred h-hhhhccCCCCCccCCC----C--CC-----CC------CCCCCcccccccccccCC--------------------CC
Q psy12044 215 L-RRWLESTKTPMAIDPI----C--SV-----PP------RLSSVTIKQLSIDELACE--------------------PQ 256 (767)
Q Consensus 215 l-~~~l~~~~~~~~~~~~----C--~~-----p~------~l~g~~i~~l~~~~l~C~--------------------P~ 256 (767)
+ ..|-.+.........- - .. .+ .+.-..+.--+...+.|. |.
T Consensus 535 lsi~WR~dnevq~rv~ved~a~~~~q~r~~~~~e~~~~~~~L~L~nVt~td~grYQCVvtN~FGStysqk~KltV~~~Ps 614 (873)
T KOG4194|consen 535 LSIEWRKDNEVQPRVDVEDFATFLSQNRNGTFGEREEYTAILHLDNVTFTDEGRYQCVVTNHFGSTYSQKAKLTVNQAPS 614 (873)
T ss_pred ceeEeeeccccCcccchhcchhhhhhhccCccchhhhhhheeeeeeeecccCceEEEEEecccCcchhheeEEEeeccCc
Confidence 1 2233222211110000 0 00 00 000001111112233443 66
Q ss_pred CCCCccceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCcee
Q psy12044 257 ITPSTFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFV 336 (767)
Q Consensus 257 i~~~~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~ 336 (767)
+...+..+++..|+.+.+.|.++|.|.|.|.|.++|..- +.+...++++...+ ...+.|.|+..+|.|.|+
T Consensus 615 FtktP~dltl~tg~mArl~CaAtG~P~PeIawqkdggtd----FPAA~eRRl~Vmpe-----dd~f~Itnvk~eD~GiYt 685 (873)
T KOG4194|consen 615 FTKTPEDLTLRTGQMARLECAATGHPRPEIAWQKDGGTD----FPAARERRLHVMPE-----DDVFFITNVKIEDQGIYT 685 (873)
T ss_pred cccCcccceeecccceeeeeeccCCCCcceeehhcCCCC----CchhhhheeeecCC-----CCEEEEecccccccceeE
Confidence 666777888999999999999999999999999976542 12222233333332 246899999999999999
Q ss_pred EeeccCCCCcccceEEEEEeeccc
Q psy12044 337 CVAENQAGSTSSNYTIRIVLKEEN 360 (767)
Q Consensus 337 CvA~N~~G~s~~s~sL~V~~~~~p 360 (767)
|.|.|.+|...++.++.|..++..
T Consensus 686 C~A~n~AG~isanAtL~V~e~p~f 709 (873)
T KOG4194|consen 686 CTAQNVAGQISANATLTVLETPSF 709 (873)
T ss_pred EeeeccccceeeceEEEEecCCcc
Confidence 999999999999999998876543
No 5
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=99.57 E-value=6.4e-15 Score=183.49 Aligned_cols=156 Identities=22% Similarity=0.182 Sum_probs=90.7
Q ss_pred CCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEE
Q psy12044 49 PNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKL 128 (767)
Q Consensus 49 ~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L 128 (767)
++|++|+|++|.+.+..+..+.+ +++|+.|+|++|.+.+..|..|.++++|++|+|++|.+++..|..|..+.+|+.|
T Consensus 140 ~~L~~L~Ls~n~~~~~~p~~~~~--l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 217 (968)
T PLN00113 140 PNLETLDLSNNMLSGEIPNDIGS--FSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWI 217 (968)
T ss_pred CCCCEEECcCCcccccCChHHhc--CCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEE
Confidence 34444444444444444444543 5666666666666666666666666666666666666666655666666666666
Q ss_pred ECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccc-cccCCCCCCCCcccccCCCCCC
Q psy12044 129 TLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKIT-TISGSNILPTGLHGIDLHHNPW 206 (767)
Q Consensus 129 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt-~ip~~~~~~~~L~~L~Ls~N~l 206 (767)
+|++|.+++..+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|.++ .+|..+..+.+|+.|+|++|.+
T Consensus 218 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l 296 (968)
T PLN00113 218 YLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296 (968)
T ss_pred ECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCee
Confidence 66666666555555666666666666666666555555666666666666666554 2333333444555555555544
No 6
>KOG4237|consensus
Probab=99.49 E-value=1.5e-15 Score=160.43 Aligned_cols=196 Identities=31% Similarity=0.427 Sum_probs=170.3
Q ss_pred EEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEECCC
Q psy12044 53 VLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSG 132 (767)
Q Consensus 53 ~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~ 132 (767)
..+-++-.|+.++...- .....|+|..|+|+.+++++|+.+.+|+.|||++|.|+.+.|++|.++.+|..|-+-+
T Consensus 50 ~VdCr~~GL~eVP~~LP-----~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg 124 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLP-----PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYG 124 (498)
T ss_pred eEEccCCCcccCcccCC-----CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhc
Confidence 45666777777765432 3677899999999999999999999999999999999999999999999988876655
Q ss_pred -CcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccccccCCCC-CCCCcccccCCCCCCCchh
Q psy12044 133 -NPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISGSNI-LPTGLHGIDLHHNPWTCDC 210 (767)
Q Consensus 133 -N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~~~-~~~~L~~L~Ls~N~l~C~c 210 (767)
|+|+.++.+.|.+|.+|+.|.+.-|++..+..++|..+++|..|.|-+|.+..|+...+ .+..++.+.+.-|++.|+|
T Consensus 125 ~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdC 204 (498)
T KOG4237|consen 125 NNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDC 204 (498)
T ss_pred CCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccc
Confidence 99999999999999999999999999999999999999999999999999999998544 5688999999999999999
Q ss_pred hhhhhhhhhccCCCCCccCCCCCCCCCCCCCcccccccccccCC
Q psy12044 211 LLIGLRRWLESTKTPMAIDPICSVPPRLSSVTIKQLSIDELACE 254 (767)
Q Consensus 211 ~l~~l~~~l~~~~~~~~~~~~C~~p~~l~g~~i~~l~~~~l~C~ 254 (767)
.+.|+.+++...... .+...|..|..+....+..++...+.|.
T Consensus 205 nL~wla~~~a~~~ie-tsgarc~~p~rl~~~Ri~q~~a~kf~c~ 247 (498)
T KOG4237|consen 205 NLPWLADDLAMNPIE-TSGARCVSPYRLYYKRINQEDARKFLCS 247 (498)
T ss_pred ccchhhhHHhhchhh-cccceecchHHHHHHHhcccchhhhhhh
Confidence 999998877665433 3566788888888888877777777775
No 7
>KOG0444|consensus
Probab=99.46 E-value=8.7e-15 Score=161.30 Aligned_cols=185 Identities=25% Similarity=0.338 Sum_probs=106.9
Q ss_pred eEEEecCCCccccccCC--CCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccC
Q psy12044 31 QTVECVNKSLITVVEGM--DPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSH 108 (767)
Q Consensus 31 ~~v~C~~~~L~~iP~~l--~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~ 108 (767)
.+++.+.++|..+|.++ .+++.+|+||+|+|..|+...|.+ |+.|-.|+|++|+|..++|. +..|..|++|+|++
T Consensus 106 t~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfin--LtDLLfLDLS~NrLe~LPPQ-~RRL~~LqtL~Ls~ 182 (1255)
T KOG0444|consen 106 TILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFIN--LTDLLFLDLSNNRLEMLPPQ-IRRLSMLQTLKLSN 182 (1255)
T ss_pred eeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHh--hHhHhhhccccchhhhcCHH-HHHHhhhhhhhcCC
Confidence 34555555555555544 345555555555555555555543 45555555555555555443 44455555555555
Q ss_pred CCCCCCCCCCCCCCCCCcEEECCCCcCc-ccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCcccccc
Q psy12044 109 NVLQTVPSDTFPDYPSLMKLTLSGNPIK-QIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTIS 187 (767)
Q Consensus 109 N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip 187 (767)
|.+....-..+..|++|+.|.+++.+-+ ...|.++..+.+|..+|||.|+|..++ +.+..+.+|+.|+||+|+|+.+.
T Consensus 183 NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vP-ecly~l~~LrrLNLS~N~iteL~ 261 (1255)
T KOG0444|consen 183 NPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVP-ECLYKLRNLRRLNLSGNKITELN 261 (1255)
T ss_pred ChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcch-HHHhhhhhhheeccCcCceeeee
Confidence 5444332223333444444444443322 122345666777777888888776654 45667788888888888888777
Q ss_pred CCCCCCCCcccccCCCCCCC----chhhhhhhhhhh
Q psy12044 188 GSNILPTGLHGIDLHHNPWT----CDCLLIGLRRWL 219 (767)
Q Consensus 188 ~~~~~~~~L~~L~Ls~N~l~----C~c~l~~l~~~l 219 (767)
.......+|++|+|+.|+++ |-|.+..+...+
T Consensus 262 ~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy 297 (1255)
T KOG0444|consen 262 MTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLY 297 (1255)
T ss_pred ccHHHHhhhhhhccccchhccchHHHhhhHHHHHHH
Confidence 66666677788888888775 556666654443
No 8
>KOG0617|consensus
Probab=99.44 E-value=3.6e-15 Score=141.58 Aligned_cols=154 Identities=24% Similarity=0.304 Sum_probs=106.4
Q ss_pred CCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcE
Q psy12044 48 DPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMK 127 (767)
Q Consensus 48 ~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~ 127 (767)
...++.|.||+|+|+.+++..-. |.+|+.|++.+|+|+.+ |..++.+++|+.|+++-|++.-++ ..|+.++.|+.
T Consensus 32 ~s~ITrLtLSHNKl~~vppnia~---l~nlevln~~nnqie~l-p~~issl~klr~lnvgmnrl~~lp-rgfgs~p~lev 106 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLTVVPPNIAE---LKNLEVLNLSNNQIEEL-PTSISSLPKLRILNVGMNRLNILP-RGFGSFPALEV 106 (264)
T ss_pred hhhhhhhhcccCceeecCCcHHH---hhhhhhhhcccchhhhc-ChhhhhchhhhheecchhhhhcCc-cccCCCchhhh
Confidence 35667777777777777766543 67777777777777776 344677777777777777776554 55777777777
Q ss_pred EECCCCcCcc-cccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccccccCCCCCCCCcccccCCCCCC
Q psy12044 128 LTLSGNPIKQ-IKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISGSNILPTGLHGIDLHHNPW 206 (767)
Q Consensus 128 L~Ls~N~l~~-l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~~~~~~~L~~L~Ls~N~l 206 (767)
|+|.+|++.. ..|..|..+..|+.|+|++|.+.-++++ ++.+++|+.|.+..|.+-++|.+++.+..|+.|.+.+|.+
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~d-vg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPD-VGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcccCChh-hhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhccccee
Confidence 7777777653 3355566666777777777777666553 6667777777777777777777766666777777777766
Q ss_pred C
Q psy12044 207 T 207 (767)
Q Consensus 207 ~ 207 (767)
.
T Consensus 186 ~ 186 (264)
T KOG0617|consen 186 T 186 (264)
T ss_pred e
Confidence 5
No 9
>KOG0617|consensus
Probab=99.43 E-value=4.8e-15 Score=140.70 Aligned_cols=171 Identities=19% Similarity=0.276 Sum_probs=134.8
Q ss_pred EEEecCCCccccccCC--CCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCC
Q psy12044 32 TVECVNKSLITVVEGM--DPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHN 109 (767)
Q Consensus 32 ~v~C~~~~L~~iP~~l--~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N 109 (767)
.+..+.+.+..+|+++ ..+|+.|+|++|+|..++...-. +++|+.|+++-|++... |..|+.++.|+.|||+.|
T Consensus 37 rLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~iss---l~klr~lnvgmnrl~~l-prgfgs~p~levldltyn 112 (264)
T KOG0617|consen 37 RLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISS---LPKLRILNVGMNRLNIL-PRGFGSFPALEVLDLTYN 112 (264)
T ss_pred hhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhh---chhhhheecchhhhhcC-ccccCCCchhhhhhcccc
Confidence 3556667888888887 67888889999998888776543 78888888888888765 677888899999999888
Q ss_pred CCCC-CCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccccccC
Q psy12044 110 VLQT-VPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISG 188 (767)
Q Consensus 110 ~Lt~-l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~ 188 (767)
++.. ..|..|..|..|+.|+|++|.+.-+++ .++++++|+.|.+..|.+-.++. .++.+..|+.|++.+|+++-+|+
T Consensus 113 nl~e~~lpgnff~m~tlralyl~dndfe~lp~-dvg~lt~lqil~lrdndll~lpk-eig~lt~lrelhiqgnrl~vlpp 190 (264)
T KOG0617|consen 113 NLNENSLPGNFFYMTTLRALYLGDNDFEILPP-DVGKLTNLQILSLRDNDLLSLPK-EIGDLTRLRELHIQGNRLTVLPP 190 (264)
T ss_pred ccccccCCcchhHHHHHHHHHhcCCCcccCCh-hhhhhcceeEEeeccCchhhCcH-HHHHHHHHHHHhcccceeeecCh
Confidence 8764 567778788888888999998887766 47888889999988888877754 57788888889999999988888
Q ss_pred CCCCC---CCcccccCCCCCCCc
Q psy12044 189 SNILP---TGLHGIDLHHNPWTC 208 (767)
Q Consensus 189 ~~~~~---~~L~~L~Ls~N~l~C 208 (767)
++... .+-+.+.+..|||.-
T Consensus 191 el~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 191 ELANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred hhhhhhhhhhHHHHhhhhCCCCC
Confidence 76643 233456777888863
No 10
>KOG0444|consensus
Probab=99.37 E-value=4.9e-14 Score=155.44 Aligned_cols=162 Identities=22% Similarity=0.276 Sum_probs=130.5
Q ss_pred ccccCC--CCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCC
Q psy12044 42 TVVEGM--DPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTF 119 (767)
Q Consensus 42 ~iP~~l--~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f 119 (767)
.||.++ +..|+.||||+|+|...+...-. -.++..|+|++|+|..++...|-+|+.|-.||||+|++..++|. +
T Consensus 94 GiP~diF~l~dLt~lDLShNqL~EvP~~LE~---AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ-~ 169 (1255)
T KOG0444|consen 94 GIPTDIFRLKDLTILDLSHNQLREVPTNLEY---AKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQ-I 169 (1255)
T ss_pred CCCchhcccccceeeecchhhhhhcchhhhh---hcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHH-H
Confidence 577777 46788888888888877655432 46788888888888888777788888888888888888888765 6
Q ss_pred CCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCcc-ccchhhhcCCCCCCeeeccCCccccccCCCCCCCCccc
Q psy12044 120 PDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIE-VIEDAAFVGLDSLEWLKLDNNKITTISGSNILPTGLHG 198 (767)
Q Consensus 120 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~-~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~~~~~~~L~~ 198 (767)
..|..|++|.|++|.+...--..+..+++|++|.+++.+-+ .-+|..+..+.+|..+|||.|+|..+|..+....+|+.
T Consensus 170 RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~Lrr 249 (1255)
T KOG0444|consen 170 RRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRR 249 (1255)
T ss_pred HHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhhe
Confidence 77888888888888887665556666778888888876432 22345688899999999999999999999999999999
Q ss_pred ccCCCCCCC
Q psy12044 199 IDLHHNPWT 207 (767)
Q Consensus 199 L~Ls~N~l~ 207 (767)
|+|++|.++
T Consensus 250 LNLS~N~it 258 (1255)
T KOG0444|consen 250 LNLSGNKIT 258 (1255)
T ss_pred eccCcCcee
Confidence 999999986
No 11
>KOG0472|consensus
Probab=99.34 E-value=2.2e-14 Score=151.83 Aligned_cols=150 Identities=26% Similarity=0.361 Sum_probs=85.4
Q ss_pred CccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEE
Q psy12044 50 NTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLT 129 (767)
Q Consensus 50 ~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~ 129 (767)
++..|++.+|++..+++.... ++.|++|+...|-++.+ |..+++|.+|+.|+|..|+|..++ .|.++..|.+|.
T Consensus 161 ~l~~l~~~~n~l~~l~~~~i~---m~~L~~ld~~~N~L~tl-P~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh 234 (565)
T KOG0472|consen 161 KLSKLDLEGNKLKALPENHIA---MKRLKHLDCNSNLLETL-PPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELH 234 (565)
T ss_pred HHHHhhccccchhhCCHHHHH---HHHHHhcccchhhhhcC-ChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHH
Confidence 344444444444444444443 34455555555554444 333555556666666666655554 355566666666
Q ss_pred CCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccccccCCCCCCCCcccccCCCCCCC
Q psy12044 130 LSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISGSNILPTGLHGIDLHHNPWT 207 (767)
Q Consensus 130 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~~~~~~~L~~L~Ls~N~l~ 207 (767)
++.|.|.-++.....++.+|.+|||.+|+++..+.+ +.-+.+|++||+|+|.|+++|...+.+ .|+.|.+.|||+.
T Consensus 235 ~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pde-~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 235 VGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPDE-ICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred hcccHHHhhHHHHhcccccceeeeccccccccCchH-HHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchH
Confidence 666666655555555666666666666666665543 444666666666666666666666655 6666666666653
No 12
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.32 E-value=4.4e-12 Score=150.33 Aligned_cols=161 Identities=21% Similarity=0.267 Sum_probs=118.0
Q ss_pred CceecccCCeeEEEecCCCccccccCCCCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCC
Q psy12044 21 SCICKWKGGKQTVECVNKSLITVVEGMDPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTN 100 (767)
Q Consensus 21 ~C~C~~~g~~~~v~C~~~~L~~iP~~l~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~ 100 (767)
.|.|.-. +...++|++.+|..+|+.++.+|+.|+|.+|+|+.++.. +++|+.|+|++|+|+.+. . ...+
T Consensus 195 ~~~Cl~~-~~~~LdLs~~~LtsLP~~l~~~L~~L~L~~N~Lt~LP~l------p~~Lk~LdLs~N~LtsLP-~---lp~s 263 (788)
T PRK15387 195 MRACLNN-GNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLPAL------PPELRTLEVSGNQLTSLP-V---LPPG 263 (788)
T ss_pred HHHHhcC-CCcEEEcCCCCCCcCCcchhcCCCEEEccCCcCCCCCCC------CCCCcEEEecCCccCccc-C---cccc
Confidence 3556433 356899999999999999999999999999999988742 578999999999999874 2 2467
Q ss_pred CCEEEccCCCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccC
Q psy12044 101 LVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDN 180 (767)
Q Consensus 101 L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~ 180 (767)
|+.|+|++|.|+.++. . ..+|+.|+|++|+|+.++. .+++|+.|+|++|.|++++. . ..+|..|++++
T Consensus 264 L~~L~Ls~N~L~~Lp~-l---p~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~Lp~-l---p~~L~~L~Ls~ 331 (788)
T PRK15387 264 LLELSIFSNPLTHLPA-L---PSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPA-L---PSELCKLWAYN 331 (788)
T ss_pred cceeeccCCchhhhhh-c---hhhcCEEECcCCccccccc----cccccceeECCCCccccCCC-C---ccccccccccc
Confidence 8888888888887653 2 2567778888888877654 24668888888888877643 1 23466666777
Q ss_pred CccccccCCCCCCCCcccccCCCCCCC
Q psy12044 181 NKITTISGSNILPTGLHGIDLHHNPWT 207 (767)
Q Consensus 181 N~Lt~ip~~~~~~~~L~~L~Ls~N~l~ 207 (767)
|+|+.+|. .+.+|+.|+|++|.+.
T Consensus 332 N~L~~LP~---lp~~Lq~LdLS~N~Ls 355 (788)
T PRK15387 332 NQLTSLPT---LPSGLQELSVSDNQLA 355 (788)
T ss_pred Cccccccc---cccccceEecCCCccC
Confidence 77776663 2246667777777665
No 13
>KOG0472|consensus
Probab=99.30 E-value=8.7e-14 Score=147.38 Aligned_cols=170 Identities=25% Similarity=0.375 Sum_probs=155.1
Q ss_pred EEEecCCCccccccCC--CCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCC
Q psy12044 32 TVECVNKSLITVVEGM--DPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHN 109 (767)
Q Consensus 32 ~v~C~~~~L~~iP~~l--~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N 109 (767)
.++|+...+.++|+++ ...+..|+..+|+++.++++.+. +.+|..|++.+|++....|..+. ++.|++||...|
T Consensus 118 ~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~slp~~~~~---~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N 193 (565)
T KOG0472|consen 118 KLDCSSNELKELPDSIGRLLDLEDLDATNNQISSLPEDMVN---LSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSN 193 (565)
T ss_pred hhhccccceeecCchHHHHhhhhhhhccccccccCchHHHH---HHHHHHhhccccchhhCCHHHHH-HHHHHhcccchh
Confidence 3667778888888887 45788899999999999988876 78999999999999999887666 999999999999
Q ss_pred CCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccccccCC
Q psy12044 110 VLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISGS 189 (767)
Q Consensus 110 ~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~ 189 (767)
-++.++|+ ++.|.+|..|+|..|+|..++ .|.++..|.+|+++.|.|+-++.+...++.+|..|||.+|+++++|.+
T Consensus 194 ~L~tlP~~-lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pde 270 (565)
T KOG0472|consen 194 LLETLPPE-LGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPDE 270 (565)
T ss_pred hhhcCChh-hcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCchH
Confidence 99988865 899999999999999999997 599999999999999999999998888999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCCc
Q psy12044 190 NILPTGLHGIDLHHNPWTC 208 (767)
Q Consensus 190 ~~~~~~L~~L~Ls~N~l~C 208 (767)
+..+.+|..||+++|.++.
T Consensus 271 ~clLrsL~rLDlSNN~is~ 289 (565)
T KOG0472|consen 271 ICLLRSLERLDLSNNDISS 289 (565)
T ss_pred HHHhhhhhhhcccCCcccc
Confidence 9999999999999999874
No 14
>KOG0618|consensus
Probab=99.29 E-value=1.2e-13 Score=159.30 Aligned_cols=181 Identities=21% Similarity=0.250 Sum_probs=150.6
Q ss_pred CceecccCCeeEEEecCCCccccccCC--CCCccEEEeeCCCCCCCCchhhhcc-----------------------CCC
Q psy12044 21 SCICKWKGGKQTVECVNKSLITVVEGM--DPNTQVLDYTGNNLKTLHNEKFQKM-----------------------GLV 75 (767)
Q Consensus 21 ~C~C~~~g~~~~v~C~~~~L~~iP~~l--~~~L~~L~Ls~N~L~~l~~~~f~~~-----------------------~L~ 75 (767)
.|.|.|.- ..+.|..+.+..+|+.+ .+.|++|+|..|.|..+++..|... .+.
T Consensus 282 ri~~~~~L--~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~ 359 (1081)
T KOG0618|consen 282 RISRITSL--VSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHA 359 (1081)
T ss_pred HHhhhhhH--HHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhH
Confidence 45565532 45777788888888866 5789999999999998887555421 123
Q ss_pred CccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEecc
Q psy12044 76 NLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELS 155 (767)
Q Consensus 76 ~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls 155 (767)
.|+.|++.+|.|+.-.-..|.++.+|+.|+|+.|+|..++...+.++..|+.|+||+|+++.++ ..+..+..|++|...
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp-~tva~~~~L~tL~ah 438 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLP-DTVANLGRLHTLRAH 438 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhh-HHHHhhhhhHHHhhc
Confidence 4677899999999877777999999999999999999999999999999999999999999998 578889999999999
Q ss_pred CCCccccchhhhcCCCCCCeeeccCCccccccCCCCCC-CCcccccCCCCCC
Q psy12044 156 KCGIEVIEDAAFVGLDSLEWLKLDNNKITTISGSNILP-TGLHGIDLHHNPW 206 (767)
Q Consensus 156 ~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~~~~~-~~L~~L~Ls~N~l 206 (767)
+|.|...+ .+..++.|+.|||+.|+|+.+--....+ ++|++|||+||.+
T Consensus 439 sN~l~~fP--e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 439 SNQLLSFP--ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred CCceeech--hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 99999887 5788999999999999999654333334 8999999999996
No 15
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.27 E-value=1.2e-11 Score=147.40 Aligned_cols=161 Identities=19% Similarity=0.313 Sum_probs=127.4
Q ss_pred CeeEEEecCCCccccccCCCCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccC
Q psy12044 29 GKQTVECVNKSLITVVEGMDPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSH 108 (767)
Q Consensus 29 ~~~~v~C~~~~L~~iP~~l~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~ 108 (767)
....+.+++.+++.+|..++++++.|+|++|.|+.++...+ .+|+.|+|++|+|+.+ |..+. .+|+.|+|++
T Consensus 179 ~~~~L~L~~~~LtsLP~~Ip~~L~~L~Ls~N~LtsLP~~l~-----~nL~~L~Ls~N~LtsL-P~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 179 NKTELRLKILGLTTIPACIPEQITTLILDNNELKSLPENLQ-----GNIKTLYANSNQLTSI-PATLP--DTIQEMELSI 250 (754)
T ss_pred CceEEEeCCCCcCcCCcccccCCcEEEecCCCCCcCChhhc-----cCCCEEECCCCccccC-Chhhh--ccccEEECcC
Confidence 35678888899999999999999999999999999876543 4899999999999976 43332 4799999999
Q ss_pred CCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccccccC
Q psy12044 109 NVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISG 188 (767)
Q Consensus 109 N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~ 188 (767)
|.|+.++.. +. .+|+.|+|++|+|+.++.. +. .+|+.|+|++|+|+.++.. + ..+|+.|+|++|+|+.+|.
T Consensus 251 N~L~~LP~~-l~--s~L~~L~Ls~N~L~~LP~~-l~--~sL~~L~Ls~N~Lt~LP~~-l--p~sL~~L~Ls~N~Lt~LP~ 321 (754)
T PRK15370 251 NRITELPER-LP--SALQSLDLFHNKISCLPEN-LP--EELRYLSVYDNSIRTLPAH-L--PSGITHLNVQSNSLTALPE 321 (754)
T ss_pred CccCcCChh-Hh--CCCCEEECcCCccCccccc-cC--CCCcEEECCCCccccCccc-c--hhhHHHHHhcCCccccCCc
Confidence 999977543 32 5799999999999977543 32 5799999999999987643 2 2468888888888888775
Q ss_pred CCCCCCCcccccCCCCCCCc
Q psy12044 189 SNILPTGLHGIDLHHNPWTC 208 (767)
Q Consensus 189 ~~~~~~~L~~L~Ls~N~l~C 208 (767)
.. +.+|+.|++++|.+.+
T Consensus 322 ~l--~~sL~~L~Ls~N~Lt~ 339 (754)
T PRK15370 322 TL--PPGLKTLEAGENALTS 339 (754)
T ss_pred cc--cccceeccccCCcccc
Confidence 43 3578888888888764
No 16
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.24 E-value=1.4e-11 Score=146.71 Aligned_cols=159 Identities=23% Similarity=0.320 Sum_probs=109.7
Q ss_pred eeEEEecCCCccccccCCCCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCC
Q psy12044 30 KQTVECVNKSLITVVEGMDPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHN 109 (767)
Q Consensus 30 ~~~v~C~~~~L~~iP~~l~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N 109 (767)
-..++++++.+..+|..+..+|+.|+|++|.|+.++.... .+|+.|+|++|.|..+ |..+. .+|+.|+|++|
T Consensus 201 L~~L~Ls~N~LtsLP~~l~~nL~~L~Ls~N~LtsLP~~l~-----~~L~~L~Ls~N~L~~L-P~~l~--s~L~~L~Ls~N 272 (754)
T PRK15370 201 ITTLILDNNELKSLPENLQGNIKTLYANSNQLTSIPATLP-----DTIQEMELSINRITEL-PERLP--SALQSLDLFHN 272 (754)
T ss_pred CcEEEecCCCCCcCChhhccCCCEEECCCCccccCChhhh-----ccccEEECcCCccCcC-ChhHh--CCCCEEECcCC
Confidence 3567888889999998888899999999999998765432 4688899999988865 44343 47888899888
Q ss_pred CCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccccccCC
Q psy12044 110 VLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISGS 189 (767)
Q Consensus 110 ~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~ 189 (767)
+|+.++. .+. .+|+.|+|++|+|+.++.. + ..+|+.|+|++|.|+.++... .++|+.|++++|.|+.+|..
T Consensus 273 ~L~~LP~-~l~--~sL~~L~Ls~N~Lt~LP~~-l--p~sL~~L~Ls~N~Lt~LP~~l---~~sL~~L~Ls~N~Lt~LP~~ 343 (754)
T PRK15370 273 KISCLPE-NLP--EELRYLSVYDNSIRTLPAH-L--PSGITHLNVQSNSLTALPETL---PPGLKTLEAGENALTSLPAS 343 (754)
T ss_pred ccCcccc-ccC--CCCcEEECCCCccccCccc-c--hhhHHHHHhcCCccccCCccc---cccceeccccCCccccCChh
Confidence 8887653 332 4788888888888876542 2 135666667777666554321 24566666666666666543
Q ss_pred CCCCCCcccccCCCCCCC
Q psy12044 190 NILPTGLHGIDLHHNPWT 207 (767)
Q Consensus 190 ~~~~~~L~~L~Ls~N~l~ 207 (767)
+ +++|+.|+|++|.+.
T Consensus 344 l--~~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 344 L--PPELQVLDVSKNQIT 359 (754)
T ss_pred h--cCcccEEECCCCCCC
Confidence 3 245666666666554
No 17
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.23 E-value=1.9e-11 Score=144.97 Aligned_cols=158 Identities=21% Similarity=0.223 Sum_probs=96.7
Q ss_pred EEEecCCCccccccCCCCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCC
Q psy12044 32 TVECVNKSLITVVEGMDPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVL 111 (767)
Q Consensus 32 ~v~C~~~~L~~iP~~l~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~L 111 (767)
.+++.++.+..+|. .+++|+.|+|++|+|++++.. ..+|+.|++++|.|+.+. . + ..+|+.|+|++|+|
T Consensus 286 ~L~Ls~N~Lt~LP~-~p~~L~~LdLS~N~L~~Lp~l------p~~L~~L~Ls~N~L~~LP-~-l--p~~Lq~LdLS~N~L 354 (788)
T PRK15387 286 KLWIFGNQLTSLPV-LPPGLQELSVSDNQLASLPAL------PSELCKLWAYNNQLTSLP-T-L--PSGLQELSVSDNQL 354 (788)
T ss_pred EEECcCCccccccc-cccccceeECCCCccccCCCC------cccccccccccCcccccc-c-c--ccccceEecCCCcc
Confidence 45666777777775 456788888888888876531 123444444444444432 1 0 12444555555554
Q ss_pred CCCCCCCCC-----------------CCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCC
Q psy12044 112 QTVPSDTFP-----------------DYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLE 174 (767)
Q Consensus 112 t~l~p~~f~-----------------~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~ 174 (767)
+.+++. .. ...+|+.|+|++|.|+.++.. ..+|+.|+|++|.|+.++. . ..+|+
T Consensus 355 s~LP~l-p~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~LP~l----~s~L~~LdLS~N~LssIP~-l---~~~L~ 425 (788)
T PRK15387 355 ASLPTL-PSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVL----PSELKELMVSGNRLTSLPM-L---PSGLL 425 (788)
T ss_pred CCCCCC-CcccceehhhccccccCcccccccceEEecCCcccCCCCc----ccCCCEEEccCCcCCCCCc-c---hhhhh
Confidence 443321 10 123566777777777765431 2467777777777776543 1 24577
Q ss_pred eeeccCCccccccCCCCCCCCcccccCCCCCCCch
Q psy12044 175 WLKLDNNKITTISGSNILPTGLHGIDLHHNPWTCD 209 (767)
Q Consensus 175 ~L~Ls~N~Lt~ip~~~~~~~~L~~L~Ls~N~l~C~ 209 (767)
.|+|++|+|+.||..+..+.+|..|+|++|+|++.
T Consensus 426 ~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 426 SLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSER 460 (788)
T ss_pred hhhhccCcccccChHHhhccCCCeEECCCCCCCch
Confidence 78888888888887777777888888888888753
No 18
>PLN03150 hypothetical protein; Provisional
Probab=99.20 E-value=5.9e-11 Score=140.24 Aligned_cols=110 Identities=18% Similarity=0.208 Sum_probs=85.0
Q ss_pred CCCEEEccCCCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeecc
Q psy12044 100 NLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLD 179 (767)
Q Consensus 100 ~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls 179 (767)
.++.|+|++|.+++..|..|..+++|+.|+|++|.|++..+..+..+++|+.|+|++|+|++.+|..+..+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36778888888888888888888888888888888888777778888888888888888888888888888888888888
Q ss_pred CCccc-cccCCCCC-CCCcccccCCCCCCCch
Q psy12044 180 NNKIT-TISGSNIL-PTGLHGIDLHHNPWTCD 209 (767)
Q Consensus 180 ~N~Lt-~ip~~~~~-~~~L~~L~Ls~N~l~C~ 209 (767)
+|+|+ .+|..+.. ..++..+++.+|+..|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~ 530 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccC
Confidence 88887 45544332 23455677888877653
No 19
>KOG0618|consensus
Probab=99.05 E-value=8.7e-12 Score=144.21 Aligned_cols=164 Identities=26% Similarity=0.287 Sum_probs=115.2
Q ss_pred CCCCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccC----------------------cccccCCCCCCE
Q psy12044 46 GMDPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVID----------------------SKAFRGLTNLVD 103 (767)
Q Consensus 46 ~l~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~----------------------p~~f~~L~~L~~ 103 (767)
..+.+++++++++|+++.++ .+... +.+|+.|.+.+|+|..+. |....+++.|++
T Consensus 238 p~p~nl~~~dis~n~l~~lp-~wi~~--~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~t 314 (1081)
T KOG0618|consen 238 PVPLNLQYLDISHNNLSNLP-EWIGA--CANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRT 314 (1081)
T ss_pred cccccceeeecchhhhhcch-HHHHh--cccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeee
Confidence 33567777888888777777 55543 677777777777664332 333455677777
Q ss_pred EEccCCCCCCCCCCCCCC-------------------------CCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCC
Q psy12044 104 LDFSHNVLQTVPSDTFPD-------------------------YPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCG 158 (767)
Q Consensus 104 L~Ls~N~Lt~l~p~~f~~-------------------------l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~ 158 (767)
|+|..|+|..+++..|.- ++.|+.|+|.+|.++.-.-..+.+..+|+.|+|++|.
T Consensus 315 LdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNr 394 (1081)
T KOG0618|consen 315 LDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNR 394 (1081)
T ss_pred eeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccc
Confidence 777777776665432221 2235556666666665554556677888888888888
Q ss_pred ccccchhhhcCCCCCCeeeccCCccccccCCCCCCCCcccccCCCCCCCchhhh
Q psy12044 159 IEVIEDAAFVGLDSLEWLKLDNNKITTISGSNILPTGLHGIDLHHNPWTCDCLL 212 (767)
Q Consensus 159 L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~~~~~~~L~~L~Ls~N~l~C~c~l 212 (767)
|..++...+.++..|+.|+||+|+|+.||..+..+..|++|...+|.+.|.-.+
T Consensus 395 L~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fPe~ 448 (1081)
T KOG0618|consen 395 LNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFPEL 448 (1081)
T ss_pred cccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCceeechhh
Confidence 888888888888888888888888888887777778888888888888876543
No 20
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=98.99 E-value=2e-10 Score=113.34 Aligned_cols=106 Identities=26% Similarity=0.382 Sum_probs=23.5
Q ss_pred CccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEE
Q psy12044 50 NTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLT 129 (767)
Q Consensus 50 ~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~ 129 (767)
.+++|+|++|.|+.+..-.. .+.+|+.|+|++|.|+.+. .|..++.|++|+|++|+|+.+.+.....+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~~Ie~L~~---~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTIENLGA---TLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY 94 (175)
T ss_dssp ----------------S--T---T-TT--EEE-TTS--S--T--T----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccccchhh---hhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence 34555555555554432111 1345555555555555543 244455555555555555544321112344555555
Q ss_pred CCCCcCccccc-CCcCCCCCccEEeccCCCcc
Q psy12044 130 LSGNPIKQIKT-GAFQPLSYLVTLELSKCGIE 160 (767)
Q Consensus 130 Ls~N~l~~l~~-~~~~~l~~L~~L~Ls~N~L~ 160 (767)
|++|+|..+.. ..+..+++|+.|+|.+|.++
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 55555544322 12333444444454444444
No 21
>PLN03150 hypothetical protein; Provisional
Probab=98.97 E-value=1.3e-09 Score=129.06 Aligned_cols=106 Identities=18% Similarity=0.121 Sum_probs=57.9
Q ss_pred cEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCC
Q psy12044 78 QKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKC 157 (767)
Q Consensus 78 ~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N 157 (767)
+.|+|++|.|.+..|..|..+++|+.|+|++|.|++.+|..+..+++|+.|+|++|.+++..|..+..+++|+.|+|++|
T Consensus 421 ~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N 500 (623)
T PLN03150 421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500 (623)
T ss_pred EEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCC
Confidence 34444444444444445555555555555555555555555555555555555555555555555555555555666666
Q ss_pred CccccchhhhcCC-CCCCeeeccCCcc
Q psy12044 158 GIEVIEDAAFVGL-DSLEWLKLDNNKI 183 (767)
Q Consensus 158 ~L~~i~~~~~~~l-~~L~~L~Ls~N~L 183 (767)
.|++..|..+..+ .++..+++.+|..
T Consensus 501 ~l~g~iP~~l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 501 SLSGRVPAALGGRLLHRASFNFTDNAG 527 (623)
T ss_pred cccccCChHHhhccccCceEEecCCcc
Confidence 5555555554432 3456677777754
No 22
>KOG0532|consensus
Probab=98.90 E-value=6.5e-11 Score=130.78 Aligned_cols=165 Identities=25% Similarity=0.301 Sum_probs=86.9
Q ss_pred EEecCCCccccccCC----CCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccC
Q psy12044 33 VECVNKSLITVVEGM----DPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSH 108 (767)
Q Consensus 33 v~C~~~~L~~iP~~l----~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~ 108 (767)
+..+++.+..+|.+- .......||+.|++..++..... +..|+.|.|..|.|..+ |.++.++..|.+|+|+.
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~elp~~~~~---f~~Le~liLy~n~~r~i-p~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSELPEEACA---FVSLESLILYHNCIRTI-PEAICNLEALTFLDLSS 130 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhccccccccCchHHHH---HHHHHHHHHHhccceec-chhhhhhhHHHHhhhcc
Confidence 445566666666533 23345667777777776655443 34555555666655554 34455666666666666
Q ss_pred CCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccccccC
Q psy12044 109 NVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISG 188 (767)
Q Consensus 109 N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~ 188 (767)
|+++.++.. +..|+ |+.|.+++|+++.++. .++.+.+|..||.+.|.|..+++. +..+.+|+.|++..|++..+|+
T Consensus 131 NqlS~lp~~-lC~lp-Lkvli~sNNkl~~lp~-~ig~~~tl~~ld~s~nei~slpsq-l~~l~slr~l~vrRn~l~~lp~ 206 (722)
T KOG0532|consen 131 NQLSHLPDG-LCDLP-LKVLIVSNNKLTSLPE-EIGLLPTLAHLDVSKNEIQSLPSQ-LGYLTSLRDLNVRRNHLEDLPE 206 (722)
T ss_pred chhhcCChh-hhcCc-ceeEEEecCccccCCc-ccccchhHHHhhhhhhhhhhchHH-hhhHHHHHHHHHhhhhhhhCCH
Confidence 666655533 33332 5556666666655544 234455555555555555554442 4444444444444444444444
Q ss_pred CCCCCCCcccccCCCCCC
Q psy12044 189 SNILPTGLHGIDLHHNPW 206 (767)
Q Consensus 189 ~~~~~~~L~~L~Ls~N~l 206 (767)
+.. .-.|..||++.|.+
T Consensus 207 El~-~LpLi~lDfScNki 223 (722)
T KOG0532|consen 207 ELC-SLPLIRLDFSCNKI 223 (722)
T ss_pred HHh-CCceeeeecccCce
Confidence 433 22344444444444
No 23
>KOG1259|consensus
Probab=98.87 E-value=2.8e-10 Score=116.93 Aligned_cols=132 Identities=27% Similarity=0.288 Sum_probs=110.2
Q ss_pred CCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEe
Q psy12044 74 LVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLE 153 (767)
Q Consensus 74 L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 153 (767)
...|+.|+|++|.|+.+. .+..-+++++.|+++.|.|..+. .+..+++|+.|+||+|.++.+.. .-..+-++++|+
T Consensus 283 Wq~LtelDLS~N~I~~iD-ESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls~~~G-wh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLITQID-ESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLAECVG-WHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchhhhh-hhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhHhhhh-hHhhhcCEeeee
Confidence 456899999999999885 45777899999999999999886 38889999999999999987754 234578899999
Q ss_pred ccCCCccccchhhhcCCCCCCeeeccCCcccccc--CCCCCCCCcccccCCCCCCCchhh
Q psy12044 154 LSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTIS--GSNILPTGLHGIDLHHNPWTCDCL 211 (767)
Q Consensus 154 Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip--~~~~~~~~L~~L~Ls~N~l~C~c~ 211 (767)
|+.|.|..+. .+..+-+|..||+++|+|..+. ..++.++.|..|.|.+||+....+
T Consensus 359 La~N~iE~LS--GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 359 LAQNKIETLS--GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhhHhhhh--hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 9999988764 3667888999999999998665 456788999999999999986443
No 24
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=98.86 E-value=1.9e-09 Score=106.37 Aligned_cols=111 Identities=27% Similarity=0.313 Sum_probs=35.0
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCCCC-CCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCC
Q psy12044 95 FRGLTNLVDLDFSHNVLQTVPSDTFP-DYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSL 173 (767)
Q Consensus 95 f~~L~~L~~L~Ls~N~Lt~l~p~~f~-~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L 173 (767)
+.+..++++|+|++|.|+.+. .++ .+.+|+.|+|++|.|+.+.. +..++.|+.|+|++|.|+.+.......+++|
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l~~--l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L 90 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKLEG--LPGLPRLKTLDLSNNRISSISEGLDKNLPNL 90 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S--TT------TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred ccccccccccccccccccccc--chhhhhcCCCEEECCCCCCccccC--ccChhhhhhcccCCCCCCccccchHHhCCcC
Confidence 334456677777777776653 243 45677777777777776643 5667777777777777777654322356777
Q ss_pred CeeeccCCccccccCC--CCCCCCcccccCCCCCCCch
Q psy12044 174 EWLKLDNNKITTISGS--NILPTGLHGIDLHHNPWTCD 209 (767)
Q Consensus 174 ~~L~Ls~N~Lt~ip~~--~~~~~~L~~L~Ls~N~l~C~ 209 (767)
+.|+|++|+|..+..- +..+++|+.|+|.+||+.-.
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~ 128 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK 128 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch
Confidence 7777777777765432 22457788888888887533
No 25
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=98.85 E-value=7.7e-10 Score=119.74 Aligned_cols=157 Identities=24% Similarity=0.242 Sum_probs=91.2
Q ss_pred CCccEEEeeCCCCCCCC------chhhhccCCCCccEEEccCCCCCccCcccccCCCC---CCEEEccCCCCCC----CC
Q psy12044 49 PNTQVLDYTGNNLKTLH------NEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTN---LVDLDFSHNVLQT----VP 115 (767)
Q Consensus 49 ~~L~~L~Ls~N~L~~l~------~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~---L~~L~Ls~N~Lt~----l~ 115 (767)
++++.|+++++.+.+.. ...+.. +.+|+.|+|++|.+....+..|..+.+ |++|+|++|.++. ..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~--~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l 128 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTK--GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLL 128 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHh--cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHH
Confidence 44777777777665311 123332 567777777777776555555554444 7777777777663 11
Q ss_pred CCCCCCC-CCCcEEECCCCcCcccc----cCCcCCCCCccEEeccCCCcccc----chhhhcCCCCCCeeeccCCccccc
Q psy12044 116 SDTFPDY-PSLMKLTLSGNPIKQIK----TGAFQPLSYLVTLELSKCGIEVI----EDAAFVGLDSLEWLKLDNNKITTI 186 (767)
Q Consensus 116 p~~f~~l-~~L~~L~Ls~N~l~~l~----~~~~~~l~~L~~L~Ls~N~L~~i----~~~~~~~l~~L~~L~Ls~N~Lt~i 186 (767)
...+..+ ++|+.|+|++|.+++.. ...+..+.+|+.|+|++|.+++. ....+..+++|+.|+|++|.++..
T Consensus 129 ~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 208 (319)
T cd00116 129 AKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE 208 (319)
T ss_pred HHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH
Confidence 1233444 67777777777776321 22344556677777777777632 122344456777777777776532
Q ss_pred c-----CCCCCCCCcccccCCCCCCC
Q psy12044 187 S-----GSNILPTGLHGIDLHHNPWT 207 (767)
Q Consensus 187 p-----~~~~~~~~L~~L~Ls~N~l~ 207 (767)
. ..+...++|+.|++++|++.
T Consensus 209 ~~~~l~~~~~~~~~L~~L~ls~n~l~ 234 (319)
T cd00116 209 GASALAETLASLKSLEVLNLGDNNLT 234 (319)
T ss_pred HHHHHHHHhcccCCCCEEecCCCcCc
Confidence 2 22223456777777777665
No 26
>KOG0532|consensus
Probab=98.84 E-value=1.5e-10 Score=128.04 Aligned_cols=169 Identities=21% Similarity=0.222 Sum_probs=146.4
Q ss_pred eEEEecCCCccccccCC--CCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccC
Q psy12044 31 QTVECVNKSLITVVEGM--DPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSH 108 (767)
Q Consensus 31 ~~v~C~~~~L~~iP~~l--~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~ 108 (767)
..++.+.+.+..+|..+ +..|..|.|.+|.|..++..... |..|+.|+|+.|+++.+... +..|+ |+.|-+++
T Consensus 78 ~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r~ip~~i~~---L~~lt~l~ls~NqlS~lp~~-lC~lp-Lkvli~sN 152 (722)
T KOG0532|consen 78 VFADLSRNRFSELPEEACAFVSLESLILYHNCIRTIPEAICN---LEALTFLDLSSNQLSHLPDG-LCDLP-LKVLIVSN 152 (722)
T ss_pred hhhhccccccccCchHHHHHHHHHHHHHHhccceecchhhhh---hhHHHHhhhccchhhcCChh-hhcCc-ceeEEEec
Confidence 45777888888898876 67899999999999988876654 88999999999999988544 55555 89999999
Q ss_pred CCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccccccC
Q psy12044 109 NVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISG 188 (767)
Q Consensus 109 N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~ 188 (767)
|+++.++++ ++.+..|..|+.+.|.|..+++ .++.+.+|+.|++..|++..++++ +.. -.|..||+|.|+++.||.
T Consensus 153 Nkl~~lp~~-ig~~~tl~~ld~s~nei~slps-ql~~l~slr~l~vrRn~l~~lp~E-l~~-LpLi~lDfScNkis~iPv 228 (722)
T KOG0532|consen 153 NKLTSLPEE-IGLLPTLAHLDVSKNEIQSLPS-QLGYLTSLRDLNVRRNHLEDLPEE-LCS-LPLIRLDFSCNKISYLPV 228 (722)
T ss_pred CccccCCcc-cccchhHHHhhhhhhhhhhchH-HhhhHHHHHHHHHhhhhhhhCCHH-HhC-CceeeeecccCceeecch
Confidence 999988754 6788999999999999999876 688899999999999999999876 444 458899999999999999
Q ss_pred CCCCCCCcccccCCCCCCCc
Q psy12044 189 SNILPTGLHGIDLHHNPWTC 208 (767)
Q Consensus 189 ~~~~~~~L~~L~Ls~N~l~C 208 (767)
.+-.+..|+.|-|.+||+..
T Consensus 229 ~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 229 DFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred hhhhhhhheeeeeccCCCCC
Confidence 99999999999999999973
No 27
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=98.81 E-value=1.3e-09 Score=117.86 Aligned_cols=159 Identities=23% Similarity=0.266 Sum_probs=113.4
Q ss_pred CCCccEEEeeCCCCCCCCchhhhccCCCC---ccEEEccCCCCCc----cCcccccCC-CCCCEEEccCCCCCCCC----
Q psy12044 48 DPNTQVLDYTGNNLKTLHNEKFQKMGLVN---LQKIYLSRCRISV----IDSKAFRGL-TNLVDLDFSHNVLQTVP---- 115 (767)
Q Consensus 48 ~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~---L~~L~Ls~N~L~~----i~p~~f~~L-~~L~~L~Ls~N~Lt~l~---- 115 (767)
.++|+.|+|++|.+.......+.. +.+ |+.|+|++|.++. .....+..+ ++|+.|+|++|.+++..
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~--l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~ 157 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLES--LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEAL 157 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHH--HhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHH
Confidence 468999999999998766655553 444 9999999998884 223455666 88999999999988422
Q ss_pred CCCCCCCCCCcEEECCCCcCcccc----cCCcCCCCCccEEeccCCCccccch----hhhcCCCCCCeeeccCCcccccc
Q psy12044 116 SDTFPDYPSLMKLTLSGNPIKQIK----TGAFQPLSYLVTLELSKCGIEVIED----AAFVGLDSLEWLKLDNNKITTIS 187 (767)
Q Consensus 116 p~~f~~l~~L~~L~Ls~N~l~~l~----~~~~~~l~~L~~L~Ls~N~L~~i~~----~~~~~l~~L~~L~Ls~N~Lt~ip 187 (767)
...+..+.+|+.|+|++|.+++.. ...+..+++|+.|+|++|.+++... ..+..+++|+.|++++|.++...
T Consensus 158 ~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~ 237 (319)
T cd00116 158 AKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAG 237 (319)
T ss_pred HHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHH
Confidence 234566778999999999887421 2234455789999999998875533 34556788999999999887421
Q ss_pred C-----CCC-CCCCcccccCCCCCCCc
Q psy12044 188 G-----SNI-LPTGLHGIDLHHNPWTC 208 (767)
Q Consensus 188 ~-----~~~-~~~~L~~L~Ls~N~l~C 208 (767)
. ... ....|+.|++++|.+..
T Consensus 238 ~~~l~~~~~~~~~~L~~L~l~~n~i~~ 264 (319)
T cd00116 238 AAALASALLSPNISLLTLSLSCNDITD 264 (319)
T ss_pred HHHHHHHHhccCCCceEEEccCCCCCc
Confidence 1 110 13678899999998863
No 28
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=98.75 E-value=5.6e-08 Score=123.07 Aligned_cols=148 Identities=21% Similarity=0.312 Sum_probs=76.6
Q ss_pred CCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcE
Q psy12044 48 DPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMK 127 (767)
Q Consensus 48 ~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~ 127 (767)
+.+|+.|.+.++.+..++.. |. +.+|+.|+|.+|+|..+ +..+..+++|+.|+|++|......|. +..+++|+.
T Consensus 588 p~~Lr~L~~~~~~l~~lP~~-f~---~~~L~~L~L~~s~l~~L-~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~ 661 (1153)
T PLN03210 588 PPKLRLLRWDKYPLRCMPSN-FR---PENLVKLQMQGSKLEKL-WDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLET 661 (1153)
T ss_pred CcccEEEEecCCCCCCCCCc-CC---ccCCcEEECcCcccccc-ccccccCCCCCEEECCCCCCcCcCCc-cccCCcccE
Confidence 44566666666666555443 22 45666666666665544 33455566666666665542222222 555666666
Q ss_pred EECCCCcCcccccCCcCCCCCccEEeccCC-CccccchhhhcCCCCCCeeeccCCcc-ccccCCCCCCCCcccccCCCCC
Q psy12044 128 LTLSGNPIKQIKTGAFQPLSYLVTLELSKC-GIEVIEDAAFVGLDSLEWLKLDNNKI-TTISGSNILPTGLHGIDLHHNP 205 (767)
Q Consensus 128 L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N-~L~~i~~~~~~~l~~L~~L~Ls~N~L-t~ip~~~~~~~~L~~L~Ls~N~ 205 (767)
|+|++|......|..+..+.+|+.|+|++| .++.++. .+ ++.+|+.|+|++|.. ..+|. ...+|+.|+|++|.
T Consensus 662 L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~-~i-~l~sL~~L~Lsgc~~L~~~p~---~~~nL~~L~L~~n~ 736 (1153)
T PLN03210 662 LKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT-GI-NLKSLYRLNLSGCSRLKSFPD---ISTNISWLDLDETA 736 (1153)
T ss_pred EEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCC-cC-CCCCCCEEeCCCCCCcccccc---ccCCcCeeecCCCc
Confidence 666665443334445556666666666654 3333332 12 455666666665532 23332 12345555555555
Q ss_pred C
Q psy12044 206 W 206 (767)
Q Consensus 206 l 206 (767)
+
T Consensus 737 i 737 (1153)
T PLN03210 737 I 737 (1153)
T ss_pred c
Confidence 3
No 29
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=98.75 E-value=6.5e-08 Score=122.46 Aligned_cols=98 Identities=18% Similarity=0.130 Sum_probs=56.9
Q ss_pred EEEecCCCccccccCC-CCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCC
Q psy12044 32 TVECVNKSLITVVEGM-DPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNV 110 (767)
Q Consensus 32 ~v~C~~~~L~~iP~~l-~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~ 110 (767)
.+...+..+..+|..+ +.+|+.|+|++|.|..++... . .+++|+.|+|++|.....+|. +..+++|+.|+|++|.
T Consensus 593 ~L~~~~~~l~~lP~~f~~~~L~~L~L~~s~l~~L~~~~-~--~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~ 668 (1153)
T PLN03210 593 LLRWDKYPLRCMPSNFRPENLVKLQMQGSKLEKLWDGV-H--SLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCS 668 (1153)
T ss_pred EEEecCCCCCCCCCcCCccCCcEEECcCcccccccccc-c--cCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCC
Confidence 3455555666677655 567777777777776665433 2 266677777766543333332 5556666666666654
Q ss_pred CCCCCCCCCCCCCCCcEEECCCC
Q psy12044 111 LQTVPSDTFPDYPSLMKLTLSGN 133 (767)
Q Consensus 111 Lt~l~p~~f~~l~~L~~L~Ls~N 133 (767)
.....|..+..+++|+.|+|++|
T Consensus 669 ~L~~lp~si~~L~~L~~L~L~~c 691 (1153)
T PLN03210 669 SLVELPSSIQYLNKLEDLDMSRC 691 (1153)
T ss_pred CccccchhhhccCCCCEEeCCCC
Confidence 33334455556666666666654
No 30
>KOG1259|consensus
Probab=98.73 E-value=2e-09 Score=110.85 Aligned_cols=137 Identities=25% Similarity=0.246 Sum_probs=103.1
Q ss_pred ccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCC
Q psy12044 93 KAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDS 172 (767)
Q Consensus 93 ~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~ 172 (767)
..+..+..|++|||++|.|+.+. ++..-++.++.|++|.|.|..+.. +..+++|+.|||++|.++.+.... ..+-+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~~iD-ESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls~~~Gwh-~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLITQID-ESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLAECVGWH-LKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchhhhh-hhhhhccceeEEeccccceeeehh--hhhcccceEeecccchhHhhhhhH-hhhcC
Confidence 34455678999999999999887 456667999999999999998865 788999999999999998876543 34788
Q ss_pred CCeeeccCCccccccCCCCCCCCcccccCCCCCCCchhhhhhhhhhhccCCCCCccCCCCCCCCCCCCCccccc
Q psy12044 173 LEWLKLDNNKITTISGSNILPTGLHGIDLHHNPWTCDCLLIGLRRWLESTKTPMAIDPICSVPPRLSSVTIKQL 246 (767)
Q Consensus 173 L~~L~Ls~N~Lt~ip~~~~~~~~L~~L~Ls~N~l~C~c~l~~l~~~l~~~~~~~~~~~~C~~p~~l~g~~i~~l 246 (767)
++.|.|+.|.|.++..- ..+-+|..||+++|++.---. ........|-.-..+.++++..+
T Consensus 354 IKtL~La~N~iE~LSGL-~KLYSLvnLDl~~N~Ie~lde------------V~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 354 IKTLKLAQNKIETLSGL-RKLYSLVNLDLSSNQIEELDE------------VNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred EeeeehhhhhHhhhhhh-HhhhhheeccccccchhhHHH------------hcccccccHHHHHhhcCCCcccc
Confidence 99999999999877642 345678899999999852111 11124455665556666666553
No 31
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.69 E-value=1.6e-08 Score=82.13 Aligned_cols=59 Identities=37% Similarity=0.540 Sum_probs=29.1
Q ss_pred CCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCc
Q psy12044 124 SLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNK 182 (767)
Q Consensus 124 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~ 182 (767)
+|+.|+|++|+|+.+++..|.++++|+.|+|++|.|+.+++.+|.++++|+.|+|++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444444444444444555555555555554444445555555555555544
No 32
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=98.67 E-value=1.4e-08 Score=113.79 Aligned_cols=151 Identities=33% Similarity=0.416 Sum_probs=75.6
Q ss_pred CccEEEeeCCCCCCCCchhhhccCCC-CccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEE
Q psy12044 50 NTQVLDYTGNNLKTLHNEKFQKMGLV-NLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKL 128 (767)
Q Consensus 50 ~L~~L~Ls~N~L~~l~~~~f~~~~L~-~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L 128 (767)
.++.|++.+|.++.+++.... +. +|+.|++++|.+..+. ..+..+++|+.|++++|.++.+++. ...++.|+.|
T Consensus 117 ~l~~L~l~~n~i~~i~~~~~~---~~~nL~~L~l~~N~i~~l~-~~~~~l~~L~~L~l~~N~l~~l~~~-~~~~~~L~~L 191 (394)
T COG4886 117 NLTSLDLDNNNITDIPPLIGL---LKSNLKELDLSDNKIESLP-SPLRNLPNLKNLDLSFNDLSDLPKL-LSNLSNLNNL 191 (394)
T ss_pred ceeEEecCCcccccCcccccc---chhhcccccccccchhhhh-hhhhccccccccccCCchhhhhhhh-hhhhhhhhhe
Confidence 355555555555555443322 21 4555555555555442 2244555555555555555554432 1134455555
Q ss_pred ECCCCcCcccccC----------------------CcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccccc
Q psy12044 129 TLSGNPIKQIKTG----------------------AFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTI 186 (767)
Q Consensus 129 ~Ls~N~l~~l~~~----------------------~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~i 186 (767)
++++|+++.++.. .+..+.++..|.+.+|.+..+ +..+..+.+|+.|++++|.++.+
T Consensus 192 ~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~~i 270 (394)
T COG4886 192 DLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQISSI 270 (394)
T ss_pred eccCCccccCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeec-cchhccccccceecccccccccc
Confidence 5555555544432 233444444444555544443 22345555666666666666666
Q ss_pred cCCCCCCCCcccccCCCCCCC
Q psy12044 187 SGSNILPTGLHGIDLHHNPWT 207 (767)
Q Consensus 187 p~~~~~~~~L~~L~Ls~N~l~ 207 (767)
+. +....+++.|++++|.+.
T Consensus 271 ~~-~~~~~~l~~L~~s~n~~~ 290 (394)
T COG4886 271 SS-LGSLTNLRELDLSGNSLS 290 (394)
T ss_pred cc-ccccCccCEEeccCcccc
Confidence 55 444456666666666554
No 33
>cd05762 Ig8_MLCK Eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). Ig8_MLCK: the eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). MLCK is a key regulator of different forms of cell motility involving actin and myosin II. Agonist stimulation of smooth muscle cells increases cytosolic Ca2+, which binds calmodulin. This Ca2+-calmodulin complex in turn binds to and activates MLCK. Activated MLCK leads to the phosphorylation of the 20 kDa myosin regulatory light chain (RLC) of myosin II and the stimulation of actin-activated myosin MgATPase activity. MLCK is widely present in vertebrate tissues; it phosphorylates the 20 kDa RLC of both smooth and nonmuscle myosin II. Phosphorylation leads to the activation of the myosin motor domain and altered structural properties of myosin II. In smooth muscle MLCK it is involved in initiating contraction. In nonmuscle cells, MLCK may participate in cell division and cell motility; it has
Probab=98.57 E-value=1e-07 Score=85.36 Aligned_cols=91 Identities=22% Similarity=0.333 Sum_probs=71.7
Q ss_pred CCccceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEe
Q psy12044 259 PSTFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCV 338 (767)
Q Consensus 259 ~~~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~Cv 338 (767)
..+....+..|+.+.|.|.+.|.|.+.+.|.+++..+..... +.... ....+.|.|.++..+|.|.|+|.
T Consensus 5 ~~p~~~~v~~G~~v~l~C~~~G~p~p~v~W~kdg~~l~~~~~-------~~~~~---~~~~s~L~I~~~~~~D~G~Ytc~ 74 (98)
T cd05762 5 QFPEDMKVRAGESVELFCKVTGTQPITCTWMKFRKQIQEGEG-------IKIEN---TENSSKLTITEGQQEHCGCYTLE 74 (98)
T ss_pred ECCcCEEEECCCEEEEEEEEcccCCCceEEEECCEEecCCCc-------EEEEe---cCCeeEEEECCCChhhCEEEEEE
Confidence 344567788999999999999999999999999988753321 11111 12346899999999999999999
Q ss_pred eccCCCCcccceEEEEEeecc
Q psy12044 339 AENQAGSTSSNYTIRIVLKEE 359 (767)
Q Consensus 339 A~N~~G~s~~s~sL~V~~~~~ 359 (767)
+.|..|...+.+.|.|..++.
T Consensus 75 a~N~~G~~~~~~~l~V~~~P~ 95 (98)
T cd05762 75 VENKLGSRQAQVNLTVVDKPD 95 (98)
T ss_pred EEcCCCceeEEEEEEEecCCC
Confidence 999999999988888776543
No 34
>cd05851 Ig3_Contactin-1 Third Ig domain of contactin-1. Ig3_Contactin-1: Third Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=98.56 E-value=9.3e-08 Score=83.73 Aligned_cols=82 Identities=24% Similarity=0.329 Sum_probs=63.4
Q ss_pred CCccceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEe
Q psy12044 259 PSTFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCV 338 (767)
Q Consensus 259 ~~~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~Cv 338 (767)
.......+..|+.+.|.|.+.|.|.|.++|.+++..+..... .. .....|.|.++..+|.|.|.|.
T Consensus 6 ~~~~~~~~~~G~~v~l~C~~~G~P~P~v~W~k~~~~~~~~~~---------~~-----~~~~~L~I~~v~~~D~G~Y~C~ 71 (88)
T cd05851 6 VKFKDTYALKGQNVTLECFALGNPVPVIRWRKILEPMPATAE---------IS-----MSGAVLKIFNIQPEDEGTYECE 71 (88)
T ss_pred EccccEEEeCCCcEEEEEEecccCCCEEEEEECCcCCCCCCE---------Ee-----cCCCEEEECcCChhhCEEEEEE
Confidence 344456778999999999999999999999998765432110 00 1124799999999999999999
Q ss_pred eccCCCCcccceEEEE
Q psy12044 339 AENQAGSTSSNYTIRI 354 (767)
Q Consensus 339 A~N~~G~s~~s~sL~V 354 (767)
|.|..|.....+.+.|
T Consensus 72 A~N~~G~~~~~~~l~V 87 (88)
T cd05851 72 AENIKGKDKHQARVYV 87 (88)
T ss_pred EEcCCCceEEEEEEEE
Confidence 9999999877766554
No 35
>KOG1187|consensus
Probab=98.54 E-value=2.3e-08 Score=110.49 Aligned_cols=69 Identities=14% Similarity=0.277 Sum_probs=58.3
Q ss_pred CCCcccHHHHHhcccCCCCCCCCccccCCCCcceEEe-eCCceEEEeccccCCCcchhhhhhhCCCCcccchhhccccc
Q psy12044 427 ESPKYTSVNATSATCMDKVNGGYIIADGHNDMMLYAT-DSGILVATNNMNTYPSYSISYQIEQNPDLVNDAESVDKDRR 504 (767)
Q Consensus 427 ~~~~fs~~El~~AT~~nnFs~~nlIG~GgfG~VYKG~-~dG~~VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~~~~ 504 (767)
..+.|+|.||++|| +||+++|+||+||||.||||. .||+.||+++....+... +.||.||++.+++.+-
T Consensus 61 ~~~~fs~~el~~AT--~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-------~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 61 PLRSFSYDELRKAT--NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-------EREFLNEVEILSRLRH 130 (361)
T ss_pred CcceeeHHHHHHHH--hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-------hhHHHHHHHHHhcCCC
Confidence 45679999999999 999999999999999999999 999999998643332221 4569999999998876
No 36
>KOG3207|consensus
Probab=98.50 E-value=3.4e-08 Score=106.76 Aligned_cols=159 Identities=25% Similarity=0.211 Sum_probs=93.3
Q ss_pred CCCccEEEeeCCCCCCCCch-hhhccCCCCccEEEccCCCCCccCccc-ccCCCCCCEEEccCCCCCCCCC-CCCCCCCC
Q psy12044 48 DPNTQVLDYTGNNLKTLHNE-KFQKMGLVNLQKIYLSRCRISVIDSKA-FRGLTNLVDLDFSHNVLQTVPS-DTFPDYPS 124 (767)
Q Consensus 48 ~~~L~~L~Ls~N~L~~l~~~-~f~~~~L~~L~~L~Ls~N~L~~i~p~~-f~~L~~L~~L~Ls~N~Lt~l~p-~~f~~l~~ 124 (767)
+++++.|||+.|-|....+- .+.. .|++|+.|+|+.|++....... -..++.|+.|.|+.|.|+.-.- .....+++
T Consensus 145 ~~~v~~LdLS~NL~~nw~~v~~i~e-qLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPs 223 (505)
T KOG3207|consen 145 LPNVRDLDLSRNLFHNWFPVLKIAE-QLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPS 223 (505)
T ss_pred CCcceeecchhhhHHhHHHHHHHHH-hcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCc
Confidence 46677777777777654432 1222 4777777777777766533221 1245677777777777663110 12234567
Q ss_pred CcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccch-hhhcCCCCCCeeeccCCccccccCC-C------CCCCCc
Q psy12044 125 LMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIED-AAFVGLDSLEWLKLDNNKITTISGS-N------ILPTGL 196 (767)
Q Consensus 125 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~-~~~~~l~~L~~L~Ls~N~Lt~ip~~-~------~~~~~L 196 (767)
|+.|+|..|....+.......+..|+.|+|++|++..... .....++.|+.|+++.+.+.+|..- . ....+|
T Consensus 224 l~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL 303 (505)
T KOG3207|consen 224 LEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKL 303 (505)
T ss_pred HHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccc
Confidence 7777777775444444444456667777777776665541 2345567777777777777654321 1 233567
Q ss_pred ccccCCCCCCC
Q psy12044 197 HGIDLHHNPWT 207 (767)
Q Consensus 197 ~~L~Ls~N~l~ 207 (767)
+.|++..|++.
T Consensus 304 ~~L~i~~N~I~ 314 (505)
T KOG3207|consen 304 EYLNISENNIR 314 (505)
T ss_pred eeeecccCccc
Confidence 77777777764
No 37
>cd05745 Ig3_Peroxidasin Third immunoglobulin (Ig)-like domain of peroxidasin. Ig3_Peroxidasin: the third immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells which have undergone programmed cell death, and protection of the organism against non-self.
Probab=98.49 E-value=1.5e-07 Score=79.36 Aligned_cols=73 Identities=25% Similarity=0.487 Sum_probs=57.8
Q ss_pred ccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcc
Q psy12044 268 EGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTS 347 (767)
Q Consensus 268 ~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~ 347 (767)
+|..+.|.|.+.+.|.|.++|.+++..+..... ... ...+.|.|.++..+|.|.|.|.|.|..|...
T Consensus 1 eG~~v~l~C~~~g~P~p~i~W~k~g~~~~~~~~-------~~~------~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~ 67 (74)
T cd05745 1 EGQTVDFLCEAQGYPQPVIAWTKGGSQLSVDRR-------HLV------LSSGTLRISRVALHDQGQYECQAVNIVGSQR 67 (74)
T ss_pred CCCeEEEEeECCEecCCEEEEEECCEECCCCCC-------eEE------ccCCeEEEeeCCHHhCEEEEEEEEeCCCcee
Confidence 478899999999999999999998876643211 111 1234799999999999999999999999987
Q ss_pred cceEEE
Q psy12044 348 SNYTIR 353 (767)
Q Consensus 348 ~s~sL~ 353 (767)
..+.+.
T Consensus 68 ~~~~L~ 73 (74)
T cd05745 68 TVAQLT 73 (74)
T ss_pred EEEEEe
Confidence 766554
No 38
>cd04975 Ig4_SCFR_like Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR) and similar proteins. Ig4_SCFR_like; fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). In addition to SCFR this group also includes the fourth Ig domain of platelet-derived growth factor receptors (PDGFR), alpha and beta, the fourth Ig domain of macrophage colony stimulating factor (M-CSF), and the Ig domain of the receptor tyrosine kinase KIT. SCFR and the PDGFR alpha and beta have similar organization: an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR, this fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth SCFR_Ig-like domain abolishes
Probab=98.48 E-value=3.8e-07 Score=82.05 Aligned_cols=89 Identities=25% Similarity=0.371 Sum_probs=67.2
Q ss_pred cceeecccccccccccccc-cCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeec
Q psy12044 262 FYLEIQEGKNVSLLCKVSA-IPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAE 340 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~a~g-~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~ 340 (767)
...++..|+.+.|.|.+.+ .|.|.+.|.+++..+...... .............++|.|..+..+|.|.|+|.|.
T Consensus 11 ~~~~v~~G~~v~L~c~v~g~~P~p~v~W~Kdg~~i~~~~~~-----~~~~~~~~~~~~~~~L~i~~v~~~D~G~Ytc~A~ 85 (101)
T cd04975 11 TTIFVNLGENLNLVVEVEAYPPPPHINWTYDNRTLTNKLTE-----IVTSENESEYRYVSELKLVRLKESEAGTYTFLAS 85 (101)
T ss_pred ceEEEECCCCEEEEEEEEecCCCCccEEEeCCeeCCCCcce-----eEEEeccCcceEEEEEEEeecCHhhCeeEEEEEE
Confidence 3567889999999999999 899999999999887642111 0111111122356789999999999999999999
Q ss_pred cCCCCcccceEEEEE
Q psy12044 341 NQAGSTSSNYTIRIV 355 (767)
Q Consensus 341 N~~G~s~~s~sL~V~ 355 (767)
|..|.....+.+.|.
T Consensus 86 N~~G~~~~t~~L~V~ 100 (101)
T cd04975 86 NSDASKSLTFELYVN 100 (101)
T ss_pred CCCccEEEEEEEEEE
Confidence 999987777666553
No 39
>cd05863 Ig2_VEGFR-3 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). Ig2_VEGFR-3: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-3 (Flt-4) binds two members of the VEGF family (VEGF-C and -D) and is involved in tumor angiogenesis and growth.
Probab=98.45 E-value=2.2e-07 Score=76.99 Aligned_cols=66 Identities=26% Similarity=0.395 Sum_probs=54.6
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceE
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYT 351 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~s 351 (767)
+.|.|.+.+.|.|.+.|++++..+... ...+.|.|.++..+|.|.|+|.|.|..|...++++
T Consensus 1 ~~l~c~v~g~P~P~v~W~kdg~~l~~~------------------~~~~~L~i~~v~~~D~G~YtC~a~N~~g~~~~~~~ 62 (67)
T cd05863 1 VKLPVKVAAYPPPEFQWYKDGKLISGK------------------HSQHSLQIKDVTEASAGTYTLVLWNSAAGLEKRIS 62 (67)
T ss_pred CEEEEEEEEeCCCEEEEEECCEECccc------------------CCcCEEEECCCCHHHCEEEEEEEEECCccEEEEEE
Confidence 368899999999999999999877421 12357999999999999999999999998777776
Q ss_pred EEEE
Q psy12044 352 IRIV 355 (767)
Q Consensus 352 L~V~ 355 (767)
+.+.
T Consensus 63 ~~l~ 66 (67)
T cd05863 63 LELI 66 (67)
T ss_pred EEEE
Confidence 6553
No 40
>KOG1859|consensus
Probab=98.45 E-value=5.2e-09 Score=118.53 Aligned_cols=128 Identities=25% Similarity=0.298 Sum_probs=106.0
Q ss_pred CccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEecc
Q psy12044 76 NLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELS 155 (767)
Q Consensus 76 ~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls 155 (767)
.|...+.++|.|.... .++.-++.|+.|+|+.|+++... .+..|++|++|||+.|.+..++.-...++. |+.|+|+
T Consensus 165 ~L~~a~fsyN~L~~mD-~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMD-ESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHHhHH-HHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 3555677788887763 56778899999999999999886 688999999999999999998865555555 9999999
Q ss_pred CCCccccchhhhcCCCCCCeeeccCCccccccCC--CCCCCCcccccCCCCCCCch
Q psy12044 156 KCGIEVIEDAAFVGLDSLEWLKLDNNKITTISGS--NILPTGLHGIDLHHNPWTCD 209 (767)
Q Consensus 156 ~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~--~~~~~~L~~L~Ls~N~l~C~ 209 (767)
+|.++.+.. +.+|.+|+.|||++|-|.+..+- ++.+..|+.|+|.|||+-|.
T Consensus 241 nN~l~tL~g--ie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 241 NNALTTLRG--IENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred ccHHHhhhh--HHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 999998764 77899999999999998865543 23457889999999999886
No 41
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=98.44 E-value=1.2e-07 Score=106.32 Aligned_cols=149 Identities=30% Similarity=0.357 Sum_probs=119.2
Q ss_pred EEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCC-CCCEEEccCCCCCCCCCCCCCCCCCCcEEECC
Q psy12044 53 VLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLT-NLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLS 131 (767)
Q Consensus 53 ~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~-~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls 131 (767)
.|++..|.+......... ++.++.|++.+|.++.+.+. ...+. +|+.|++++|.+..++ ..+..+++|+.|+++
T Consensus 97 ~l~~~~~~~~~~~~~~~~---~~~l~~L~l~~n~i~~i~~~-~~~~~~nL~~L~l~~N~i~~l~-~~~~~l~~L~~L~l~ 171 (394)
T COG4886 97 SLDLNLNRLRSNISELLE---LTNLTSLDLDNNNITDIPPL-IGLLKSNLKELDLSDNKIESLP-SPLRNLPNLKNLDLS 171 (394)
T ss_pred eeeccccccccCchhhhc---ccceeEEecCCcccccCccc-cccchhhcccccccccchhhhh-hhhhccccccccccC
Confidence 578888887544444433 67899999999999998653 44553 9999999999999885 347889999999999
Q ss_pred CCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccccccCCCCCCCCcccccCCCCCCCc
Q psy12044 132 GNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISGSNILPTGLHGIDLHHNPWTC 208 (767)
Q Consensus 132 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~~~~~~~L~~L~Ls~N~l~C 208 (767)
+|+++.+++. ...++.|+.|++++|++..++.. ...+..|+.|.+++|.+..++.......++..+.+.+|.+.+
T Consensus 172 ~N~l~~l~~~-~~~~~~L~~L~ls~N~i~~l~~~-~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 172 FNDLSDLPKL-LSNLSNLNNLDLSGNKISDLPPE-IELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred Cchhhhhhhh-hhhhhhhhheeccCCccccCchh-hhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee
Confidence 9999999873 33688999999999999999874 234566999999999766666666677788888888888775
No 42
>cd05852 Ig5_Contactin-1 Fifth Ig domain of contactin-1. Ig5_Contactin-1: fifth Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=98.42 E-value=2.8e-07 Score=77.76 Aligned_cols=72 Identities=29% Similarity=0.450 Sum_probs=56.5
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCccc
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSS 348 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~ 348 (767)
|..+.|.|.+.+.|.|.+.|.+++..+.... .+... ..+.|.|.++..+|.|.|.|.|.|..|.+..
T Consensus 1 G~~~~l~C~~~g~P~p~v~W~k~~~~l~~~~-------r~~~~------~~g~L~I~~v~~~D~G~Y~C~A~N~~G~~~~ 67 (73)
T cd05852 1 GGRVIIECKPKAAPKPKFSWSKGTELLVNNS-------RISIW------DDGSLEILNITKLDEGSYTCFAENNRGKANS 67 (73)
T ss_pred CCeEEEEEecceeCCCEEEEEeCCEecccCC-------CEEEc------CCCEEEECcCChhHCEEEEEEEECCCCceeE
Confidence 5678899999999999999999876553221 11111 1347999999999999999999999999888
Q ss_pred ceEEE
Q psy12044 349 NYTIR 353 (767)
Q Consensus 349 s~sL~ 353 (767)
...|.
T Consensus 68 ~~~l~ 72 (73)
T cd05852 68 TGVLS 72 (73)
T ss_pred EEEEE
Confidence 76654
No 43
>cd05735 Ig8_DSCAM Eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig8_DSCAM: the eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=98.42 E-value=6.7e-07 Score=78.29 Aligned_cols=83 Identities=20% Similarity=0.261 Sum_probs=62.4
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCcccccccceeecc-cCcceeeeEEEEeeeccCCCCceeEeeccCCCCcc
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTE-EGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTS 347 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~-~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~ 347 (767)
|+.+.|.|.+.+.|.+.+.|.+++..+.... .+ +.... .......+.|.|.++..+|.|.|+|.|.|..|...
T Consensus 1 g~~~~l~C~~~g~p~~~i~W~k~~~~i~~~~-----~r-~~~~~~~~~~~~~s~L~I~~~~~~D~G~YtC~A~N~~G~~~ 74 (88)
T cd05735 1 GQKKEMSCTAHGEKPIIVRWEKEDRIINPEM-----SR-YLVSTKEVGDEVISTLQILPTVREDSGFFSCHAINSYGEDR 74 (88)
T ss_pred CCeEEEEEEEECCCCCEEEEeeCCEECCCCC-----Cc-EEEEEecCCCcEEEEEEECCCCcccCEEEEEEEEcCCCcce
Confidence 5778999999999999999999887653221 11 11111 11123357899999999999999999999999999
Q ss_pred cceEEEEEee
Q psy12044 348 SNYTIRIVLK 357 (767)
Q Consensus 348 ~s~sL~V~~~ 357 (767)
..+.|.|...
T Consensus 75 ~~~~L~V~~~ 84 (88)
T cd05735 75 GIIQLTVQEP 84 (88)
T ss_pred EEEEEEEeCC
Confidence 8888877653
No 44
>cd05892 Ig_Myotilin_C C-terminal immunoglobulin (Ig)-like domain of myotilin. Ig_Myotilin_C: C-terminal immunoglobulin (Ig)-like domain of myotilin. Mytolin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to the latter family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Myotilin is most abundant in skeletal and cardiac muscle, and is involved in maintaining sarcomere integrity. It binds to alpha-actinin, filamin and actin. Mutations in myotilin lead to muscle disorders.
Probab=98.40 E-value=4.5e-07 Score=76.94 Aligned_cols=74 Identities=30% Similarity=0.468 Sum_probs=55.3
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceE
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYT 351 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~s 351 (767)
+.|.|.+.|.|.|.+.|.+++..+.... ..+.....+. ...+|.|.++..+|.|.|.|.|.|..|.+.....
T Consensus 1 v~l~C~v~G~P~P~i~W~k~~~~i~~~~------~r~~~~~~~~--g~~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~a~ 72 (75)
T cd05892 1 VKLECQISAIPPPKIFWKRNNEMVQYNT------DRISLYQDNS--GRVTLLIKNVNKKDAGWYTVSAVNEAGVATCHAR 72 (75)
T ss_pred CEEEEEEEecCCCeEEEEECCEECcCCC------CeEEEEEcCC--CcEEEEECCCChhhCEEEEEEEEcCcCeEEEEEE
Confidence 4689999999999999999988775321 1112211111 1247999999999999999999999999887766
Q ss_pred EE
Q psy12044 352 IR 353 (767)
Q Consensus 352 L~ 353 (767)
|.
T Consensus 73 L~ 74 (75)
T cd05892 73 LD 74 (75)
T ss_pred Ee
Confidence 54
No 45
>cd05737 Ig_Myomesin_like_C C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Ig_Myomesin_like_C: domain similar to the C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Myomesin and M-protein are both structural proteins localized to the M-band, a transverse structure in the center of the sarcomere, and are candidates for M-band bridges. Both proteins are modular, consisting mainly of repetitive Ig-like and fibronectin type III (FnIII) domains. Myomesin is expressed in all types of vertebrate striated muscle; M-protein has a muscle-type specific expression pattern. Myomesin is present in both slow and fast fibers; M-protein is present only in fast fibers. It has been suggested that myomesin acts as a molecular spring with alternative splicing as a means of modifying its elasticity.
Probab=98.40 E-value=4.2e-07 Score=80.18 Aligned_cols=83 Identities=24% Similarity=0.380 Sum_probs=63.3
Q ss_pred cceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeecc
Q psy12044 262 FYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAEN 341 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N 341 (767)
...++.+|+.+.|.|.+.+.|.|.+.|++++..+..... +...... .....|.|.++..+|.|.|.|.|.|
T Consensus 9 ~~v~v~~G~~v~L~C~v~G~P~p~v~W~k~g~~l~~~~~-------~~~~~~~--~~~~~L~I~~v~~~D~G~Y~C~a~N 79 (92)
T cd05737 9 DVVTIMEGKTLNLTCTVFGDPDPEVSWLKNDQALALSDH-------YNVKVEQ--GKYASLTIKGVSSEDSGKYGIVVKN 79 (92)
T ss_pred ceEEEeCCCcEEEEEEEEecCCCeEEEEECCEECccCCC-------EEEEEcC--CCEEEEEEccCChhhCEEEEEEEEE
Confidence 356788999999999999999999999998877643211 1111110 1235799999999999999999999
Q ss_pred CCCCcccceEEE
Q psy12044 342 QAGSTSSNYTIR 353 (767)
Q Consensus 342 ~~G~s~~s~sL~ 353 (767)
..|.....+.+.
T Consensus 80 ~~G~~~~~~~v~ 91 (92)
T cd05737 80 KYGGETVDVTVS 91 (92)
T ss_pred CCCcceEEEEEe
Confidence 999887766554
No 46
>cd05728 Ig4_Contactin-2-like Fourth Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig4_Contactin-2-like: fourth Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=98.36 E-value=6.1e-07 Score=77.91 Aligned_cols=79 Identities=27% Similarity=0.504 Sum_probs=62.6
Q ss_pred ccceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeec
Q psy12044 261 TFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAE 340 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~ 340 (767)
+....+..|+.+.|.|.+.+.|.|.+.|.+++..+..... +. ...+.|.|.++..+|.|.|.|.|.
T Consensus 6 p~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~g~~~~~~~~-------~~-------~~~~~L~i~~~~~~D~G~Y~C~a~ 71 (85)
T cd05728 6 ISDTEADIGSSLRWECKASGNPRPAYRWLKNGQPLASENR-------IE-------VEAGDLRITKLSLSDSGMYQCVAE 71 (85)
T ss_pred CCccEEcCCCcEEEEEEeeEeCCCEEEEEECCEECCCCCe-------EE-------EeCCEEEEeeCCHHHCEEEEEEEE
Confidence 3456788999999999999999999999998876643211 11 123479999999999999999999
Q ss_pred cCCCCcccceEEE
Q psy12044 341 NQAGSTSSNYTIR 353 (767)
Q Consensus 341 N~~G~s~~s~sL~ 353 (767)
|..|...+++.+.
T Consensus 72 N~~G~~~~~~~l~ 84 (85)
T cd05728 72 NKHGTIYASAELA 84 (85)
T ss_pred CCCCeEEEEEEEE
Confidence 9999877766554
No 47
>cd05855 Ig_TrkB_d5 Fifth domain (immunoglobulin-like) of Trk receptor TrkB. TrkB_d5: the fifth domain of Trk receptor TrkB, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors, which mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. The Trks are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkB shares significant sequence homology and domain organization with TrkA, and TrkC. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. In some cell systems NT-3 can activate TrkA and TrkB receptors. TrKB transcripts are found throughout multiple structures of the central and peripheral nervous systems.
Probab=98.35 E-value=9.4e-07 Score=75.67 Aligned_cols=76 Identities=17% Similarity=0.275 Sum_probs=57.0
Q ss_pred cccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceEE
Q psy12044 273 SLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYTI 352 (767)
Q Consensus 273 sL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~sL 352 (767)
.+.|.+.|.|.|.++|++++..+....... ......+.....+.|.|..+...|+|.|+|+|.|..|.+.+++.+
T Consensus 2 ~i~~~v~G~P~Pti~W~kng~~l~~~~~~~-----~~~~~~~~~~~~~~L~i~~~~~~D~G~YtC~A~N~~G~~~~~~~~ 76 (79)
T cd05855 2 CIPFTVKGNPKPTLQWFHEGAILNESEYIC-----TKIHVINNTEYHGCLQLDNPTHLNNGIYTLVAKNEYGEDEKNVSA 76 (79)
T ss_pred eEEEEEeEeCCCceEEEECCEECCCCccee-----eeeEeecccceEEEEEECCCCcccCEEEEEEEEcCCcccceEEEe
Confidence 367899999999999999998886543211 111111222345789999999999999999999999998887765
Q ss_pred E
Q psy12044 353 R 353 (767)
Q Consensus 353 ~ 353 (767)
.
T Consensus 77 ~ 77 (79)
T cd05855 77 H 77 (79)
T ss_pred e
Confidence 4
No 48
>cd05859 Ig4_PDGFR-alpha Fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. IG4_PDGFR-alpha: The fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFR alpha binds to all three PDGFs, whereas the PDGFR beta (not included in this group) binds only to PDGF-B. PDGF alpha is organized as an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFR alpha and PDGFR beta are essential for normal development.
Probab=98.35 E-value=7.4e-07 Score=80.20 Aligned_cols=87 Identities=18% Similarity=0.294 Sum_probs=66.5
Q ss_pred ceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecc--cCcceeeeEEEEeeeccCCCCceeEeec
Q psy12044 263 YLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTE--EGTEIKKSELLIYNSNIDDNGTFVCVAE 340 (767)
Q Consensus 263 ~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~--~g~~~~~s~L~I~nvs~sD~GtY~CvA~ 340 (767)
..++..+..+.|.|.+.+.|.|.+.|.+++..+...... ..... .......++|.|.++..+|.|.|+|.|.
T Consensus 12 ~~~~~~~~~~~l~~~v~g~P~P~v~W~kdg~~l~~~~~~------~~~~~~~~~~~~~~s~L~I~~v~~~D~G~Ytc~A~ 85 (101)
T cd05859 12 LEFANLHEVKEFVVEVEAYPPPQIRWLKDNRTLIENLTE------ITTSEHNVQETRYVSKLKLIRAKEEDSGLYTALAQ 85 (101)
T ss_pred eEEEecCCcEEEEEEEEEeCCCceEEEECCEECcCCcce------EEeccccccceeeccEEEEeeCCHHHCEEEEEEEE
Confidence 456677889999999999999999999999887643311 11100 0122345789999999999999999999
Q ss_pred cCCCCcccceEEEEE
Q psy12044 341 NQAGSTSSNYTIRIV 355 (767)
Q Consensus 341 N~~G~s~~s~sL~V~ 355 (767)
|..|....++.+.|.
T Consensus 86 N~~g~~~~t~~l~V~ 100 (101)
T cd05859 86 NEDAVKSYTFALQIQ 100 (101)
T ss_pred cCCceEEEEEEEEEE
Confidence 999988777766653
No 49
>cd05894 Ig_C5_MyBP-C C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). Ig_C5_MyBP_C : the C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). MyBP_C consists of repeated domains, Ig and fibronectin type 3, and various linkers. Three isoforms of MYBP_C exist and are included in this group: cardiac(c), and fast and slow skeletal muscle (s) MyBP_C. cMYBP_C has insertions between and inside domains and an additional cardiac-specific Ig domain at the N-terminus. For cMYBP_C an interaction has been demonstrated between this C5 domain and the Ig C8 domain.
Probab=98.34 E-value=1e-06 Score=76.75 Aligned_cols=82 Identities=16% Similarity=0.281 Sum_probs=62.9
Q ss_pred ceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccC
Q psy12044 263 YLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQ 342 (767)
Q Consensus 263 ~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~ 342 (767)
.+.+..|+.+.|.|.+.|.|.|.+.|.+++..+..... .+.... ....+.|.|.++..+|.|.|.|.|.|.
T Consensus 4 ~~~v~~G~~v~l~c~~~G~P~P~v~W~k~~~~i~~~~~------r~~~~~---~~~~~~L~I~~~~~~D~G~Y~c~a~N~ 74 (86)
T cd05894 4 TIVVVAGNKLRLDVPISGEPAPTVTWSRGDKAFTETEG------RVRVES---YKDLSSFVIEGAEREDEGVYTITVTNP 74 (86)
T ss_pred EEEEEcCCEEEEEeeEeecCCCeEEEEECCEECccCCC------eEEEEE---cCCeEEEEECCCccCcCEEEEEEEEeC
Confidence 35677899999999999999999999998877643210 111111 112468999999999999999999999
Q ss_pred CCCcccceEEE
Q psy12044 343 AGSTSSNYTIR 353 (767)
Q Consensus 343 ~G~s~~s~sL~ 353 (767)
.|....++.+.
T Consensus 75 ~G~~~~~~~l~ 85 (86)
T cd05894 75 VGEDHASLFVK 85 (86)
T ss_pred CCcEEEEEEEE
Confidence 99987766554
No 50
>cd05867 Ig4_L1-CAM_like Fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig4_L1-CAM_like: fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=98.33 E-value=7.1e-07 Score=75.69 Aligned_cols=75 Identities=25% Similarity=0.553 Sum_probs=58.0
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCccc
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSS 348 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~ 348 (767)
|+.+.|.|.+.+.|.|.++|.+++..+...... . .+. ...+.|.|.++..+|.|.|.|.|.|..|...+
T Consensus 1 G~~v~l~C~~~G~P~p~i~W~k~g~~i~~~~~~----~-~~~------~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~ 69 (76)
T cd05867 1 GETARLDCQVEGIPTPNITWSINGAPIEGTDPD----P-RRH------VSSGALILTDVQPSDTAVYQCEARNRHGNLLA 69 (76)
T ss_pred CCeEEEEEEeeEeCCCeEEEEECCEECCCCCCC----c-eEE------eeCCEEEECCCChhhCEEEEEEEECCCCeEEE
Confidence 567899999999999999999998776432210 0 011 12357999999999999999999999999887
Q ss_pred ceEEEE
Q psy12044 349 NYTIRI 354 (767)
Q Consensus 349 s~sL~V 354 (767)
++.+.|
T Consensus 70 ~~~l~V 75 (76)
T cd05867 70 NAHVHV 75 (76)
T ss_pred EEEEEE
Confidence 776654
No 51
>cd04972 Ig_TrkABC_d4 Fourth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d4: the fourth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor fo
Probab=98.33 E-value=9.8e-07 Score=77.43 Aligned_cols=81 Identities=20% Similarity=0.387 Sum_probs=62.5
Q ss_pred ceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccC
Q psy12044 263 YLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQ 342 (767)
Q Consensus 263 ~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~ 342 (767)
...+..|+.+.|.|.+.|.|.|.+.|.+++..+...... . . ......+.|.|.++...|.|.|.|.|.|.
T Consensus 9 ~~~v~~G~~v~l~C~~~G~P~p~v~W~~~g~~~~~~~~~-------~-~--~~~~~~~~L~I~~v~~~D~g~Y~C~A~N~ 78 (90)
T cd04972 9 ATVVYEGGTATIRCTAEGSPLPKVEWIIAGLIVIQTRTD-------T-L--ETTVDIYNLQLSNITSETQTTVTCTAENP 78 (90)
T ss_pred CEEEcCCCcEEEEEEEEEcCCCeEEEEECCEEccCCccE-------E-E--EecCCEEEEEEecCCcccCEEEEEEEECC
Confidence 455789999999999999999999999998765432110 0 0 01122458999999999999999999999
Q ss_pred CCCcccceEEE
Q psy12044 343 AGSTSSNYTIR 353 (767)
Q Consensus 343 ~G~s~~s~sL~ 353 (767)
.|...+.+.|.
T Consensus 79 ~G~~~~~~~L~ 89 (90)
T cd04972 79 VGQANVSVQVT 89 (90)
T ss_pred CCceeEEEEEe
Confidence 99987766554
No 52
>cd05730 Ig3_NCAM-1_like Third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig3_NCAM-1_like: domain similar to the third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1,and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the
Probab=98.32 E-value=1e-06 Score=77.99 Aligned_cols=83 Identities=27% Similarity=0.520 Sum_probs=65.1
Q ss_pred ceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccC
Q psy12044 263 YLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQ 342 (767)
Q Consensus 263 ~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~ 342 (767)
...+..|+.+.|.|.+.+.|.|.+.|.+++..+.... ..+.+. ...+.|.|.++..+|.|.|.|.|.|.
T Consensus 12 ~~~~~~G~~v~L~C~~~g~P~p~v~W~k~g~~~~~~~------~~~~~~-----~~~~~L~I~~v~~~D~G~Y~C~a~N~ 80 (95)
T cd05730 12 NATANLGQSVTLACDADGFPEPTMTWTKDGEPIESGE------EKYSFN-----EDGSEMTILDVDKLDEAEYTCIAENK 80 (95)
T ss_pred ceEEeCCCCEEEEEeccEeCCCEEEEEECCEECcCCC------CEEEEe-----CCCCEEEECCCChhhCEEEEEEEEcC
Confidence 4567889999999999999999999999887664321 111111 12346999999999999999999999
Q ss_pred CCCcccceEEEEEe
Q psy12044 343 AGSTSSNYTIRIVL 356 (767)
Q Consensus 343 ~G~s~~s~sL~V~~ 356 (767)
.|.....+.+.|..
T Consensus 81 ~G~~~~~~~L~V~~ 94 (95)
T cd05730 81 AGEQEAEIHLKVFA 94 (95)
T ss_pred CCeEEEEEEEEEEe
Confidence 99988888777654
No 53
>cd04974 Ig3_FGFR Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig3_FGFR: third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs.
Probab=98.32 E-value=1.5e-06 Score=76.41 Aligned_cols=85 Identities=22% Similarity=0.367 Sum_probs=56.6
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCcccccccceeec----ccCcceeeeEEEEeeeccCCCCceeEeeccCCC
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYST----EEGTEIKKSELLIYNSNIDDNGTFVCVAENQAG 344 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~----~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G 344 (767)
|..+.|.|.+.+.|.|.|+|.+++.. ....+........... ..........|.|.++..+|.|.|.|.|.|..|
T Consensus 1 G~~v~l~C~v~g~P~P~i~W~k~~~~-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G 79 (90)
T cd04974 1 GSDVEFHCKVYSDAQPHIQWLKHVEV-NGSKYGPDGLPYVTVLKVAGINTTDNESEVLYLRNVSFDDAGEYTCLAGNSIG 79 (90)
T ss_pred CCcEEEEEEEeCCCCCeEEEEEeccc-CCceeCCCCCceEEEEEecCCcccccccceEEEeccccccCcEEEEEeecccC
Confidence 56789999999999999999985321 0111110111000000 111112234789999999999999999999999
Q ss_pred CcccceEEEE
Q psy12044 345 STSSNYTIRI 354 (767)
Q Consensus 345 ~s~~s~sL~V 354 (767)
...+++.|.|
T Consensus 80 ~~~~sa~L~V 89 (90)
T cd04974 80 PSHHSAWLTV 89 (90)
T ss_pred cccCCEEEEe
Confidence 9988887765
No 54
>cd04968 Ig3_Contactin_like Third Ig domain of contactin. Ig3_Contactin_like: Third Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=98.30 E-value=1e-06 Score=76.86 Aligned_cols=80 Identities=25% Similarity=0.359 Sum_probs=62.1
Q ss_pred ccceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeec
Q psy12044 261 TFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAE 340 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~ 340 (767)
+....+..|..+.|.|.+.+.|.|.+.|.+++..+..... . ......|.|.++..+|.|.|.|.+.
T Consensus 8 p~~~~~~~g~~v~l~C~~~g~P~p~v~W~k~~~~~~~~~~-------~-------~~~~~~L~i~~v~~~D~G~Y~C~a~ 73 (88)
T cd04968 8 PKDTYALKGQNVTLECFALGNPVPQIKWRKVDGSMPSSAE-------I-------SMSGAVLKIPNIQFEDEGTYECEAE 73 (88)
T ss_pred CCceEEeCCCcEEEEEEeeEeCCCEEEEEECCCcCCCccE-------E-------EEeCCEEEECCCCcccCEEEEEEEE
Confidence 3456678899999999999999999999997654322111 0 0134579999999999999999999
Q ss_pred cCCCCcccceEEEE
Q psy12044 341 NQAGSTSSNYTIRI 354 (767)
Q Consensus 341 N~~G~s~~s~sL~V 354 (767)
|..|.......+.|
T Consensus 74 N~~G~~~~~~~l~V 87 (88)
T cd04968 74 NIKGKDTHQGRIYV 87 (88)
T ss_pred ECCCcEEEEEEEEE
Confidence 99999877666544
No 55
>cd05869 Ig5_NCAM-1 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig5_NCAM-1: The fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM) and heterophilic (NCAM-non-NCAM) interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (tr
Probab=98.30 E-value=1.3e-06 Score=77.76 Aligned_cols=83 Identities=22% Similarity=0.387 Sum_probs=59.8
Q ss_pred ecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCC
Q psy12044 266 IQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGS 345 (767)
Q Consensus 266 v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~ 345 (767)
...|+.+.|.|.+.|.|.|.++|.+++..+........ ..+.... ....+.|.|.++..+|.|.|.|.|.|..|.
T Consensus 14 ~~~g~~v~l~C~~~G~P~P~v~W~~~~~~~~~~~~~~~--~~~~v~~---~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~ 88 (97)
T cd05869 14 MELEEQITLTCEASGDPIPSITWRTSTRNISSEEKTLD--GHIVVRS---HARVSSLTLKYIQYTDAGEYLCTASNTIGQ 88 (97)
T ss_pred EEcCCCEEEEEEeeEeCCCEEEEEECCccccCCccccC--ccEEEEc---CccEEEEEEecCccCcCEEEEEEEecCCCC
Confidence 44579999999999999999999998765532211100 1111111 112367999999999999999999999999
Q ss_pred cccceEEE
Q psy12044 346 TSSNYTIR 353 (767)
Q Consensus 346 s~~s~sL~ 353 (767)
...++.|.
T Consensus 89 ~~~~~~l~ 96 (97)
T cd05869 89 DSQSMYLE 96 (97)
T ss_pred eeEEEEEE
Confidence 88766654
No 56
>cd05854 Ig6_Contactin-2 Sixth Ig domain of contactin-2. Ig6_Contactin-2: Sixth Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=98.30 E-value=1.3e-06 Score=75.99 Aligned_cols=80 Identities=26% Similarity=0.470 Sum_probs=58.5
Q ss_pred cccccccccccCCC--cEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCccc
Q psy12044 271 NVSLLCKVSAIPEA--KITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSS 348 (767)
Q Consensus 271 ~vsL~C~a~g~P~p--~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~ 348 (767)
+++|.|.+.+.|.| .+.|.+++..+...... .+ +... ......++|.|.+++..|.|.|+|.|.|..|...+
T Consensus 2 ~~~L~C~a~g~P~p~~~v~W~~~g~~i~~~~~~---~~-~~~~--~~~~~~~~L~I~~v~~~D~G~YtC~A~n~~g~~~~ 75 (85)
T cd05854 2 NLTLQCHASHDPTMDLTFTWSLDDFPIDLDKPN---GH-YRRM--EVKETIGDLVIVNAQLSHAGTYTCTAQTVVDSASA 75 (85)
T ss_pred cEEEEEEEecCCCCCeEEEEEECCeEccccCCC---Cc-EEEE--EecceEeEEEEccCChhhCeEEEEEEecCCCCEEE
Confidence 57899999999987 57999988776432211 00 1000 01123468999999999999999999999999988
Q ss_pred ceEEEEEe
Q psy12044 349 NYTIRIVL 356 (767)
Q Consensus 349 s~sL~V~~ 356 (767)
++.|.|..
T Consensus 76 ~~~L~V~~ 83 (85)
T cd05854 76 SATLVVRG 83 (85)
T ss_pred EEEEEEEC
Confidence 88887754
No 57
>KOG3207|consensus
Probab=98.29 E-value=1.1e-07 Score=102.83 Aligned_cols=159 Identities=21% Similarity=0.238 Sum_probs=80.6
Q ss_pred CCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccC-cccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCc
Q psy12044 48 DPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVID-SKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLM 126 (767)
Q Consensus 48 ~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~-p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~ 126 (767)
+++|+.|+|+.|++.-........ .+++|+.|.|+.|.|+.-. -..+..+++|+.|+|..|..-.+......-+..|+
T Consensus 171 Lp~Le~LNls~Nrl~~~~~s~~~~-~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~ 249 (505)
T KOG3207|consen 171 LPSLENLNLSSNRLSNFISSNTTL-LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQ 249 (505)
T ss_pred cccchhcccccccccCCccccchh-hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHh
Confidence 355666666666665433332221 3556666666666666321 12234556666666666643222222333445566
Q ss_pred EEECCCCcCccccc-CCcCCCCCccEEeccCCCccccchhh------hcCCCCCCeeeccCCccccccC--CCCCCCCcc
Q psy12044 127 KLTLSGNPIKQIKT-GAFQPLSYLVTLELSKCGIEVIEDAA------FVGLDSLEWLKLDNNKITTISG--SNILPTGLH 197 (767)
Q Consensus 127 ~L~Ls~N~l~~l~~-~~~~~l~~L~~L~Ls~N~L~~i~~~~------~~~l~~L~~L~Ls~N~Lt~ip~--~~~~~~~L~ 197 (767)
.|+|++|.+..... ...+.++.|+.|+++.|.|..+.... ....++|+.|+++.|++...+. .+..+.+|+
T Consensus 250 ~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk 329 (505)
T KOG3207|consen 250 ELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLK 329 (505)
T ss_pred hccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhh
Confidence 66666666554431 23445566666666666655442111 2334566666666666654432 222334555
Q ss_pred cccCCCCCCC
Q psy12044 198 GIDLHHNPWT 207 (767)
Q Consensus 198 ~L~Ls~N~l~ 207 (767)
.|.+..|.++
T Consensus 330 ~l~~~~n~ln 339 (505)
T KOG3207|consen 330 HLRITLNYLN 339 (505)
T ss_pred hhhccccccc
Confidence 5555555554
No 58
>cd05868 Ig4_NrCAM Fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). Ig4_ NrCAM: fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six IG-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=98.29 E-value=8.6e-07 Score=75.31 Aligned_cols=75 Identities=21% Similarity=0.498 Sum_probs=57.3
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCccc
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSS 348 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~ 348 (767)
|..+.|.|.+.+.|.|.++|.+++..+...... . ... .....|.+.++...|.|.|.|.|.|..|...+
T Consensus 1 g~~~~l~C~a~G~P~P~i~W~k~g~~i~~~~~~----~-~~~------~~~~~l~i~~v~~~D~G~Y~C~A~N~~G~~~~ 69 (76)
T cd05868 1 GEDGTLICRANGNPKPSISWLTNGVPIEIAPTD----P-SRK------VDGDTIIFSKVQERSSAVYQCNASNEYGYLLA 69 (76)
T ss_pred CCCEEEEEEeeEeCCCeEEEEECCEEccccCCC----c-eEE------ecCCEEEECCCCHhhCEEEEEEEEcCCCEEEE
Confidence 567889999999999999999998776422110 0 001 11236888999999999999999999999888
Q ss_pred ceEEEE
Q psy12044 349 NYTIRI 354 (767)
Q Consensus 349 s~sL~V 354 (767)
++.+.|
T Consensus 70 ~~~l~v 75 (76)
T cd05868 70 NAFVNV 75 (76)
T ss_pred EEEEEe
Confidence 777654
No 59
>cd05732 Ig5_NCAM-1_like Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM) and similar proteins. Ig5_NCAM-1 like: domain similar to the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM mole
Probab=98.29 E-value=1.5e-06 Score=76.99 Aligned_cols=87 Identities=18% Similarity=0.293 Sum_probs=62.8
Q ss_pred cceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeecc
Q psy12044 262 FYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAEN 341 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N 341 (767)
....+.+|+.+.|.|.+.+.|.|.+.|.+++..+........ ..+... .....+.|.|.++..+|.|.|.|.|.|
T Consensus 9 ~~~~~~~g~~v~l~C~~~g~p~p~v~W~~~~~~~~~~~~~~~--~~~~~~---~~~~~~~L~I~~v~~~D~G~Y~C~a~N 83 (96)
T cd05732 9 ENQTAVELEQITLTCEAEGDPIPEITWRRATRNFSEGDKSLD--GRIVVR---GHARVSSLTLKDVQLTDAGRYDCEASN 83 (96)
T ss_pred CceeEecCCcEEEEEEEeEcCCCcEEEEECCcccCCCCcccc--ceEEEe---CCccEEEEEECcCCcCcCEEeEEEEEe
Confidence 356778899999999999999999999998754432211100 011111 112346899999999999999999999
Q ss_pred CCCCcccceEEE
Q psy12044 342 QAGSTSSNYTIR 353 (767)
Q Consensus 342 ~~G~s~~s~sL~ 353 (767)
..|....++.+.
T Consensus 84 ~~G~~~~s~~l~ 95 (96)
T cd05732 84 RIGGDQQSMYLE 95 (96)
T ss_pred CCCCcEEEEEEe
Confidence 999987666553
No 60
>cd05747 Ig5_Titin_like M5, fifth immunoglobulin (Ig)-like domain of human titin C terminus and similar proteins. Ig5_Titin_like: domain similar to the M5, fifth immunoglobulin (Ig)-like domain from the human titin C terminus. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic; depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone, and appears to function similar to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching.
Probab=98.28 E-value=1.4e-06 Score=76.83 Aligned_cols=87 Identities=25% Similarity=0.445 Sum_probs=65.9
Q ss_pred CCCCCccceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCce
Q psy12044 256 QITPSTFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTF 335 (767)
Q Consensus 256 ~i~~~~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY 335 (767)
.+...+....+..|+.+.|.|.+.+.|.|.+.|.+++..+..... +.... ....+.|.|.++..+|.|.|
T Consensus 5 ~~~~~p~~~~~~~G~~~~L~C~~~g~P~p~v~W~k~g~~l~~~~~-------~~~~~---~~~~~~L~i~~~~~~D~G~Y 74 (92)
T cd05747 5 TILTKPRSLTVSEGESARFSCDVDGEPAPTVTWMREGQIIVSSQR-------HQITS---TEYKSTFEISKVQMSDEGNY 74 (92)
T ss_pred cccccCccEEEeCCCcEEEEEEEeecCCCEEEEEECCEECCCCCc-------EEEEE---cCCeeEEEECCCCcccCEeE
Confidence 344445567889999999999999999999999998876543211 11111 12346899999999999999
Q ss_pred eEeeccCCCCcccceEE
Q psy12044 336 VCVAENQAGSTSSNYTI 352 (767)
Q Consensus 336 ~CvA~N~~G~s~~s~sL 352 (767)
.|.+.|..|.....+.|
T Consensus 75 ~C~a~N~~G~~~~~~~l 91 (92)
T cd05747 75 TVVVENSEGKQEAQFTL 91 (92)
T ss_pred EEEEEcCCCCEeEEEEe
Confidence 99999999987765543
No 61
>cd05893 Ig_Palladin_C C-terminal immunoglobulin (Ig)-like domain of palladin. Ig_Palladin_C: C-terminal immunoglobulin (Ig)-like domain of palladin. Palladin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to this family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Palladin binds to alpha-actinin ezrin, vasodilator-stimulated phosphoprotein VASP, SPIN90 (DIP, mDia interacting protein), and Src. Palladin also binds F-actin directly, via its Ig3 domain. Palladin is expressed as several alternatively spliced isoforms, having various combinations of Ig-like domains, in a cell-type-specific manner. It has been suggested that palladin's different Ig-like domains may be specialized for distinct functions.
Probab=98.28 E-value=1e-06 Score=74.67 Aligned_cols=74 Identities=26% Similarity=0.430 Sum_probs=54.6
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceE
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYT 351 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~s 351 (767)
+.|.|.+.|.|.|.++|.+++..+.... ..+.....+ .....|.|.++..+|.|.|.|.|.|..|.......
T Consensus 1 v~l~C~v~G~P~P~v~W~k~~~~l~~~~------~~~~~~~~~--~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~a~ 72 (75)
T cd05893 1 VRLECRVSGVPHPQIFWKKENESLTHNT------DRVSMHQDN--CGYICLLIQGATKEDAGWYTVSAKNEAGIVSCTAR 72 (75)
T ss_pred CEEEEEEeEecCCEEEEEECCEECCCCC------CeEEEEEcC--CCEEEEEECCCCHHHCEEEEEEEEcCCCEEEEEEE
Confidence 4689999999999999999987764321 111111111 11236999999999999999999999999877666
Q ss_pred EE
Q psy12044 352 IR 353 (767)
Q Consensus 352 L~ 353 (767)
|.
T Consensus 73 L~ 74 (75)
T cd05893 73 LD 74 (75)
T ss_pred Ee
Confidence 54
No 62
>PF07679 I-set: Immunoglobulin I-set domain; InterPro: IPR013098 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents I-set domains, which are found in several cell adhesion molecules, including vascular (VCAM), intercellular (ICAM), neural (NCAM) and mucosal addressin (MADCAM) cell adhesion molecules, as well as junction adhesion molecules (JAM). I-set domains are also present in several other diverse protein families, including several tyrosine-protein kinase receptors, the hemolymph protein hemolin, the muscle proteins titin, telokin, and twitchin, the neuronal adhesion molecule axonin-1 [], and the signalling molecule semaphorin 4D that is involved in axonal guidance, immune function and angiogenesis [].; PDB: 3MTR_A 2EDK_A 3DMK_B 1KOA_A 3NCM_A 2NCM_A 2V9Q_A 2CR3_A 3QQN_A 3QR2_A ....
Probab=98.27 E-value=7.9e-07 Score=77.52 Aligned_cols=85 Identities=28% Similarity=0.531 Sum_probs=66.9
Q ss_pred CccceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEee
Q psy12044 260 STFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVA 339 (767)
Q Consensus 260 ~~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA 339 (767)
......+..|+.+.|.|.+.+.|.+.+.|.+++..+...... ..... .....|.|.++...|.|.|.|.+
T Consensus 6 ~~~~~~v~~G~~~~l~c~~~~~p~~~v~W~~~~~~l~~~~~~-------~~~~~---~~~~~L~I~~v~~~D~G~Y~C~~ 75 (90)
T PF07679_consen 6 KPKDVTVKEGESVTLECEVSGNPPPTVTWYKNGRPLTSSQRY-------QIESD---GGSSSLTIKNVTREDAGTYTCVA 75 (90)
T ss_dssp ESSEEEEETTSEEEEEEEEEESSSSEEEEEETTEEEESSSSE-------EEEEE---TTEEEEEESSESGGGSEEEEEEE
T ss_pred ecCCEEEeCCCEEEEEEEEEeCCCCcccccccccceeeeeee-------eeecc---cceeEEccCCCChhhCEEEEEEE
Confidence 345678889999999999999999999999998887663221 11111 14678999999999999999999
Q ss_pred ccCCCCcccceEEEE
Q psy12044 340 ENQAGSTSSNYTIRI 354 (767)
Q Consensus 340 ~N~~G~s~~s~sL~V 354 (767)
.|..|.....+.+.|
T Consensus 76 ~n~~g~~~~~~~l~V 90 (90)
T PF07679_consen 76 SNSSGEATASVNLTV 90 (90)
T ss_dssp EETTEEEEEEEEEEE
T ss_pred EECCCEEEEEEEEEC
Confidence 999888777666543
No 63
>cd05876 Ig3_L1-CAM Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM: third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=98.26 E-value=1e-06 Score=73.66 Aligned_cols=70 Identities=26% Similarity=0.471 Sum_probs=53.5
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceE
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYT 351 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~s 351 (767)
+.|.|.+.|.|.|.+.|.+++..+..... .. ......|.|.++..+|.|.|.|.|.|..|.....+.
T Consensus 1 ~~L~C~~~G~P~P~v~W~k~~~~~~~~~~-------~~------~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 67 (71)
T cd05876 1 LVLECIAEGLPTPEVHWDRIDGPLSPNRT-------KK------LNNNKTLQLDNVLESDDGEYVCTAENSEGSARHHYT 67 (71)
T ss_pred CEEEEEeeEecCCeEEEEECCcCCCCCce-------eE------EcCCCEEEEcccCHHhCEEEEEEEEcCCCeEEEEEE
Confidence 35889999999999999998765432111 00 112457999999999999999999999998877666
Q ss_pred EEE
Q psy12044 352 IRI 354 (767)
Q Consensus 352 L~V 354 (767)
+.|
T Consensus 68 l~V 70 (71)
T cd05876 68 VTV 70 (71)
T ss_pred EEE
Confidence 554
No 64
>cd05857 Ig2_FGFR Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. Ig2_FGFR: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three IG-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin sulfate proteoglycans.
Probab=98.25 E-value=1.6e-06 Score=75.00 Aligned_cols=80 Identities=21% Similarity=0.440 Sum_probs=60.8
Q ss_pred eecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCC
Q psy12044 265 EIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAG 344 (767)
Q Consensus 265 ~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G 344 (767)
.+..|..+.|.|.+.+.|.|.+.|++++..+...... ..+.. ......|.|.++..+|.|.|.|.+.|..|
T Consensus 5 ~v~~G~~~~L~C~~~g~P~p~i~W~k~g~~l~~~~~~----~~~~~-----~~~~~~l~i~~~~~~D~G~Y~C~a~N~~G 75 (85)
T cd05857 5 AVPAANTVKFRCPAAGNPTPTMRWLKNGKEFKQEHRI----GGYKV-----RNQHWSLIMESVVPSDKGNYTCVVENEYG 75 (85)
T ss_pred EcCCCCEEEEEEEcCCCCCCEEEEEECCEECCCCCce----eeeEE-----eCCceEEEEccCCcccCEEEEEEEEeCCC
Confidence 4668999999999999999999999998776533211 00001 01234688999999999999999999999
Q ss_pred CcccceEEE
Q psy12044 345 STSSNYTIR 353 (767)
Q Consensus 345 ~s~~s~sL~ 353 (767)
.....+.+.
T Consensus 76 ~~~~~~~l~ 84 (85)
T cd05857 76 SINHTYHLD 84 (85)
T ss_pred EEEEEEEEE
Confidence 988776654
No 65
>cd04976 Ig2_VEGFR Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). Ig2_VEGFR: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A. VEGFR-1 may play an inhibitory part in these processes by binding VEGF and interfering with its interaction with VEGFR-2. VEGFR-1 has a signa
Probab=98.25 E-value=1.1e-06 Score=73.70 Aligned_cols=70 Identities=26% Similarity=0.390 Sum_probs=55.2
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceE
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYT 351 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~s 351 (767)
+.|.|.+.+.|.|.+.|.+++..+..... +. .....|.|.++..+|.|.|+|.|.|..|....+++
T Consensus 1 ~~l~c~v~g~P~p~v~W~k~g~~l~~~~~--------~~------~~~~~L~I~~v~~~D~G~YtC~a~N~~g~~~~~~~ 66 (71)
T cd04976 1 VRLPVKVKAYPPPEIQWYKNGKLISEKNR--------TK------KSGHSLTIKDVTEEDAGNYTVVLTNKQAKLEKRLT 66 (71)
T ss_pred CEEEeEEEEeCCCEEEEEECCEECCCCCE--------EE------cCCCEEEECcCCHHHCEEEEEEEEcCCccEEEEEE
Confidence 35789999999999999999887754311 11 12357999999999999999999999998877776
Q ss_pred EEEE
Q psy12044 352 IRIV 355 (767)
Q Consensus 352 L~V~ 355 (767)
+.+.
T Consensus 67 ~~~~ 70 (71)
T cd04976 67 FTLV 70 (71)
T ss_pred EEEE
Confidence 6553
No 66
>cd05723 Ig4_Neogenin Fourth immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig4_Neogenin: fourth immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=98.25 E-value=1.2e-06 Score=73.41 Aligned_cols=69 Identities=22% Similarity=0.451 Sum_probs=52.8
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceE
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYT 351 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~s 351 (767)
+.|.|.+.|.|.|.++|.+++..+..... +... ....|.|.++..+|.|.|.|.|.|..|...+.+.
T Consensus 2 v~l~C~~~G~P~p~v~W~k~g~~~~~~~~-------~~~~------~~~~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~ 68 (71)
T cd05723 2 VIFECEVTGKPTPTVKWVKNGDMVIPSDY-------FKIV------KEHNLQVLGLVKSDEGFYQCIAENDVGNVQASAQ 68 (71)
T ss_pred EEEEEEEEEeCCCEEEEEECCeECCCCCC-------EEEE------ecCCEEEEcCCcccCEEEEEEEEcCCCEEEEEEE
Confidence 57899999999999999998876543211 1111 1234788899999999999999999999877665
Q ss_pred EE
Q psy12044 352 IR 353 (767)
Q Consensus 352 L~ 353 (767)
+.
T Consensus 69 L~ 70 (71)
T cd05723 69 LI 70 (71)
T ss_pred EE
Confidence 54
No 67
>cd04978 Ig4_L1-NrCAM_like Fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). Ig4_L1-NrCAM_like: fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). These proteins belong to the L1 subfamily of cell adhesion molecules (CAMs) and are comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. These molecules are primarily expressed in the nervous system. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=98.24 E-value=1.4e-06 Score=73.43 Aligned_cols=75 Identities=27% Similarity=0.517 Sum_probs=58.2
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCccc
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSS 348 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~ 348 (767)
|+.+.|.|.+.+.|.|.+.|.+++..+...... .. .......|.|.++...|.|.|.|.|.|..|...+
T Consensus 1 G~~~~l~C~~~g~P~p~i~W~~~g~~~~~~~~~------~~-----~~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~ 69 (76)
T cd04978 1 GETGRLDCEAEGIPQPTITWRLNGVPIEELPPD------PR-----RRVDGGTLILSNVQPNDTAVYQCNASNVHGYLLA 69 (76)
T ss_pred CCeEEEEEEceeeCCCEEEEEECCEECCCCCCc------ce-----EEccCCEEEECCCChhhCEEEEEEEEccCCeEEE
Confidence 567889999999999999999988766543211 00 0112357999999999999999999999999887
Q ss_pred ceEEEE
Q psy12044 349 NYTIRI 354 (767)
Q Consensus 349 s~sL~V 354 (767)
++.+.|
T Consensus 70 ~~~l~V 75 (76)
T cd04978 70 NAFVHV 75 (76)
T ss_pred eEEEEE
Confidence 776654
No 68
>cd04969 Ig5_Contactin_like Fifth Ig domain of contactin. Ig5_Contactin_like: Fifth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=98.24 E-value=1.4e-06 Score=73.27 Aligned_cols=72 Identities=29% Similarity=0.460 Sum_probs=56.3
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCccc
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSS 348 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~ 348 (767)
|..+.|.|.+.+.|.|.++|.+++..+..... +... ....|.|.++...|.|.|.|.|.|..|....
T Consensus 1 G~~v~L~C~~~g~P~p~v~W~k~~~~~~~~~~-------~~~~------~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~ 67 (73)
T cd04969 1 GGDVIIECKPKAAPKPTISWSKGTELLTNSSR-------ICIW------PDGSLEILNVTKSDEGKYTCFAENFFGKANS 67 (73)
T ss_pred CCeEEEEEeeeEcCCCEEEEEECCEEcccCCC-------EEEC------CCCeEEEccCChhHCEEEEEEEECCCCceEE
Confidence 56788999999999999999998876543211 1111 1246999999999999999999999999887
Q ss_pred ceEEE
Q psy12044 349 NYTIR 353 (767)
Q Consensus 349 s~sL~ 353 (767)
.+.+.
T Consensus 68 ~~~l~ 72 (73)
T cd04969 68 TGSLS 72 (73)
T ss_pred EEEEE
Confidence 76654
No 69
>cd05870 Ig5_NCAM-2 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). Ig5_NCAM-2: the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=98.24 E-value=3.2e-06 Score=75.48 Aligned_cols=87 Identities=21% Similarity=0.319 Sum_probs=61.2
Q ss_pred cceeecccccccccccccccCCCcEEEeec--CeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEee
Q psy12044 262 FYLEIQEGKNVSLLCKVSAIPEAKITWLFD--GVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVA 339 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~a~g~P~p~itW~~~--g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA 339 (767)
.+..+.+|+.++|.|.+.+.|.|.+.|.+. +..+........ ..+.... ......|.|.++..+|.|.|.|.|
T Consensus 9 ~~~~~~~G~~v~l~C~~~G~P~p~i~W~k~~~g~~~~~~~~~~~--~r~~v~~---~~~~~~L~I~~v~~~D~G~Y~C~A 83 (98)
T cd05870 9 KNETTVENGAATLSCKAEGEPIPEITWKRASDGHTFSEGDKSPD--GRIEVKG---QHGESSLHIKDVKLSDSGRYDCEA 83 (98)
T ss_pred ccEEEcCCCcEEEEEecccCCCCeEEEEECCCCceeccCCcCcC--ceEEEee---cCCeeEEEEeeCCcCCCEEEEEEE
Confidence 456788999999999999999999999984 332221110000 1111111 112357999999999999999999
Q ss_pred ccCCCCcccceEEE
Q psy12044 340 ENQAGSTSSNYTIR 353 (767)
Q Consensus 340 ~N~~G~s~~s~sL~ 353 (767)
.|..|....++.|.
T Consensus 84 ~N~~G~~~~~~~l~ 97 (98)
T cd05870 84 ASRIGGHQKSMYLD 97 (98)
T ss_pred eccCCcceeEEEEe
Confidence 99999887766553
No 70
>KOG0531|consensus
Probab=98.23 E-value=2.9e-07 Score=104.11 Aligned_cols=150 Identities=30% Similarity=0.346 Sum_probs=107.9
Q ss_pred CCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEE
Q psy12044 49 PNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKL 128 (767)
Q Consensus 49 ~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L 128 (767)
..+..+++..|.|..+... +. .+.+|..|++.+|+|..+... +..+.+|++|+|++|.|+.+.+ +..++.|+.|
T Consensus 72 ~~l~~l~l~~n~i~~~~~~-l~--~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L 145 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAKILNH-LS--KLKSLEALDLYDNKIEKIENL-LSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL 145 (414)
T ss_pred HhHHhhccchhhhhhhhcc-cc--cccceeeeeccccchhhcccc-hhhhhcchheeccccccccccc--hhhccchhhh
Confidence 4566777888888763322 22 267888888888888887432 6678888888888888888753 5677778888
Q ss_pred ECCCCcCcccccCCcCCCCCccEEeccCCCccccch-hhhcCCCCCCeeeccCCccccccCCCCCCCCcccccCCCCCCC
Q psy12044 129 TLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIED-AAFVGLDSLEWLKLDNNKITTISGSNILPTGLHGIDLHHNPWT 207 (767)
Q Consensus 129 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~-~~~~~l~~L~~L~Ls~N~Lt~ip~~~~~~~~L~~L~Ls~N~l~ 207 (767)
++++|.|+.+.. +..+..|+.++|++|.++.+.. . ...+.+|+.+.+.+|.+..+.... ....+..+++.+|.+.
T Consensus 146 ~l~~N~i~~~~~--~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~~~-~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 146 NLSGNLISDISG--LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEGLD-LLKKLVLLSLLDNKIS 221 (414)
T ss_pred eeccCcchhccC--CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccchH-HHHHHHHhhcccccce
Confidence 888888888764 5568888888888888888776 2 466778888888888887665332 1234444566666665
Q ss_pred c
Q psy12044 208 C 208 (767)
Q Consensus 208 C 208 (767)
.
T Consensus 222 ~ 222 (414)
T KOG0531|consen 222 K 222 (414)
T ss_pred e
Confidence 4
No 71
>cd04971 Ig_TrKABC_d5 Fifth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d5: the fifth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrkB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor foun
Probab=98.22 E-value=2.8e-06 Score=73.21 Aligned_cols=77 Identities=18% Similarity=0.280 Sum_probs=56.1
Q ss_pred ccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceEEE
Q psy12044 274 LLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYTIR 353 (767)
Q Consensus 274 L~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~sL~ 353 (767)
+.|.+.|.|.|.++|.+++..+....... ..............+.|.|.++...|.|.|+|+|.|..|.+.+.+.+.
T Consensus 3 i~~~v~G~P~P~v~W~k~g~~i~~~~~~~---~~~~~~~~~~~~~~~~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~~~ 79 (81)
T cd04971 3 IPFTVRGNPKPTLTWYHNGAVLNESDYIR---TEIHYEVTTPTEYHGCLQFDNPTHVNNGNYTLVASNEYGQDSKSISAH 79 (81)
T ss_pred EEEEeEeeCCCcEEEEECCEECcCCCcee---EEEEeecccccccEEEEEECCCCcccCeEEEEEEEeCCCCeeeEEEee
Confidence 57899999999999999998876443110 000011111234466899999999999999999999999988776654
No 72
>cd05864 Ig2_VEGFR-2 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). Ig2_VEGF-2: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-2 (KDR/Flk-1) is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF-A also interacts with VEGFR-1, which it binds more strongly than VEGFR-2. VEGFR-2 and -1 may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=98.22 E-value=1.4e-06 Score=72.93 Aligned_cols=68 Identities=21% Similarity=0.329 Sum_probs=54.3
Q ss_pred cccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceEE
Q psy12044 273 SLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYTI 352 (767)
Q Consensus 273 sL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~sL 352 (767)
.+.|.+.|.|.|.+.|++++..+..... . .....|.|.++..+|.|.|+|.|.|..|......++
T Consensus 2 ~~~c~v~G~P~P~v~W~k~g~~l~~~~~---------~------~~~~~L~I~~v~~~D~G~YtC~a~N~~G~~~~~~t~ 66 (70)
T cd05864 2 KIPVKYYGYPPPEVKWYKNGQLIVLNHT---------F------KRGVHLTIYEVTEKDAGNYTVVLTNPITKEEQRHTF 66 (70)
T ss_pred EEEeEEEEeCCCEEEEEECCEECCCCCE---------E------ccCCEEEECcCCHHHCEEEEEEEEECCCceeeEEEE
Confidence 5789999999999999999988754211 0 112469999999999999999999999988776666
Q ss_pred EEE
Q psy12044 353 RIV 355 (767)
Q Consensus 353 ~V~ 355 (767)
.+.
T Consensus 67 ~l~ 69 (70)
T cd05864 67 QLV 69 (70)
T ss_pred EEE
Confidence 543
No 73
>KOG4579|consensus
Probab=98.22 E-value=7.6e-08 Score=89.15 Aligned_cols=133 Identities=19% Similarity=0.221 Sum_probs=90.0
Q ss_pred ccEEEccCCCCCccC--cccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEec
Q psy12044 77 LQKIYLSRCRISVID--SKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLEL 154 (767)
Q Consensus 77 L~~L~Ls~N~L~~i~--p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 154 (767)
+..++|++|.|..+. +..+.....|...+|++|.+...++..-...+.++.|+|++|.|+.++.+ +..++.|+.|++
T Consensus 29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE-~Aam~aLr~lNl 107 (177)
T KOG4579|consen 29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEE-LAAMPALRSLNL 107 (177)
T ss_pred hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHH-HhhhHHhhhccc
Confidence 334555555544331 11233334455566777777666655444445677777788877777665 777888888888
Q ss_pred cCCCccccchhhhcCCCCCCeeeccCCccccccCCCCCCCCcccccCCCCCCCchhh
Q psy12044 155 SKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISGSNILPTGLHGIDLHHNPWTCDCL 211 (767)
Q Consensus 155 s~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~~~~~~~L~~L~Ls~N~l~C~c~ 211 (767)
+.|.|...+.- +..+.+|..|+..+|.+..|+-..+-....-.+++.+++|...|.
T Consensus 108 ~~N~l~~~p~v-i~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 108 RFNPLNAEPRV-IAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred ccCccccchHH-HHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcccccCc
Confidence 88888776554 444888899999999999988776655666667888999987765
No 74
>cd05744 Ig_Myotilin_C_like Immunoglobulin (Ig)-like domain of myotilin, palladin, and myopalladin. Ig_Myotilin_like_C: immunoglobulin (Ig)-like domain in myotilin, palladin, and myopalladin. Myotilin, palladin, and myopalladin function as scaffolds that regulate actin organization. Myotilin and myopalladin are most abundant in skeletal and cardiac muscle; palladin is ubiquitously expressed in the organs of developing vertebrates and plays a key role in cellular morphogenesis. The three family members each interact with specific molecular partners: all three bind to alpha-actinin; in addition, palladin also binds to vasodilator-stimulated phosphoprotein (VASP) and ezrin, myotilin binds to filamin and actin, and myopalladin also binds to nebulin and cardiac ankyrin repeat protein (CARP).
Probab=98.21 E-value=1.9e-06 Score=73.04 Aligned_cols=74 Identities=31% Similarity=0.441 Sum_probs=54.8
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceE
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYT 351 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~s 351 (767)
+.|.|.+.+.|.|.+.|.+++..+..... .+.....+ .....|.|.++..+|.|.|.|.|.|..|.....+.
T Consensus 1 v~L~C~v~G~P~P~v~W~k~~~~i~~~~~------r~~~~~~~--~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 72 (75)
T cd05744 1 VRLECRVSAIPPPQIFWKKNNEMLTYNTD------RISLYQDN--CGRICLLIQNANKEDAGWYTVSAVNEAGVVSCNAR 72 (75)
T ss_pred CEEEEEEeecCCCeEEEEECCEECCCCCC------cEEEEEcC--CCeEEEEECCCCcccCEEEEEEEEcCCCcEEEEEE
Confidence 46899999999999999999887753211 11111111 11236999999999999999999999999877766
Q ss_pred EE
Q psy12044 352 IR 353 (767)
Q Consensus 352 L~ 353 (767)
+.
T Consensus 73 l~ 74 (75)
T cd05744 73 LD 74 (75)
T ss_pred Ee
Confidence 54
No 75
>cd05856 Ig2_FGFRL1-like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). Ig2_FGFRL1-like: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). FGFRL1 is comprised of a signal peptide, three extracellular Ig-like modules, a transmembrane segment, and a short intracellular domain. FGFRL1 is expressed preferentially in skeletal tissues. Similar to FGF receptors, the expressed protein interacts specifically with heparin and with FGF2. FGFRL1 does not have a protein tyrosine kinase domain at its C terminus; neither does its cytoplasmic domain appear to interact with a signaling partner. It has been suggested that FGFRL1 may not have any direct signaling function, but instead acts as a decoy receptor trapping FGFs and preventing them from binding other receptors.
Probab=98.20 E-value=2.1e-06 Score=73.36 Aligned_cols=77 Identities=30% Similarity=0.558 Sum_probs=58.7
Q ss_pred eeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCC
Q psy12044 264 LEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQA 343 (767)
Q Consensus 264 ~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~ 343 (767)
.....|+.+.|.|.+.+.|.|.+.|.+++..+...... ........|.|.++..+|.|.|.|.+.|..
T Consensus 4 ~~~~~G~~v~L~C~~~g~p~p~i~W~k~~~~~~~~~~~------------~~~~~~~~L~i~~v~~~D~G~Y~C~a~N~~ 71 (82)
T cd05856 4 IARPVGSSVRLKCVASGNPRPDITWLKDNKPLTPTEIG------------ESRKKKWTLSLKNLKPEDSGKYTCHVSNRA 71 (82)
T ss_pred eeccCCCeEEEEEEeeEeCCCcEEEEECCcCCcCCccc------------eecCceEEEEEccCChhhCEEEEEEEEcCC
Confidence 34567899999999999999999999987655322111 001123579999999999999999999999
Q ss_pred CCcccceEE
Q psy12044 344 GSTSSNYTI 352 (767)
Q Consensus 344 G~s~~s~sL 352 (767)
|.....+.+
T Consensus 72 G~~~~~~~v 80 (82)
T cd05856 72 GEINATYKV 80 (82)
T ss_pred ccEEEEEEE
Confidence 987665544
No 76
>cd05725 Ig3_Robo Third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig3_Robo: domain similar to the third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=98.20 E-value=1.7e-06 Score=71.79 Aligned_cols=68 Identities=22% Similarity=0.418 Sum_probs=51.6
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceE
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYT 351 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~s 351 (767)
+.|.|.+.+.|.|.+.|.+++..+.... +... ....|.|.++..+|.|.|.|.|.|..|.......
T Consensus 1 v~l~C~~~g~P~p~v~W~k~~~~~~~~~--------~~~~------~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 66 (69)
T cd05725 1 VEFQCEVGGDPVPTVLWRKEDGELPKGR--------AEIL------DDKSLKIRNVTAGDEGSYTCEAENMVGKIEASAS 66 (69)
T ss_pred CEEEEECccCCCCEEEEEECCccCCCCc--------EEEe------eCCEEEECcCChhHCEEEEEEEEcCCCcEEEEEE
Confidence 4688999999999999999865442211 1111 2346999999999999999999999998776655
Q ss_pred EE
Q psy12044 352 IR 353 (767)
Q Consensus 352 L~ 353 (767)
+.
T Consensus 67 l~ 68 (69)
T cd05725 67 LT 68 (69)
T ss_pred EE
Confidence 43
No 77
>cd05748 Ig_Titin_like Immunoglobulin (Ig)-like domain of titin and similar proteins. Ig_Titin_like: immunoglobulin (Ig)-like domain found in titin-like proteins. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic, depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone. It appears to function similarly to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching. Within the sarcomere, titin is also attached to or is associated with myosin binding protein C (MyBP-C). MyBP-C appears to contribute to the generation of passive tension by titin, and similar to titin has repeated Ig-like and FN-
Probab=98.19 E-value=2e-06 Score=72.37 Aligned_cols=72 Identities=26% Similarity=0.452 Sum_probs=55.0
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceE
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYT 351 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~s 351 (767)
+.|.|.+.|.|.|.+.|.+++..+..... +.... ....+.|.|.++...|.|.|.|.|.|..|.....+.
T Consensus 2 ~~l~c~~~G~P~p~v~W~k~g~~l~~~~~-------~~~~~---~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 71 (74)
T cd05748 2 VRLEVPISGRPTPTVTWSKDGKPLKLSGR-------VQIET---TASSTSLVIKNAERSDSGKYTLTLKNPAGEKSATIN 71 (74)
T ss_pred EEEEeeEeeeCCCeEEEEECCEEcCCCCe-------EEEEE---CCCeEEEEECCCCcCcCEEEEEEEECCCccEEEEEE
Confidence 56899999999999999999887632211 11111 123568999999999999999999999998877665
Q ss_pred EE
Q psy12044 352 IR 353 (767)
Q Consensus 352 L~ 353 (767)
+.
T Consensus 72 l~ 73 (74)
T cd05748 72 VK 73 (74)
T ss_pred EE
Confidence 54
No 78
>cd05865 Ig1_NCAM-1 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. Ig1_NCAM-1: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (trans
Probab=98.18 E-value=2.5e-06 Score=75.97 Aligned_cols=84 Identities=29% Similarity=0.563 Sum_probs=59.8
Q ss_pred ceeecccccccccccccccCC-CcEEEee-cCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeec
Q psy12044 263 YLEIQEGKNVSLLCKVSAIPE-AKITWLF-DGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAE 340 (767)
Q Consensus 263 ~~~v~~G~~vsL~C~a~g~P~-p~itW~~-~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~ 340 (767)
...+..|+.+.|.|.+.+.|. |.+.|.+ ++..+.... ..+..... ....++|.|.++..+|.|.|+|.|.
T Consensus 9 ~~~v~~G~~v~l~C~v~G~P~~p~i~W~~~~g~~l~~~~------~r~~v~~~--~~~~~~L~I~~v~~~D~G~YtC~A~ 80 (96)
T cd05865 9 QGEISVGESKFFLCQVAGEAKDKDISWFSPNGEKLTPNQ------QRISVVRN--DDYSSTLTIYNANIDDAGIYKCVVS 80 (96)
T ss_pred ccEECCCCeEEEEEEEeCCCCCCEEEEECCCCcCccccC------CeEEEEeC--CCCceEEEEeccChhhCEEEEEEEE
Confidence 446788999999999999995 7999998 665443211 01111111 1124689999999999999999999
Q ss_pred cCC-CCcccceEEEE
Q psy12044 341 NQA-GSTSSNYTIRI 354 (767)
Q Consensus 341 N~~-G~s~~s~sL~V 354 (767)
|.. |.+.+++.+.|
T Consensus 81 N~~~g~~~~s~~l~v 95 (96)
T cd05865 81 NEDEGESEATVNVKI 95 (96)
T ss_pred cCCCCcEEEEEEEEE
Confidence 996 77666655543
No 79
>cd05891 Ig_M-protein_C C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). Ig_M-protein_C: the C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). M-protein is a structural protein localized to the M-band, a transverse structure in the center of the sarcomere, and is a candidate for M-band bridges. M-protein is modular consisting mainly of repetitive IG-like and fibronectin type III (FnIII) domains, and has a muscle-type specific expression pattern. M-protein is present in fast fibers.
Probab=98.18 E-value=2.4e-06 Score=75.48 Aligned_cols=83 Identities=24% Similarity=0.414 Sum_probs=62.8
Q ss_pred cceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeecc
Q psy12044 262 FYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAEN 341 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N 341 (767)
..+.+.+|+.+.|.|.+.+.|.|.+.|++++..+..... ...... .+ ..+.|.|.++..+|.|.|.|.|.|
T Consensus 9 ~~v~v~eG~~v~L~C~v~g~P~p~i~W~k~~~~~~~~~~-----~~~~~~-~~---~~~~L~I~~~~~~D~G~Y~C~a~N 79 (92)
T cd05891 9 DVVTIMEGKTLNLTCTVFGNPDPEVIWFKNDQDIELSEH-----YSVKLE-QG---KYASLTIKGVTSEDSGKYSINVKN 79 (92)
T ss_pred CcEEEcCCCEEEEEEEEEEeCCCeEEEEECCEECCCCCC-----EEEEEc-CC---CEEEEEECCCChhhCEEEEEEEEe
Confidence 356788999999999999999999999998766543211 001111 11 125799999999999999999999
Q ss_pred CCCCcccceEEE
Q psy12044 342 QAGSTSSNYTIR 353 (767)
Q Consensus 342 ~~G~s~~s~sL~ 353 (767)
..|.....+.++
T Consensus 80 ~~G~~~~~~~v~ 91 (92)
T cd05891 80 KYGGETVDVTVS 91 (92)
T ss_pred CCCceeeEEEEE
Confidence 999988776654
No 80
>cd05746 Ig4_Peroxidasin Fourth immunoglobulin (Ig)-like domain of peroxidasin. Ig4_Peroxidasin: the fourth immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted, and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells, which have undergone programmed cell death, and protection of the organism against non-self.
Probab=98.17 E-value=2e-06 Score=71.46 Aligned_cols=68 Identities=29% Similarity=0.527 Sum_probs=52.2
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceE
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYT 351 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~s 351 (767)
+.|.|.+.+.|.|.+.|.+++..+..... +... ..+.|.|.++..+|.|.|.|.|.|..|....++.
T Consensus 1 v~L~C~~~g~P~p~i~W~k~g~~~~~~~~-------~~~~------~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 67 (69)
T cd05746 1 VQIPCSAQGDPEPTITWNKDGVQVTESGK-------FHIS------PEGYLAIRDVGVADQGRYECVARNTIGYASVSMV 67 (69)
T ss_pred CEeEecceEeCCCEEEEEECCEECCCCCC-------EEEC------CCCEEEECcCChhhCEEEEEEEECCCCcEEEEEE
Confidence 46899999999999999998876543211 1111 1357999999999999999999999998776554
Q ss_pred E
Q psy12044 352 I 352 (767)
Q Consensus 352 L 352 (767)
|
T Consensus 68 L 68 (69)
T cd05746 68 L 68 (69)
T ss_pred e
Confidence 3
No 81
>cd05731 Ig3_L1-CAM_like Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM_like: domain similar to the third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM and human neurofascin.
Probab=98.15 E-value=2.2e-06 Score=71.25 Aligned_cols=70 Identities=24% Similarity=0.465 Sum_probs=52.7
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceE
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYT 351 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~s 351 (767)
+.|.|.+.+.|.|.+.|.+++..+...... . ......|.|.++..+|.|.|.|.|.|..|.....+.
T Consensus 1 v~l~C~~~g~P~p~v~W~k~~~~~~~~~~~--------~-----~~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 67 (71)
T cd05731 1 LLLECIAEGLPTPEISWIKIGGELPADRTK--------F-----ENFNKTLKIDNVSEEDDGEYRCTASNSLGSARHTIS 67 (71)
T ss_pred CEEEEEeeEecCCeEEEEECCeECCCCcee--------E-----ecCCCEEEECCCCHHHCEEEEEEEEeCCceEEEEEE
Confidence 358899999999999999987654321110 0 112357999999999999999999999998776665
Q ss_pred EEE
Q psy12044 352 IRI 354 (767)
Q Consensus 352 L~V 354 (767)
+.|
T Consensus 68 l~V 70 (71)
T cd05731 68 VTV 70 (71)
T ss_pred EEE
Confidence 544
No 82
>cd05760 Ig2_PTK7 Second immunoglobulin (Ig)-like domain of protein tyrosine kinase (PTK) 7, also known as CCK4. Ig2_PTK7: domain similar to the second immunoglobulin (Ig)-like domain in protein tyrosine kinase (PTK) 7, also known as CCK4. PTK7 is a subfamily of the receptor protein tyrosine kinase family, and is referred to as an RPTK-like molecule. RPTKs transduce extracellular signals across the cell membrane, and play important roles in regulating cell proliferation, migration, and differentiation. PTK7 is organized as an extracellular portion having seven Ig-like domains, a single transmembrane region, and a cytoplasmic tyrosine kinase-like domain. PTK7 is considered a pseudokinase as it has several unusual residues in some of the highly conserved tyrosine kinase (TK) motifs; it is predicted to lack TK activity. PTK7 may function as a cell-adhesion molecule. PTK7 mRNA is expressed at high levels in placenta, melanocytes, liver, lung, pancreas, and kidney. PTK7 is overexpressed in s
Probab=98.14 E-value=3.8e-06 Score=71.46 Aligned_cols=72 Identities=26% Similarity=0.528 Sum_probs=53.1
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceE
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYT 351 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~s 351 (767)
++|.|.+.+.|.|.+.|.+++..+..... .+... ...+.|.|.++..+|.|.|.|.|.|..|.......
T Consensus 1 v~L~C~~~g~P~p~v~W~k~g~~l~~~~~------~~~~~-----~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~s~~~ 69 (77)
T cd05760 1 VTLRCHIDGHPRPTYQWFRDGTPLSDGQG------NYSVS-----SKERTLTLRSAGPDDSGLYYCCAHNAFGSVCSSQN 69 (77)
T ss_pred CEEEEEeeecCCCcEEEEECCEECCCCCc------cEEEe-----CCCCEEEEeeCCcccCEEEEEEEEeCCCeEeeCce
Confidence 46899999999999999999876643211 11111 12347999999999999999999999998755444
Q ss_pred EEE
Q psy12044 352 IRI 354 (767)
Q Consensus 352 L~V 354 (767)
+++
T Consensus 70 ~~l 72 (77)
T cd05760 70 FTL 72 (77)
T ss_pred EEE
Confidence 444
No 83
>cd05743 Ig_Perlecan_D2_like Immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Ig_Perlecan_D2_like: the immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Perlecan consists of five domains. Domain I has three putative heparan sulfate attachment sites; domain II has four LDL receptor-like repeats, and one Ig-like repeat; domain III resembles the short arm of laminin chains; domain IV has multiple Ig-like repeats (21 repeats in human perlecan); and domain V resembles the globular G domain of the laminin A chain and internal repeats of EGF. Perlecan may participate in a variety of biological functions including cell binding, LDL-metabolism, basement membrane assembly and selective permeability, calcium binding, and growth- and neurite-promoting activities.
Probab=98.14 E-value=2.2e-06 Score=73.10 Aligned_cols=74 Identities=23% Similarity=0.345 Sum_probs=55.1
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCccc
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSS 348 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~ 348 (767)
|..+.|.|.+.+.|.|.+.|.+++..+..... +.... ....+.|.|.++..+|.|.|.|.|.|..|...+
T Consensus 1 G~~v~l~C~~~g~P~p~v~W~~~~~~~~~~~~-------~~~~~---~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~ 70 (78)
T cd05743 1 GETVEFTCVATGVPTPIINWRLNWGHVPDSAR-------VSITS---EGGYGTLTIRDVKESDQGAYTCEAINTRGMVFG 70 (78)
T ss_pred CCEEEEEEEEEEecCCEEEEEECCeECCCCCC-------EEEEE---CCCEEEEEECCCChHHCEEEEEEEEecCCEEEe
Confidence 56789999999999999999988765532211 11111 112467999999999999999999999998766
Q ss_pred ceEE
Q psy12044 349 NYTI 352 (767)
Q Consensus 349 s~sL 352 (767)
...+
T Consensus 71 ~~~~ 74 (78)
T cd05743 71 IPDG 74 (78)
T ss_pred cccE
Confidence 5443
No 84
>cd07693 Ig1_Robo First immunoglobulin (Ig)-like domain in Robo (roundabout) receptors and similar proteins. Ig1_Robo: domain similar to the first immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit res
Probab=98.13 E-value=7.8e-06 Score=72.39 Aligned_cols=94 Identities=27% Similarity=0.445 Sum_probs=58.8
Q ss_pred CCCCccceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCcee
Q psy12044 257 ITPSTFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFV 336 (767)
Q Consensus 257 i~~~~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~ 336 (767)
+...+....+.+|+.+.|.|.+.+.|.|.+.|.+++..+........ .. ......+.. ....+....+...|.|.|.
T Consensus 4 i~~~p~~~~v~~G~~~~l~C~~~g~P~p~i~W~k~g~~l~~~~~~~~-~~-~~~~~~~~~-~~~~i~~~~~~~~D~G~Y~ 80 (100)
T cd07693 4 IVEHPSDLIVSKGDPATLNCKAEGRPTPTIQWLKNGQPLETDKDDPR-SH-RIVLPSGSL-FFLRVVHGRKGRSDEGVYV 80 (100)
T ss_pred EEecCceeEEcCCCeEEEEeeCCcCCCCEEEEEECCEECccccCCCC-cc-eEEecCCcE-EEEEeeccCCCcCcCEEEE
Confidence 33444567788999999999999999999999999877654221100 01 111111110 0011112223688999999
Q ss_pred EeeccCCCC-cccceEEE
Q psy12044 337 CVAENQAGS-TSSNYTIR 353 (767)
Q Consensus 337 CvA~N~~G~-s~~s~sL~ 353 (767)
|.|.|..|. ....+.+.
T Consensus 81 C~a~N~~G~~~s~~~~l~ 98 (100)
T cd07693 81 CVAHNSLGEAVSRNASLE 98 (100)
T ss_pred EEEEccccceecceEEEE
Confidence 999999998 44444443
No 85
>cd05739 Ig3_RPTP_IIa_LAR_like Third immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig3_RPTP_IIa_LAR_like: domain similar to the third immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple IG-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains. Included in this group is Drosophila LAR (DLAR).
Probab=98.13 E-value=3.7e-06 Score=70.06 Aligned_cols=67 Identities=21% Similarity=0.420 Sum_probs=49.9
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCccc
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSS 348 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~ 348 (767)
|..+.|.|.+.|.|.|.+.|.+++..+...... ......|.|.++ .|.|.|.|.|.|..|...+
T Consensus 1 G~~v~L~C~a~G~P~P~v~W~k~g~~l~~~~~~--------------~~~~~~L~i~~~--~d~G~Y~C~A~N~~G~~~~ 64 (69)
T cd05739 1 GGSVNLTCVAVGAPMPYVKWMKGGEELTKEDEM--------------PVGRNVLELTNI--YESANYTCVAISSLGMIEA 64 (69)
T ss_pred CCeEEEEEEeeecCCCEEEEEECCEECCCccce--------------ecCccEEEEecc--ccCeeEEEEEEeCCCEEEE
Confidence 567899999999999999999988765332111 011246788886 4789999999999998665
Q ss_pred ceE
Q psy12044 349 NYT 351 (767)
Q Consensus 349 s~s 351 (767)
.+.
T Consensus 65 ~a~ 67 (69)
T cd05739 65 TAQ 67 (69)
T ss_pred EEE
Confidence 543
No 86
>cd05758 Ig5_KIRREL3-like Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2) and similar proteins. Ig5_KIRREL3-like: domain similar to the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=98.12 E-value=9.2e-06 Score=72.49 Aligned_cols=86 Identities=19% Similarity=0.246 Sum_probs=61.7
Q ss_pred cceeecccccccccccccccCCC-cEEEeecCeeccCCCcccccccceeeccc-CcceeeeEEEEeeeccCC-CCceeEe
Q psy12044 262 FYLEIQEGKNVSLLCKVSAIPEA-KITWLFDGVPIQNESMSASESHAVYSTEE-GTEIKKSELLIYNSNIDD-NGTFVCV 338 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~a~g~P~p-~itW~~~g~~l~~~s~~~~~~~~~~~~~~-g~~~~~s~L~I~nvs~sD-~GtY~Cv 338 (767)
....+..|..+.|.|.+.+.|.| .+.|.+++..+...... .+..... ......+.|.|.++..+| .|.|.|.
T Consensus 9 ~~~~~~~G~~v~L~C~~~g~P~P~~v~W~~~~~~i~~~~~~-----r~~i~~~~~~~~~~s~L~I~~v~~~d~~G~Y~C~ 83 (98)
T cd05758 9 ATQYAILGDKGRVECFIFSTPPPDRIVWTWKENELESGSSG-----RYTVETDPSPGGVLSTLTISNTQESDFQTSYNCT 83 (98)
T ss_pred CcEEEeCCCcEEEEEEEcccCCCCEeEEEECCEEccCCCCC-----CEEEEEecCCCceEEEEEECCccccccceeEEEE
Confidence 34557889999999999999999 59999988766432210 1111111 112234689999999855 8999999
Q ss_pred eccCCCCcccceEE
Q psy12044 339 AENQAGSTSSNYTI 352 (767)
Q Consensus 339 A~N~~G~s~~s~sL 352 (767)
|.|..|.+...+.|
T Consensus 84 A~N~~G~~~~~~~L 97 (98)
T cd05758 84 AWNSFGSGTAIISL 97 (98)
T ss_pred EEcCCCcccEEEEe
Confidence 99999998776554
No 87
>cd05764 Ig_2 Subgroup of the immunoglobulin (Ig) superfamily. Ig_2: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=98.12 E-value=3.8e-06 Score=70.63 Aligned_cols=72 Identities=32% Similarity=0.607 Sum_probs=53.5
Q ss_pred cccccccccccccCCCcEEEee-cCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcc
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLF-DGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTS 347 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~-~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~ 347 (767)
|+.+.|.|.+.+.|.|.+.|.+ ++..+..... ... ...+.|.|.++...|.|.|.|.|.|..|...
T Consensus 1 G~~~~l~C~~~g~P~p~v~W~~~~~~~~~~~~~-------~~~------~~~~~L~i~~~~~~D~G~Y~C~a~N~~G~~~ 67 (74)
T cd05764 1 GQRATLRCKARGDPEPAIHWISPDGKLISNSSR-------TLV------YDNGTLDILITTVKDTGSFTCIASNAAGEAT 67 (74)
T ss_pred CCeEEEEEEccCcCCCEEEEEeCCCEEecCCCe-------EEE------ecCCEEEEEECChhhCEEEEEEEECCCCeEE
Confidence 5678899999999999999997 4544432211 111 1124688999999999999999999999877
Q ss_pred cceEEE
Q psy12044 348 SNYTIR 353 (767)
Q Consensus 348 ~s~sL~ 353 (767)
..+.+.
T Consensus 68 ~~~~l~ 73 (74)
T cd05764 68 ATVELH 73 (74)
T ss_pred EEEEEE
Confidence 665554
No 88
>cd05765 Ig_3 Subgroup of the immunoglobulin (Ig) superfamily. Ig_3: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=98.11 E-value=4.4e-06 Score=71.35 Aligned_cols=80 Identities=26% Similarity=0.477 Sum_probs=54.2
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCccc
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSS 348 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~ 348 (767)
|+.+.|.|.+.+.|.|.+.|+++...-............ .+ .....+.|.|.++..+|.|.|.|.|.|..|....
T Consensus 1 G~~v~l~C~~~g~P~p~v~W~k~~~~~~~~~~~~~~~~~-~~----~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~ 75 (81)
T cd05765 1 GETASFHCDVTGRPPPEITWEKQVHGKENLIMRPNHVRG-NV----VVTNIGQLVIYNAQPQDAGLYTCTARNSGGLLRA 75 (81)
T ss_pred CCcEEEEeeccccCCCcEEEEecCCCCcceeecCCcccC-CE----EEccccEEEEccCCcccCEEEEEEEecCCceEEE
Confidence 567899999999999999999863210000000000000 00 0112357999999999999999999999999887
Q ss_pred ceEEE
Q psy12044 349 NYTIR 353 (767)
Q Consensus 349 s~sL~ 353 (767)
.+.|.
T Consensus 76 ~~~l~ 80 (81)
T cd05765 76 NFPLS 80 (81)
T ss_pred EEEEe
Confidence 77664
No 89
>cd05763 Ig_1 Subgroup of the immunoglobulin (Ig) superfamily. Ig_1: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=98.11 E-value=4.7e-06 Score=70.35 Aligned_cols=74 Identities=27% Similarity=0.487 Sum_probs=52.6
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceE
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYT 351 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~s 351 (767)
+.|.|.+.+.|.|.++|.+++....... ....+... ...+.|.|.++..+|.|.|.|.|.|..|....++.
T Consensus 1 a~l~C~~~G~P~P~v~W~k~~~~~~~~~----~~~~~~~~-----~~~~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~~~ 71 (75)
T cd05763 1 ARLECAATGHPTPQIAWQKDGGTDFPAA----RERRMHVM-----PEDDVFFIVDVKIEDTGVYSCTAQNTAGSISANAT 71 (75)
T ss_pred CEeEeecccccCCEEEEEeCCCccCCcc----cccceEEe-----cCCCEEEEeeCCcccCEEEEEEEEcCCCEEEeeEE
Confidence 3588999999999999999775321110 00111111 11246899999999999999999999998877766
Q ss_pred EEE
Q psy12044 352 IRI 354 (767)
Q Consensus 352 L~V 354 (767)
+.|
T Consensus 72 l~V 74 (75)
T cd05763 72 LTV 74 (75)
T ss_pred EEE
Confidence 654
No 90
>cd05858 Ig3_FGFR-2 Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor 2 (FGFR2). Ig3_FGFR-2-like; domain similar to the third immunoglobulin (Ig)-like domain of human fibroblast growth factor receptor 2 (FGFR2). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs. FGFR2 is required for male sex determination.
Probab=98.11 E-value=5e-06 Score=72.98 Aligned_cols=81 Identities=23% Similarity=0.439 Sum_probs=55.8
Q ss_pred cccccccccccccCCCcEEEeecC----eeccCCCcccccccceeecc-cC---cceeeeEEEEeeeccCCCCceeEeec
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDG----VPIQNESMSASESHAVYSTE-EG---TEIKKSELLIYNSNIDDNGTFVCVAE 340 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g----~~l~~~s~~~~~~~~~~~~~-~g---~~~~~s~L~I~nvs~sD~GtY~CvA~ 340 (767)
|..+.|.|.+.+.|.|.++|.+.. ..+..... ....... .+ .....+.|.|.++..+|.|.|.|.|.
T Consensus 1 G~~v~L~C~~~g~P~P~i~W~k~~~~~g~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~ 75 (90)
T cd05858 1 GSTVEFVCKVYSDAQPHIQWLKHVEKNGSKYGPDGL-----PYVTVLKTAGVNTTDKEMEVLYLRNVTFEDAGEYTCLAG 75 (90)
T ss_pred CCeEEEEEEEecCCCCEEEEEEecccCCcEeCCCCC-----eeEEEeccCCceecCCceeEEEEccCCHHHCEEEEEEEE
Confidence 567899999999999999999843 22221110 0001100 01 01123689999999999999999999
Q ss_pred cCCCCcccceEEEE
Q psy12044 341 NQAGSTSSNYTIRI 354 (767)
Q Consensus 341 N~~G~s~~s~sL~V 354 (767)
|..|....+..|.|
T Consensus 76 N~~G~~~~~a~L~V 89 (90)
T cd05858 76 NSIGISHHSAWLTV 89 (90)
T ss_pred eCCCcccceEEEEE
Confidence 99999887776654
No 91
>cd05740 Ig_CEACAM_D4 Fourth immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). Ig_CEACAM_D4: immunoglobulin (Ig)-like domain 4 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the
Probab=98.11 E-value=5.7e-06 Score=72.93 Aligned_cols=75 Identities=20% Similarity=0.323 Sum_probs=58.6
Q ss_pred CccceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEee
Q psy12044 260 STFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVA 339 (767)
Q Consensus 260 ~~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA 339 (767)
.+.+..+.+|+.+.|.|.+.+. .|.+.|.+++..+..... ... .....|.|.++..+|.|.|.|.|
T Consensus 9 ~~~~~~v~~g~~v~l~C~a~g~-~p~i~W~kng~~l~~~~~--------~~~-----~~~~~L~I~~v~~~D~G~Y~C~a 74 (91)
T cd05740 9 SVGNQPPEDNQPVTLTCEAEGQ-ATYIWWVNNGSLLVPPRL--------QLS-----NDNRTLTFNNVTRSDTGHYQCEA 74 (91)
T ss_pred ccCccccccCCcEEEEEEeCCC-CCEEEEEECCEECCCCCE--------EEe-----CCCCEEEECcCChhhCEEEEEEE
Confidence 3445678899999999999999 999999998876543211 111 12347999999999999999999
Q ss_pred ccCCCCccc
Q psy12044 340 ENQAGSTSS 348 (767)
Q Consensus 340 ~N~~G~s~~ 348 (767)
.|..|...+
T Consensus 75 ~N~~G~~~S 83 (91)
T cd05740 75 SNEVSNMTS 83 (91)
T ss_pred EcCCCCEEe
Confidence 999997554
No 92
>KOG0531|consensus
Probab=98.10 E-value=5.4e-07 Score=101.89 Aligned_cols=150 Identities=31% Similarity=0.356 Sum_probs=115.8
Q ss_pred CCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcE
Q psy12044 48 DPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMK 127 (767)
Q Consensus 48 ~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~ 127 (767)
..++..|++.+|.|..+... +. .+.+|+.|+|++|.|+.+.+ +..+..|+.|++++|.|+.+. .|..+..|+.
T Consensus 94 ~~~l~~l~l~~n~i~~i~~~-l~--~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~~--~~~~l~~L~~ 166 (414)
T KOG0531|consen 94 LKSLEALDLYDNKIEKIENL-LS--SLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDIS--GLESLKSLKL 166 (414)
T ss_pred ccceeeeeccccchhhcccc-hh--hhhcchheeccccccccccc--hhhccchhhheeccCcchhcc--CCccchhhhc
Confidence 57899999999999988773 22 27899999999999999865 678888999999999999885 4666899999
Q ss_pred EECCCCcCccccc-CCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccccccCCCCCCC-CcccccCCCCC
Q psy12044 128 LTLSGNPIKQIKT-GAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISGSNILPT-GLHGIDLHHNP 205 (767)
Q Consensus 128 L~Ls~N~l~~l~~-~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~~~~~~-~L~~L~Ls~N~ 205 (767)
+++++|.+..+.. . ...+.+|+.+++.+|.+..+.. +..+..+..+++..|.++.+.+...... .|+.+++.+|+
T Consensus 167 l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~--~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~ 243 (414)
T KOG0531|consen 167 LDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEG--LDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNR 243 (414)
T ss_pred ccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccc--hHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCc
Confidence 9999999998876 3 4677889999999998887654 3334455555777887776654322111 26777888887
Q ss_pred CC
Q psy12044 206 WT 207 (767)
Q Consensus 206 l~ 207 (767)
+.
T Consensus 244 i~ 245 (414)
T KOG0531|consen 244 IS 245 (414)
T ss_pred cc
Confidence 65
No 93
>cd05726 Ig4_Robo Fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig4_Robo: domain similar to the fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=98.10 E-value=7.3e-06 Score=71.88 Aligned_cols=82 Identities=23% Similarity=0.378 Sum_probs=58.0
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCccc-ccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcc
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSA-SESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTS 347 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~-~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~ 347 (767)
|..+.|.|.+.+.|.|.+.|.+++.......... .....+... ..+.|.|.++..+|.|.|.|.|.|..|...
T Consensus 1 G~~v~L~C~~~g~P~p~v~W~k~g~~~~~~~~~~~~~~~r~~v~------~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~ 74 (90)
T cd05726 1 GRTVTFQCEATGNPQPAIFWQKEGSQNLLFSYQPPQSSSRFSVS------QTGDLTITNVQRSDVGYYICQTLNVAGSIL 74 (90)
T ss_pred CCEEEEEEECCccCCCEEEEEeCCCcceeecccCCCCCCeEEEC------CCCeEEEeeCChhhCEEEEEEEEcCCCceE
Confidence 5678999999999999999998764321100000 000111111 134699999999999999999999999988
Q ss_pred cceEEEEEe
Q psy12044 348 SNYTIRIVL 356 (767)
Q Consensus 348 ~s~sL~V~~ 356 (767)
..+.+.|..
T Consensus 75 ~~~~l~V~~ 83 (90)
T cd05726 75 TKAYLEVTD 83 (90)
T ss_pred EEEEEEEee
Confidence 888777764
No 94
>cd04970 Ig6_Contactin_like Sixth Ig domain of contactin. Ig6_Contactin_like: Sixth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=98.10 E-value=4.8e-06 Score=72.15 Aligned_cols=80 Identities=25% Similarity=0.466 Sum_probs=56.8
Q ss_pred cccccccccccCCC--cEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCccc
Q psy12044 271 NVSLLCKVSAIPEA--KITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSS 348 (767)
Q Consensus 271 ~vsL~C~a~g~P~p--~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~ 348 (767)
.+.|.|.+.+.|.| .+.|.+++..+...... ....... .....+.|.|.++...|.|.|.|.|.|..|...+
T Consensus 2 ~~~L~C~~~g~P~p~i~~~W~~~g~~i~~~~~~-~~~~~~~-----~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~~ 75 (85)
T cd04970 2 SITLQCHASHDPTLDLTFTWSFNGVPIDFDKDG-GHYRRVG-----GKDSNGDLMIRNAQLKHAGKYTCTAQTVVDSLSA 75 (85)
T ss_pred cEEEEEEEecCCCCCeEEEEEECCeEeeccCCC-ccEEEEe-----cccccceEEEccCCHHhCeeeEEEEecCCCcEEE
Confidence 56899999999988 56899988776432211 0000000 0112467999999999999999999999998887
Q ss_pred ceEEEEEe
Q psy12044 349 NYTIRIVL 356 (767)
Q Consensus 349 s~sL~V~~ 356 (767)
+..+.|..
T Consensus 76 ~~~l~V~~ 83 (85)
T cd04970 76 SADLIVRG 83 (85)
T ss_pred EEEEEEEC
Confidence 77776654
No 95
>KOG1909|consensus
Probab=98.10 E-value=6.5e-07 Score=94.73 Aligned_cols=136 Identities=20% Similarity=0.259 Sum_probs=67.2
Q ss_pred CCccEEEeeCCCCCCCCchhhhcc--CCCCccEEEccCCCCCccCccc-------------ccCCCCCCEEEccCCCCCC
Q psy12044 49 PNTQVLDYTGNNLKTLHNEKFQKM--GLVNLQKIYLSRCRISVIDSKA-------------FRGLTNLVDLDFSHNVLQT 113 (767)
Q Consensus 49 ~~L~~L~Ls~N~L~~l~~~~f~~~--~L~~L~~L~Ls~N~L~~i~p~~-------------f~~L~~L~~L~Ls~N~Lt~ 113 (767)
+.|++|+||+|-|.--....|..+ .+.+|++|+|.||.+....... ...-++|+.+...+|++..
T Consensus 92 ~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 92 PKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLEN 171 (382)
T ss_pred CceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccccc
Confidence 367777777777664333333211 3566777777777665432222 2223466666666666554
Q ss_pred CCC----CCCCCCCCCcEEECCCCcCccc----ccCCcCCCCCccEEeccCCCcccc----chhhhcCCCCCCeeeccCC
Q psy12044 114 VPS----DTFPDYPSLMKLTLSGNPIKQI----KTGAFQPLSYLVTLELSKCGIEVI----EDAAFVGLDSLEWLKLDNN 181 (767)
Q Consensus 114 l~p----~~f~~l~~L~~L~Ls~N~l~~l----~~~~~~~l~~L~~L~Ls~N~L~~i----~~~~~~~l~~L~~L~Ls~N 181 (767)
-.. ..|...+.|+.+.+..|.|..- ...+|..+++|+.|||++|-++.. ....+..+++|+.|++++|
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc 251 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC 251 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence 321 1233445555555555554321 122344455555555555554422 1233444455555555555
Q ss_pred ccc
Q psy12044 182 KIT 184 (767)
Q Consensus 182 ~Lt 184 (767)
.+.
T Consensus 252 ll~ 254 (382)
T KOG1909|consen 252 LLE 254 (382)
T ss_pred ccc
Confidence 544
No 96
>cd05853 Ig6_Contactin-4 Sixth Ig domain of contactin-4. Ig6_Contactin-4: sixth Ig domain of the neural cell adhesion molecule contactin-4. Contactins are neural cell adhesion molecules, and are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. Highest expresson of contactin-4 is in testes, thyroid, small intestine, uterus and brain. Contactin-4 plays a role in the response of neuroblastoma cells to differentiating agents, such as retinoids. The contactin 4 gene is associated with cerebellar degeneration in spinocerebellar ataxia type 16.
Probab=98.09 E-value=4.7e-06 Score=72.41 Aligned_cols=80 Identities=21% Similarity=0.388 Sum_probs=57.9
Q ss_pred cccccccccccC--CCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCccc
Q psy12044 271 NVSLLCKVSAIP--EAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSS 348 (767)
Q Consensus 271 ~vsL~C~a~g~P--~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~ 348 (767)
.+.|.|.+.+.+ .+.+.|.++++.+..... ..+ +...+.....+.|.|.+++..|.|.|+|.|.|..+...+
T Consensus 2 ~~~l~C~v~~d~~l~~~~~W~~dg~~i~~~~~---~~~---~~~~~~~~~~~~L~I~nv~~~dsG~YtC~a~n~~~~~~a 75 (85)
T cd05853 2 SIVLPCQVSHDHSLDIVFTWSFNGHLIDFQKD---GDH---FERVGGQDSAGDLMIRSIQLKHAGKYVCMVQTSVDKLSA 75 (85)
T ss_pred cEEEEEEeccCCCCCcEEEEEECCEECcccCC---Ccc---EEEeccCCCCCcEEEecCCHHHCEEEEEEEEcccCceEE
Confidence 467899998754 778999999988852211 111 111111123457999999999999999999999999988
Q ss_pred ceEEEEEe
Q psy12044 349 NYTIRIVL 356 (767)
Q Consensus 349 s~sL~V~~ 356 (767)
...|.|..
T Consensus 76 ~a~L~V~~ 83 (85)
T cd05853 76 AADLIVRG 83 (85)
T ss_pred EEEEEEec
Confidence 88777764
No 97
>KOG1859|consensus
Probab=98.05 E-value=1.3e-07 Score=107.57 Aligned_cols=128 Identities=26% Similarity=0.340 Sum_probs=95.9
Q ss_pred CccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEE
Q psy12044 50 NTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLT 129 (767)
Q Consensus 50 ~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~ 129 (767)
.|...+++.|.|..+... +.- ++.|+.|+|++|+++... .+..+++|++|||+.|.|..++--....+. |+.|.
T Consensus 165 ~L~~a~fsyN~L~~mD~S-Lql--l~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDES-LQL--LPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hHhhhhcchhhHHhHHHH-HHH--HHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeee
Confidence 466678888888766543 221 678888999999988874 688888999999999998887754444444 88999
Q ss_pred CCCCcCcccccCCcCCCCCccEEeccCCCccccch-hhhcCCCCCCeeeccCCcccc
Q psy12044 130 LSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIED-AAFVGLDSLEWLKLDNNKITT 185 (767)
Q Consensus 130 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~-~~~~~l~~L~~L~Ls~N~Lt~ 185 (767)
|++|.++.+.. +.+|.+|+.|||+.|-|.+... ..+..|..|+.|.|.+|.|-.
T Consensus 239 lrnN~l~tL~g--ie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 239 LRNNALTTLRG--IENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred ecccHHHhhhh--HHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 99998887754 6778889999999987776532 124456778888999987753
No 98
>cd04973 Ig1_FGFR First immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig1_FGFR: The first immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for all FGFs.
Probab=98.02 E-value=8.8e-06 Score=69.58 Aligned_cols=75 Identities=21% Similarity=0.447 Sum_probs=56.7
Q ss_pred ceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccC
Q psy12044 263 YLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQ 342 (767)
Q Consensus 263 ~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~ 342 (767)
...+..|..+.|.|.+.+. .+.+.|++++..+..... +.. ....|.|.++..+|+|.|.|.+.|.
T Consensus 3 ~~~~~~G~~v~l~C~~~~~-~~~v~W~k~g~~l~~~~~-------~~~-------~~~~L~I~~~~~~DsG~Y~C~a~n~ 67 (79)
T cd04973 3 SYSAHPGDLLQLRCRLRDD-VQSINWTKDGVQLGENNR-------TRI-------TGEEVQIKDAVPRDSGLYACVTSSP 67 (79)
T ss_pred cEEecCCCCEEEEEEecCC-CceEEEeeCCcCCCCCce-------EEE-------eCCEEEECCCChhhCEEEEEEEeCC
Confidence 3567789999999999886 578999999877643211 111 1236999999999999999999999
Q ss_pred CCCcccceEE
Q psy12044 343 AGSTSSNYTI 352 (767)
Q Consensus 343 ~G~s~~s~sL 352 (767)
.|.....+.+
T Consensus 68 ~g~~~~~~~v 77 (79)
T cd04973 68 SGSDTTYFSV 77 (79)
T ss_pred CCcccEEEEE
Confidence 8876655443
No 99
>cd05742 Ig1_VEGFR_like First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor (R) and similar proteins. Ig1_VEGFR_like: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R) related proteins. The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF-A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF
Probab=98.01 E-value=7.9e-06 Score=70.63 Aligned_cols=80 Identities=19% Similarity=0.340 Sum_probs=56.4
Q ss_pred ccccccccccccc--CCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCc
Q psy12044 269 GKNVSLLCKVSAI--PEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGST 346 (767)
Q Consensus 269 G~~vsL~C~a~g~--P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s 346 (767)
|+.+.|.|.+.+. |.+.+.|.+++........... . ..........+.|.|.+++.+|.|.|.|.+.|..|..
T Consensus 1 Ge~~~L~C~~~g~~~~~~~i~W~~~~~~~~~~~~~~~--~---~~~~~~~~~~s~L~I~~v~~~DsG~Y~C~a~n~~~~~ 75 (84)
T cd05742 1 GETLVLNCTVLTELNEGVDFQWTYPGKKRGRGKSMVT--R---QSLSEATELSSTLTIPNATLKDSGTYTCAASSGTMDQ 75 (84)
T ss_pred CCeEEEEEEEEeCCCccEEEEEecCCcccCCceEeec--c---cccccceEEEEEEEECCCChhhCEEEEEEEccCCCce
Confidence 5678999999999 8899999987754432211100 0 0111112345789999999999999999999999887
Q ss_pred ccceEEE
Q psy12044 347 SSNYTIR 353 (767)
Q Consensus 347 ~~s~sL~ 353 (767)
.++..+.
T Consensus 76 ~~s~~v~ 82 (84)
T cd05742 76 KESTKVN 82 (84)
T ss_pred EEEEEEE
Confidence 7665543
No 100
>cd05773 Ig8_hNephrin_like Eighth immunoglobulin-like domain of nephrin. Ig8_hNephrin_like: domain similar to the eighth immunoglobulin-like domain in human nephrin. Nephrin is an integral component of the slit diaphragm, and is a central component of the glomerular ultrafilter. Nephrin plays a structural role, and has a role in signaling. Nephrin is a transmembrane protein having a short intracellular portion, and an extracellular portion comprised of eight Ig-like domains, and one fibronectin type III-like domain. The extracellular portions of nephrin, from neighboring foot processes of separate podocyte cells, may interact with each other, and in association with other components of the slit diaphragm, form a porous molecular sieve within the slit pore. The intracellular portion of nephrin is associated with linker proteins, which connect nephrin to the actin cytoskeleton. The intracellular portion is tyrosine phosphorylated, and mediates signaling from the slit diaphragm into the p
Probab=98.00 E-value=1.7e-05 Score=72.33 Aligned_cols=84 Identities=21% Similarity=0.390 Sum_probs=60.6
Q ss_pred ccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeec-cCCCCceeEeeccCCCCc
Q psy12044 268 EGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSN-IDDNGTFVCVAENQAGST 346 (767)
Q Consensus 268 ~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs-~sD~GtY~CvA~N~~G~s 346 (767)
.|..+.|.|.+.+.|.+.++|.+++..+..... . ....... ......+.|.|.++. .+|.|.|.|.|.|..|..
T Consensus 22 ~g~~v~L~C~a~G~P~p~i~W~k~g~~l~~~~~---r-~~~~~~~-~~~~~~s~L~I~~v~~~~D~G~Y~C~A~N~~G~~ 96 (109)
T cd05773 22 GSSDANLVCQAQGVPRVQFRWAKNGVPLDLGNP---R-YEETTEH-TGTVHTSILTIINVSAALDYALFTCTAHNSLGED 96 (109)
T ss_pred CCCEEEEEEECcccCCCEEEEEECCEECCCCCC---e-EEEEeec-cCccceeEEEECcCCccCCCEEEEEEEEeCCccC
Confidence 467899999999999999999999877643211 0 0000111 112224789999987 589999999999999998
Q ss_pred ccceEEEEEe
Q psy12044 347 SSNYTIRIVL 356 (767)
Q Consensus 347 ~~s~sL~V~~ 356 (767)
...+.|.+..
T Consensus 97 ~~~i~L~~~~ 106 (109)
T cd05773 97 SLDIQLVSTS 106 (109)
T ss_pred cEEEEEEecC
Confidence 8777776653
No 101
>cd05724 Ig2_Robo Second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig2_Robo: domain similar to the second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antago
Probab=97.95 E-value=2e-05 Score=68.03 Aligned_cols=75 Identities=29% Similarity=0.509 Sum_probs=57.5
Q ss_pred cceeecccccccccccc-cccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeec
Q psy12044 262 FYLEIQEGKNVSLLCKV-SAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAE 340 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~a-~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~ 340 (767)
....+..|+.+.|.|.+ .+.|.|.+.|.+++..+..... + +... ..+.|.|.++...|.|.|.|.+.
T Consensus 4 ~~~~~~~G~~v~l~C~~~~g~p~p~i~W~k~g~~~~~~~~-----~-~~~~------~~~~L~I~~~~~~D~G~Y~C~a~ 71 (86)
T cd05724 4 SDTQVAVGEMAVLECSPPRGHPEPTVSWRKDGQPLNLDNE-----R-VRIV------DDGNLLIAEARKSDEGTYKCVAT 71 (86)
T ss_pred ccEEEeCCCCEEEEEECCCCCCCCEEEEEECCEECCCCCC-----C-EEEc------cCCEEEEeECCcccCEEEEEEEE
Confidence 34567789999999998 7899999999998876643211 0 1111 13579999999999999999999
Q ss_pred cCCCCccc
Q psy12044 341 NQAGSTSS 348 (767)
Q Consensus 341 N~~G~s~~ 348 (767)
|..|....
T Consensus 72 N~~G~~~s 79 (86)
T cd05724 72 NMVGERES 79 (86)
T ss_pred eccCceee
Confidence 99987643
No 102
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=97.94 E-value=4.4e-06 Score=107.99 Aligned_cols=78 Identities=31% Similarity=0.574 Sum_probs=64.4
Q ss_pred eccCCccccccCCCCC-CCCcccccCCCCCCCchhhhhhhhhhhccCCCCC--ccCCCCCCCCCCCCCcccccccccccC
Q psy12044 177 KLDNNKITTISGSNIL-PTGLHGIDLHHNPWTCDCLLIGLRRWLESTKTPM--AIDPICSVPPRLSSVTIKQLSIDELAC 253 (767)
Q Consensus 177 ~Ls~N~Lt~ip~~~~~-~~~L~~L~Ls~N~l~C~c~l~~l~~~l~~~~~~~--~~~~~C~~p~~l~g~~i~~l~~~~l~C 253 (767)
||++|+|+.|+...+. +.+|+.|+|++|||.|||++.||..|++...... .....|..|..++++.+.++...++.|
T Consensus 1 DLSnN~LstLp~g~F~~L~sL~~LdLsgNPw~CDC~L~WL~~WL~~~~v~v~~~~~i~CasP~~LrG~~L~~l~~~d~~C 80 (2740)
T TIGR00864 1 DISNNKISTIEEGICANLCNLSEIDLSGNPFECDCGLARLPRWAEEKGVKVRQPEAALCAGPGALAGQPLLGIPLLDSGC 80 (2740)
T ss_pred CCCCCcCCccChHHhccCCCceEEEeeCCccccccccHHHHHHHHhcCccccCCcccCCCCChHHCCCCcccCCcccCCC
Confidence 5777888877776553 4678889999999999999999999998875433 356789999999999999998887777
Q ss_pred C
Q psy12044 254 E 254 (767)
Q Consensus 254 ~ 254 (767)
.
T Consensus 81 ~ 81 (2740)
T TIGR00864 81 D 81 (2740)
T ss_pred C
Confidence 6
No 103
>KOG1644|consensus
Probab=97.93 E-value=1.1e-05 Score=79.82 Aligned_cols=81 Identities=23% Similarity=0.315 Sum_probs=39.5
Q ss_pred EEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEECCC
Q psy12044 53 VLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSG 132 (767)
Q Consensus 53 ~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~ 132 (767)
.++|.+.++..+..-.. .+.+...++|++|.|..+. .|..++.|.+|.|++|+|+.+.|..-..+++|..|.|.+
T Consensus 23 e~~LR~lkip~ienlg~---~~d~~d~iDLtdNdl~~l~--~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~Ltn 97 (233)
T KOG1644|consen 23 ELDLRGLKIPVIENLGA---TLDQFDAIDLTDNDLRKLD--NLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTN 97 (233)
T ss_pred ccccccccccchhhccc---cccccceecccccchhhcc--cCCCccccceEEecCCcceeeccchhhhccccceEEecC
Confidence 44555555444332111 1334455555555555442 245555555555555555555554444445555555555
Q ss_pred CcCccc
Q psy12044 133 NPIKQI 138 (767)
Q Consensus 133 N~l~~l 138 (767)
|.|..+
T Consensus 98 Nsi~~l 103 (233)
T KOG1644|consen 98 NSIQEL 103 (233)
T ss_pred cchhhh
Confidence 555433
No 104
>cd05736 Ig2_Follistatin_like Second immunoglobulin (Ig)-like domain of a follistatin-like molecule encoded by the Mahya gene and similar proteins. Ig2_Follistatin_like: domain similar to the second immunoglobulin (Ig)-like domain found in a follistatin-like molecule encoded by the CNS-related Mahya gene. Mahya genes have been retained in certain Bilaterian branches during evolution. They are conserved in Hymenoptera and Deuterostomes, but are absent from other metazoan species such as fruit fly and nematode. Mahya proteins are secretory, with a follistatin-like domain (Kazal-type serine/threonine protease inhibitor domain and EF-hand calcium-binding domain), two Ig-like domains, and a novel C-terminal domain. Mahya may be involved in learning and memory and in processing of sensory information in Hymenoptera and vertebrates. Follistatin is a secreted, multidomain protein that binds activins with high affinity and antagonizes their signaling.
Probab=97.90 E-value=2.2e-05 Score=66.39 Aligned_cols=73 Identities=30% Similarity=0.545 Sum_probs=55.2
Q ss_pred cccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceEE
Q psy12044 273 SLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYTI 352 (767)
Q Consensus 273 sL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~sL 352 (767)
.|.|.+.+.|.|.+.|.+++..+..... ..+.... ....|.|.++...|.|.|.|.+.|..|.+...+.+
T Consensus 2 ~L~C~v~g~P~p~v~W~k~~~~l~~~~~-----~~~~~~~-----~~~~l~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l 71 (76)
T cd05736 2 SLRCHAEGIPLPRLTWLKNGMDITPKLS-----KQLTLIA-----NGSELHISNVRYEDTGAYTCIAKNEAGVDEDISSL 71 (76)
T ss_pred EeEeEeeecCCCEEEEEECCEECCCCCC-----ccEEEeC-----CCCEEEECcCCcccCEEEEEEEEcCCCCcceEEEE
Confidence 5789999999999999998876643211 1111111 12468999999999999999999999998887777
Q ss_pred EEE
Q psy12044 353 RIV 355 (767)
Q Consensus 353 ~V~ 355 (767)
.|.
T Consensus 72 ~V~ 74 (76)
T cd05736 72 FVE 74 (76)
T ss_pred EEE
Confidence 653
No 105
>cd05738 Ig2_RPTP_IIa_LAR_like Second immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig2_RPTP_IIa_LAR_like: domain similar to the second immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple Ig-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains.
Probab=97.88 E-value=2.1e-05 Score=66.29 Aligned_cols=64 Identities=34% Similarity=0.627 Sum_probs=48.1
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCc
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGST 346 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s 346 (767)
++|.|.+.|.|.|.+.|++++..+..... ..+... ..+.|.|.++..+|.|.|.|.|.|..|..
T Consensus 1 a~l~C~~~G~P~p~v~W~k~~~~~~~~~~-----~~~~~~------~~g~L~i~~~~~~D~G~Y~C~a~N~~G~~ 64 (74)
T cd05738 1 ATMLCAASGNPDPEITWFKDFLPVDTTSN-----GRIKQL------RSGALQIENSEESDQGKYECVATNSAGTR 64 (74)
T ss_pred CEEEEEEeEecCCEEEEEECCEECccCCC-----CCEEEc------CCcEEEECCCChhhCEEEEEEEECCCCce
Confidence 36899999999999999998876532110 111111 13468999999999999999999999975
No 106
>cd07702 Ig2_VEGFR-1 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). Ig2_VEGFR-1: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-1 binds VEGF-A strongly; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-1 may play an inhibitory rolet in the function of VEGFR-2 by binding VEGF-A and interfering with its interaction with VEGFR-2. VEGFR-1 has a signaling role in mediating monocyte chemotaxis and may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=97.88 E-value=1.6e-05 Score=66.77 Aligned_cols=67 Identities=25% Similarity=0.368 Sum_probs=49.8
Q ss_pred cccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceEE
Q psy12044 273 SLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYTI 352 (767)
Q Consensus 273 sL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~sL 352 (767)
.|.|.+.|.|.|.+.|.+++..+..... .+. . ...+|.|.++..+|.|.|+|.+.|..........+
T Consensus 2 ~l~c~v~g~P~P~v~W~kdg~~l~~~~~------~~~--~-----~~~~L~I~~v~~~D~G~YtC~a~~~~~~~~~~~~i 68 (72)
T cd07702 2 RLTPKVKAFPAPEVIWLKDGLPAAEKCS------RYH--V-----DGYSLVIKDVTEEDAGIYTILLGIKQYNLFKNLTI 68 (72)
T ss_pred eEEeeEEEcCCCeEEEEECCEECCCCCc------EEE--e-----CCCEEEECcCCHHHCEEEEEEEEccccceEeeEEE
Confidence 5789999999999999999977654211 011 1 12369999999999999999999986655544433
No 107
>cd05861 Ig1_PDGFR-alphabeta Frst immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). Ig1_PDGFR-alphabeta: The first immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFRalpha binds to all three PDGFs, whereas the PDGFRbeta binds only to PDGF-B. PDGFRs alpha and beta have similar organization: an extracellular component with five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFRalpha and PDGFRbeta are essential for normal development.
Probab=97.86 E-value=3.6e-05 Score=66.69 Aligned_cols=70 Identities=19% Similarity=0.414 Sum_probs=49.4
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCC
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAG 344 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G 344 (767)
|+.+.|.|.+.+.|.+.+.|.++++..... .. . . ... ........+.|.|.+++.+|.|.|.|.+.|..+
T Consensus 1 Ge~~~l~C~~~~~~~~~~~W~~~~~~~~~~-~~-~-~--~~~-~~~~~~~~s~L~I~~~~~~DsG~Y~C~a~n~~~ 70 (84)
T cd05861 1 GETITVNCIVQGNEVVDFSWTYPGKDIGKG-IP-E-V--EEV-KVPATTLRSTLTFPHATVEDSGTYECAAHESTQ 70 (84)
T ss_pred CCcEEEEEEEECCCccEEEEEECCccCCCC-ce-E-E--EEE-ecCCcEEEEEEEECCCCcCCCEEEEEEEEECcc
Confidence 577899999999999999999866532111 00 0 0 000 011223467899999999999999999998776
No 108
>cd05898 Ig5_KIRREL3 Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). Ig5_KIRREL3: the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1). These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development. Neph1 and 2 may mediate axonal guidance and synapse formation in certain areas of the CNS. In the kidney, they participate in the formation of the slit diaphragm.
Probab=97.86 E-value=4.9e-05 Score=67.87 Aligned_cols=89 Identities=19% Similarity=0.236 Sum_probs=62.7
Q ss_pred CCccceeecccccccccccccccCCC-cEEEeecCeeccCCCcccccccceeeccc-CcceeeeEEEEeeeccCC-CCce
Q psy12044 259 PSTFYLEIQEGKNVSLLCKVSAIPEA-KITWLFDGVPIQNESMSASESHAVYSTEE-GTEIKKSELLIYNSNIDD-NGTF 335 (767)
Q Consensus 259 ~~~~~~~v~~G~~vsL~C~a~g~P~p-~itW~~~g~~l~~~s~~~~~~~~~~~~~~-g~~~~~s~L~I~nvs~sD-~GtY 335 (767)
.......+.+|+.+.|.|.+.+.|.| .|.|.+.+..+.... ...+.+.+. ......++|.|.++...| .|.|
T Consensus 6 ~~~~s~~~~~G~~~~L~C~~~s~P~P~~i~W~w~~~~i~~~~-----~~r~~I~~~~~~~g~~S~L~I~~~~~~d~~g~Y 80 (98)
T cd05898 6 SSEQVQYAVRGERGKVKCFIGSTPPPDRIAWAWKENVLESGT-----SERYTVERTSTGSGVLSTLTINNIMEADFQTHY 80 (98)
T ss_pred ecCceEEEeCCCcEEEEEEEccCCCCcEEEEEEccccccCCC-----CCCEEEEEEccCCCcEEEEEECCCccccCCcEE
Confidence 44445677899999999999999887 568887765443221 112222221 223456889999998877 6899
Q ss_pred eEeeccCCCCcccceEE
Q psy12044 336 VCVAENQAGSTSSNYTI 352 (767)
Q Consensus 336 ~CvA~N~~G~s~~s~sL 352 (767)
.|.|.|..|.....+.|
T Consensus 81 ~C~a~N~~G~d~~~i~L 97 (98)
T cd05898 81 NCTAWNSFGSGTAIIQL 97 (98)
T ss_pred EEEEEeCCccceEEEEe
Confidence 99999999998776554
No 109
>cd04977 Ig1_NCAM-1_like First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1 and similar proteins. Ig1_NCAM-1 like: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the s
Probab=97.86 E-value=2.1e-05 Score=69.35 Aligned_cols=74 Identities=31% Similarity=0.604 Sum_probs=53.3
Q ss_pred cceeecccccccccccccccCCCcEEEee-cCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeec
Q psy12044 262 FYLEIQEGKNVSLLCKVSAIPEAKITWLF-DGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAE 340 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~a~g~P~p~itW~~-~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~ 340 (767)
....+..|+.+.|.|.+.+.|. .+.|.+ ++..+.... + ..... .....+.|.|.++..+|.|.|.|.|.
T Consensus 8 ~~~~v~~G~~~~l~C~~~G~p~-~i~W~~~~~~~~~~~~------~-~~~~~--~~~~~~~L~I~~v~~~D~G~Y~C~A~ 77 (92)
T cd04977 8 SQGEISVGESKFFLCQVIGEPK-DISWFSPNGEKLVTQQ------Q-ISVVQ--NDDVRSTLTIYNANIEDAGIYKCVAT 77 (92)
T ss_pred CcEEECCCCeEEEEEEeEeeCC-eEEEECCCCCEeccCC------C-EEEEe--CCCCEEEEEEecCCcccCEEEEEEEE
Confidence 3467889999999999999974 999997 454332211 1 11111 12245689999999999999999999
Q ss_pred cCCCC
Q psy12044 341 NQAGS 345 (767)
Q Consensus 341 N~~G~ 345 (767)
|..|.
T Consensus 78 N~~g~ 82 (92)
T cd04977 78 DAKGT 82 (92)
T ss_pred cCCCC
Confidence 98654
No 110
>cd05749 Ig2_Tyro3_like Second immunoglobulin (Ig)-like domain of Axl/Tyro3 receptor tyrosine kinases (RTKs). Ig2_Tyro3_like: the second immunoglobulin (Ig)-like domain in the Axl/Tyro3 family of receptor tyrosine kinases (RTKs). This family includes Axl (also known as Ark, Ufo, and Tyro7), Tyro3 (also known as Sky, Rse, Brt, Dtk, and Tif), and Mer (also known as Nyk, c-Eyk, and Tyro12). Axl/Tyro3 family receptors have an extracellular portion with two Ig-like domains followed by two fibronectin-types III (FNIII) domains, a membrane-spanning single helix, and a cytoplasmic tyrosine kinase domain. Axl, Tyro3 and Mer are widely expressed in adult tissues, though they show higher expression in the brain, in the lymphatic and vascular systems, and in the testis. Axl, Tyro3, and Mer bind the vitamin K dependent protein Gas6 with high affinity, and in doing so activate their tyrosine kinase activity. Axl/Gas6 signaling may play a part in cell adhesion processes, prevention of apoptosis, and c
Probab=97.85 E-value=2.9e-05 Score=66.87 Aligned_cols=70 Identities=26% Similarity=0.432 Sum_probs=53.6
Q ss_pred ccceeecccccccccccccccCCC-cEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEee
Q psy12044 261 TFYLEIQEGKNVSLLCKVSAIPEA-KITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVA 339 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~g~P~p-~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA 339 (767)
+....+..|+.+.|.|.+.|.|.| .|.|.+++..+... . ....+.|.|..+ .|.|.|.|.|
T Consensus 5 P~~~~v~~G~~v~l~C~a~G~P~P~~I~W~k~g~~l~~~-~---------------~~~~s~L~i~~~--~d~g~Y~C~A 66 (81)
T cd05749 5 PEDLSVTANTPFNLTCQAVGPPEPVEILWWQGGSPLGDP-P---------------APSPSVLNVPGL--NETSKFSCEA 66 (81)
T ss_pred CCceEEcCCCCEEEEEEeeeecCCeEEEEEECCEECCCC-C---------------CCCCCEEEEccc--cCCeEEEEEE
Confidence 345678899999999999999999 79999999876430 0 011246777766 4789999999
Q ss_pred ccCCCCccc
Q psy12044 340 ENQAGSTSS 348 (767)
Q Consensus 340 ~N~~G~s~~ 348 (767)
.|..|...+
T Consensus 67 ~N~~G~~~s 75 (81)
T cd05749 67 HNAKGVTTS 75 (81)
T ss_pred EeccCcEEe
Confidence 999996543
No 111
>cd05848 Ig1_Contactin-5 First Ig domain of contactin-5. Ig1_Contactin-5: First Ig domain of the neural cell adhesion molecule contactin-5. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains, anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. In rats, a lack of contactin-5 (NB-2) results in an impairment of the neuronal activity in the auditory system. Contactin-5 is expressed specifically in the postnatal nervous system, peaking at about 3 weeks postnatal. Contactin-5 is highly expressed in the adult human brain in the occipital lobe and in the amygdala; lower levels of expression have been detected in the corpus callosum, caudate nucleus, and spinal cord.
Probab=97.84 E-value=2.3e-05 Score=69.48 Aligned_cols=69 Identities=32% Similarity=0.544 Sum_probs=51.9
Q ss_pred ccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeec-cCCCCceeEeeccCCCCc
Q psy12044 268 EGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSN-IDDNGTFVCVAENQAGST 346 (767)
Q Consensus 268 ~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs-~sD~GtY~CvA~N~~G~s 346 (767)
+|+.+.|.|.+.+.|.|.++|.+++..+..... ..+. ...+.|.|.++. ..|.|.|.|.|.|..|..
T Consensus 18 ~g~~v~l~C~~~G~P~P~i~W~k~g~~l~~~~~-----~~~~-------~~~g~L~i~~~~~~~D~G~Y~C~A~N~~G~~ 85 (94)
T cd05848 18 DEKKVILNCEARGNPVPTYRWLRNGTEIDTESD-----YRYS-------LIDGNLIISNPSEVKDSGRYQCLATNSIGSI 85 (94)
T ss_pred CCCEEEEEEEeeecCCCEEEEEECCeECccCCC-----ceEE-------eeCCeEEEccCCccCcCEEEEEEEEcCCCeE
Confidence 578899999999999999999998877643211 1111 112467888875 689999999999999976
Q ss_pred cc
Q psy12044 347 SS 348 (767)
Q Consensus 347 ~~ 348 (767)
.+
T Consensus 86 ~S 87 (94)
T cd05848 86 LS 87 (94)
T ss_pred Ee
Confidence 43
No 112
>cd05750 Ig_Pro_neuregulin Immunoglobulin (Ig)-like domain in neuregulins (NRGs). Ig_Pro_neuregulin: immunoglobulin (Ig)-like domain in neuregulins (NRGs). NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. There are four members of the neuregulin gene family (NRG1, -2, -3, and -4). The NRG-1 protein, binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. The other NRGs proteins bind one or the other or both of these ErbBs. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates processes such as target cell differentiation, and Schwann cell surv
Probab=97.83 E-value=2.4e-05 Score=65.66 Aligned_cols=71 Identities=25% Similarity=0.539 Sum_probs=51.4
Q ss_pred cccccccc-cCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccce
Q psy12044 273 SLLCKVSA-IPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNY 350 (767)
Q Consensus 273 sL~C~a~g-~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~ 350 (767)
.|.|.+.+ .|.|.+.|.+++..+...... ..+... .....+.|.|.++..+|.|.|.|.|.|..|.....+
T Consensus 2 ~l~C~~~g~~P~p~~~W~k~g~~l~~~~~~----~~~~~~---~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~ 73 (75)
T cd05750 2 VLKCEATSEYPSLRFKWFKDGKELNRKNKP----RNIKIR---NKKKNSELQINKAKLADSGEYTCVVENILGNDTVTA 73 (75)
T ss_pred EEEEEccCCCCCceEEEEcCCeeccccCCc----ceEEEE---ecCceEEEEEccCCcccCeEEEEEEEEcCCceeEEE
Confidence 58899999 999999999988766432211 000010 112346899999999999999999999999865543
No 113
>cd05756 Ig1_IL1R_like First immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig1_IL1R_like: domain similar to the first immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=97.83 E-value=3.4e-05 Score=68.47 Aligned_cols=81 Identities=19% Similarity=0.325 Sum_probs=58.5
Q ss_pred ceeecccccccccccccc-----cCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeE
Q psy12044 263 YLEIQEGKNVSLLCKVSA-----IPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVC 337 (767)
Q Consensus 263 ~~~v~~G~~vsL~C~a~g-----~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~C 337 (767)
...+.+|+.+.|.|.+.+ .|.+.+.|++++..+...... ..+ + . ...+.|.|.++..+|.|.|.|
T Consensus 8 ~~~v~~G~~~~L~C~~~g~~~~~~p~~~v~Wyk~~~~~~~~~~~--~~r-~--~-----~~~~~L~I~~~~~~DsG~Y~C 77 (94)
T cd05756 8 KSYVLEGEPVVIKCPLFYSYIAQSPGLNLTWYKSDGKTPIPTEE--RSR-M--H-----QQKDLLWFLPAALEDSGLYTC 77 (94)
T ss_pred EEEEecCCCeEEECCCCCcccccCCCceEEEEEcCCCCcccccc--cce-e--e-----ecCCeEEEccCCcccCeEEEE
Confidence 445678999999999998 688999999987543211100 000 1 0 013579999999999999999
Q ss_pred eeccCCCCcccceEEE
Q psy12044 338 VAENQAGSTSSNYTIR 353 (767)
Q Consensus 338 vA~N~~G~s~~s~sL~ 353 (767)
.+.|..|.....+.|.
T Consensus 78 ~~~N~~g~~~~~~~L~ 93 (94)
T cd05756 78 VVRNSTYCMKVSISLT 93 (94)
T ss_pred EEcCCCccEEEEEEEE
Confidence 9999998877655543
No 114
>cd05866 Ig1_NCAM-2 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2. Ig1_NCAM-2: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2 (OCAM/mamFas II, RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=97.82 E-value=2.8e-05 Score=68.72 Aligned_cols=75 Identities=33% Similarity=0.585 Sum_probs=55.4
Q ss_pred cceeecccccccccccccccCCCcEEEeec-CeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeec
Q psy12044 262 FYLEIQEGKNVSLLCKVSAIPEAKITWLFD-GVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAE 340 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~a~g~P~p~itW~~~-g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~ 340 (767)
....+..|+.+.|.|.+.|.|. .+.|+++ +..+.... + +.....+ ....|.|.++..+|.|.|.|.|.
T Consensus 8 ~~~~v~~G~~v~l~C~~~G~P~-~v~W~k~~g~~~~~~~------r-~~~~~~g---~~~~L~I~~v~~~D~G~Y~C~A~ 76 (92)
T cd05866 8 SKVELSVGESKFFTCTAIGEPE-SIDWYNPQGEKIVSSQ------R-VVVQKEG---VRSRLTIYNANIEDAGIYRCQAT 76 (92)
T ss_pred cceEEcCCCeEEEEEEEEEeCC-eEEEEeCCCeEecCCC------C-EEEEeCC---CeeEEEEecCChHHCEEEEEEEE
Confidence 3456789999999999999998 8999984 54443211 1 1111111 23589999999999999999999
Q ss_pred cCCCCcc
Q psy12044 341 NQAGSTS 347 (767)
Q Consensus 341 N~~G~s~ 347 (767)
|..|...
T Consensus 77 N~~G~~~ 83 (92)
T cd05866 77 DAKGQTQ 83 (92)
T ss_pred cCCCcEE
Confidence 9998754
No 115
>cd05850 Ig1_Contactin-2 First Ig domain of contactin-2. Ig1_Contactin-2: First Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=97.80 E-value=4.2e-05 Score=67.75 Aligned_cols=68 Identities=29% Similarity=0.520 Sum_probs=50.6
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeec-cCCCCceeEeeccCCCCcc
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSN-IDDNGTFVCVAENQAGSTS 347 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs-~sD~GtY~CvA~N~~G~s~ 347 (767)
|..+.|.|.+.+.|.|.++|.+++..+..... .+ +. . ..+.|.|.++. ..|.|.|.|.|.|..|...
T Consensus 19 g~~v~l~C~a~g~P~p~i~W~~~g~~l~~~~~----~~-~~-~------~~g~L~I~~~~~~~D~G~Y~C~A~N~~G~~~ 86 (94)
T cd05850 19 EEKVTLGCRARASPPATYRWKMNGTEIKFAPE----SR-YT-L------VAGNLVINNPQKARDAGSYQCLAINRCGTVV 86 (94)
T ss_pred CCeEEEEeEceeCCCCEEEEEECCEECccCCC----ce-EE-E------ECCeEEEccCCccCcCEEEEEEEEcCcCcEE
Confidence 46799999999999999999999877642211 00 11 1 12468887765 5899999999999999765
Q ss_pred c
Q psy12044 348 S 348 (767)
Q Consensus 348 ~ 348 (767)
+
T Consensus 87 s 87 (94)
T cd05850 87 S 87 (94)
T ss_pred E
Confidence 4
No 116
>cd05722 Ig1_Neogenin First immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig1_Neogenin: first immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=97.79 E-value=5e-05 Score=67.22 Aligned_cols=74 Identities=32% Similarity=0.441 Sum_probs=53.3
Q ss_pred ceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeee-----ccCCCCceeE
Q psy12044 263 YLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNS-----NIDDNGTFVC 337 (767)
Q Consensus 263 ~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nv-----s~sD~GtY~C 337 (767)
...+..|+.+.|.|.+.+.|.|.+.|.+++..+..... ....... .+.+.+.++ ...|.|.|.|
T Consensus 8 ~~~~~~g~~v~l~C~v~g~P~p~i~W~k~g~~l~~~~~-----~~~~~~~------~~~l~i~~v~~~~~~~~D~G~Y~C 76 (95)
T cd05722 8 DIVAVRGGPVVLNCSAEGEPPPKIEWKKDGVLLNLVSD-----ERRQQLP------NGSLLITSVVHSKHNKPDEGFYQC 76 (95)
T ss_pred CeEEcCCCCEEEeeecccCCCCEEEEEECCeECccccC-----cceEEcc------CCeEEEeeeeccCCCCCcCEEEEE
Confidence 45567899999999999999999999998877654321 0011111 223555555 5789999999
Q ss_pred eeccC-CCCcc
Q psy12044 338 VAENQ-AGSTS 347 (767)
Q Consensus 338 vA~N~-~G~s~ 347 (767)
.|.|. .|...
T Consensus 77 ~a~N~~~G~~~ 87 (95)
T cd05722 77 VAQNDSLGSIV 87 (95)
T ss_pred EEECCccCcEE
Confidence 99999 88753
No 117
>cd05849 Ig1_Contactin-1 First Ig domain of contactin-1. Ig1_Contactin-1: First Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may, through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=97.77 E-value=3.7e-05 Score=68.01 Aligned_cols=67 Identities=25% Similarity=0.432 Sum_probs=50.3
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeec-cCCCCceeEeeccCCCCcc
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSN-IDDNGTFVCVAENQAGSTS 347 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs-~sD~GtY~CvA~N~~G~s~ 347 (767)
+..+.|.|.+.|.|.|.++|.+++..+.... .+ +. . ..+.|.|.++. ..|.|.|.|.|.|..|...
T Consensus 19 ~~~v~l~C~a~G~P~P~i~W~k~~~~i~~~~-----~~-~~-~------~~g~L~I~~~~~~~D~G~Y~C~A~N~~G~~~ 85 (93)
T cd05849 19 EGKVSVNCRARANPFPIYKWRKNNLDIDLTN-----DR-YS-M------VGGNLVINNPDKYKDAGRYVCIVSNIYGKVR 85 (93)
T ss_pred CCeEEEeCcCccCCCCEEEEEECCEEccCCC-----Ce-EE-E------ECCEEEECcCCcCCCCEEEEEEEEeCcceEE
Confidence 4479999999999999999999887653211 01 11 1 13578888875 6899999999999999765
Q ss_pred c
Q psy12044 348 S 348 (767)
Q Consensus 348 ~ 348 (767)
+
T Consensus 86 s 86 (93)
T cd05849 86 S 86 (93)
T ss_pred E
Confidence 4
No 118
>KOG4579|consensus
Probab=97.77 E-value=2.6e-06 Score=79.21 Aligned_cols=132 Identities=21% Similarity=0.248 Sum_probs=88.4
Q ss_pred CccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEE
Q psy12044 50 NTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLT 129 (767)
Q Consensus 50 ~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~ 129 (767)
.+-.|+|+.+.|..+......-.....|+.++|++|.+....+..-..++.++.|+|++|.|+.++.+ +..++.|+.|+
T Consensus 28 E~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE-~Aam~aLr~lN 106 (177)
T KOG4579|consen 28 ELHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEE-LAAMPALRSLN 106 (177)
T ss_pred HhhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHH-HhhhHHhhhcc
Confidence 34557777777765554433322356677778888888887666555666788888888888888755 88888888888
Q ss_pred CCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccc
Q psy12044 130 LSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKIT 184 (767)
Q Consensus 130 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt 184 (767)
++.|.|...+.. +..|.+|-.|+..+|.+..++-+.|. -..+-.+++.++.+.
T Consensus 107 l~~N~l~~~p~v-i~~L~~l~~Lds~~na~~eid~dl~~-s~~~al~~lgnepl~ 159 (177)
T KOG4579|consen 107 LRFNPLNAEPRV-IAPLIKLDMLDSPENARAEIDVDLFY-SSLPALIKLGNEPLG 159 (177)
T ss_pred cccCccccchHH-HHHHHhHHHhcCCCCccccCcHHHhc-cccHHHHHhcCCccc
Confidence 888888776553 44477788888888887777665332 223333444444444
No 119
>cd05734 Ig7_DSCAM Seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig7_DSCAM: the seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=97.76 E-value=5.2e-05 Score=64.66 Aligned_cols=70 Identities=20% Similarity=0.389 Sum_probs=47.0
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCccc-ccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcc
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSA-SESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTS 347 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~-~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~ 347 (767)
+.|.|.+.+.|.|.+.|.+++.......... .....+.. ...++|.|.++..+|.|.|.|.|.|..|...
T Consensus 1 v~l~C~~~G~P~P~v~W~~~~~~~~~~~~~~~~~~~r~~~------~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~ 71 (79)
T cd05734 1 VTLNCSAEGYPPPTIVWKHSKGRGHPQHTHTCCLAGRIQL------LSNGSLLIKHVLEEDSGYYLCKVSNDVGADA 71 (79)
T ss_pred CEeEeeCeEeCCCEEEEEECCCccccccccccccCCCEEE------ecCCeEEECcCCcccCEEEEEEEEeCCCCCC
Confidence 4689999999999999998543211110000 00011111 1236799999999999999999999999763
No 120
>cd05729 Ig2_FGFR_like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor and similar proteins. Ig2_FGFR_like: domain similar to the second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three Ig-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin
Probab=97.72 E-value=6.8e-05 Score=64.22 Aligned_cols=80 Identities=31% Similarity=0.568 Sum_probs=58.7
Q ss_pred eecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCC
Q psy12044 265 EIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAG 344 (767)
Q Consensus 265 ~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G 344 (767)
.+..|..+.|.|.+.+.|.+.+.|.+++..+....... . .........|.|.++..+|.|.|.|.+.|..|
T Consensus 5 ~~~~G~~~~l~C~~~~~p~~~v~W~k~~~~~~~~~~~~-------~--~~~~~~~~~l~i~~~~~~d~g~Y~C~~~n~~g 75 (85)
T cd05729 5 AVPAGSTVRLKCPASGNPRPTITWLKDGKPFKKEHRIG-------G--YKVRKKKWTLILESVVPSDSGKYTCIVENKYG 75 (85)
T ss_pred EecCCCcEEEEEEcCCCCCCeEEEEECCEECcccCcee-------E--EEccCcEEEEEEeECCcccCEEEEEEEEECCc
Confidence 45578999999999999999999999876554322110 0 00112345789999999999999999999998
Q ss_pred CcccceEEE
Q psy12044 345 STSSNYTIR 353 (767)
Q Consensus 345 ~s~~s~sL~ 353 (767)
....++.+.
T Consensus 76 ~~~~~~~l~ 84 (85)
T cd05729 76 SINHTYKVD 84 (85)
T ss_pred eEEEEEEEe
Confidence 876655543
No 121
>cd05733 Ig6_L1-CAM_like Sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig6_L1-CAM_like: domain similar to the sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains NrCAM [Ng(neuronglia)CAM-related cell adhesion molecule], which is primarily expressed in the nervous system, and human neurofascin.
Probab=97.69 E-value=5.3e-05 Score=64.39 Aligned_cols=67 Identities=25% Similarity=0.449 Sum_probs=47.3
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeecc----CCCCceeEeeccCCCCcc
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNI----DDNGTFVCVAENQAGSTS 347 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~----sD~GtY~CvA~N~~G~s~ 347 (767)
+.|.|.+.|.|.|.++|.+++..+..... .+ +... ...+.|.|.++.. .|.|.|.|.|.|..|...
T Consensus 1 i~l~C~~~G~P~P~v~W~k~g~~l~~~~~----~~-~~~~-----~~~g~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~ 70 (77)
T cd05733 1 IVIKCEAKGNPPPTFSWTRNGTHFDPEKD----PR-VTMK-----PDSGTLVIDNMNGGRAEDYEGEYQCYASNELGTAI 70 (77)
T ss_pred CEEEeeCcccCCCeEEEEECCeECCCCCC----CC-EEEe-----CCCCEEEEeccCCCCCcCCCEEEEEEEEcCCCcEE
Confidence 46889999999999999998876643211 01 1111 1235677877754 689999999999999765
Q ss_pred c
Q psy12044 348 S 348 (767)
Q Consensus 348 ~ 348 (767)
+
T Consensus 71 s 71 (77)
T cd05733 71 S 71 (77)
T ss_pred c
Confidence 4
No 122
>cd05754 Ig3_Perlecan_like Third immunoglobulin (Ig)-like domain found in Perlecan and similar proteins. Ig3_Perlecan_like: domain similar to the third immunoglobulin (Ig)-like domain found in Perlecan. Perlecan is a large multi-domain heparin sulfate proteoglycan, important in tissue development and organogenesis. Perlecan can be represented as 5 major portions; its fourth major portion (domain IV) is a tandem repeat of immunoglobulin-like domains (Ig2-Ig15), which can vary in size due to alternative splicing. Perlecan binds many cellular and extracellular ligands. Its domain IV region has many binding sites. Some of these have been mapped at the level of individual Ig-like domains, including a site restricted to the Ig5 domain for heparin/sulfatide, a site restricted to the Ig3 domain for nidogen-1 and nidogen-2, a site restricted to Ig4-5 for fibronectin, and sites restricted to Ig2 and to Ig13-15 for fibulin-2.
Probab=97.67 E-value=6e-05 Score=65.20 Aligned_cols=75 Identities=24% Similarity=0.428 Sum_probs=57.2
Q ss_pred ccceeecccccccccccccc-cCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEee
Q psy12044 261 TFYLEIQEGKNVSLLCKVSA-IPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVA 339 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~g-~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA 339 (767)
+....+..|+.++|.|.+.+ .|.+.+.|.+++..+.... ....+.|.|.++..+|.|.|.|.+
T Consensus 8 p~~~~v~~G~~v~L~C~~~~~~~~~~i~W~~~~~~~~~~~----------------~~~~~~L~I~~v~~~DsG~Y~C~a 71 (85)
T cd05754 8 PRSQEVRPGADVSFICRAKSKSPAYTLVWTRVGGGLPSRA----------------MDFNGILTIRNVQLSDAGTYVCTG 71 (85)
T ss_pred CCceEEcCCCCEEEEEEcCCCCCCcEEEEEECCCcCCCcc----------------cccCCEEEECCCCHHHCEEEEEEE
Confidence 34567789999999999865 6888999999764432110 012357999999999999999999
Q ss_pred ccCCCCcccceE
Q psy12044 340 ENQAGSTSSNYT 351 (767)
Q Consensus 340 ~N~~G~s~~s~s 351 (767)
.|..|...+.+.
T Consensus 72 ~n~~g~~~~~~~ 83 (85)
T cd05754 72 SNMLDTDEATAT 83 (85)
T ss_pred eccCCeEeEEEE
Confidence 999998776544
No 123
>cd05874 Ig6_NrCAM Sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). Ig6_NrCAM: sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=97.64 E-value=7.3e-05 Score=63.63 Aligned_cols=67 Identities=21% Similarity=0.404 Sum_probs=45.6
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeecc----CCCCceeEeeccCCCCcc
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNI----DDNGTFVCVAENQAGSTS 347 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~----sD~GtY~CvA~N~~G~s~ 347 (767)
+.|.|.+.|.|.|.++|.+++..+..... .. .... ...++|.|..+.. .|.|.|.|.|.|..|...
T Consensus 1 ~~l~C~a~G~P~P~i~W~k~g~~l~~~~~----~~-~~~~-----~~~g~l~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~ 70 (77)
T cd05874 1 IVIQCEAKGKPPPSFSWTRNGTHFDIDKD----PK-VTMK-----PNTGTLVINIMNGEKAEAYEGVYQCTARNERGAAV 70 (77)
T ss_pred CEEEeeCcccCCCeEEEEECCeECCCcCC----CC-EEEe-----CCCceEEEeccccCCCCCCCEEEEEEEEcCCCeEE
Confidence 36889999999999999998876532111 00 1111 1134677766654 368999999999999765
Q ss_pred c
Q psy12044 348 S 348 (767)
Q Consensus 348 ~ 348 (767)
+
T Consensus 71 s 71 (77)
T cd05874 71 S 71 (77)
T ss_pred e
Confidence 4
No 124
>cd05882 Ig1_Necl-1 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig1_Necl-1: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-1, Necl-1 (also known as celll adhesion molecule 3 (CADM3), SynCAM2, IGSF4). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the format
Probab=97.62 E-value=0.00011 Score=65.20 Aligned_cols=79 Identities=16% Similarity=0.235 Sum_probs=53.6
Q ss_pred ccceeecccccccccccccccCCCcEEEeecCeeccC-CCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEee
Q psy12044 261 TFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQN-ESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVA 339 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~-~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA 339 (767)
..+..+..|+.+.|.|.+.+.|.+.+.|.++++.+.. .........++..... ......|.|.++..+|.|.|+|.+
T Consensus 4 ~~~~tv~~G~tv~L~C~v~g~~~~~v~W~k~~~~~~~~~~~~~~~~~r~~~~~~--~~~~~~L~I~nV~~~D~G~YtC~~ 81 (95)
T cd05882 4 TQDETVAVGGTVTLKCGVKEHDNSSLQWSNTAQQTLYFGEKRALRDNRIQLVKS--TPTELIISISNVQLSDEGEYTCSI 81 (95)
T ss_pred cccEEEecCCcEEEEEEEeCCCCCeEEEeccCccEEEeCCeEEEeCCeEEEEeC--CCceEEEEECCCCcccCEEEEEEE
Confidence 4467888999999999999999999999987653211 1100000011111111 113468999999999999999999
Q ss_pred cc
Q psy12044 340 EN 341 (767)
Q Consensus 340 ~N 341 (767)
..
T Consensus 82 ~t 83 (95)
T cd05882 82 FT 83 (95)
T ss_pred Ee
Confidence 75
No 125
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=97.59 E-value=0.00016 Score=67.29 Aligned_cols=109 Identities=26% Similarity=0.429 Sum_probs=53.1
Q ss_pred CCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEe
Q psy12044 74 LVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLE 153 (767)
Q Consensus 74 L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 153 (767)
+.+|+.+.+.. .+..+...+|.++.+|+.|.+..+ +..+....|..+.+|+.+.+.+ .+..+....|..+.+|+.+.
T Consensus 11 ~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~l~~i~ 87 (129)
T PF13306_consen 11 CSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTNLKNID 87 (129)
T ss_dssp -TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TTECEEE
T ss_pred CCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-cccccccccccccccccccc
Confidence 55666666653 466666666666666666666554 6666666666666666666654 55555556666666676666
Q ss_pred ccCCCccccchhhhcCCCCCCeeeccCCccccccC
Q psy12044 154 LSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISG 188 (767)
Q Consensus 154 Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~ 188 (767)
+..+ +..+....|.+. .|+.+.+.. .++.|+.
T Consensus 88 ~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~ 119 (129)
T PF13306_consen 88 IPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEE 119 (129)
T ss_dssp ETTT--BEEHTTTTTT--T--EEE-TT-B-SS---
T ss_pred cCcc-ccEEchhhhcCC-CceEEEECC-CccEECC
Confidence 6554 555555566665 666666654 4444443
No 126
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=97.59 E-value=0.00016 Score=67.36 Aligned_cols=117 Identities=21% Similarity=0.430 Sum_probs=64.5
Q ss_pred CCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEE
Q psy12044 49 PNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKL 128 (767)
Q Consensus 49 ~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L 128 (767)
.+|+.+.+.. .+..+....|.. +.+|+.|.+..+ +..+...+|.++.+|+.+.+.+ .+..+....|..+.+|+.+
T Consensus 12 ~~l~~i~~~~-~~~~I~~~~F~~--~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~l~~i 86 (129)
T PF13306_consen 12 SNLESITFPN-TIKKIGENAFSN--CTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTNLKNI 86 (129)
T ss_dssp TT--EEEETS-T--EE-TTTTTT---TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TTECEE
T ss_pred CCCCEEEECC-CeeEeChhhccc--cccccccccccc-ccccceeeeecccccccccccc-ccccccccccccccccccc
Confidence 3577777764 577777777773 667888888764 7777777788877788888854 6666666777778888888
Q ss_pred ECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCC
Q psy12044 129 TLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSL 173 (767)
Q Consensus 129 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L 173 (767)
.+..+ +..+....|.+. .|+.+.+.. .++.+....|.++.+|
T Consensus 87 ~~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l 128 (129)
T PF13306_consen 87 DIPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKL 128 (129)
T ss_dssp EETTT--BEEHTTTTTT--T--EEE-TT-B-SS----GGG-----
T ss_pred ccCcc-ccEEchhhhcCC-CceEEEECC-CccEECCccccccccC
Confidence 88765 677777777776 788877765 5666666677776665
No 127
>KOG1644|consensus
Probab=97.58 E-value=8.9e-05 Score=73.46 Aligned_cols=123 Identities=24% Similarity=0.341 Sum_probs=89.7
Q ss_pred cEEEccCCCCCccCccccc-CCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccC
Q psy12044 78 QKIYLSRCRISVIDSKAFR-GLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSK 156 (767)
Q Consensus 78 ~~L~Ls~N~L~~i~p~~f~-~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~ 156 (767)
+.++|...++..+.- ++ .+.+...+||++|.|..+. .|..++.|.+|.|++|+|+.+.+..-..+++|..|.|.+
T Consensus 22 ~e~~LR~lkip~ien--lg~~~d~~d~iDLtdNdl~~l~--~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~Ltn 97 (233)
T KOG1644|consen 22 RELDLRGLKIPVIEN--LGATLDQFDAIDLTDNDLRKLD--NLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTN 97 (233)
T ss_pred cccccccccccchhh--ccccccccceecccccchhhcc--cCCCccccceEEecCCcceeeccchhhhccccceEEecC
Confidence 345555555554422 22 2347789999999987764 578899999999999999999887666678899999999
Q ss_pred CCccccch-hhhcCCCCCCeeeccCCccccccCC----CCCCCCcccccCCCC
Q psy12044 157 CGIEVIED-AAFVGLDSLEWLKLDNNKITTISGS----NILPTGLHGIDLHHN 204 (767)
Q Consensus 157 N~L~~i~~-~~~~~l~~L~~L~Ls~N~Lt~ip~~----~~~~~~L~~L~Ls~N 204 (767)
|+|..+.. .-+..+++|+.|.+-+|.++....- +...++|+.||+++=
T Consensus 98 Nsi~~l~dl~pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~kV 150 (233)
T KOG1644|consen 98 NSIQELGDLDPLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQKV 150 (233)
T ss_pred cchhhhhhcchhccCCccceeeecCCchhcccCceeEEEEecCcceEeehhhh
Confidence 98875532 2356788999999999988765432 234578888887653
No 128
>cd05752 Ig1_FcgammaR_like Frst immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig1_FcgammaR_like: domain similar to the first immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=97.55 E-value=0.00017 Score=61.62 Aligned_cols=62 Identities=21% Similarity=0.468 Sum_probs=49.6
Q ss_pred CccceeecccccccccccccccCC-CcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEe
Q psy12044 260 STFYLEIQEGKNVSLLCKVSAIPE-AKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCV 338 (767)
Q Consensus 260 ~~~~~~v~~G~~vsL~C~a~g~P~-p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~Cv 338 (767)
.+....+.+|+.++|.|.+.+.|. ..+.|++++..+.. ....|.|.++ .+|+|.|.|.
T Consensus 6 ~P~~~~v~~G~~V~L~C~~~~~p~~~~~~W~kng~~l~~--------------------~~~~l~i~~~-~~dsG~Y~C~ 64 (78)
T cd05752 6 DPPWTTIFQGEKVTLTCNGFNSPEQNSTQWYHNGKLLET--------------------TTNSYRIRAA-NNDSGEYRCQ 64 (78)
T ss_pred CCCCeEeeCCCCEEEEEeCCCCCCCccEEEEECCEEeec--------------------cCCeEEEeec-ccCCEEeEEE
Confidence 344567889999999999999886 47999999876521 1246888899 9999999999
Q ss_pred eccC
Q psy12044 339 AENQ 342 (767)
Q Consensus 339 A~N~ 342 (767)
|.|.
T Consensus 65 a~~~ 68 (78)
T cd05752 65 TQGS 68 (78)
T ss_pred CCCC
Confidence 9875
No 129
>cd04967 Ig1_Contactin First Ig domain of contactin. Ig1_Contactin: First Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 weeks postnata
Probab=97.55 E-value=0.00014 Score=63.77 Aligned_cols=69 Identities=30% Similarity=0.581 Sum_probs=50.4
Q ss_pred ccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeec-cCCCCceeEeeccCCCCc
Q psy12044 268 EGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSN-IDDNGTFVCVAENQAGST 346 (767)
Q Consensus 268 ~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs-~sD~GtY~CvA~N~~G~s 346 (767)
.+..+.|.|.+.+.|.|.++|.+++..+...... . + ....+.|.|.++. .+|.|.|.|.|.|..|..
T Consensus 18 ~~~~~~l~C~~~g~p~p~i~W~k~~~~l~~~~~~----~-~-------~~~~~~L~i~~~~~~~d~G~Y~C~a~N~~G~~ 85 (91)
T cd04967 18 DEGKVSLNCRARGSPPPTYRWLMNGTEIDDEPDS----R-Y-------SLVGGNLVISNPSKAKDAGRYQCLASNIVGTV 85 (91)
T ss_pred CCCEEEEEEeeeEcCCCEEEEEECCEECCCCCCC----C-E-------EEECCEEEEecCCccCCCEEEEEEEEcCCCEE
Confidence 3467999999999999999999988766322110 0 1 1123468888876 489999999999999965
Q ss_pred cc
Q psy12044 347 SS 348 (767)
Q Consensus 347 ~~ 348 (767)
.+
T Consensus 86 ~S 87 (91)
T cd04967 86 LS 87 (91)
T ss_pred Ee
Confidence 43
No 130
>cd05895 Ig_Pro_neuregulin-1 Immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. Ig_Pro_neuregulin-1: immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. There are many NRG-1 isoforms which arise from the alternative splicing of mRNA. NRG-1 belongs to the neuregulin gene family, which is comprised of four genes. This group represents NRG-1. NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, and heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. The NRG-1 protein binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates process
Probab=97.54 E-value=0.00011 Score=62.07 Aligned_cols=71 Identities=24% Similarity=0.507 Sum_probs=49.0
Q ss_pred cccccccc-cCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcccc
Q psy12044 273 SLLCKVSA-IPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSN 349 (767)
Q Consensus 273 sL~C~a~g-~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s 349 (767)
.|.|.+.+ .|.+.+.|++++..+...... ...+.. . .....+.|.|.++...|.|.|.|.+.|..|....+
T Consensus 2 ~L~C~a~~~~p~~~~~W~~~g~~i~~~~~~---~~~~~~-~--~~~~~~~L~I~~~~~~DsG~Y~C~a~N~~g~~~~~ 73 (76)
T cd05895 2 VLRCETVSEYPSLRFKWFKNGKEIGAKNKP---DNKIKI-R--KKKKSSELQISKASLADNGEYKCMVSSKLGNDSVT 73 (76)
T ss_pred EEEEecccCCCCCceEEEECCcccccCCCC---CceEEE-E--eCCcEEEEEECcCCcccCEEEEEEEEeCCCceeEE
Confidence 57898764 688899999988766432111 000111 0 11234679999999999999999999999876554
No 131
>KOG4658|consensus
Probab=97.52 E-value=6e-05 Score=92.05 Aligned_cols=139 Identities=21% Similarity=0.222 Sum_probs=102.9
Q ss_pred CccccccCC-CCCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCC--CCccCcccccCCCCCCEEEccCCCCCCCC
Q psy12044 39 SLITVVEGM-DPNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCR--ISVIDSKAFRGLTNLVDLDFSHNVLQTVP 115 (767)
Q Consensus 39 ~L~~iP~~l-~~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~--L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~ 115 (767)
++..+|... ...++.+.+-+|.+..+....- .++|+.|-+..|. +..+....|..++.|+.|||++|.=-+-.
T Consensus 512 ~~~~~~~~~~~~~~rr~s~~~~~~~~~~~~~~----~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~L 587 (889)
T KOG4658|consen 512 GLSEIPQVKSWNSVRRMSLMNNKIEHIAGSSE----NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKL 587 (889)
T ss_pred CccccccccchhheeEEEEeccchhhccCCCC----CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcC
Confidence 455566544 3567888888888876654432 4578888888886 66666667888899999999887644555
Q ss_pred CCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCc
Q psy12044 116 SDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNK 182 (767)
Q Consensus 116 p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~ 182 (767)
|..++.|-+|++|+|++..++.++. .+.+|..|.+|++..+.-...++..+..+.+|++|.|-...
T Consensus 588 P~~I~~Li~LryL~L~~t~I~~LP~-~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 588 PSSIGELVHLRYLDLSDTGISHLPS-GLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred ChHHhhhhhhhcccccCCCccccch-HHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 6778888889999999888887755 67888888888888876555556666678888888876654
No 132
>KOG1026|consensus
Probab=97.52 E-value=0.0002 Score=84.01 Aligned_cols=118 Identities=21% Similarity=0.281 Sum_probs=62.4
Q ss_pred CCCCCCeeeccCCc---cccccCCCCCCCCcccccCCCCCCCchhhhhhhhhhhccCCCCCccCCCCCCCCCCCCCcccc
Q psy12044 169 GLDSLEWLKLDNNK---ITTISGSNILPTGLHGIDLHHNPWTCDCLLIGLRRWLESTKTPMAIDPICSVPPRLSSVTIKQ 245 (767)
Q Consensus 169 ~l~~L~~L~Ls~N~---Lt~ip~~~~~~~~L~~L~Ls~N~l~C~c~l~~l~~~l~~~~~~~~~~~~C~~p~~l~g~~i~~ 245 (767)
..+.|...+++.|. +..++...+....+..+.+..|++.|.|+.+|+..|-....-.......|..... ...+..
T Consensus 107 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~c~~~~~--~~~~~~ 184 (774)
T KOG1026|consen 107 YNSRLRRDNLSTNDTGVLGSLSTNGFETLSLTELSLVGNPFTCSCSIRWLDRYREDGFCVPYRGLACLNFLS--NGTVAN 184 (774)
T ss_pred ccccccccccchhhhccccccccccccccccchhhhccCCCCcchhhhHHhhhcccCCCCCchhhHHHhhcC--Cceehh
Confidence 34445566666665 3344444444456667777789999999999888554433111112233432221 000100
Q ss_pred cccccccCC-CCCCCCccceeecccccccccccccccCCCcEEEee
Q psy12044 246 LSIDELACE-PQITPSTFYLEIQEGKNVSLLCKVSAIPEAKITWLF 290 (767)
Q Consensus 246 l~~~~l~C~-P~i~~~~~~~~v~~G~~vsL~C~a~g~P~p~itW~~ 290 (767)
.....|. +..........+..+..+++.|...+.+.+.+.|..
T Consensus 185 --~~~~~~~~~~~~~~~~~~~v~~~~~~~~~c~~~~~~vp~~~~~~ 228 (774)
T KOG1026|consen 185 --ESIQLCGEIENRIRAANLTVEEGSSITLKCSQAGIPVPCHYWFP 228 (774)
T ss_pred --hhhhhhcchhhhhhhhhhhhcccchheeeeecccCCCcceeeec
Confidence 0011122 111112223455667778888888888888877765
No 133
>KOG4658|consensus
Probab=97.52 E-value=6.3e-05 Score=91.82 Aligned_cols=140 Identities=21% Similarity=0.227 Sum_probs=108.0
Q ss_pred CCCccccccCC-CCCccEEEeeCCC--CCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCC
Q psy12044 37 NKSLITVVEGM-DPNTQVLDYTGNN--LKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQT 113 (767)
Q Consensus 37 ~~~L~~iP~~l-~~~L~~L~Ls~N~--L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~ 113 (767)
+.....++... .+.+++|-+..|. +..+....|.. ++.|+.|||++|.=-+..|..+++|-+|++|+|++..++.
T Consensus 532 ~~~~~~~~~~~~~~~L~tLll~~n~~~l~~is~~ff~~--m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~~ 609 (889)
T KOG4658|consen 532 NNKIEHIAGSSENPKLRTLLLQRNSDWLLEISGEFFRS--LPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGISH 609 (889)
T ss_pred ccchhhccCCCCCCccceEEEeecchhhhhcCHHHHhh--CcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCccc
Confidence 34455555444 4579999999997 78888888875 8999999999987767779999999999999999999997
Q ss_pred CCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCC--ccccchhhhcCCCCCCeeecc
Q psy12044 114 VPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCG--IEVIEDAAFVGLDSLEWLKLD 179 (767)
Q Consensus 114 l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~--L~~i~~~~~~~l~~L~~L~Ls 179 (767)
+| ..+.+|.+|.+|++..+.....++..+..+.+|++|.|.... .+...-..+..+.+|+.|...
T Consensus 610 LP-~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 610 LP-SGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred cc-hHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence 76 568999999999999997666667777779999999986543 333333344555555555543
No 134
>cd05757 Ig2_IL1R_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig2_IL1R_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three IG-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta. This group also contains ILIR-like 1 (IL1
Probab=97.49 E-value=0.00028 Score=62.32 Aligned_cols=79 Identities=22% Similarity=0.270 Sum_probs=58.9
Q ss_pred eeeccccccccccccccc-----CCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEe
Q psy12044 264 LEIQEGKNVSLLCKVSAI-----PEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCV 338 (767)
Q Consensus 264 ~~v~~G~~vsL~C~a~g~-----P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~Cv 338 (767)
..+..|....|.|...+. |.|.+.|+++++.+...... .. ..+.|.|.++..+|.|.|+|.
T Consensus 5 ~~~~~g~~~~l~Cp~~~~~~~~~~~p~i~Wyk~~~~i~~~~~~--------~~------~~~~L~I~~v~~~DsG~YtC~ 70 (92)
T cd05757 5 QILFSTKGGKIVCPDLDDFKNENTLPPVQWYKDCKLLEGDRKR--------FV------KGSKLLIQNVTEEDAGNYTCK 70 (92)
T ss_pred EEEeeccCCEEECCChHHccCCCCCCcEEEeECCEECCCCccE--------Ee------cCCEEEEeeCChhhCEEEEEE
Confidence 356678899999976532 57899999999877543211 00 345899999999999999999
Q ss_pred eccCCCCcccceEEEEEe
Q psy12044 339 AENQAGSTSSNYTIRIVL 356 (767)
Q Consensus 339 A~N~~G~s~~s~sL~V~~ 356 (767)
+.|..+....+++..+.+
T Consensus 71 ~~n~~~~~~~~~t~t~~l 88 (92)
T cd05757 71 LTFTHNGKQYNVTRTISL 88 (92)
T ss_pred EEecCCCEEEEEEEEEEE
Confidence 999988876666555443
No 135
>cd07701 Ig1_Necl-3 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig1_Necl-3: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-3, Necl-3 (also known as cell adhesion molecule 2 (CADM2), SynCAM2, IGSF4D). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-3 accumulates in central and peripheral nervous system tissue, and has been shown to selectively interact with oligodendrocytes.
Probab=97.45 E-value=0.0002 Score=63.57 Aligned_cols=79 Identities=14% Similarity=0.302 Sum_probs=52.5
Q ss_pred ccceeecccccccccccccccCCCcEEEeecCeecc--CCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEe
Q psy12044 261 TFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQ--NESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCV 338 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~--~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~Cv 338 (767)
..++.+.+|+.+.|.|.+.+.|.+.+.|...++.+. ....... ..++.... .......|.|.++..+|.|.|.|.
T Consensus 4 ~~~v~v~eG~~v~L~C~~~~~p~~~v~W~~~~~~~l~~~~~~~~~-~~r~~~~~--~~~~~~sL~I~~v~~~DsG~Y~C~ 80 (95)
T cd07701 4 TQNVTVVEGGTANLTCRVDQNDNTSLQWSNPAQQTLYFDDKKALR-DNRIELVR--ASWHELSISISDVSLSDEGQYTCS 80 (95)
T ss_pred cceEEEecCCcEEEEEEEecCCceEEEEeCCCCeEEEEcCccccc-CCCEEEEE--CCCCcEEEEECcCCcccCEEEEEE
Confidence 346788999999999999999999999986432211 1110000 01111110 012346799999999999999999
Q ss_pred eccC
Q psy12044 339 AENQ 342 (767)
Q Consensus 339 A~N~ 342 (767)
+.+.
T Consensus 81 ~~t~ 84 (95)
T cd07701 81 LFTM 84 (95)
T ss_pred eEee
Confidence 9874
No 136
>cd05875 Ig6_hNeurofascin_like Sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). Ig6_hNeurofascin_like: the sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). NF belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and a cytoplasmic domain. NF has many alternatively spliced isoforms having different temporal expression patterns during development. NF participates in axon subcellular targeting and synapse formation, however little is known of the functions of the different isoforms.
Probab=97.44 E-value=0.00016 Score=61.48 Aligned_cols=67 Identities=22% Similarity=0.361 Sum_probs=45.7
Q ss_pred ccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeecc----CCCCceeEeeccCCCCcc
Q psy12044 272 VSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNI----DDNGTFVCVAENQAGSTS 347 (767)
Q Consensus 272 vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~----sD~GtY~CvA~N~~G~s~ 347 (767)
+.|.|.+.|.|.|.++|.+++..+..... .+ +.. ....+.|.|.++.. .|.|.|.|.|.|..|.+.
T Consensus 1 ~~l~C~~~G~P~P~v~W~k~g~~~~~~~~----~~-~~~-----~~~~~~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~ 70 (77)
T cd05875 1 IIIECEAKGNPVPTFQWTRNGKFFNVAKD----PR-VSM-----RRRSGTLVIDFSGGGRPEDYEGEYQCFARNNLGTAL 70 (77)
T ss_pred CEEEEeccccCCCEEEEEECCEEccCcCC----Cc-EEE-----eCCCceEEEeccCCCCCCCCCEEEEEEEEeccceEE
Confidence 35899999999999999998875521110 00 111 11235688877642 358999999999999765
Q ss_pred c
Q psy12044 348 S 348 (767)
Q Consensus 348 ~ 348 (767)
+
T Consensus 71 s 71 (77)
T cd05875 71 S 71 (77)
T ss_pred E
Confidence 4
No 137
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.41 E-value=0.00016 Score=54.49 Aligned_cols=39 Identities=38% Similarity=0.444 Sum_probs=22.0
Q ss_pred CccEEeccCCCccccchhhhcCCCCCCeeeccCCcccccc
Q psy12044 148 YLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTIS 187 (767)
Q Consensus 148 ~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip 187 (767)
+|+.|+|++|+|+.+++ .+..+++|+.|+|++|+|++++
T Consensus 2 ~L~~L~l~~N~i~~l~~-~l~~l~~L~~L~l~~N~i~~i~ 40 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPP-ELSNLPNLETLNLSNNPISDIS 40 (44)
T ss_dssp T-SEEEETSSS-SSHGG-HGTTCTTSSEEEETSSCCSBEG
T ss_pred cceEEEccCCCCcccCc-hHhCCCCCCEEEecCCCCCCCc
Confidence 45666666666665544 3556666666666666666554
No 138
>cd05862 Ig1_VEGFR First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). IG1_VEGFR: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF_A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angioge
Probab=97.34 E-value=0.00042 Score=60.28 Aligned_cols=82 Identities=17% Similarity=0.285 Sum_probs=54.1
Q ss_pred cccccccccccccC--CCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCc
Q psy12044 269 GKNVSLLCKVSAIP--EAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGST 346 (767)
Q Consensus 269 G~~vsL~C~a~g~P--~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s 346 (767)
|+.+.|.|.+.+.+ ...+.|..++........... .+ ..........+.|.|.++...|.|.|.|.|.|..|..
T Consensus 1 Ge~~~L~C~~~~~~~~~~~~~W~~p~~~~~~~~~~~~-~~---~~~~~~~~~~s~L~I~~~~~~DsG~Y~C~a~n~~~~~ 76 (86)
T cd05862 1 GEKLVLNCTARTELNVGIDFQWDYPGKKEQRAKSVSE-NR---RSLQEHTELSSTLTIENVTLSDLGRYTCTASSGQMIA 76 (86)
T ss_pred CCcEEEEEEEEeCCCCcEEEEEEcCCcccccceeccc-cc---ccccccceeeeEEEEecCCcccCEEEEEEEeecceEe
Confidence 56788999998765 457799887654321111100 00 0001123356799999999999999999999988877
Q ss_pred ccceEEEE
Q psy12044 347 SSNYTIRI 354 (767)
Q Consensus 347 ~~s~sL~V 354 (767)
.....+.|
T Consensus 77 ~~~t~~~V 84 (86)
T cd05862 77 KNSTIVIV 84 (86)
T ss_pred cccEEEEE
Confidence 66665544
No 139
>KOG1909|consensus
Probab=97.31 E-value=6.2e-05 Score=80.06 Aligned_cols=189 Identities=21% Similarity=0.284 Sum_probs=137.6
Q ss_pred HHhhhccCCCCCceecccCCeeEEEecCCCcc-ccccCC------CCCccEEEeeCCCCCCCCchhhhc-----------
Q psy12044 10 TIIKIVSACPTSCICKWKGGKQTVECVNKSLI-TVVEGM------DPNTQVLDYTGNNLKTLHNEKFQK----------- 71 (767)
Q Consensus 10 ~~~~~~~~CP~~C~C~~~g~~~~v~C~~~~L~-~iP~~l------~~~L~~L~Ls~N~L~~l~~~~f~~----------- 71 (767)
++..+-..||. .+.++.+++-+. ..++.+ ..+|++|.|.+|.|...-...++.
T Consensus 83 ~l~~aL~~~~~---------L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~ 153 (382)
T KOG1909|consen 83 MLSKALLGCPK---------LQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKA 153 (382)
T ss_pred HHHHHHhcCCc---------eeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhcc
Confidence 34445567772 356888876664 222222 678999999999998654444222
Q ss_pred cCCCCccEEEccCCCCCccC----cccccCCCCCCEEEccCCCCCCC----CCCCCCCCCCCcEEECCCCcCcccc----
Q psy12044 72 MGLVNLQKIYLSRCRISVID----SKAFRGLTNLVDLDFSHNVLQTV----PSDTFPDYPSLMKLTLSGNPIKQIK---- 139 (767)
Q Consensus 72 ~~L~~L~~L~Ls~N~L~~i~----p~~f~~L~~L~~L~Ls~N~Lt~l----~p~~f~~l~~L~~L~Ls~N~l~~l~---- 139 (767)
..-++|+++..++|++.... ...|...+.|+.+.+..|.|..- ....|..+++|+.|+|.+|.++...
T Consensus 154 ~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~L 233 (382)
T KOG1909|consen 154 ASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVAL 233 (382)
T ss_pred CCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHH
Confidence 12468999999999998643 45678889999999999987642 2345778999999999999998543
Q ss_pred cCCcCCCCCccEEeccCCCccccchhhhc-----CCCCCCeeeccCCcccc-----ccCCCCCCCCcccccCCCCCCC
Q psy12044 140 TGAFQPLSYLVTLELSKCGIEVIEDAAFV-----GLDSLEWLKLDNNKITT-----ISGSNILPTGLHGIDLHHNPWT 207 (767)
Q Consensus 140 ~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~-----~l~~L~~L~Ls~N~Lt~-----ip~~~~~~~~L~~L~Ls~N~l~ 207 (767)
...+..+++|+.|++++|.++.--..+|. ..++|+.|.|.+|.|+. +.......+.|..|+|++|.+.
T Consensus 234 akaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 234 AKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 34567788999999999999865443332 36899999999999873 2222234578999999999993
No 140
>KOG3513|consensus
Probab=97.30 E-value=0.00056 Score=82.57 Aligned_cols=92 Identities=28% Similarity=0.533 Sum_probs=74.6
Q ss_pred CCCCCCccceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCc
Q psy12044 255 PQITPSTFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGT 334 (767)
Q Consensus 255 P~i~~~~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~Gt 334 (767)
|..........+..|.++++.|.+.+.|.|.++|.+++..+......+ ......++|.|.+++..|.|.
T Consensus 332 P~w~~~~~d~~~~~gs~v~~eC~a~g~P~p~v~WlkNg~pl~~~~r~~-----------~~~i~~g~L~is~v~~~dsg~ 400 (1051)
T KOG3513|consen 332 PYWLQKPQDTEADTGSNVTLECKASGKPNPTVKWLKNGEPLEPAERDP-----------RYKIDDGTLIISNVQESDSGV 400 (1051)
T ss_pred chhhcccceeEecCCCCeEEEEEecCCCCCceEEeeCCeecCccCCCc-----------ceEEeCCEEEEEecccccCeE
Confidence 445555666788899999999999999999999999998876332210 011234689999999999999
Q ss_pred eeEeeccCCCCcccceEEEEEee
Q psy12044 335 FVCVAENQAGSTSSNYTIRIVLK 357 (767)
Q Consensus 335 Y~CvA~N~~G~s~~s~sL~V~~~ 357 (767)
|.|.|+|..|...+++.|.|...
T Consensus 401 YQC~A~Nk~G~i~anA~L~V~a~ 423 (1051)
T KOG3513|consen 401 YQCIAENKYGTIYANAELKVLAS 423 (1051)
T ss_pred EEeeeecccceEeeeeEEEEEcc
Confidence 99999999999999999998764
No 141
>smart00408 IGc2 Immunoglobulin C-2 Type.
Probab=97.29 E-value=0.00045 Score=54.53 Aligned_cols=63 Identities=41% Similarity=0.722 Sum_probs=47.7
Q ss_pred ccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCC
Q psy12044 268 EGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAG 344 (767)
Q Consensus 268 ~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G 344 (767)
+|+.+.|.|.+.+.+.+.+.|.+++..+.. .. . .......|.|.++...|.|.|.|.+.|..|
T Consensus 1 ~g~~~~l~C~~~~~~~~~v~W~~~~~~~~~-~~--------~-----~~~~~~~L~i~~~~~~d~G~Y~C~~~n~~g 63 (63)
T smart00408 1 EGQSVTLTCPAEGDPVPNITWLKDGKPLPE-SN--------R-----LSASGSTLTIKSVSLEDSGEYTCVAENSAG 63 (63)
T ss_pred CCceEEEEeeCccCCCCeEEEEECCEECCC-CC--------E-----EecCCcEEEEeeCCcccCEEEEEEEecCCC
Confidence 367789999988889999999997765541 00 0 012235799999999999999999988654
No 142
>cd05873 Ig_Sema4D_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4D. Ig_Sema4D_like; Immunoglobulin (Ig)-like domain of Sema4D. Sema4D is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4D has extracellular Sema and Ig domains, a transmembrane domain, and a short cytoplasmic domain. Sema4D plays a part in the development of GABAergic synapses. Sema4D in addition is an immune semaphorin. It is abundant on resting T cells; its expression is weak on resting B cells and antigen presenting cells (APCs), but is upregulated by various stimuli. The receptor used by Sema4D in the immune system is CD72. Sem4D enhances the activation of B cells and DCs through binding CD72, perhaps by reducing CD72s inhibitory signals. The receptor used by Sema4D in the non-lymphatic tissues is plexin-B1. Sem4D is anchored to the cell surface but its extracellular domain can be released from the cell surface by a metalloproteas
Probab=97.29 E-value=0.00044 Score=60.38 Aligned_cols=67 Identities=27% Similarity=0.504 Sum_probs=51.1
Q ss_pred cceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeecc
Q psy12044 262 FYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAEN 341 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N 341 (767)
....+..|..+.|.|.+.+ +.+.+.|.+++..+.... ..+.. ....|.|.+++.+|.|.|.|.+.+
T Consensus 4 ~~~~v~~G~~v~L~C~~~~-~~~~i~W~~ng~~i~~~~------~r~~~-------~~~~L~I~nv~~~DsG~Y~C~a~e 69 (87)
T cd05873 4 RQRTFKLGNNAELKCSPKS-NLARVVWKFDGKVLTPES------AKYLL-------YRDGLLIFNASEADAGRYQCLSVE 69 (87)
T ss_pred ceEEEECCCCEEEEEECCC-CCCeEEEEECCEECCCCC------ceEEE-------ECCcEEEeCCCHHHCEEEEEEEEe
Confidence 3567788999999999865 678999999998775431 11111 124589999999999999999986
Q ss_pred C
Q psy12044 342 Q 342 (767)
Q Consensus 342 ~ 342 (767)
.
T Consensus 70 ~ 70 (87)
T cd05873 70 K 70 (87)
T ss_pred c
Confidence 5
No 143
>cd04979 Ig_Semaphorin_C Immunoglobulin (Ig)-like domain of semaphorin. Ig_Semaphorin_C; Immunoglobulin (Ig)-like domain in semaphorins. Semaphorins are transmembrane protein that have important roles in a variety of tissues. Functionally, semaphorins were initially characterized for their importance in the development of the nervous system and in axonal guidance. Later they have been found to be important for the formation and functioning of the cardiovascular, endocrine, gastrointestinal, hepatic, immune, musculoskeletal, renal, reproductive, and respiratory systems. Semaphorins function through binding to their receptors and transmembrane semaphorins also serves as receptors themselves. Although molecular mechanism of semaphorins is poorly understood, the Ig-like domains may involve in ligand binding or dimerization.
Probab=97.29 E-value=0.00045 Score=60.28 Aligned_cols=72 Identities=26% Similarity=0.487 Sum_probs=51.1
Q ss_pred cceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeecc
Q psy12044 262 FYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAEN 341 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N 341 (767)
....+..|+.+.|.|.+.+ |.+.+.|.+++..+...... ..+ +.. ....|.|.++..+|.|.|.|.+.+
T Consensus 4 ~~~~v~~g~~v~L~C~~~~-p~~~i~W~k~~~~~~~~~~~--~~~-~~~-------~~~~L~I~~~~~~D~G~Y~C~a~~ 72 (89)
T cd04979 4 KVVTVVEGNSVFLECSPKS-NLASVVWLFQGGPLQRKEEP--EER-LLV-------TEDGLLIRSVSPADAGVYTCQSVE 72 (89)
T ss_pred eEEEEECCCcEEEEEeCCC-CCceEEEEECCcccccccCc--Cce-EEE-------cCCCEEEccCCHHHCEEEEEEEec
Confidence 3456778999999999887 88899999987654332110 000 111 123488999999999999999987
Q ss_pred CCC
Q psy12044 342 QAG 344 (767)
Q Consensus 342 ~~G 344 (767)
..+
T Consensus 73 ~~~ 75 (89)
T cd04979 73 HGF 75 (89)
T ss_pred Ccc
Confidence 644
No 144
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.28 E-value=0.00017 Score=54.39 Aligned_cols=35 Identities=29% Similarity=0.449 Sum_probs=12.8
Q ss_pred ccEEEccCCCCCccCcccccCCCCCCEEEccCCCCC
Q psy12044 77 LQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQ 112 (767)
Q Consensus 77 L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt 112 (767)
|+.|+|++|+|+.+.+ .|.+|++|+.|+|++|.|+
T Consensus 3 L~~L~l~~N~i~~l~~-~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 3 LEELDLSNNQITDLPP-ELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp -SEEEETSSS-SSHGG-HGTTCTTSSEEEETSSCCS
T ss_pred ceEEEccCCCCcccCc-hHhCCCCCCEEEecCCCCC
Confidence 3444444444443321 2334444444444444333
No 145
>cd05717 Ig1_Necl-1-3_like First (N-terminal) immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-3 (also known as cell adhesion molecules CADM3, CADM1, and CADM2 respectively). Ig1_Necl-1-3_like: N-terminal immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), and Necl-3 (CADM2). At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1, Necl-2, and Necl-3 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the form
Probab=97.27 E-value=0.00067 Score=59.97 Aligned_cols=81 Identities=16% Similarity=0.282 Sum_probs=52.5
Q ss_pred ccceeecccccccccccccccCCCcEEEeecCeeccC-CCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEee
Q psy12044 261 TFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQN-ESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVA 339 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~-~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA 339 (767)
...+.+.+|+.+.|.|.+.+.+.+.+.|...++.... .........++.... .......|.|.+++.+|.|.|.|.+
T Consensus 4 ~~~~~v~~G~~v~L~C~~~~~~~~~v~W~~p~~~~~~~~~~~~~~~~r~~~~~--~~~~~~~L~I~~v~~~DsG~Y~C~~ 81 (95)
T cd05717 4 TQDVTVVEGGTATLKCRVKNNDNSSLQWSNPNQQTLYFNDKRALRDNRIQLVN--FSANELSISISNVSLSDEGRYTCSL 81 (95)
T ss_pred CCcEEEcCCCCEEEEEEECCCCCceEEEeCCCCcEEEeccccccccCcEEEEc--CCCCeeEEEEccCCcccCEEEEEEE
Confidence 3466788999999999998888899999864322110 000000011111111 1123457999999999999999999
Q ss_pred ccCC
Q psy12044 340 ENQA 343 (767)
Q Consensus 340 ~N~~ 343 (767)
.+..
T Consensus 82 ~~~~ 85 (95)
T cd05717 82 YTMP 85 (95)
T ss_pred ecCC
Confidence 8654
No 146
>cd05860 Ig4_SCFR Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). Ig4_SCFR: The fourth Immunoglobulin (Ig)-like domain in stem cell factor receptor (SCFR). SCFR is organized as an extracellular component having five IG-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR. This fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth domain abolishes the ligand-induced dimerization of SCFR and completely inhibits signal transduction.
Probab=97.22 E-value=0.0012 Score=58.98 Aligned_cols=87 Identities=22% Similarity=0.372 Sum_probs=67.5
Q ss_pred ceeecccccccccccccccCCCc-EEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeecc
Q psy12044 263 YLEIQEGKNVSLLCKVSAIPEAK-ITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAEN 341 (767)
Q Consensus 263 ~~~v~~G~~vsL~C~a~g~P~p~-itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N 341 (767)
..++..|+.+.|.|.+.+.|.|. +.|.+++..+.+.... ..........++.++|++..+..+|.|.|+|.|.|
T Consensus 12 ~~~v~~gE~~~L~V~ieAYP~p~~~~W~~~~~~l~~~~~~-----~~~~~~~~~~rY~S~L~L~Rlk~~E~G~YTf~a~N 86 (101)
T cd05860 12 TIFVNAGENLDLIVEYEAYPKPEHQQWIYMNRTLTNTSDH-----YVKSRNESNNRYVSELHLTRLKGTEGGTYTFLVSN 86 (101)
T ss_pred eEEEECCCCEEEEEEEEeCCCCeeeEEEcCCcccCccccc-----eeEEeccCceEEEEEEEEeecChhhCcEEEEEEEC
Confidence 46788999999999999999997 9999987765433321 11222223456789999999999999999999999
Q ss_pred CCCCcccceEEEE
Q psy12044 342 QAGSTSSNYTIRI 354 (767)
Q Consensus 342 ~~G~s~~s~sL~V 354 (767)
....+...+.+.|
T Consensus 87 ~~~~~s~tF~l~v 99 (101)
T cd05860 87 SDASASVTFNVYV 99 (101)
T ss_pred CCCeEEEEEEEEE
Confidence 9888776666654
No 147
>cd07690 Ig1_CD4 First immunoglobulin (Ig) domain of CD4. Ig1_CD4; first immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=97.18 E-value=0.00052 Score=60.83 Aligned_cols=81 Identities=17% Similarity=0.256 Sum_probs=52.6
Q ss_pred eecccccccccccccccCCCcEEEeecCeec-cCCC--c----ccccccceeecccCcceeeeEEEEeeeccCCCCceeE
Q psy12044 265 EIQEGKNVSLLCKVSAIPEAKITWLFDGVPI-QNES--M----SASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVC 337 (767)
Q Consensus 265 ~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l-~~~s--~----~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~C 337 (767)
.+..|++++|.|.+.+.+.+.+.|.+.++.. .... + .......+.....+.......|.|.++..+|.|+|.|
T Consensus 3 ~~~~G~~VtL~C~~s~~~~~~i~W~~~~~k~~~g~~~~l~~~~~~~~~~r~~~~~~~~~~g~~~L~I~~l~~sDsgtY~C 82 (94)
T cd07690 3 LGKKGDTAELPCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRNLWDQGSFPLIIKNLKIEDSDTYIC 82 (94)
T ss_pred EeeCCCCEEEEEEeCCCCCcEEEEEECCcEEccCcCCEEEEecccccCCCCceecccCCCCeEEEEECCCCHHHCEEEEE
Confidence 4568999999999999999999998654221 1111 0 0000011111112223345679999999999999999
Q ss_pred eeccCCCC
Q psy12044 338 VAENQAGS 345 (767)
Q Consensus 338 vA~N~~G~ 345 (767)
.+.|..+.
T Consensus 83 ~v~~~~~~ 90 (94)
T cd07690 83 EVEDKKEE 90 (94)
T ss_pred EECCccce
Confidence 99887553
No 148
>KOG3653|consensus
Probab=97.18 E-value=0.00035 Score=77.02 Aligned_cols=26 Identities=23% Similarity=0.088 Sum_probs=23.0
Q ss_pred CCccccCCCCcceEEeeCCceEEEec
Q psy12044 448 GYIIADGHNDMMLYATDSGILVATNN 473 (767)
Q Consensus 448 ~nlIG~GgfG~VYKG~~dG~~VA~~~ 473 (767)
.-+||+|+||.||||.-+++.||+|-
T Consensus 215 ~eli~~Grfg~V~KaqL~~~~VAVKi 240 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLDNRLVAVKI 240 (534)
T ss_pred HHHhhcCccceeehhhccCceeEEEe
Confidence 34899999999999996669999987
No 149
>PRK15386 type III secretion protein GogB; Provisional
Probab=97.11 E-value=0.0017 Score=72.18 Aligned_cols=133 Identities=21% Similarity=0.258 Sum_probs=78.3
Q ss_pred CCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCC-CCCCCCCCCCCCCCCCcE
Q psy12044 49 PNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHN-VLQTVPSDTFPDYPSLMK 127 (767)
Q Consensus 49 ~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N-~Lt~l~p~~f~~l~~L~~ 127 (767)
.+++.|++++|.|+.++ .+ ..+|+.|.+++|.--...|+.+ ..+|+.|+|++| .+..++ .+|+.
T Consensus 52 ~~l~~L~Is~c~L~sLP--~L----P~sLtsL~Lsnc~nLtsLP~~L--P~nLe~L~Ls~Cs~L~sLP-------~sLe~ 116 (426)
T PRK15386 52 RASGRLYIKDCDIESLP--VL----PNELTEITIENCNNLTTLPGSI--PEGLEKLTVCHCPEISGLP-------ESVRS 116 (426)
T ss_pred cCCCEEEeCCCCCcccC--CC----CCCCcEEEccCCCCcccCCchh--hhhhhheEccCcccccccc-------cccce
Confidence 56778888888887776 22 2468888887743333334433 247888888877 555433 34667
Q ss_pred EECCCCcCcccccCCcCCC-CCccEEeccCCCcc-cc-chhhhcCCCCCCeeeccCCccccccCCCCCCCCcccccCCCC
Q psy12044 128 LTLSGNPIKQIKTGAFQPL-SYLVTLELSKCGIE-VI-EDAAFVGLDSLEWLKLDNNKITTISGSNILPTGLHGIDLHHN 204 (767)
Q Consensus 128 L~Ls~N~l~~l~~~~~~~l-~~L~~L~Ls~N~L~-~i-~~~~~~~l~~L~~L~Ls~N~Lt~ip~~~~~~~~L~~L~Ls~N 204 (767)
|+|+.|.+..+. .+ ++|+.|.+.+++.. .. .+.. -..+|+.|++++|....+|.. .+.+|+.|.++.|
T Consensus 117 L~L~~n~~~~L~-----~LPssLk~L~I~~~n~~~~~~lp~~--LPsSLk~L~Is~c~~i~LP~~--LP~SLk~L~ls~n 187 (426)
T PRK15386 117 LEIKGSATDSIK-----NVPNGLTSLSINSYNPENQARIDNL--ISPSLKTLSLTGCSNIILPEK--LPESLQSITLHIE 187 (426)
T ss_pred EEeCCCCCcccc-----cCcchHhheeccccccccccccccc--cCCcccEEEecCCCcccCccc--ccccCcEEEeccc
Confidence 777766544321 12 35667776443211 10 0110 125788888888876665543 3467888888765
Q ss_pred C
Q psy12044 205 P 205 (767)
Q Consensus 205 ~ 205 (767)
.
T Consensus 188 ~ 188 (426)
T PRK15386 188 Q 188 (426)
T ss_pred c
Confidence 3
No 150
>cd05753 Ig2_FcgammaR_like Second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig2_FcgammaR_like: domain similar to the second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=97.10 E-value=0.00079 Score=58.15 Aligned_cols=64 Identities=23% Similarity=0.331 Sum_probs=49.9
Q ss_pred eecccccccccccccc-cCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCC
Q psy12044 265 EIQEGKNVSLLCKVSA-IPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQA 343 (767)
Q Consensus 265 ~v~~G~~vsL~C~a~g-~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~ 343 (767)
.+.+|+.++|.|.+.. .+...+.|.+++..+... .....|.|.++..+|+|.|.|.+.+..
T Consensus 10 ~V~~G~~vtL~C~~~~~~~~~~~~w~k~g~~~~~~------------------~~~~~l~I~~~~~~dsG~Y~C~~~~~~ 71 (83)
T cd05753 10 VVFEGEPLVLRCHGWKNKPVYKVTYYRDGKAKKYS------------------HSNSNLSIPQATLSDSGSYHCSGIIGS 71 (83)
T ss_pred eecCCCCEEEEeeCCCCCcceEEEEEECCeEcccc------------------CCCceEEECccCHHHCEEEEEEEEeCC
Confidence 5778999999999854 566789999987544210 113579999999999999999999887
Q ss_pred CCc
Q psy12044 344 GST 346 (767)
Q Consensus 344 G~s 346 (767)
|..
T Consensus 72 ~~~ 74 (83)
T cd05753 72 YDY 74 (83)
T ss_pred cee
Confidence 743
No 151
>KOG3665|consensus
Probab=97.09 E-value=0.0003 Score=83.92 Aligned_cols=133 Identities=20% Similarity=0.195 Sum_probs=76.3
Q ss_pred CCccEEEeeCCCCC-CCCchhhhccCCCCccEEEccCCCCCccC-cccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCc
Q psy12044 49 PNTQVLDYTGNNLK-TLHNEKFQKMGLVNLQKIYLSRCRISVID-SKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLM 126 (767)
Q Consensus 49 ~~L~~L~Ls~N~L~-~l~~~~f~~~~L~~L~~L~Ls~N~L~~i~-p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~ 126 (767)
.+|+.|++++...- .-.+..++. -|++|+.|.+.+=.+.... -..+.++++|..||+|+.+++.+ ..++.|++|+
T Consensus 122 ~nL~~LdI~G~~~~s~~W~~kig~-~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq 198 (699)
T KOG3665|consen 122 QNLQHLDISGSELFSNGWPKKIGT-MLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQ 198 (699)
T ss_pred HhhhhcCccccchhhccHHHHHhh-hCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHH
Confidence 45677777765432 222333333 3677777777765554322 23355677777777777777766 4566777777
Q ss_pred EEECCCCcCccc-ccCCcCCCCCccEEeccCCCccccch------hhhcCCCCCCeeeccCCccc
Q psy12044 127 KLTLSGNPIKQI-KTGAFQPLSYLVTLELSKCGIEVIED------AAFVGLDSLEWLKLDNNKIT 184 (767)
Q Consensus 127 ~L~Ls~N~l~~l-~~~~~~~l~~L~~L~Ls~N~L~~i~~------~~~~~l~~L~~L~Ls~N~Lt 184 (767)
.|.+.+=.+..- .-..+.+|++|+.||+|......... +.-..|+.|+.||.|++.+.
T Consensus 199 ~L~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~ 263 (699)
T KOG3665|consen 199 VLSMRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDIN 263 (699)
T ss_pred HHhccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcchh
Confidence 777666555431 11224457777777777654332221 11123677777777766554
No 152
>PRK15386 type III secretion protein GogB; Provisional
Probab=97.03 E-value=0.0022 Score=71.25 Aligned_cols=131 Identities=18% Similarity=0.255 Sum_probs=86.1
Q ss_pred eEEEecCCCccccccCCCCCccEEEeeC-CCCCCCCchhhhccCCCCccEEEccCC-CCCccCcccccCCCCCCEEEccC
Q psy12044 31 QTVECVNKSLITVVEGMDPNTQVLDYTG-NNLKTLHNEKFQKMGLVNLQKIYLSRC-RISVIDSKAFRGLTNLVDLDFSH 108 (767)
Q Consensus 31 ~~v~C~~~~L~~iP~~l~~~L~~L~Ls~-N~L~~l~~~~f~~~~L~~L~~L~Ls~N-~L~~i~p~~f~~L~~L~~L~Ls~ 108 (767)
..++-++..+..+| .++.+|+.|.+++ +.++.++ ..+ ..+|+.|+|++| .|..+ | .+|+.|+|+.
T Consensus 55 ~~L~Is~c~L~sLP-~LP~sLtsL~Lsnc~nLtsLP-~~L----P~nLe~L~Ls~Cs~L~sL-P------~sLe~L~L~~ 121 (426)
T PRK15386 55 GRLYIKDCDIESLP-VLPNELTEITIENCNNLTTLP-GSI----PEGLEKLTVCHCPEISGL-P------ESVRSLEIKG 121 (426)
T ss_pred CEEEeCCCCCcccC-CCCCCCcEEEccCCCCcccCC-chh----hhhhhheEccCccccccc-c------cccceEEeCC
Confidence 45666677899998 6889999999998 4455444 333 258999999998 66543 3 3588888887
Q ss_pred CCCCCCCCCCCCCC-CCCcEEECCCCc-Ccccc-cCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccc
Q psy12044 109 NVLQTVPSDTFPDY-PSLMKLTLSGNP-IKQIK-TGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKIT 184 (767)
Q Consensus 109 N~Lt~l~p~~f~~l-~~L~~L~Ls~N~-l~~l~-~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt 184 (767)
|.+..+. .+ ++|+.|.+.+++ ..... +.. -..+|+.|++++|....++. .+ ..+|+.|.++.|...
T Consensus 122 n~~~~L~-----~LPssLk~L~I~~~n~~~~~~lp~~--LPsSLk~L~Is~c~~i~LP~-~L--P~SLk~L~ls~n~~~ 190 (426)
T PRK15386 122 SATDSIK-----NVPNGLTSLSINSYNPENQARIDNL--ISPSLKTLSLTGCSNIILPE-KL--PESLQSITLHIEQKT 190 (426)
T ss_pred CCCcccc-----cCcchHhheeccccccccccccccc--cCCcccEEEecCCCcccCcc-cc--cccCcEEEecccccc
Confidence 7654322 22 367788875433 21111 111 12689999999988665432 22 258999999887543
No 153
>KOG1025|consensus
Probab=97.00 E-value=0.00026 Score=82.37 Aligned_cols=27 Identities=15% Similarity=0.129 Sum_probs=21.7
Q ss_pred CCCccccCCCCcceEEe--eCCc----eEEEec
Q psy12044 447 GGYIIADGHNDMMLYAT--DSGI----LVATNN 473 (767)
Q Consensus 447 ~~nlIG~GgfG~VYKG~--~dG~----~VA~~~ 473 (767)
...+||+|+||.||||. |.|. .||++-
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKv 732 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKV 732 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEE
Confidence 34489999999999999 8885 456655
No 154
>KOG2982|consensus
Probab=96.96 E-value=0.0004 Score=72.50 Aligned_cols=43 Identities=12% Similarity=-0.039 Sum_probs=23.4
Q ss_pred CCCCeeeccCCccccccCCCC--CCCCcccccCCCCCCCchhhhh
Q psy12044 171 DSLEWLKLDNNKITTISGSNI--LPTGLHGIDLHHNPWTCDCLLI 213 (767)
Q Consensus 171 ~~L~~L~Ls~N~Lt~ip~~~~--~~~~L~~L~Ls~N~l~C~c~l~ 213 (767)
+++..+-+..|.|.....+-. ..+.+.-|+|+.|.+-.+-.+.
T Consensus 199 pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD 243 (418)
T KOG2982|consen 199 PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVD 243 (418)
T ss_pred ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHH
Confidence 455556666666654432221 2355566777777776544433
No 155
>cd05845 Ig2_L1-CAM_like Second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig2_L1-CAM_like: domain similar to the second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=96.95 E-value=0.0015 Score=57.91 Aligned_cols=72 Identities=19% Similarity=0.297 Sum_probs=52.7
Q ss_pred cceeeccccccccccc-ccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCC-ceeEee
Q psy12044 262 FYLEIQEGKNVSLLCK-VSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNG-TFVCVA 339 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~-a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~G-tY~CvA 339 (767)
..+.+.+|+.+.|.|. ..+.|.|.+.|..+...... . ..++.. ...+.|.|.++...|.| .|.|.|
T Consensus 11 ~~v~V~eG~~~~L~C~pP~g~P~P~i~W~~~~~~~i~-----~-~~Ri~~------~~~GnL~fs~v~~~D~g~~Y~C~a 78 (95)
T cd05845 11 RPVEVEEGDSVVLPCNPPKSAVPLRIYWMNSDLLHIT-----Q-DERVSM------GQNGNLYFANVEEQDSHPDYICHA 78 (95)
T ss_pred ceeEEecCCCEEEEecCCCCCCCCEEEEECCCCcccc-----c-cccEEE------CCCceEEEEEEehhhCCCCeEEEE
Confidence 3567889999999997 69999999999975432211 0 111111 12368999999999999 799999
Q ss_pred ccCCCC
Q psy12044 340 ENQAGS 345 (767)
Q Consensus 340 ~N~~G~ 345 (767)
.|....
T Consensus 79 ~~~~~~ 84 (95)
T cd05845 79 HFPGLR 84 (95)
T ss_pred Eccccc
Confidence 987644
No 156
>cd05871 Ig_Semaphorin_classIII Immunoglobulin (Ig)-like domain of class III semaphorin. Ig_Semaphorin_class III; Immunoglobulin (Ig)-like domain of class III semaphorins. Semaphorins are classified into various classes on the basis of structural features additional to the Sema domain. Class III semaphorins are a vertebrate class having a Sema domain, an Ig domain, a short basic domain, and are secreted. They have been shown to be axonal guidance cues and have a part in the regulation of the cardiovascular, immune and respiratory systems. Sema3A, the prototype member of this class III subfamily, induces growth cone collapse and is an inhibitor of axonal sprouting. In perinatal rat cortex as a chemoattractant, it functions to direct, for pyramidal neurons, the orientated extension of apical dendrites. It may play a role, prior to the development of apical dendrites, in signaling the radial migration of newborn cortical neurons towards the upper layers. Sema3A selectively inhibits vascula
Probab=96.87 E-value=0.0022 Score=56.41 Aligned_cols=81 Identities=23% Similarity=0.345 Sum_probs=50.4
Q ss_pred eeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeecc-C
Q psy12044 264 LEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAEN-Q 342 (767)
Q Consensus 264 ~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N-~ 342 (767)
....+|+.+.|.|.. ..|.+.+.|+++.............. ......+.|.|.++..+|.|.|.|.+.+ .
T Consensus 6 ~~~~eG~~v~L~C~~-~~p~p~v~Wykq~~g~~~~~~~~~~~--------r~~~~~~~L~I~~~~~~DsG~Y~C~a~~~~ 76 (91)
T cd05871 6 VYGVENNSTFLECLP-KSPQASVKWLFQRGGDQRKEEVKTEE--------RLIHTERGLLLRSLQRSDAGVYTCTAVEHS 76 (91)
T ss_pred EEEecCCcEEEEEEC-CCCCceEEEEEECCCCCccccccccc--------cEEEecCeEEEeeCChhHCEEEEEEEEccC
Confidence 456789999999996 47899999998322111000000000 0111234599999999999999999974 4
Q ss_pred CCCcccceEEE
Q psy12044 343 AGSTSSNYTIR 353 (767)
Q Consensus 343 ~G~s~~s~sL~ 353 (767)
.+.....+.|.
T Consensus 77 ~~~~~~~~~l~ 87 (91)
T cd05871 77 FSQTLAKYTLH 87 (91)
T ss_pred CeEEEEEEEEE
Confidence 44444434333
No 157
>KOG2739|consensus
Probab=96.87 E-value=0.00043 Score=71.33 Aligned_cols=85 Identities=27% Similarity=0.414 Sum_probs=39.8
Q ss_pred CCCccEEEccCCCCCccCcccccCCCCCCEEEccCC--CCCCCCCCCCCCCCCCcEEECCCCcCccccc-CCcCCCCCcc
Q psy12044 74 LVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHN--VLQTVPSDTFPDYPSLMKLTLSGNPIKQIKT-GAFQPLSYLV 150 (767)
Q Consensus 74 L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N--~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~-~~~~~l~~L~ 150 (767)
+..|+.|.+.+..++.+. .|..|++|+.|.++.| .+.+-.+-....+++|++|+|++|+|.-+.. ..+..+.+|.
T Consensus 42 ~~~le~ls~~n~gltt~~--~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~lstl~pl~~l~nL~ 119 (260)
T KOG2739|consen 42 FVELELLSVINVGLTTLT--NFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKDLSTLRPLKELENLK 119 (260)
T ss_pred ccchhhhhhhccceeecc--cCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccccccccchhhhhcchh
Confidence 345555555555555442 2445556666666666 3332222222334566666666665543211 1123344455
Q ss_pred EEeccCCCcc
Q psy12044 151 TLELSKCGIE 160 (767)
Q Consensus 151 ~L~Ls~N~L~ 160 (767)
.|++.+|..+
T Consensus 120 ~Ldl~n~~~~ 129 (260)
T KOG2739|consen 120 SLDLFNCSVT 129 (260)
T ss_pred hhhcccCCcc
Confidence 5555555443
No 158
>KOG0196|consensus
Probab=96.85 E-value=0.00063 Score=79.05 Aligned_cols=74 Identities=19% Similarity=0.161 Sum_probs=46.8
Q ss_pred CCcccHHHHHhcccCCCCCCC---------CccccCCCCcceEEe--eCC---ceEEEec-cccC---------CCcchh
Q psy12044 428 SPKYTSVNATSATCMDKVNGG---------YIIADGHNDMMLYAT--DSG---ILVATNN-MNTY---------PSYSIS 483 (767)
Q Consensus 428 ~~~fs~~El~~AT~~nnFs~~---------nlIG~GgfG~VYKG~--~dG---~~VA~~~-~~~~---------~~~~~~ 483 (767)
..-+||+|-..|- ..|..+ .+||.|-||.||+|. ..| ..||++. .+.| +.++++
T Consensus 607 iDP~TYEDPnqAv--reFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIM 684 (996)
T KOG0196|consen 607 IDPHTYEDPNQAV--REFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIM 684 (996)
T ss_pred cCCccccCccHHH--HHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhc
Confidence 3457888877776 566422 589999999999998 445 5799988 4444 444443
Q ss_pred hhhhhCCCCcccchhhccccc
Q psy12044 484 YQIEQNPDLVNDAESVDKDRR 504 (767)
Q Consensus 484 ~~~e~npdlin~~e~~~~~~~ 504 (767)
+ |=.+|++|-=--+|-|-++
T Consensus 685 G-QFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 685 G-QFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred c-cCCCCcEEEEEEEEecCce
Confidence 3 2236666654334444333
No 159
>KOG3513|consensus
Probab=96.85 E-value=0.0017 Score=78.63 Aligned_cols=80 Identities=29% Similarity=0.442 Sum_probs=63.4
Q ss_pred eeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCC
Q psy12044 264 LEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQA 343 (767)
Q Consensus 264 ~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~ 343 (767)
..+..|..+.+.|.+.+.|.+.+.|.+.+..+..... +...+ .++|.|.+++.+|.|.|+|+|.|..
T Consensus 436 ~~a~~g~~v~i~C~~~asP~p~~~W~k~~~~~~~~~r-------~~i~e------dGtL~I~n~t~~DaG~YtC~A~N~~ 502 (1051)
T KOG3513|consen 436 VMAVVGGTVTIDCKPFASPKPKVSWLKGGEKLLQSGR-------IRILE------DGTLEISNVTRSDAGKYTCVAENKL 502 (1051)
T ss_pred EEEEeCCeEEEeeccCCCCcceEEEEcCCcccccCce-------EEECC------CCcEEecccCcccCcEEEEEEEccc
Confidence 3567899999999999999999999997763322211 22222 3579999999999999999999999
Q ss_pred CCcccceEEEEEe
Q psy12044 344 GSTSSNYTIRIVL 356 (767)
Q Consensus 344 G~s~~s~sL~V~~ 356 (767)
|.+.+...|.|.-
T Consensus 503 G~a~~~~~L~Vkd 515 (1051)
T KOG3513|consen 503 GKAESTGNLIVKD 515 (1051)
T ss_pred CccceEEEEEEec
Confidence 9999888776653
No 160
>KOG2120|consensus
Probab=96.80 E-value=6.3e-05 Score=78.33 Aligned_cols=86 Identities=17% Similarity=0.096 Sum_probs=60.9
Q ss_pred CccEEEeeCCCCCCCCc-hhhhccCCCCccEEEccCCCCCccCcccccCCCCCCEEEccCCC-CCCCCC-CCCCCCCCCc
Q psy12044 50 NTQVLDYTGNNLKTLHN-EKFQKMGLVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNV-LQTVPS-DTFPDYPSLM 126 (767)
Q Consensus 50 ~L~~L~Ls~N~L~~l~~-~~f~~~~L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~-Lt~l~p-~~f~~l~~L~ 126 (767)
.|++|||++..|+.-.- ..+. .+.+|+.|.|.++++...+...+.+-.+|+.|+|+.+. |+...- -.|.+++.|.
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs--~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~ 263 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILS--QCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLD 263 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHH--HHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHh
Confidence 47888998888774321 2233 37788999999999988777778888889999988764 443211 1256778888
Q ss_pred EEECCCCcCcc
Q psy12044 127 KLTLSGNPIKQ 137 (767)
Q Consensus 127 ~L~Ls~N~l~~ 137 (767)
.|+|+++.+..
T Consensus 264 ~LNlsWc~l~~ 274 (419)
T KOG2120|consen 264 ELNLSWCFLFT 274 (419)
T ss_pred hcCchHhhccc
Confidence 88888887653
No 161
>smart00082 LRRCT Leucine rich repeat C-terminal domain.
Probab=96.79 E-value=0.00042 Score=53.78 Aligned_cols=49 Identities=33% Similarity=0.681 Sum_probs=38.3
Q ss_pred CCCCchhhhhhhhhhhccCC-CCCccCCCCCCCCCCCCCcccccccccccC
Q psy12044 204 NPWTCDCLLIGLRRWLESTK-TPMAIDPICSVPPRLSSVTIKQLSIDELAC 253 (767)
Q Consensus 204 N~l~C~c~l~~l~~~l~~~~-~~~~~~~~C~~p~~l~g~~i~~l~~~~l~C 253 (767)
|+|.|+|.+.|+..|+.... ........|..|..+. ..+..+...++.|
T Consensus 1 NP~~CdC~l~~~~~w~~~~~~~~~~~~~~C~~P~~~~-~~l~~~~~~~~~C 50 (51)
T smart00082 1 NPFICDCELRWLLRWLQANEHLQDPVSLRCASPSSLR-GPLLELLHSEFKC 50 (51)
T ss_pred CCccCcCCchHHHHHHHhCCccCCCCCCEeCCcHHHH-hHHHcCCHhhCCC
Confidence 89999999999999998832 2233578899999888 5577777666666
No 162
>smart00410 IG_like Immunoglobulin like. IG domains that cannot be classified into one of IGv1, IGc1, IGc2, IG.
Probab=96.77 E-value=0.0065 Score=50.69 Aligned_cols=77 Identities=34% Similarity=0.620 Sum_probs=54.7
Q ss_pred eeecccccccccccccccCCCcEEEeec-CeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccC
Q psy12044 264 LEIQEGKNVSLLCKVSAIPEAKITWLFD-GVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQ 342 (767)
Q Consensus 264 ~~v~~G~~vsL~C~a~g~P~p~itW~~~-g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~ 342 (767)
..+..|+.+.|.|.+.+.+.+.+.|.++ +..+..... ........ ...|.|.++...|.|.|.|.+.+.
T Consensus 4 ~~~~~g~~~~l~C~~~~~~~~~~~W~~~~~~~v~~~~~-------~~~~~~~~---~~~l~i~~~~~~d~G~Y~C~v~~~ 73 (86)
T smart00410 4 VTVKEGESVTLSCEVSGSPPPEVTWYKQGGKLLAESGR-------FSVSRSGS---NSTLTISNVTPEDSGTYTCAATNS 73 (86)
T ss_pred EEEeCCCeEEEEEEEccCCCCeEEEEECCCEEcCCCCc-------EEEEEcCC---eeEEEEEeeccccCeEEEEEEEcC
Confidence 4567899999999999888899999997 555431110 11111111 467999999999999999999977
Q ss_pred CCCcccce
Q psy12044 343 AGSTSSNY 350 (767)
Q Consensus 343 ~G~s~~s~ 350 (767)
.+.....+
T Consensus 74 ~~~~~~~~ 81 (86)
T smart00410 74 SGSASSTT 81 (86)
T ss_pred CCeEEEEE
Confidence 66654443
No 163
>smart00409 IG Immunoglobulin.
Probab=96.77 E-value=0.0065 Score=50.69 Aligned_cols=77 Identities=34% Similarity=0.620 Sum_probs=54.7
Q ss_pred eeecccccccccccccccCCCcEEEeec-CeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccC
Q psy12044 264 LEIQEGKNVSLLCKVSAIPEAKITWLFD-GVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQ 342 (767)
Q Consensus 264 ~~v~~G~~vsL~C~a~g~P~p~itW~~~-g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~ 342 (767)
..+..|+.+.|.|.+.+.+.+.+.|.++ +..+..... ........ ...|.|.++...|.|.|.|.+.+.
T Consensus 4 ~~~~~g~~~~l~C~~~~~~~~~~~W~~~~~~~v~~~~~-------~~~~~~~~---~~~l~i~~~~~~d~G~Y~C~v~~~ 73 (86)
T smart00409 4 VTVKEGESVTLSCEVSGSPPPEVTWYKQGGKLLAESGR-------FSVSRSGS---NSTLTISNVTPEDSGTYTCAATNS 73 (86)
T ss_pred EEEeCCCeEEEEEEEccCCCCeEEEEECCCEEcCCCCc-------EEEEEcCC---eeEEEEEeeccccCeEEEEEEEcC
Confidence 4567899999999999888899999997 555431110 11111111 467999999999999999999977
Q ss_pred CCCcccce
Q psy12044 343 AGSTSSNY 350 (767)
Q Consensus 343 ~G~s~~s~ 350 (767)
.+.....+
T Consensus 74 ~~~~~~~~ 81 (86)
T smart00409 74 SGSASSTT 81 (86)
T ss_pred CCeEEEEE
Confidence 66654443
No 164
>cd05727 Ig2_Contactin-2-like Second Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig2_Contactin-2-like: second Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=96.77 E-value=0.0019 Score=57.39 Aligned_cols=73 Identities=19% Similarity=0.456 Sum_probs=52.4
Q ss_pred eeecccccccccccc-cccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccC
Q psy12044 264 LEIQEGKNVSLLCKV-SAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQ 342 (767)
Q Consensus 264 ~~v~~G~~vsL~C~a-~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~ 342 (767)
..+.+|..+.|.|.. .+.|.+.+.|.+++..+.-. .+ .+.+. ....+.|.+.+++.+|.|.|.|.|.|.
T Consensus 13 ~~v~eG~~~~L~C~pP~g~P~p~~~W~k~~~~~~~~---~d-~r~~~------~~~~G~L~fs~v~~~D~g~Y~C~A~n~ 82 (96)
T cd05727 13 VKVKEGWGVVLFCDPPPHYPDLSYRWLLNEFPNFIP---ED-GRRFV------SQTNGNLYIAKVEASDRGNYSCFVSSP 82 (96)
T ss_pred eeeeeCCcEEEeeCCCCCCCCCEEEEEECCcccccc---cC-CCeEE------eCCCCcEEEeecCHhhCceeEEEEEec
Confidence 457789999999965 67899999999986432110 00 11111 113468999999999999999999998
Q ss_pred CCCc
Q psy12044 343 AGST 346 (767)
Q Consensus 343 ~G~s 346 (767)
....
T Consensus 83 ~~~~ 86 (96)
T cd05727 83 SSTK 86 (96)
T ss_pred ccCC
Confidence 6544
No 165
>PF13895 Ig_2: Immunoglobulin domain; PDB: 2V5R_B 2V5M_A 2V5S_B 2GI7_A 3LAF_A 4DEP_C 3O4O_B 2EC8_A 2E9W_A 1J87_A ....
Probab=96.60 E-value=0.0014 Score=54.95 Aligned_cols=61 Identities=34% Similarity=0.734 Sum_probs=48.0
Q ss_pred eeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCC
Q psy12044 264 LEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQA 343 (767)
Q Consensus 264 ~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~ 343 (767)
..+..|+.+.|.|.+.+.|...+.|.+++..+... ...+.+..+..+|.|.|.|.+.+..
T Consensus 9 ~~v~~g~~~~l~C~~~~~p~~~~~w~~~~~~~~~~--------------------~~~~~~~~~~~~~~g~y~C~~~~~~ 68 (80)
T PF13895_consen 9 QSVEEGDSVTLTCSVSGNPPPQVQWYKNGSPINSS--------------------QNGLFIPNVSPEDSGNYTCRASNGS 68 (80)
T ss_dssp SEEETTSEEEEEEEEESSSSSEEEEEETTEEEEEE--------------------SSEEEESSEEGGGTEEEEEEEEETT
T ss_pred eEEeCCCcEEEEEEEEcccceeeeeeeeeeeeeee--------------------eeeeeeeeeccccCEEEEEEEEeCC
Confidence 45678999999999999988999999977555311 1116677888999999999998855
Q ss_pred C
Q psy12044 344 G 344 (767)
Q Consensus 344 G 344 (767)
+
T Consensus 69 ~ 69 (80)
T PF13895_consen 69 G 69 (80)
T ss_dssp E
T ss_pred C
Confidence 4
No 166
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=96.58 E-value=0.0017 Score=67.17 Aligned_cols=161 Identities=19% Similarity=0.212 Sum_probs=107.4
Q ss_pred CCCccEEEeeCCCCCCCCchhhhcc--CCCCccEEEccCCCCCc---c-------CcccccCCCCCCEEEccCCCCCCCC
Q psy12044 48 DPNTQVLDYTGNNLKTLHNEKFQKM--GLVNLQKIYLSRCRISV---I-------DSKAFRGLTNLVDLDFSHNVLQTVP 115 (767)
Q Consensus 48 ~~~L~~L~Ls~N~L~~l~~~~f~~~--~L~~L~~L~Ls~N~L~~---i-------~p~~f~~L~~L~~L~Ls~N~Lt~l~ 115 (767)
...++.++||+|.|..--...+.+. .-.+|+..+++.-.... . .-.++.+++.|+.++||.|.|....
T Consensus 29 ~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~ 108 (388)
T COG5238 29 MDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEF 108 (388)
T ss_pred hcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCccc
Confidence 5678999999999986544444321 24567777776542221 1 1245678899999999999887654
Q ss_pred CCC----CCCCCCCcEEECCCCcCcccccCCcC-------------CCCCccEEeccCCCccccchh----hhcCCCCCC
Q psy12044 116 SDT----FPDYPSLMKLTLSGNPIKQIKTGAFQ-------------PLSYLVTLELSKCGIEVIEDA----AFVGLDSLE 174 (767)
Q Consensus 116 p~~----f~~l~~L~~L~Ls~N~l~~l~~~~~~-------------~l~~L~~L~Ls~N~L~~i~~~----~~~~l~~L~ 174 (767)
|.. ++.-..|.+|.|++|.+.-+-...++ .-+.|++++...|++...+.. .|..-..|.
T Consensus 109 ~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk 188 (388)
T COG5238 109 PEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHENLK 188 (388)
T ss_pred chHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHHhhcCce
Confidence 433 45557899999999987654433222 346789999999988765442 233335788
Q ss_pred eeeccCCcccc--cc----CCCCCCCCcccccCCCCCCCc
Q psy12044 175 WLKLDNNKITT--IS----GSNILPTGLHGIDLHHNPWTC 208 (767)
Q Consensus 175 ~L~Ls~N~Lt~--ip----~~~~~~~~L~~L~Ls~N~l~C 208 (767)
.+.+..|.|.. +. ...+...+|..|||++|-|+-
T Consensus 189 ~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~ 228 (388)
T COG5238 189 EVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTL 228 (388)
T ss_pred eEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhh
Confidence 88888887762 21 122345788999999998873
No 167
>PF00047 ig: Immunoglobulin domain The Prosite family only concerns antibodies and MHCs.; InterPro: IPR013151 Members of the immunoglobulin superfamily are found in hundreds of proteins of different functions. Examples include antibodies, the giant muscle kinase titin and receptor tyrosine kinases. Immunoglobulin-like domains may be involved in protein-protein and protein-ligand interactions. The Pfam alignments do not include the first and last strand of the immunoglobulin-like domain.; PDB: 1B6U_A 3O4O_C 3VH8_H 1BIH_A 2C9A_A 2V5Y_A 1BQH_K 2ATP_A 3B9K_A 1NEZ_H ....
Probab=96.58 E-value=0.0013 Score=53.25 Aligned_cols=63 Identities=32% Similarity=0.588 Sum_probs=42.7
Q ss_pred cccccccccc-cccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEee
Q psy12044 269 GKNVSLLCKV-SAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVA 339 (767)
Q Consensus 269 G~~vsL~C~a-~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA 339 (767)
|+.+.|.|.+ ...+...+.|.+++......... .....+. .....|.|.++..+|.|.|.|.|
T Consensus 1 G~~v~L~C~~~~~~~~~~~~W~~~~~~~~~~~~~-------~~~~~~~-~~~~~L~i~~v~~~d~G~Y~C~v 64 (64)
T PF00047_consen 1 GSSVTLTCSVSSGPPPTTVTWSKNGQSLPEGSTT-------NRSTNSV-SSTSRLTISNVTPEDSGTYTCVV 64 (64)
T ss_dssp TSEEEEEEEEEESSSTSEEEEEETTTTTSEEEEE-------EEEETTT-EEEEEEEESSCTGGGTEEEEEEE
T ss_pred CCeEEEEeecCCCCCCcEEEEEECCccccCccee-------Eeecccc-eeeeEEEEccCCHHHCEEEEEEC
Confidence 5778999999 77788899999977554322211 0000010 01114999999999999999986
No 168
>KOG2123|consensus
Probab=96.56 E-value=0.00012 Score=75.61 Aligned_cols=100 Identities=22% Similarity=0.201 Sum_probs=60.3
Q ss_pred CCCccEEEccCCCCCccCcccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEECCCCcCccccc-CCcCCCCCccEE
Q psy12044 74 LVNLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKT-GAFQPLSYLVTL 152 (767)
Q Consensus 74 L~~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~-~~~~~l~~L~~L 152 (767)
|.+.+.|++.+|.|..+ .....|+.|+.|.|+-|+|+.+.| |..|++|+.|+|..|.|..+.. .-+.++++|+.|
T Consensus 18 l~~vkKLNcwg~~L~DI--sic~kMp~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~L 93 (388)
T KOG2123|consen 18 LENVKKLNCWGCGLDDI--SICEKMPLLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTL 93 (388)
T ss_pred HHHhhhhcccCCCccHH--HHHHhcccceeEEeeccccccchh--HHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhH
Confidence 44566677777776665 234566677777777777776653 5666777777777776665532 224556677777
Q ss_pred eccCCCccccch-----hhhcCCCCCCeee
Q psy12044 153 ELSKCGIEVIED-----AAFVGLDSLEWLK 177 (767)
Q Consensus 153 ~Ls~N~L~~i~~-----~~~~~l~~L~~L~ 177 (767)
.|..|...+..+ ..+.-|++|+.||
T Consensus 94 WL~ENPCc~~ag~nYR~~VLR~LPnLkKLD 123 (388)
T KOG2123|consen 94 WLDENPCCGEAGQNYRRKVLRVLPNLKKLD 123 (388)
T ss_pred hhccCCcccccchhHHHHHHHHcccchhcc
Confidence 776665544432 2233456666554
No 169
>cd05759 Ig2_KIRREL3-like Second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). Ig2_KIRREL3-like: domain similar to the second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=96.54 E-value=0.011 Score=50.68 Aligned_cols=75 Identities=31% Similarity=0.469 Sum_probs=48.7
Q ss_pred ccccccccc-cCCCcEEEeecCeeccCCCcccccccceeecccC-cceeeeEEEEeeeccCCCCceeEeeccCCCCcccc
Q psy12044 272 VSLLCKVSA-IPEAKITWLFDGVPIQNESMSASESHAVYSTEEG-TEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSN 349 (767)
Q Consensus 272 vsL~C~a~g-~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g-~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s 349 (767)
+.|.|.+.+ .|.+.++|+++++.+...... ......+ .....+.|.+......|.+.|+|.|.|........
T Consensus 2 ~~L~C~v~g~~P~~~v~W~~~g~~l~~~~~~------~~~~~~~~~~~~~s~L~i~~~~~~~~~~y~C~a~n~~l~~~~~ 75 (82)
T cd05759 2 YNLTCRARGAKPAAEIIWFRDGEVLDGATYS------KELLKDGKRETTVSTLPITPSDHDTGRTFTCRARNEALPTGKE 75 (82)
T ss_pred EEEEEEEeCccCCCEEEEEECCEEccCceee------eeEecCCCeEEEEEEEEEeCceecCCCEEEEEEcCccCCCCcE
Confidence 468899987 588899999998876532211 1111122 22334677777766778889999999887555443
Q ss_pred eEE
Q psy12044 350 YTI 352 (767)
Q Consensus 350 ~sL 352 (767)
.++
T Consensus 76 ~s~ 78 (82)
T cd05759 76 TSV 78 (82)
T ss_pred EEE
Confidence 333
No 170
>PF01462 LRRNT: Leucine rich repeat N-terminal domain; InterPro: IPR000372 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. LRRs are often flanked by cysteine-rich domains: an N-terminal LRR domain and a C-terminal LRR domain (IPR000483 from INTERPRO). This entry represents the N-terminal LRR domain. ; PDB: 3E6J_A 1W8A_A 2V9S_C 2V9T_B 3TWI_D 3ZYN_A 3ZYO_A 1OOK_G 1QYY_G 1SQ0_B ....
Probab=96.52 E-value=0.0015 Score=44.11 Aligned_cols=28 Identities=36% Similarity=0.858 Sum_probs=22.3
Q ss_pred CCCCCceecccCCeeEEEecCCCccccccCCC
Q psy12044 17 ACPTSCICKWKGGKQTVECVNKSLITVVEGMD 48 (767)
Q Consensus 17 ~CP~~C~C~~~g~~~~v~C~~~~L~~iP~~l~ 48 (767)
+||..|.|. ...|+|++++|..+|.+|+
T Consensus 1 ~CP~~C~C~----~~~V~C~~~~L~~vP~~lP 28 (28)
T PF01462_consen 1 ACPRPCTCS----GLTVDCSGRGLTAVPSDLP 28 (28)
T ss_dssp SSETTSEEE----TTEEEETTSS-SSS-STS-
T ss_pred CcCCCCEec----CCEeECCCCCCCccCCCCc
Confidence 599999998 3679999999999998764
No 171
>PHA02785 IL-beta-binding protein; Provisional
Probab=96.51 E-value=0.0061 Score=66.77 Aligned_cols=82 Identities=21% Similarity=0.354 Sum_probs=56.8
Q ss_pred cceeecccccccccccccccCC---CcEEEeecCeeccCCCcccccccceeec-----ccCcceeeeEEEEeeeccCCCC
Q psy12044 262 FYLEIQEGKNVSLLCKVSAIPE---AKITWLFDGVPIQNESMSASESHAVYST-----EEGTEIKKSELLIYNSNIDDNG 333 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~a~g~P~---p~itW~~~g~~l~~~s~~~~~~~~~~~~-----~~g~~~~~s~L~I~nvs~sD~G 333 (767)
....+..|..+.|.|.+.+.|. +.+.|.+++..+......... .+... ........+.|.|.++..+|.|
T Consensus 228 ~~~~~~~G~~v~L~C~a~g~P~~~~~~v~W~kng~~i~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~L~I~~V~~~D~G 305 (326)
T PHA02785 228 EGVVTSIGSNLTIACRVSLRPPTTDADVFWISNGMYYEEDDEDGDG--RISVANKIYTTDKRRVITSRLNINPVKEEDAT 305 (326)
T ss_pred CcEEecCCCcEEEEEEEECCCCCCCceEEEEECCEECCCcCCCCce--eEEEecCccccccceeeeEEEEECCcchhcCe
Confidence 4556678999999999999886 479999999877543211110 01110 1111223568999999999999
Q ss_pred ceeEeeccCCCC
Q psy12044 334 TFVCVAENQAGS 345 (767)
Q Consensus 334 tY~CvA~N~~G~ 345 (767)
.|.|.|.|..|.
T Consensus 306 ~Y~C~A~n~~~~ 317 (326)
T PHA02785 306 TFTCMAFTIPSI 317 (326)
T ss_pred eeEEEEEeccCc
Confidence 999999997744
No 172
>KOG4221|consensus
Probab=96.50 E-value=0.0044 Score=75.04 Aligned_cols=88 Identities=28% Similarity=0.474 Sum_probs=67.4
Q ss_pred CCccceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEe
Q psy12044 259 PSTFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCV 338 (767)
Q Consensus 259 ~~~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~Cv 338 (767)
..+....+.+|+.+.|.|.+.+.|.|.+.|.+++..+.-.+.. +. ....+.|.|.+++..|.|.|+|.
T Consensus 242 ~~p~~~~v~~g~~v~leCvvs~~p~p~v~Wlrng~~i~~ds~r--------iv----l~g~~slliS~a~~~dSg~YtC~ 309 (1381)
T KOG4221|consen 242 DEPSNAVVVEGDDVVLECVVSGVPKPSVKWLRNGEKISVDSYR--------IV----LVGGSSLLISNATDDDSGKYTCR 309 (1381)
T ss_pred cCCCccccccCCcEEEEEEecCCCCCceEEeeCCeeeeecceE--------EE----EecccceEEeccccccCceEEEE
Confidence 3445567889999999999999999999999998777544311 11 12346799999999999999999
Q ss_pred eccCCCCcccceEEEEEeec
Q psy12044 339 AENQAGSTSSNYTIRIVLKE 358 (767)
Q Consensus 339 A~N~~G~s~~s~sL~V~~~~ 358 (767)
|.|..-...+...+.|..++
T Consensus 310 Atn~~D~idasaev~V~a~P 329 (1381)
T KOG4221|consen 310 ATNTNDSIDASAEVTVLAPP 329 (1381)
T ss_pred ecCCCcccccceEEEEEcCC
Confidence 99966666666667766653
No 173
>KOG2982|consensus
Probab=96.46 E-value=0.0037 Score=65.48 Aligned_cols=106 Identities=19% Similarity=0.235 Sum_probs=55.1
Q ss_pred EEEeeCCCCCCCCc-hhhhccCCCCccEEEccCCCCCccC--cccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEE
Q psy12044 53 VLDYTGNNLKTLHN-EKFQKMGLVNLQKIYLSRCRISVID--SKAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLT 129 (767)
Q Consensus 53 ~L~Ls~N~L~~l~~-~~f~~~~L~~L~~L~Ls~N~L~~i~--p~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~ 129 (767)
.|.+.++.|..... ..|+. ..+.++.|+|..|.|+.+. ...+.+|+.|+.|+|+.|.+...+...-..+.+|+.|-
T Consensus 49 llvln~~~id~~gd~~~~~~-~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lV 127 (418)
T KOG2982|consen 49 LLVLNGSIIDNEGDVMLFGS-SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLV 127 (418)
T ss_pred hheecCCCCCcchhHHHHHH-HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEE
Confidence 44444555543332 22222 3456666677777666542 23345666667777777666655432213455666666
Q ss_pred CCCCcCcccc-cCCcCCCCCccEEeccCCCc
Q psy12044 130 LSGNPIKQIK-TGAFQPLSYLVTLELSKCGI 159 (767)
Q Consensus 130 Ls~N~l~~l~-~~~~~~l~~L~~L~Ls~N~L 159 (767)
|.+..+..-. ...+..++.++.|.++.|++
T Consensus 128 LNgT~L~w~~~~s~l~~lP~vtelHmS~N~~ 158 (418)
T KOG2982|consen 128 LNGTGLSWTQSTSSLDDLPKVTELHMSDNSL 158 (418)
T ss_pred EcCCCCChhhhhhhhhcchhhhhhhhccchh
Confidence 6666554322 22334455566666665543
No 174
>KOG2739|consensus
Probab=96.45 E-value=0.0012 Score=67.99 Aligned_cols=89 Identities=27% Similarity=0.264 Sum_probs=57.8
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEECCCC--cCcccccCCcCCCCCccEEeccCCCccccch-hhhcCCC
Q psy12044 95 FRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSGN--PIKQIKTGAFQPLSYLVTLELSKCGIEVIED-AAFVGLD 171 (767)
Q Consensus 95 f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~N--~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~-~~~~~l~ 171 (767)
+-.+..|+.|.+.+..++.+. .|..|++|+.|.++.| ++.+-.......+++|++|+|++|.|..+.. ..+..+.
T Consensus 39 ~d~~~~le~ls~~n~gltt~~--~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~lstl~pl~~l~ 116 (260)
T KOG2739|consen 39 TDEFVELELLSVINVGLTTLT--NFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKDLSTLRPLKELE 116 (260)
T ss_pred cccccchhhhhhhccceeecc--cCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccccccccchhhhhc
Confidence 445667777777777777663 4667888888888888 4443333334445888888888887764311 1244556
Q ss_pred CCCeeeccCCcccc
Q psy12044 172 SLEWLKLDNNKITT 185 (767)
Q Consensus 172 ~L~~L~Ls~N~Lt~ 185 (767)
+|..|++.+|..+.
T Consensus 117 nL~~Ldl~n~~~~~ 130 (260)
T KOG2739|consen 117 NLKSLDLFNCSVTN 130 (260)
T ss_pred chhhhhcccCCccc
Confidence 67777777765554
No 175
>cd05713 Ig_MOG_like Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). Ig_MOG_like: immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). MOG, a minor component of the myelin sheath, is an important CNS-specific autoantigen, linked to the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). It is a transmembrane protein having an extracellular Ig domain. MOG is expressed in the CNS on the outermost lamellae of the myelin sheath, and on the surface of oligodendrocytes, and may participate in the completion, compaction, and/or maintenance of myelin. This group also includes butyrophilin (BTN). BTN is the most abundant protein in bovine milk-fat globule membrane (MFGM).
Probab=96.36 E-value=0.0074 Score=53.71 Aligned_cols=36 Identities=17% Similarity=0.303 Sum_probs=28.7
Q ss_pred eeeEEEEeeeccCCCCceeEeeccCCCCcccceEEE
Q psy12044 318 KKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYTIR 353 (767)
Q Consensus 318 ~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~sL~ 353 (767)
...+|.|.++..+|.|+|.|.+.+..+...+.+.|.
T Consensus 63 ~~~sL~I~~v~~~D~G~Y~C~v~~~~~~~~~~i~l~ 98 (100)
T cd05713 63 GSVALRIHNVRASDEGLYTCFFQSDGFYEEATVELK 98 (100)
T ss_pred CcEEEEEEcCChhhCEEEEEEEecCCcEEEEEEEEE
Confidence 456899999999999999999998776655444443
No 176
>smart00013 LRRNT Leucine rich repeat N-terminal domain.
Probab=96.28 E-value=0.004 Score=43.81 Aligned_cols=31 Identities=35% Similarity=0.849 Sum_probs=27.1
Q ss_pred CCCCCceecccCCeeEEEecCCCccccccCCCCCc
Q psy12044 17 ACPTSCICKWKGGKQTVECVNKSLITVVEGMDPNT 51 (767)
Q Consensus 17 ~CP~~C~C~~~g~~~~v~C~~~~L~~iP~~l~~~L 51 (767)
+||..|.|. ...|+|++++|..+|.+++.+.
T Consensus 1 ~CP~~C~C~----~~~V~C~~~~L~~vP~~iP~~t 31 (33)
T smart00013 1 ACPAPCNCS----GTAVDCSGRGLTEVPLDLPPDT 31 (33)
T ss_pred CcCCCCEEC----CCEeEeCCCCcCccCCCCCccc
Confidence 599999997 3679999999999999988654
No 177
>cd05879 Ig_P0 Immunoglobulin (Ig)-like domain of Protein zero (P0). Ig_P0ex: immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin.
Probab=96.25 E-value=0.016 Score=53.45 Aligned_cols=89 Identities=19% Similarity=0.270 Sum_probs=54.9
Q ss_pred ceeeccccccccccccccc----CCCcEEEeecCee------cc---CCCccc----ccccceeecccCcceeeeEEEEe
Q psy12044 263 YLEIQEGKNVSLLCKVSAI----PEAKITWLFDGVP------IQ---NESMSA----SESHAVYSTEEGTEIKKSELLIY 325 (767)
Q Consensus 263 ~~~v~~G~~vsL~C~a~g~----P~p~itW~~~g~~------l~---~~s~~~----~~~~~~~~~~~g~~~~~s~L~I~ 325 (767)
.+.+..|+.+.|.|..... +...+.|.+.... +. +..... ....+..+..+ ......+|.|.
T Consensus 7 ev~a~~G~~v~L~C~f~~~~~~~~~~~v~W~~~~~~~~~~~~v~~y~~g~~~~~~~~~f~~Rv~f~g~-~~~~daSI~I~ 85 (116)
T cd05879 7 EVYGTVGSDVTLSCSFWSSEWISDDISFTWHYQPDGSRDAISIFHYGKGQPYIDDVGPFKERIEWVGN-PSRKDGSIVIH 85 (116)
T ss_pred eEEEEcCCcEEEEEEEecCCCCCCcEEEEEEEcCCCCCccEEEEEeCCCceecccccCccCceEEeCC-CCcCeeEEEEc
Confidence 4567889999999998663 3468999662210 10 000000 00112222221 13456789999
Q ss_pred eeccCCCCceeEeeccCCCCcccceEE
Q psy12044 326 NSNIDDNGTFVCVAENQAGSTSSNYTI 352 (767)
Q Consensus 326 nvs~sD~GtY~CvA~N~~G~s~~s~sL 352 (767)
+++.+|.|+|+|...|..+.......+
T Consensus 86 nv~~sD~G~Y~C~v~n~p~~~~~~~~~ 112 (116)
T cd05879 86 NLDYTDNGTFTCDVKNPPDIVGKSSQV 112 (116)
T ss_pred cCCcccCEEEEEEEEcCCCcCCceeEE
Confidence 999999999999999987765544433
No 178
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=96.22 E-value=0.0031 Score=65.27 Aligned_cols=191 Identities=17% Similarity=0.131 Sum_probs=113.8
Q ss_pred HHHhhhccCCCCCceecccCCeeEEEecCCCcc-ccccCC------CCCccEEEeeCCCCCCCCchhhhc----------
Q psy12044 9 ATIIKIVSACPTSCICKWKGGKQTVECVNKSLI-TVVEGM------DPNTQVLDYTGNNLKTLHNEKFQK---------- 71 (767)
Q Consensus 9 ~~~~~~~~~CP~~C~C~~~g~~~~v~C~~~~L~-~iP~~l------~~~L~~L~Ls~N~L~~l~~~~f~~---------- 71 (767)
.+++++-..||. .++|+.+++.+. ..|+.+ ...+.+|.|++|.+.-+-...+++
T Consensus 82 ~~Ll~aLlkcp~---------l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKK 152 (388)
T COG5238 82 VMLLKALLKCPR---------LQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKK 152 (388)
T ss_pred HHHHHHHhcCCc---------ceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhh
Confidence 445666677884 245777766554 344433 357888888888887655444431
Q ss_pred -cCCCCccEEEccCCCCCccC----cccccCCCCCCEEEccCCCCCCCCC-----CCCCCCCCCcEEECCCCcCccccc-
Q psy12044 72 -MGLVNLQKIYLSRCRISVID----SKAFRGLTNLVDLDFSHNVLQTVPS-----DTFPDYPSLMKLTLSGNPIKQIKT- 140 (767)
Q Consensus 72 -~~L~~L~~L~Ls~N~L~~i~----p~~f~~L~~L~~L~Ls~N~Lt~l~p-----~~f~~l~~L~~L~Ls~N~l~~l~~- 140 (767)
..-+.|+.+....|++..-. ...|..-.+|+++.+..|.|.--.- ..+..+.+|+.|+|..|.++....
T Consensus 153 aa~kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~ 232 (388)
T COG5238 153 AADKPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSR 232 (388)
T ss_pred hccCCCceEEEeccchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHH
Confidence 13456788888888776532 1223444678888888886653211 112345788888888888775432
Q ss_pred ---CCcCCCCCccEEeccCCCccccchhhh----c--CCCCCCeeeccCCccc-cccCCCC-------CCCCcccccCCC
Q psy12044 141 ---GAFQPLSYLVTLELSKCGIEVIEDAAF----V--GLDSLEWLKLDNNKIT-TISGSNI-------LPTGLHGIDLHH 203 (767)
Q Consensus 141 ---~~~~~l~~L~~L~Ls~N~L~~i~~~~~----~--~l~~L~~L~Ls~N~Lt-~ip~~~~-------~~~~L~~L~Ls~ 203 (767)
.++...+.|+.|.|..|-++.--..++ . ..++|..|.+.+|.+. ++...++ ..+-|..|.+.|
T Consensus 233 ~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ng 312 (388)
T COG5238 233 YLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNG 312 (388)
T ss_pred HHHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHcc
Confidence 334455667888888887764433222 1 2467777777777554 2211111 234556677777
Q ss_pred CCCCc
Q psy12044 204 NPWTC 208 (767)
Q Consensus 204 N~l~C 208 (767)
|.+.=
T Consensus 313 Nr~~E 317 (388)
T COG5238 313 NRIKE 317 (388)
T ss_pred Ccchh
Confidence 87763
No 179
>KOG3665|consensus
Probab=96.13 E-value=0.003 Score=75.59 Aligned_cols=131 Identities=20% Similarity=0.220 Sum_probs=90.6
Q ss_pred CCccEEEccCCCCCc--cCcccccCCCCCCEEEccCCCCCCCC-CCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccE
Q psy12044 75 VNLQKIYLSRCRISV--IDSKAFRGLTNLVDLDFSHNVLQTVP-SDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVT 151 (767)
Q Consensus 75 ~~L~~L~Ls~N~L~~--i~p~~f~~L~~L~~L~Ls~N~Lt~l~-p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~ 151 (767)
.+|+.|+|++...-. +.-..-.-||+|+.|.+++-.+..-. ...+.++++|..||+|+.+++.+ ..++.|.+|+.
T Consensus 122 ~nL~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~ 199 (699)
T KOG3665|consen 122 QNLQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQV 199 (699)
T ss_pred HhhhhcCccccchhhccHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHH
Confidence 578888888764432 22233345789999999876654321 12345778999999999999887 45778899999
Q ss_pred EeccCCCccc-cchhhhcCCCCCCeeeccCCcccccc-------CCCCCCCCcccccCCCCCCC
Q psy12044 152 LELSKCGIEV-IEDAAFVGLDSLEWLKLDNNKITTIS-------GSNILPTGLHGIDLHHNPWT 207 (767)
Q Consensus 152 L~Ls~N~L~~-i~~~~~~~l~~L~~L~Ls~N~Lt~ip-------~~~~~~~~L~~L~Ls~N~l~ 207 (767)
|.+.+=.+.. ..-..+.+|++|+.||+|.......+ +....++.|+.||.++..+.
T Consensus 200 L~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~ 263 (699)
T KOG3665|consen 200 LSMRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDIN 263 (699)
T ss_pred HhccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcchh
Confidence 8888766654 22234677999999999987554322 11123578999999988765
No 180
>cd05897 Ig2_IL1R2_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). Ig2_IL1R2_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds the type II (IL1R2) represented in this group. Mature IL1R2 consists of three IG-like domains, a transmembrane domain, and a short cytoplasmic domain. It lacks the large cytoplasmic domain of Mature IL1R1, and does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=96.08 E-value=0.016 Score=51.49 Aligned_cols=75 Identities=19% Similarity=0.345 Sum_probs=50.4
Q ss_pred eecccccccccccc-c----ccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEee
Q psy12044 265 EIQEGKNVSLLCKV-S----AIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVA 339 (767)
Q Consensus 265 ~v~~G~~vsL~C~a-~----g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA 339 (767)
.+..|....|.|.- . ..+.+.++|++++..+...... +.. ......|.|.++..+|.|.|+|.+
T Consensus 6 ~~~~~~~~~l~Cp~~~~f~~~~~~~~v~WYKd~~~l~~~~~~------~~~-----~~~~~~L~I~~v~~~D~G~YtC~~ 74 (95)
T cd05897 6 ILFTSTSGKLVCPDLSDFTINRTDVELQWYKDSVLLDKDNEK------FYS-----LKGSTYLHIIDVSLNDSGYYTCKL 74 (95)
T ss_pred EeccccCcEEECCCHHHcccCCCCCcEEEccCCEECcCCCcc------eEe-----cCCCCEEEEEEcChhhCEEEEEEE
Confidence 34567777888852 2 3466799999999776533211 000 011235999999999999999999
Q ss_pred ccCCCCcccce
Q psy12044 340 ENQAGSTSSNY 350 (767)
Q Consensus 340 ~N~~G~s~~s~ 350 (767)
.+..|...-++
T Consensus 75 ~~~~~g~~y~v 85 (95)
T cd05897 75 QFTHEGKKYNI 85 (95)
T ss_pred EEeeCCEEEEE
Confidence 99876654333
No 181
>PF13927 Ig_3: Immunoglobulin domain; PDB: 2D3V_A 1G0X_A 1VDG_A 1P7Q_D 3D2U_H 1UFU_A 1UGN_A 3VH8_H 3OQ3_B 4DKD_C ....
Probab=96.08 E-value=0.0032 Score=51.90 Aligned_cols=57 Identities=33% Similarity=0.573 Sum_probs=40.9
Q ss_pred ccccccccccC-CCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeecc
Q psy12044 272 VSLLCKVSAIP-EAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAEN 341 (767)
Q Consensus 272 vsL~C~a~g~P-~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N 341 (767)
+.|.|.+.+.+ .+.+.|.. .. ..............+.|.+.++..+|.|.|.|+|.|
T Consensus 18 ~~l~C~~~~~~~~~~~~W~~-~~------------~~~~~~~~~~~~~~~~L~i~~v~~~~~g~y~C~a~N 75 (75)
T PF13927_consen 18 VTLTCSAEGGPPPPSISWYD-SN------------PSFNSNSRGSSSSNSTLTISNVTRSDNGTYTCIASN 75 (75)
T ss_dssp EEEEEEESSEESSEEEEEET-EE------------EEEEEEEEEEEEEEEEEEESSCCGGGTEEEEEEEEE
T ss_pred EEEEEEEccccCCeEEEEEe-cC------------CceeeeeeeccceeeEEEEccCCHHhCcEEEEEEEC
Confidence 89999999988 88999991 00 001111122234567899999999999999999976
No 182
>PHA02826 IL-1 receptor-like protein; Provisional
Probab=96.04 E-value=0.01 Score=61.46 Aligned_cols=68 Identities=21% Similarity=0.389 Sum_probs=50.4
Q ss_pred eeecccccccccccccc-----cCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEe
Q psy12044 264 LEIQEGKNVSLLCKVSA-----IPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCV 338 (767)
Q Consensus 264 ~~v~~G~~vsL~C~a~g-----~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~Cv 338 (767)
..+.+|..+.|.|.+.+ .|.|.++|.+++..+..... +... ...+.|.|.++..+|.|.|+|.
T Consensus 139 ~~~~~G~~v~L~C~~~~~~~~~~p~p~I~WyKng~~l~~~~r-------~~~~-----~~~~~L~I~~V~~~DsG~YtC~ 206 (227)
T PHA02826 139 YQFNSGKDSKLHCYGTDGISSTFKDYTLTWYKNGNIVLYTDR-------IQLR-----NNNSTLVIKSATHDDSGIYTCN 206 (227)
T ss_pred ceEecCCCEEEEeeCCCCccccCCCceEEEEECCEECCCCCC-------EEEe-----CCCCEEEECcCCHHhCEEEEEE
Confidence 34567999999998763 45789999999987743321 1111 1235799999999999999999
Q ss_pred eccCC
Q psy12044 339 AENQA 343 (767)
Q Consensus 339 A~N~~ 343 (767)
+....
T Consensus 207 a~~~~ 211 (227)
T PHA02826 207 LRFNK 211 (227)
T ss_pred EEEeE
Confidence 98754
No 183
>cd05881 Ig1_Necl-2 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig1_Necl-2: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-2, Necl-2 (also known as cell adhesion molecule 1 (CADM1), SynCAM1, IGSF4A, Tslc1, sgIGSF, and RA175). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-2 is expressed in a wide variety of tissues, and is a
Probab=96.02 E-value=0.011 Score=52.54 Aligned_cols=79 Identities=14% Similarity=0.196 Sum_probs=52.8
Q ss_pred ccceeecccccccccccccccCCCcEEEeecCeeccC-CCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEee
Q psy12044 261 TFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQN-ESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVA 339 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~-~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA 339 (767)
..++++.+|+.+.|.|.+.......+.|...++.+.. .........++..... .....+|.|.++..+|.|.|.|.+
T Consensus 4 ~~nvtv~~G~ta~L~C~v~~~~~~~v~w~~~~~~~i~~~~~~~~~d~Rf~~~~~--~~~~~tL~I~~vq~~D~G~Y~Cqv 81 (95)
T cd05881 4 TEDVTVVEGEVAIISCRVKNNDDSVIQLLNPNRQTIYFRDVRPLKDSRFQLVNF--SSNELRVSLSNVSLSDEGRYFCQL 81 (95)
T ss_pred cCceEEcCCCcEEEEEEEccCCccEEEEEecCCcEEEecCccccCCcCEEEEeC--CCCEEEEEECcCCcccCEEEEEEE
Confidence 3467888999999999999988888999886643321 1111111112222211 123457999999999999999998
Q ss_pred cc
Q psy12044 340 EN 341 (767)
Q Consensus 340 ~N 341 (767)
..
T Consensus 82 ~t 83 (95)
T cd05881 82 YT 83 (95)
T ss_pred Ec
Confidence 64
No 184
>cd05714 Ig_CSPGs_LP Immunoglobulin (Ig)-like domain of chondroitin sulfate proteoglycans (CSPGs), human cartilage link protein (LP) and similar proteins. Ig_CSPGs_LP: immunoglobulin (Ig)-like domain similar to that found in chondroitin sulfate proteoglycans (CSPGs) and human cartilage link protein (LP). Included in this group are the CSPGs aggrecan, versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue.
Probab=95.89 E-value=0.016 Score=52.28 Aligned_cols=86 Identities=17% Similarity=0.295 Sum_probs=50.3
Q ss_pred cccccccccccccC------CCcEEEeecC---e---ecc--CCCc-ccccccceeecccCcceeeeEEEEeeeccCCCC
Q psy12044 269 GKNVSLLCKVSAIP------EAKITWLFDG---V---PIQ--NESM-SASESHAVYSTEEGTEIKKSELLIYNSNIDDNG 333 (767)
Q Consensus 269 G~~vsL~C~a~g~P------~p~itW~~~g---~---~l~--~~s~-~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~G 333 (767)
|+.++|.|.....+ .+.+.|.+.. . .+. .... .....................|.|.+++.+|.|
T Consensus 2 G~~V~L~C~~~~~~~~~~~~~~~i~W~k~~~~~~~~~~v~~~~~~~~~~~~~~~~r~~~~~~~~~~~sL~I~~v~~sD~G 81 (106)
T cd05714 2 GGNVTLPCRFHLEPALSAPHGPRIKWTKLESDGAKEVDVLVAIGGRVKVYGSGRVRVPLYPADPGDASLVITDLRLEDSG 81 (106)
T ss_pred CCCEEEeEEeECCcccCCCCCcEEEEEEeCCCCCceEEEEEEcCCEEEEcCCCceEEEeeCCCCCcceEEECCCCHHHCE
Confidence 78899999876653 5689999852 1 010 0000 000000001111112335678999999999999
Q ss_pred ceeEeeccCCCCcccceEEEE
Q psy12044 334 TFVCVAENQAGSTSSNYTIRI 354 (767)
Q Consensus 334 tY~CvA~N~~G~s~~s~sL~V 354 (767)
+|.|.+.+..+.....+.|.|
T Consensus 82 ~Y~C~v~~~~~~~~~~v~L~V 102 (106)
T cd05714 82 RYRCEVIDGIEDEQDTVELEV 102 (106)
T ss_pred EEEEEEEcCCCceEEEEEEEE
Confidence 999999986555444444443
No 185
>KOG2123|consensus
Probab=95.82 E-value=0.00066 Score=70.31 Aligned_cols=82 Identities=30% Similarity=0.308 Sum_probs=58.6
Q ss_pred CCCCCEEEccCCCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccch-hhhcCCCCCCee
Q psy12044 98 LTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIED-AAFVGLDSLEWL 176 (767)
Q Consensus 98 L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~-~~~~~l~~L~~L 176 (767)
+.+.+.|++.++.|+.+. ....|+.|+.|.||-|+|+.+.+ |..+++|+.|+|..|.|..+.. .-+.++++|+.|
T Consensus 18 l~~vkKLNcwg~~L~DIs--ic~kMp~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~L 93 (388)
T KOG2123|consen 18 LENVKKLNCWGCGLDDIS--ICEKMPLLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTL 93 (388)
T ss_pred HHHhhhhcccCCCccHHH--HHHhcccceeEEeeccccccchh--HHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhH
Confidence 556777888888887763 35577888888888888887765 6677888888888887776643 235566777777
Q ss_pred eccCCcc
Q psy12044 177 KLDNNKI 183 (767)
Q Consensus 177 ~Ls~N~L 183 (767)
.|..|.-
T Consensus 94 WL~ENPC 100 (388)
T KOG2123|consen 94 WLDENPC 100 (388)
T ss_pred hhccCCc
Confidence 7666643
No 186
>cd05885 Ig2_Necl-4 Second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Ig2_Necl-4: second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1-Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Ig domains are likely to participate in ligand binding and recognition. Necl-4 is expressed on Schwann cells, and plays a key part in initiating peripheral nervous system (PNS) myelination. In injured peripheral nerve cells, the mRNA signal for both Necl-4 and Necl-5 was observed to be elevated. Necl-4 participates in cell-cell adhesion and is proposed to play a role in tumor suppression.
Probab=95.80 E-value=0.052 Score=46.58 Aligned_cols=68 Identities=19% Similarity=0.263 Sum_probs=48.4
Q ss_pred cccccccc-ccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCcc
Q psy12044 272 VSLLCKVS-AIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTS 347 (767)
Q Consensus 272 vsL~C~a~-g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~ 347 (767)
+.|.|... +.|.+.|+|+++++.+....... .........++|.+.-....|.+.|+|.|.|.++...
T Consensus 2 ~~L~C~s~~skP~a~i~W~k~~~~l~~~~~~~--------~~~~~~t~~s~L~~~~~~~Ddg~~~~C~A~n~a~~~~ 70 (80)
T cd05885 2 VELTCLSPRSKPAATLRWYRDRKELKGVISQQ--------ENGKTVSVSNTIRFPVDRKDDGAILSCEASHPALVSQ 70 (80)
T ss_pred EEEEEeCCCccCCCeEEEEECCEECCCCcccc--------cCCceEEEEEEEEEEeeeccCCcEEEEEEEChhhCCC
Confidence 46788764 57889999999999885432110 1112223466789988888889999999999987654
No 187
>cd05900 Ig_Aggrecan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. Ig_Aggrecan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. These aggregates contribute to the tissue's load bearing properties. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Aggrecan has a wide distribution in connective tissue and extracellular matrices. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=95.77 E-value=0.027 Score=51.63 Aligned_cols=86 Identities=14% Similarity=0.195 Sum_probs=49.7
Q ss_pred ccccccccccccccC------------CCcEEEeec--Ce---ecc-C-CC--cccccccceeecccCcceeeeEEEEee
Q psy12044 268 EGKNVSLLCKVSAIP------------EAKITWLFD--GV---PIQ-N-ES--MSASESHAVYSTEEGTEIKKSELLIYN 326 (767)
Q Consensus 268 ~G~~vsL~C~a~g~P------------~p~itW~~~--g~---~l~-~-~s--~~~~~~~~~~~~~~g~~~~~s~L~I~n 326 (767)
.|++++|.|...... .+.|.|.+. +. .+. . .. +......++.+...........|.|.+
T Consensus 1 ~G~~VtLpC~~~~~~~~~~~~~~~~~~~~~I~W~k~~~g~~~~ii~~~~~~~~~~~~f~~R~sl~~~~~~~~~asL~I~n 80 (112)
T cd05900 1 LGSSLLIPCYFQDPIAKDPGAPTVAPLSPRIKWSFISKEKESVLLVATEGKVRVNTEYLDRVSLPNYPAIPSDATLEITE 80 (112)
T ss_pred CCCcEEEeeEEeCCcCccccccccCCCCCEEEEEEecCCCccEEEEEECCeEEECccccCeEEecccCCCCCCcEEEEee
Confidence 378889999876432 468999973 21 110 0 00 010111122222222234567899999
Q ss_pred eccCCCCceeEeeccCCCCcccceEEE
Q psy12044 327 SNIDDNGTFVCVAENQAGSTSSNYTIR 353 (767)
Q Consensus 327 vs~sD~GtY~CvA~N~~G~s~~s~sL~ 353 (767)
+..+|.|+|.|.+..........+.+.
T Consensus 81 l~~sDsG~Y~C~V~~g~~~~~~~v~l~ 107 (112)
T cd05900 81 LRSNDSGTYRCEVMHGIEDNYDTVEVQ 107 (112)
T ss_pred cccccCEEEEEEEecCCCCceeEEEEE
Confidence 999999999999986544444444333
No 188
>cd05877 Ig_LP_like Immunoglobulin (Ig)-like domain of human cartilage link protein (LP). Ig_LP_like: immunoglobulin (Ig)-like domain similar to that that found in human cartilage link protein (LP). In cartilage, chondroitin-keratan sulfate proteoglycan (CSPG), aggrecan, forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=95.75 E-value=0.022 Score=51.28 Aligned_cols=86 Identities=19% Similarity=0.307 Sum_probs=52.3
Q ss_pred ccccccccccccccC------CCcEEEeecCe---e-----ccCCCc---ccccccceeecccCcceeeeEEEEeeeccC
Q psy12044 268 EGKNVSLLCKVSAIP------EAKITWLFDGV---P-----IQNESM---SASESHAVYSTEEGTEIKKSELLIYNSNID 330 (767)
Q Consensus 268 ~G~~vsL~C~a~g~P------~p~itW~~~g~---~-----l~~~s~---~~~~~~~~~~~~~g~~~~~s~L~I~nvs~s 330 (767)
.|+.++|.|.....+ ...+.|.+... . +..... ......++.+. ........|.|.++..+
T Consensus 1 ~G~~vtL~C~~~~~~~~~~~~~~~v~W~k~~~~~~~~~~~~~~~~~~~~~~~~~~~R~~~~--~~~~~~~sL~I~~v~~~ 78 (106)
T cd05877 1 RGGNVTLPCRYHYEPELSAPRKIRVKWTKLESDYLKEEDVLVAIGTRHKSYGSYQGRVFLR--RAHDLDASLVITDLRLE 78 (106)
T ss_pred CCCcEEEEeEeECCCcCCCCccceEEEEEecCCCCeeEEEEEEcCcEEEeccCccCcEEec--CCCCCcEEEEEccCChH
Confidence 378899999876552 45799998421 0 011000 00001112221 11233568999999999
Q ss_pred CCCceeEeeccCCCCcccceEEEEE
Q psy12044 331 DNGTFVCVAENQAGSTSSNYTIRIV 355 (767)
Q Consensus 331 D~GtY~CvA~N~~G~s~~s~sL~V~ 355 (767)
|.|+|.|.+.+..+.....+.+.|.
T Consensus 79 DsG~Y~C~v~~~~~~~~~~~~l~v~ 103 (106)
T cd05877 79 DYGRYRCEVIDGLEDESVVVALRLR 103 (106)
T ss_pred HCEEEEEEEEecccceEEEEEEEEE
Confidence 9999999999877776666665554
No 189
>PHA02826 IL-1 receptor-like protein; Provisional
Probab=95.68 E-value=0.014 Score=60.55 Aligned_cols=91 Identities=16% Similarity=0.166 Sum_probs=57.1
Q ss_pred ceeecccccccccccccccC-----------CCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCC
Q psy12044 263 YLEIQEGKNVSLLCKVSAIP-----------EAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDD 331 (767)
Q Consensus 263 ~~~v~~G~~vsL~C~a~g~P-----------~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD 331 (767)
...+.+|+.+.|.|.+.+.+ .+.+.|.+.+....- .......................|.|.++..+|
T Consensus 31 ~~~v~eGe~v~L~C~~~~~~~~~~~~~~~~~~~~V~W~k~~s~~~v-~~~~~~~~~~~i~~~~~~~r~~~L~I~~v~~~D 109 (227)
T PHA02826 31 PVYAKFGDPMVLLCTGKHYKKSIFFDKTFITSYNVTWSKTDSLAFV-RDSGARTKIKKITHNEIGDRSENLWIGNVINID 109 (227)
T ss_pred eEEecCCCCEEEEccccccccccccccccCCCccEEEEeCCeEEEE-EcCCCccccccccccceecCCCeEEECCCChHH
Confidence 45778999999999986643 458999997543110 000000000000001111124589999999999
Q ss_pred CCceeEeeccCCCCcccceEEEE
Q psy12044 332 NGTFVCVAENQAGSTSSNYTIRI 354 (767)
Q Consensus 332 ~GtY~CvA~N~~G~s~~s~sL~V 354 (767)
.|.|.|.+.|..+.....+.+.|
T Consensus 110 sG~Y~C~a~N~~~~~~~~i~L~V 132 (227)
T PHA02826 110 EGIYICTISSGNICEESTIRLTF 132 (227)
T ss_pred CEEEEEEEEECCcceEEEEEEEE
Confidence 99999999998877666665555
No 190
>cd05872 Ig_Sema4B_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4B. Ig_Sema4B_like; Immunoglobulin (Ig)-like domain of Sema4B_like. Sema4B is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4B has extracellular Sema and Ig domains, a transmembrane domain and a short cytoplasmic domain. Sema4B has been shown to preferentially regulate the development of the postsynaptic specialization at the glutamatergic synapses. This cytoplasmic domain includes a PDZ-binding motif upon which the synaptic localization of Sem4B is dependent. Sema4B is a ligand of CLCP1, CLCP1 was identified in an expression profiling analysis, which compared a highly metastic lung cancer subline with its low metastic parental line. Sema4B was shown to promote CLCP1 endocytosis, and their interaction is a potential target for therapeutic intervention of metastasis.
Probab=95.67 E-value=0.029 Score=48.68 Aligned_cols=64 Identities=27% Similarity=0.500 Sum_probs=47.9
Q ss_pred cceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeec
Q psy12044 262 FYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAE 340 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~ 340 (767)
...++..|..+.|.|...+. ...+.|.+++..+..... +... ..-|.|..+...|+|.|.|.+.
T Consensus 4 ~~~tv~~g~~v~L~C~~~s~-~A~v~W~~ng~~l~~~~r-------~~~~-------~~GLlI~~~~~~dsG~Y~C~s~ 67 (85)
T cd05872 4 KNRTVAPGADVVLPCQLRSN-LASPVWLFNGTPLNAQFS-------YRVG-------TDGLLILVTSPEHSGTYRCYSE 67 (85)
T ss_pred eEEEEecCCCEEEECCCCCC-CccEEEEECCcccCCCcc-------eEEe-------CCCCEEEECCHhhCEEEEEEEe
Confidence 35678899999999998775 669999999877643211 1111 1236789999999999999986
No 191
>cd04983 IgV_TCR_alpha_like Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) alpha chain and similar proteins. IgV_TCR_alpha: immunoglobulin (Ig) variable domain of the alpha chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group represents the variable domain of the alpha chain of TCRs and also includes the variable domain of delta chains of TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=95.67 E-value=0.018 Score=51.94 Aligned_cols=82 Identities=26% Similarity=0.341 Sum_probs=52.5
Q ss_pred ccceeecccccccccccccccCCCcEEEeecCe---e---ccCCCccc-ccccceeecccCcceeeeEEEEeeeccCCCC
Q psy12044 261 TFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGV---P---IQNESMSA-SESHAVYSTEEGTEIKKSELLIYNSNIDDNG 333 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~---~---l~~~s~~~-~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~G 333 (767)
+..+.+.+|+.+.|.|.+.+.+...+.|.+... . +....... ....++...... ......|.|.++..+|+|
T Consensus 5 ~~~v~~~~G~~v~L~C~~~~~~~~~v~W~k~~~~~~~~~l~~~~~~~~~~~~~r~~~~~~~-~~~~~~L~I~~~~~~DsG 83 (109)
T cd04983 5 PQSLSVQEGENVTLNCNYSTSTFYYLFWYRQYPGQGPQFLIYISSNGEEKEKGRFSATLDK-SRKSSSLHISAAQLSDSA 83 (109)
T ss_pred CCceEEcCCCCEEEEEEECCCCccEEEEEEECCCCCeEEEEEEecCCCcccCCcEEEEEcc-cCCEEEEEECCCCHHHCE
Confidence 445678899999999999887888999987421 0 00000000 011112221111 234568999999999999
Q ss_pred ceeEeeccCC
Q psy12044 334 TFVCVAENQA 343 (767)
Q Consensus 334 tY~CvA~N~~ 343 (767)
.|.|.+.+..
T Consensus 84 ~Y~C~~~~~~ 93 (109)
T cd04983 84 VYFCALSESG 93 (109)
T ss_pred EEEEEEecCC
Confidence 9999998654
No 192
>KOG2052|consensus
Probab=95.64 E-value=0.0046 Score=68.00 Aligned_cols=25 Identities=24% Similarity=0.085 Sum_probs=22.7
Q ss_pred CccccCCCCcceEEeeCCceEEEec
Q psy12044 449 YIIADGHNDMMLYATDSGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~~dG~~VA~~~ 473 (767)
..||+|.||.|+||.-.|.-||+|-
T Consensus 217 e~IGkGRyGEVwrG~wrGe~VAVKi 241 (513)
T KOG2052|consen 217 EIIGKGRFGEVWRGRWRGEDVAVKI 241 (513)
T ss_pred EEecCccccceeeccccCCceEEEE
Confidence 5799999999999998888999866
No 193
>cd05880 Ig_EVA1 Immunoglobulin (Ig)-like domain of epithelial V-like antigen 1 (EVA). Ig_EVA: immunoglobulin (Ig) domain of epithelial V-like antigen 1 (EVA). EVA is also known as myelin protein zero-like 2. EVA is an adhesion molecule, which may play a role in structural organization of the thymus and early lymphocyte development.
Probab=95.54 E-value=0.03 Score=51.55 Aligned_cols=84 Identities=24% Similarity=0.352 Sum_probs=50.6
Q ss_pred ccceeecccccccccccccccC----CCcEEEeec----Ce--eccCC--Ccc--cc-cc-cceeecccCcceeeeEEEE
Q psy12044 261 TFYLEIQEGKNVSLLCKVSAIP----EAKITWLFD----GV--PIQNE--SMS--AS-ES-HAVYSTEEGTEIKKSELLI 324 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~g~P----~p~itW~~~----g~--~l~~~--s~~--~~-~~-~~~~~~~~g~~~~~s~L~I 324 (767)
+..+++..|+++.|.|.....+ ...+.|.+. +. .+... ... .. .. .+..+. .........|.|
T Consensus 5 ~~~v~~~~G~~v~L~C~~s~~~~~~~~~~i~W~~~~~~~~~~~~v~~~~~~~~~~~~~~f~~R~~~~-~~~~~~~~sL~I 83 (115)
T cd05880 5 SKEVEAVNGTDVRLKCTFSSSAPIGDTLVITWNFRPLDGGREESVFYYHKRPYPPPDGRFKGRVVWD-GNIMRRDASILI 83 (115)
T ss_pred CceEEEEcCCCEEEEEEEEeCCCCCCcEEEEEEEECCCCCceeEEEEECCCccccCcccccCeEEEe-cCCcCCceEEEE
Confidence 3457788999999999876433 246999752 11 11000 000 00 00 011111 122234567999
Q ss_pred eeeccCCCCceeEeeccCCCC
Q psy12044 325 YNSNIDDNGTFVCVAENQAGS 345 (767)
Q Consensus 325 ~nvs~sD~GtY~CvA~N~~G~ 345 (767)
.+++.+|.|+|.|.+.|..+.
T Consensus 84 ~~v~~~D~G~Y~C~v~~~~~~ 104 (115)
T cd05880 84 WQLQPTDNGTYTCQVKNPPDV 104 (115)
T ss_pred eeCChhhCEEEEEEEEeCCCC
Confidence 999999999999999987764
No 194
>PHA02785 IL-beta-binding protein; Provisional
Probab=95.35 E-value=0.025 Score=61.90 Aligned_cols=78 Identities=23% Similarity=0.390 Sum_probs=56.9
Q ss_pred ecccccccccccc-----cccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeec
Q psy12044 266 IQEGKNVSLLCKV-----SAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAE 340 (767)
Q Consensus 266 v~~G~~vsL~C~a-----~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~ 340 (767)
..+|+.+.+.|.+ .+.|.+.++|.+++.... + ...... ...|.|.++..+|+|.|.|.+.
T Consensus 38 ~~~ge~~~l~C~~~~~~~~g~p~~~i~W~K~g~~~~---------~-~~~~~~-----g~~l~i~~~~~~DsG~Y~C~a~ 102 (326)
T PHA02785 38 ELENEPVILPCPQINTLSSGYNILDILWEKRGADND---------R-IIPIDN-----GSNMLILNPTQSDSGIYICITK 102 (326)
T ss_pred hhcCCCEEEECCCccccccCCCCceEEEEECCCccc---------e-EEEccC-----CceEEEcccCcccCeEEEEEEE
Confidence 4468899999986 688899999999864211 0 111111 2247788899999999999999
Q ss_pred cCCCCcccceEEEEEeec
Q psy12044 341 NQAGSTSSNYTIRIVLKE 358 (767)
Q Consensus 341 N~~G~s~~s~sL~V~~~~ 358 (767)
|..|.....+.+.|....
T Consensus 103 N~~g~~~~s~~L~V~~~~ 120 (326)
T PHA02785 103 NETYCDMMSLNLTIVSVS 120 (326)
T ss_pred CCCcceEEEEEEEEEecC
Confidence 999887777777776543
No 195
>cd05899 IgV_TCR_beta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) bet a chain. IgV_TCR_beta: immunoglobulin (Ig) variable domain of the beta chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group includes the variable domain of the alpha chain of alpha/beta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=95.27 E-value=0.023 Score=51.64 Aligned_cols=80 Identities=18% Similarity=0.368 Sum_probs=50.3
Q ss_pred ccceeecccccccccccccccCCCcEEEeecC--eecc---CC---Ccccc-c--ccceeecccCcceeeeEEEEeeecc
Q psy12044 261 TFYLEIQEGKNVSLLCKVSAIPEAKITWLFDG--VPIQ---NE---SMSAS-E--SHAVYSTEEGTEIKKSELLIYNSNI 329 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g--~~l~---~~---s~~~~-~--~~~~~~~~~g~~~~~s~L~I~nvs~ 329 (767)
+..+.+.+|+.++|.|...+ +...+.|++.. .... .. ..... . ..++... ........|.|.++..
T Consensus 5 p~~~~v~~G~~v~l~C~~~~-~~~~v~Wykq~~g~~~~~l~~~~~~~~~~~~~~~~~r~~~~--~~~~~~~~L~I~~~~~ 81 (110)
T cd05899 5 PRYLIKGRGQSVTLRCSQTS-GHDNMYWYRQDPGKGLQLLFYSNGGSLNEEEGDPKDRFSAS--RPSLTRSSLTIKSAEP 81 (110)
T ss_pred CCceEEcCCCcEEEEEEECC-CCCEEEEEEECCCCCcEEEEEEcCCCceEecCccCCceEEE--CcCCCccEEEECCCCh
Confidence 34567889999999999887 77889998832 1111 00 00000 0 0111111 1112356899999999
Q ss_pred CCCCceeEeeccCC
Q psy12044 330 DDNGTFVCVAENQA 343 (767)
Q Consensus 330 sD~GtY~CvA~N~~ 343 (767)
+|.|.|.|.+.+..
T Consensus 82 ~Dsg~Y~Ca~~~~~ 95 (110)
T cd05899 82 EDSAVYLCASSLGG 95 (110)
T ss_pred hhCEEEEEEeeCCC
Confidence 99999999987643
No 196
>cd05878 Ig_Aggrecan_like Immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG). Ig_Aggrecan_like: immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG)s. Included in this group are the Ig domains of other CSPGs: versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substi
Probab=95.21 E-value=0.047 Score=49.81 Aligned_cols=86 Identities=15% Similarity=0.225 Sum_probs=50.8
Q ss_pred cccccccccccccC----------CCcEEEeec--Ceecc-----CCCc-ccccc-cceeecccCcceeeeEEEEeeecc
Q psy12044 269 GKNVSLLCKVSAIP----------EAKITWLFD--GVPIQ-----NESM-SASES-HAVYSTEEGTEIKKSELLIYNSNI 329 (767)
Q Consensus 269 G~~vsL~C~a~g~P----------~p~itW~~~--g~~l~-----~~s~-~~~~~-~~~~~~~~g~~~~~s~L~I~nvs~ 329 (767)
|+.++|.|.....+ ...+.|.+. +.... .... ..... .++.+...........|.|.+++.
T Consensus 2 G~~V~LpC~~~~~~~~~~~~~~~~~~~i~W~k~~~~~~~~v~~~~~~~~~~~~~f~gR~~~~~~~~~~~~asL~I~~l~~ 81 (110)
T cd05878 2 SSSVLLPCYFTLPPALPPPSNAPESPRIKWTKLSGQKEVTVLVAQDGVVKVGQEYQGRVSLPNYPENRGDASLEISRLRS 81 (110)
T ss_pred CCCEEEeeEeeCCccccccccCCCCCEEEEEEecCCCcEEEEEEECCEEEecccccCeEEeccCCCCCCcEEEEECCCCh
Confidence 77889999886543 367999984 21110 0110 00111 112222222233457899999999
Q ss_pred CCCCceeEeeccCCCCcccceEEEE
Q psy12044 330 DDNGTFVCVAENQAGSTSSNYTIRI 354 (767)
Q Consensus 330 sD~GtY~CvA~N~~G~s~~s~sL~V 354 (767)
+|.|+|.|.+........+.+.|.|
T Consensus 82 sD~G~Y~C~v~~~~~~~~~~v~l~V 106 (110)
T cd05878 82 SDSGVYRCEVMHGIEDEQDTVPLEV 106 (110)
T ss_pred hhCEEEEEEEEeCCCcceEEEEEEE
Confidence 9999999999876555555555444
No 197
>cd05896 Ig1_IL1RAPL-1_like First immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). Ig1_ IL1RAPL-1_like: domain similar to the first immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). IL-1 alpha and IL-1 beta are cytokines which participates in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of
Probab=95.16 E-value=0.052 Score=48.79 Aligned_cols=80 Identities=11% Similarity=0.203 Sum_probs=50.8
Q ss_pred eeeccccccccccccc-----------ccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCC
Q psy12044 264 LEIQEGKNVSLLCKVS-----------AIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDN 332 (767)
Q Consensus 264 ~~v~~G~~vsL~C~a~-----------g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~ 332 (767)
..+.+|+.+.|.|... ......+.|++++......... .+...........|.|..+..+|+
T Consensus 10 ~~~~~GE~v~l~C~~~~~~~~~~~~~~~~~~~~v~WyK~~~~~~~~~~~-------~~~~~Ri~~~~~~Lwf~Pa~~eDS 82 (104)
T cd05896 10 YMVLAGEPVRIKCALFYGYIRTNYSMAQSAGLSLMWYKSSGDGEEPIEI-------IFDGVRMSKEEDSIWFRPAELQDS 82 (104)
T ss_pred EEEcCCCeEEEECCCccccccccccccccCCceEEEEECCCCCCCCCcc-------cccceeEEEeCCEEEEEeCChhhC
Confidence 4567899999999862 1223479999976333221110 000011222345799999999999
Q ss_pred CceeEeeccCCCCcccce
Q psy12044 333 GTFVCVAENQAGSTSSNY 350 (767)
Q Consensus 333 GtY~CvA~N~~G~s~~s~ 350 (767)
|.|+|++.|........+
T Consensus 83 G~Y~C~~rN~t~C~~~~i 100 (104)
T cd05896 83 GLYTCVLRNSTYCMKVSM 100 (104)
T ss_pred eEEEEEECCCCcceEEEE
Confidence 999999998775544433
No 198
>cd05751 Ig1_LILRB1_like First immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1) and similar proteins. Ig1_LILRB1_like: domain similar to the first immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1). This group includes, LILRA5 (LIR9), an activating natural cytotoxicity receptor NKp46, and the immune-type receptor glycoprotein VI (GPVI). LILRs are a family of immunoreceptors expressed on expressed on T and B cells, on monocytes, dendritic cells, and subgroups of natural killer (NK) cells. The human LILR family contains nine proteins (LILRA1-3,and 5, and LILRB1-5). From functional assays, and as the cytoplasmic domains of various LILRs, for example LILRB1 (LIR-1), LILRB2 (LIR-2), and LILRB3 (LIR-3) contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) it is thought that LIR proteins are inhibitory receptors. Of the eight LIR family proteins, only LIR-1(LILRB1), and LIR-2 (LILRB2),
Probab=95.15 E-value=0.043 Score=48.12 Aligned_cols=64 Identities=16% Similarity=0.276 Sum_probs=46.2
Q ss_pred eecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccC
Q psy12044 265 EIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQ 342 (767)
Q Consensus 265 ~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~ 342 (767)
.+..|.+++|.|... .+...+.|.+++....... . ........+.|.+++.+|.|.|.|...+.
T Consensus 12 vV~~G~~VtL~C~~~-~~~~~f~l~k~g~~~~~~~-~------------~~~~~~~~f~i~~v~~~~~G~Y~C~~~~~ 75 (91)
T cd05751 12 VVPLGKPVTLRCQGP-YGAVEYRLYREGSTFAVKK-P------------PEPQNKAKFFIPSMKREHAGRYRCYYRSG 75 (91)
T ss_pred ccCCCCcEEEEEecC-CCCCEEEEEECCCCccccc-c------------CCCceeEEEEccCCChhHCEEEEEEEECC
Confidence 567899999999875 6667788888775432110 0 01123457899999999999999999875
No 199
>cd05715 Ig_P0-like Immunoglobulin (Ig)-like domain of Protein zero (P0) and similar proteins. Ig_P0ex-like: domain similar to the immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an extracellular Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin. This group also contains the Ig domain of Sodium channel subunit beta-2
Probab=95.11 E-value=0.078 Score=48.68 Aligned_cols=84 Identities=23% Similarity=0.338 Sum_probs=50.3
Q ss_pred cceeecccccccccccccccC----CCcEEEeecCe------ecc---CCCcc---cccc-cceeecccCcceeeeEEEE
Q psy12044 262 FYLEIQEGKNVSLLCKVSAIP----EAKITWLFDGV------PIQ---NESMS---ASES-HAVYSTEEGTEIKKSELLI 324 (767)
Q Consensus 262 ~~~~v~~G~~vsL~C~a~g~P----~p~itW~~~g~------~l~---~~s~~---~~~~-~~~~~~~~g~~~~~s~L~I 324 (767)
..+.+..|+.++|.|...... ...+.|.+... .+. ..... .... .++.+. .........|.|
T Consensus 6 ~~v~v~~G~~vtL~C~~s~~~~~~~~~~v~W~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~R~~~~-~~~~~~~~sL~I 84 (116)
T cd05715 6 REVYAVNGSDVRLKCTFSSSEPISDDISVTWSFQPEGSGDTESIFHYHKGPYYPLKDGRFKDRVEWV-GNPSRKDASIVI 84 (116)
T ss_pred CeEEEEcCCCeEEEeEEeCCCCcCCceEEEEEEecCCCCCcEEEEEEcCCccccccCccccCcEEEe-cCCcCCeeEEEE
Confidence 346778999999999875432 25699976221 111 00000 0011 111111 112234578999
Q ss_pred eeeccCCCCceeEeeccCCCCc
Q psy12044 325 YNSNIDDNGTFVCVAENQAGST 346 (767)
Q Consensus 325 ~nvs~sD~GtY~CvA~N~~G~s 346 (767)
.+++.+|.|.|.|.+.|.....
T Consensus 85 ~~v~~~D~G~Y~C~v~~~~~~~ 106 (116)
T cd05715 85 HNLQFTDNGTYTCDVKNPPDIV 106 (116)
T ss_pred eeCCcccCEEEEEEEEeCCCCC
Confidence 9999999999999999876543
No 200
>cd05718 Ig1_PVR_like First immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig1_PVR_like: domain similar to the first immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), that result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane, may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus "c
Probab=95.03 E-value=0.055 Score=47.68 Aligned_cols=36 Identities=19% Similarity=0.463 Sum_probs=27.4
Q ss_pred eeeEEEEeeeccCCCCceeEeecc-CCCCcccceEEE
Q psy12044 318 KKSELLIYNSNIDDNGTFVCVAEN-QAGSTSSNYTIR 353 (767)
Q Consensus 318 ~~s~L~I~nvs~sD~GtY~CvA~N-~~G~s~~s~sL~ 353 (767)
....|.|.++..+|.|.|.|.+.. +.|...+...+.
T Consensus 60 ~~~sL~I~~v~~~D~G~Y~C~v~~~~~g~~~~~~~l~ 96 (98)
T cd05718 60 EDATISISNLRLEDEGNYICEFATFPQGNRQKVTTLT 96 (98)
T ss_pred CceEEEEccCCcccCEEEEEEEEeCCCCcEEEEEEEE
Confidence 457899999999999999999864 556555544443
No 201
>cd05741 Ig_CEACAM_D1_like First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) and similar proteins. Ig_CEACAM_D1_like : immunoglobulin (IG)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily-like. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surf
Probab=94.99 E-value=0.027 Score=48.99 Aligned_cols=76 Identities=21% Similarity=0.246 Sum_probs=45.1
Q ss_pred cccccccccccccCCCcEEEeecCeeccCCCccc---ccccce--eecccCcceeeeEEEEeeeccCCCCceeEeeccCC
Q psy12044 269 GKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSA---SESHAV--YSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQA 343 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~---~~~~~~--~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~ 343 (767)
|+.++|.|.........+.|.+.........+.. ...... .+...-.......|.|.++..+|.|.|.|......
T Consensus 1 G~~VtL~c~~~~~~~~~i~W~~~~~~~~~~~i~~~~~~~~~~~~~~~~~R~~~~~~~sL~I~~l~~~DsG~Y~c~v~~~~ 80 (92)
T cd05741 1 GESVTLPVSNLPENLQEITWYKGKDKSVEAEIASYIATNSTVFGPAYSGRETIYPNGSLLIQNLTKEDSGTYTLQIISTN 80 (92)
T ss_pred CCcEEEEcccCCCCCEEEEEECCCCCCcceEEEEEecCCceeECCCcCCeEEEcCCceEEEccCCchhcEEEEEEEEcCC
Confidence 6788999988776677899998542221111000 000000 00000011123689999999999999999987765
Q ss_pred C
Q psy12044 344 G 344 (767)
Q Consensus 344 G 344 (767)
|
T Consensus 81 ~ 81 (92)
T cd05741 81 G 81 (92)
T ss_pred C
Confidence 3
No 202
>cd05888 Ig1_Nectin-4_like Frst immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor) and similar proteins. Ig1_Nectin-4_like: domain similar to the first immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor). Nectin-4 belongs to the nectin family, which is comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example nectin-4 trans-interacts with nectin-1. Nectin-4 has also been shown to interact with the actin filament-binding protein, afadin. Unlike the other nectins, which are widely expressed in adult tissues, nectin-4 is mainly expressed during embryogenesis, and is not detected in normal adult
Probab=94.94 E-value=0.082 Score=47.25 Aligned_cols=35 Identities=20% Similarity=0.424 Sum_probs=26.7
Q ss_pred eeeEEEEeeeccCCCCceeEeecc-CCCCcccceEE
Q psy12044 318 KKSELLIYNSNIDDNGTFVCVAEN-QAGSTSSNYTI 352 (767)
Q Consensus 318 ~~s~L~I~nvs~sD~GtY~CvA~N-~~G~s~~s~sL 352 (767)
....|.|.+++.+|.|+|.|...+ +.|...+.+.|
T Consensus 62 ~~~sL~I~nv~~sD~GtY~C~v~~~p~g~~~~~~~L 97 (100)
T cd05888 62 ADGALILRNAVQADEGKYKCRVITFPAGNFEAELVL 97 (100)
T ss_pred CceEEEEecCccccceEEEEEEEeCCCCCeeeEEEE
Confidence 456799999999999999999987 55554333433
No 203
>KOG0593|consensus
Probab=94.87 E-value=0.014 Score=61.51 Aligned_cols=56 Identities=18% Similarity=0.283 Sum_probs=41.3
Q ss_pred CccccCCCCcceEEe--eCCceEEEec-cccC---CCc--ch---hhhh-hhCCCCcccchhhccccc
Q psy12044 449 YIIADGHNDMMLYAT--DSGILVATNN-MNTY---PSY--SI---SYQI-EQNPDLVNDAESVDKDRR 504 (767)
Q Consensus 449 nlIG~GgfG~VYKG~--~dG~~VA~~~-~~~~---~~~--~~---~~~~-e~npdlin~~e~~~~~~~ 504 (767)
-.+|||+||+|||.. ..|++||++. .+.= ..+ ++ +=+. =++|+|+|=.|.-.++++
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk 75 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK 75 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence 379999999999999 9999999988 1111 111 11 1111 359999999999999888
No 204
>cd00098 IgC Immunoglobulin Constant domain. IgC: Immunoglobulin constant domain (IgC). Members of the IgC family are components of immunoglobulin, T-cell receptors, CD1 cell surface glycoproteins, secretory glycoproteins A/C, and Major Histocompatibility Complex (MHC) class I/II molecules. In immunoglobulins, each chain is composed of one variable domain (IgV) and one or more IgC domains. These names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. The IgV domain is responsible for antigen binding, and the IgC domain is involved in oligomerization and molecular interactions.
Probab=94.65 E-value=0.078 Score=46.38 Aligned_cols=74 Identities=23% Similarity=0.462 Sum_probs=51.1
Q ss_pred cccccccccccccc-C-CCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCC
Q psy12044 268 EGKNVSLLCKVSAI-P-EAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGS 345 (767)
Q Consensus 268 ~G~~vsL~C~a~g~-P-~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~ 345 (767)
.|..+.|.|.+.+. | ...++|..++..+..... ........++.....+.|.+......+.+.|+|.+.+....
T Consensus 12 ~~~~~~L~C~a~g~~P~~~~i~W~~~g~~~~~~~~----~~~~~~~~~gt~~~~s~l~v~~~~~~~~~~y~C~v~h~~~~ 87 (95)
T cd00098 12 LGGSVTLTCLATGFYPPDITVTWLKNGKELTSGVT----TTPPVPNSDGTYSVSSQLTVSPSDWNSGDTYTCVVTHESLP 87 (95)
T ss_pred cCCCeEEEEEEeeEECCCcEEEEEECCEECCCcee----ccccccCCCCCEEEEEEEEECHHHhCCCCCEEEEEEeCCCC
Confidence 57889999999998 5 368999999887754332 01122233444555666777666666899999999876543
No 205
>cd05775 Ig_SLAM-CD84_like_N N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. Ig_SLAM-CD84_like_N: The N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. The SLAM family is a group of immune-cell specific receptors that can regulate both adaptive and innate immune responses. Members of this group include proteins such as CD84, SLAM (CD150), Ly-9 (CD229), NTB-A (ly-108, SLAM6), 19A (CRACC), and SLAMF9. The genes coding for the SLAM family are nested on chromosome 1, in humans at 1q23, and in mice at 1H2. The SLAM family is a subset of the CD2 family, which also includes CD2 and CD58 located on chromosome 1 at 1p13 in humans. In mice, CD2 is located on chromosome 3, and there is no CD58 homolog. The SLAM family proteins are organized as an extracellular domain with either two or four Ig-like domains, a single transmembrane segment, and a cytoplasmic region
Probab=94.64 E-value=0.038 Score=49.14 Aligned_cols=79 Identities=20% Similarity=0.228 Sum_probs=47.3
Q ss_pred ccccccccccccc-cCCCcEEEeecCeeccCCCcc--cccccce--eec-ccCcceeeeEEEEeeeccCCCCceeEeecc
Q psy12044 268 EGKNVSLLCKVSA-IPEAKITWLFDGVPIQNESMS--ASESHAV--YST-EEGTEIKKSELLIYNSNIDDNGTFVCVAEN 341 (767)
Q Consensus 268 ~G~~vsL~C~a~g-~P~p~itW~~~g~~l~~~s~~--~~~~~~~--~~~-~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N 341 (767)
.|++++|.|.... .....+.|.+....+...... ....... .+. ..........|.|.++..+|.|.|.|....
T Consensus 3 ~G~sVtL~c~~~~~~~~~~v~W~~~~~~~i~~~~~~~~~~~~~~~~~f~~R~~~~~~~~sL~I~~~~~~DsG~Y~c~v~~ 82 (97)
T cd05775 3 LGGSVTLPLNIPDGTEIESITWSFNTSLAIITPGEETAPEIIVTDPSYKERVNFSQNDYSLQISNLKMEDAGSYRAEINT 82 (97)
T ss_pred cCCeEEEeCCCCCCcEEEEEEEecCCEeEEEecCCCCCCccEEeCCCceeeEEecCCceeEEECCCchHHCEEEEEEEEc
Confidence 5889999998765 556789999864222111100 0000000 000 000112247899999999999999999987
Q ss_pred CCCCc
Q psy12044 342 QAGST 346 (767)
Q Consensus 342 ~~G~s 346 (767)
..|..
T Consensus 83 ~~~~~ 87 (97)
T cd05775 83 KNGVT 87 (97)
T ss_pred CCCCe
Confidence 76543
No 206
>KOG2120|consensus
Probab=94.35 E-value=0.0065 Score=63.71 Aligned_cols=152 Identities=20% Similarity=0.149 Sum_probs=105.5
Q ss_pred CCccEEEeeCCCCCCCCchhhhccCCCCccEEEccCC-CCCccCc-ccccCCCCCCEEEccCCCCCCCCCCC-CCC-CCC
Q psy12044 49 PNTQVLDYTGNNLKTLHNEKFQKMGLVNLQKIYLSRC-RISVIDS-KAFRGLTNLVDLDFSHNVLQTVPSDT-FPD-YPS 124 (767)
Q Consensus 49 ~~L~~L~Ls~N~L~~l~~~~f~~~~L~~L~~L~Ls~N-~L~~i~p-~~f~~L~~L~~L~Ls~N~Lt~l~p~~-f~~-l~~ 124 (767)
..|+.|.|.+++|.+-....++. -.+|+.|+|+.+ .|+.... -.|.+++.|.+|+|+++.+....-.. ... -++
T Consensus 210 ~kLk~lSlEg~~LdD~I~~~iAk--N~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~LNlsWc~l~~~~Vtv~V~hise~ 287 (419)
T KOG2120|consen 210 SKLKNLSLEGLRLDDPIVNTIAK--NSNLVRLNLSMCSGFTENALQLLLSSCSRLDELNLSWCFLFTEKVTVAVAHISET 287 (419)
T ss_pred HhhhhccccccccCcHHHHHHhc--cccceeeccccccccchhHHHHHHHhhhhHhhcCchHhhccchhhhHHHhhhchh
Confidence 57899999999999877777774 579999999985 4444221 23678999999999999876432111 111 257
Q ss_pred CcEEECCCCcCcc-c--ccCCcCCCCCccEEeccCC-CccccchhhhcCCCCCCeeeccCCccccccCC----CCCCCCc
Q psy12044 125 LMKLTLSGNPIKQ-I--KTGAFQPLSYLVTLELSKC-GIEVIEDAAFVGLDSLEWLKLDNNKITTISGS----NILPTGL 196 (767)
Q Consensus 125 L~~L~Ls~N~l~~-l--~~~~~~~l~~L~~L~Ls~N-~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~----~~~~~~L 196 (767)
|..|+|++..-.- . ....-..+++|..|||++| .|+.-....|..++.|++|.|+.+-. |+++ +...++|
T Consensus 288 l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSlsRCY~--i~p~~~~~l~s~psl 365 (419)
T KOG2120|consen 288 LTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSLSRCYD--IIPETLLELNSKPSL 365 (419)
T ss_pred hhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeehhhhcC--CChHHeeeeccCcce
Confidence 8899998864211 1 0111245789999999987 56655555677899999999988743 2322 2345788
Q ss_pred ccccCCCC
Q psy12044 197 HGIDLHHN 204 (767)
Q Consensus 197 ~~L~Ls~N 204 (767)
.+|++.+.
T Consensus 366 ~yLdv~g~ 373 (419)
T KOG2120|consen 366 VYLDVFGC 373 (419)
T ss_pred EEEEeccc
Confidence 89988764
No 207
>cd05886 Ig1_Nectin-1_like First immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111) and similar proteins. Ig1_Nectin-1_like: domain similar to the first immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111). Nectin-1 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. In addition nectins heterophilically trans-interact with other CAMs such as nectin-like molecules (Necls), nectin-1 for example, has been shown to trans-interact with Necl-1. Nectins also interact with various other proteins, including the actin filament (F-actin)-binding protein, afadin. Mutation in the human nectin-1 gene is
Probab=94.33 E-value=0.12 Score=46.27 Aligned_cols=37 Identities=14% Similarity=0.482 Sum_probs=29.4
Q ss_pred eeeEEEEeeeccCCCCceeEeecc-CCCCcccceEEEE
Q psy12044 318 KKSELLIYNSNIDDNGTFVCVAEN-QAGSTSSNYTIRI 354 (767)
Q Consensus 318 ~~s~L~I~nvs~sD~GtY~CvA~N-~~G~s~~s~sL~V 354 (767)
...+|.|.++..+|.|+|.|...+ +.|...+.+.|.|
T Consensus 61 ~daSi~i~nl~~~D~G~Y~C~v~t~P~g~~~~~~~L~V 98 (99)
T cd05886 61 EDGTISLSRLELEDEGVYICEFATFPTGNRESQLNLTV 98 (99)
T ss_pred CcceEEEcCCccccCEEEEEEEEeCCCCCeEEEEEEEE
Confidence 567899999999999999999998 5676555555543
No 208
>cd05902 Ig_Neurocan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. Ig_Neurocan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Unlike aggrecan which is widely distributed in connective tissue and extracellular matrices, neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many differen
Probab=94.26 E-value=0.11 Score=47.39 Aligned_cols=86 Identities=14% Similarity=0.203 Sum_probs=49.9
Q ss_pred cccccccccccccC-------CCcEEEeecC-----eec----c-CCC--cccccccceeecccCcceeeeEEEEeeecc
Q psy12044 269 GKNVSLLCKVSAIP-------EAKITWLFDG-----VPI----Q-NES--MSASESHAVYSTEEGTEIKKSELLIYNSNI 329 (767)
Q Consensus 269 G~~vsL~C~a~g~P-------~p~itW~~~g-----~~l----~-~~s--~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~ 329 (767)
|..+.|.|...-.| .+.|.|.+.. ... . ... .......+..+..........+|.|.+++.
T Consensus 2 ~~~v~LpC~~~~~p~~~~~~~~~~I~W~k~~~~~~~~~~~v~v~~~~~~~~~~~y~gRvsl~~~~~~~~~asL~i~nv~~ 81 (110)
T cd05902 2 SSSVLLPCVFTLPPSASSPPEGPRIKWTKLRPASGQKQRPVLVARDNVVRVAKAFQGRVSLPGYPKNRYNASLVLSRLRY 81 (110)
T ss_pred CCcEEEeeEEEcCccccCCCCCCEEEEEEeCCCCCceEEEEEECCCCcEEEchhcccEEEeecCCCCCceEEEEECCCCH
Confidence 56788888854322 4688998731 110 0 000 111112223333333444567999999999
Q ss_pred CCCCceeEeeccCCCCcccceEEEE
Q psy12044 330 DDNGTFVCVAENQAGSTSSNYTIRI 354 (767)
Q Consensus 330 sD~GtY~CvA~N~~G~s~~s~sL~V 354 (767)
+|+|.|.|............+.|.|
T Consensus 82 ~D~G~Y~C~v~~g~~~~~~~v~L~V 106 (110)
T cd05902 82 SDSGTYRCEVVLGINDEQDTVPLEV 106 (110)
T ss_pred HHCEEEEEEEEECCcccEEEEEEEE
Confidence 9999999999875544444444433
No 209
>cd00099 IgV Immunoglobulin variable domain (IgV). IgV: Immunoglobulin variable domain (IgV). Members of the IgV family are components of immunoglobulin (Ig) and T cell receptors. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. Within the variable domain, there are regions of even more variability called the hypervariable or complementarity-determining regions (CDRs) which are responsible for antigen binding. A predominant feature of most Ig domains is the disulfide bridge connecting 2 beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=94.10 E-value=0.051 Score=48.40 Aligned_cols=79 Identities=19% Similarity=0.286 Sum_probs=49.2
Q ss_pred eeccccccccccccccc-CCCcEEEeecCe-----eccC-CCc----ccccccceeecccCcceeeeEEEEeeeccCCCC
Q psy12044 265 EIQEGKNVSLLCKVSAI-PEAKITWLFDGV-----PIQN-ESM----SASESHAVYSTEEGTEIKKSELLIYNSNIDDNG 333 (767)
Q Consensus 265 ~v~~G~~vsL~C~a~g~-P~p~itW~~~g~-----~l~~-~s~----~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~G 333 (767)
.+..|+.+.|.|..... +...+.|.+... .+.. ... ......++...... ......|.|.++..+|.|
T Consensus 2 ~v~~G~~v~L~C~~~~~~~~~~v~W~k~~~~~~~~~i~~~~~~~~~~~~~~~~r~~~~~~~-~~~~~sL~I~~v~~~D~G 80 (105)
T cd00099 2 SVSEGESVTLSCTYSGSFSSYYIFWYRQKPGKGPELLIYISSNGSQYAGGVKGRFSGTRDS-SKSSFTLTISSLQPEDSA 80 (105)
T ss_pred eecCCCCEEEEEEEeCCcCcceEEEEEECCCCCCEEEEEEeCCCCccCccCCCcEEEEEec-cCCEEEEEECCCCHHHCE
Confidence 45689999999998876 677899988322 0100 000 00011112111111 124568999999999999
Q ss_pred ceeEeeccCCC
Q psy12044 334 TFVCVAENQAG 344 (767)
Q Consensus 334 tY~CvA~N~~G 344 (767)
.|.|.+.+..+
T Consensus 81 ~Y~C~v~~~~~ 91 (105)
T cd00099 81 VYYCAVSLSGG 91 (105)
T ss_pred EEEEEEecCCC
Confidence 99999987654
No 210
>cd05774 Ig_CEACAM_D1 First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). IG_CEACAM_D1: immunoglobulin (Ig)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the D
Probab=94.08 E-value=0.068 Score=48.40 Aligned_cols=80 Identities=21% Similarity=0.192 Sum_probs=47.2
Q ss_pred eeecccccccccccccccCCCcEEEeecCeeccC-----CCcccccccc-eeecccCcceeeeEEEEeeeccCCCCceeE
Q psy12044 264 LEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQN-----ESMSASESHA-VYSTEEGTEIKKSELLIYNSNIDDNGTFVC 337 (767)
Q Consensus 264 ~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~-----~s~~~~~~~~-~~~~~~g~~~~~s~L~I~nvs~sD~GtY~C 337 (767)
..+.+|+.+.|.|.........++|++....... .......... -.+........+++|.|.+++.+|.|.|.|
T Consensus 8 ~~~~~G~~V~L~v~~~p~~~~~~~W~kg~~~~~~~~I~~y~~~~~~~~~gp~~~gR~~~~~ngSL~I~~v~~~D~G~Y~~ 87 (105)
T cd05774 8 PQVAEGENVLLLVHNLPENLLAYAWYKGKTVSPNFLIASYIISTNSSTPGPAYSGRETIYPNGSLLIQNVTQKDTGFYTL 87 (105)
T ss_pred CcccCCCCEEEEecCCCCCceEEEEEcCCCCCCCEEEEEEECCCcccccCcccCCcEEEeCCCcEEEecCCcccCEEEEE
Confidence 3567899999998765555568999984321111 1000000000 000001112234689999999999999999
Q ss_pred eeccCC
Q psy12044 338 VAENQA 343 (767)
Q Consensus 338 vA~N~~ 343 (767)
.+.+..
T Consensus 88 ~v~~~~ 93 (105)
T cd05774 88 QTITTN 93 (105)
T ss_pred EEEeCC
Confidence 998765
No 211
>cd04980 IgV_L_kappa Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. IgV_L_kappa: Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=93.66 E-value=0.089 Score=47.34 Aligned_cols=78 Identities=17% Similarity=0.221 Sum_probs=48.3
Q ss_pred ccceeecccccccccccccccC-CCcEEEeecC--e---eccCC-Cccccc-ccceeecccCcceeeeEEEEeeeccCCC
Q psy12044 261 TFYLEIQEGKNVSLLCKVSAIP-EAKITWLFDG--V---PIQNE-SMSASE-SHAVYSTEEGTEIKKSELLIYNSNIDDN 332 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~g~P-~p~itW~~~g--~---~l~~~-s~~~~~-~~~~~~~~~g~~~~~s~L~I~nvs~sD~ 332 (767)
+..+.+.+|+.++|.|.+.+.. ...+.|++.. . .+... ...... ...+... .......|.|.++..+|.
T Consensus 7 p~~~~v~~G~~v~L~C~~~~~~~~~~~~Wyrq~~g~~~~~l~~~~~~~~~~~~~r~~~~---~~~~~~~L~I~~~~~~Ds 83 (106)
T cd04980 7 PATLSVSPGESATISCKASQSVSSNYLAWYQQKPGQAPKLLIYGASTLASGTPSRFSGS---GSGTDFTLTISRVEPEDA 83 (106)
T ss_pred CCcEEECCCCCEEEEEEECCCCCCCcEEEEEECCCCCcEEEEECccccCCCCCCCEEEe---ccCCEEEEEECCCChHHC
Confidence 4456788999999999987665 6789998732 1 11110 000000 0111111 112345799999999999
Q ss_pred CceeEeecc
Q psy12044 333 GTFVCVAEN 341 (767)
Q Consensus 333 GtY~CvA~N 341 (767)
|.|.|.+.+
T Consensus 84 g~Y~Ca~~~ 92 (106)
T cd04980 84 AVYYCQQYG 92 (106)
T ss_pred EEEEEEEeC
Confidence 999999864
No 212
>cd05901 Ig_Versican Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. Ig_Versican: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Like aggrecan, versican has a wide distribution in connective tissue and extracellular matrices. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA
Probab=93.62 E-value=0.24 Score=45.73 Aligned_cols=41 Identities=15% Similarity=0.284 Sum_probs=31.4
Q ss_pred CcceeeeEEEEeeeccCCCCceeEeeccCCCCcccceEEEE
Q psy12044 314 GTEIKKSELLIYNSNIDDNGTFVCVAENQAGSTSSNYTIRI 354 (767)
Q Consensus 314 g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~sL~V 354 (767)
.......+|.|.++..+|+|.|.|............+.+.|
T Consensus 73 ~~~~g~asL~i~~v~~sD~G~Y~C~V~~g~~~~~~~v~L~V 113 (117)
T cd05901 73 PEDQGDASLTIVKLRASDAGVYRCEVMHGIEDTQDTVSLDV 113 (117)
T ss_pred CCcCCceEEEEcccccccCEEEEEEEEECCcccEEEEEEEE
Confidence 33445688999999999999999999877666655555544
No 213
>KOG4221|consensus
Probab=93.55 E-value=0.043 Score=66.92 Aligned_cols=90 Identities=27% Similarity=0.416 Sum_probs=70.2
Q ss_pred CCCCCCccceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCc
Q psy12044 255 PQITPSTFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGT 334 (767)
Q Consensus 255 P~i~~~~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~Gt 334 (767)
|.+...+..+...++..+.+.|.+.+.|.|.+.|+++|..+...... .. .....|.|.-+-..|.|.
T Consensus 329 P~~~~~p~~l~A~e~~die~ec~~~g~p~p~v~w~kNgd~~ipsdy~-------ki------~~~~~lrIlgi~~sdeg~ 395 (1381)
T KOG4221|consen 329 PGFTKAPTTLVAHESMDIEFECPVSGKPIPTVRWYKNGDRIIPSDYF-------KI------VGGGNLRILGIVKSDEGF 395 (1381)
T ss_pred CCCCCCCcceeeeeccceeEeCCCCCCCcceEEEEecCcccCcccce-------Ee------cCCCCcEEEEEecccchh
Confidence 55666666777888999999999999999999999988665442221 11 111238888899999999
Q ss_pred eeEeeccCCCCcccceEEEEEee
Q psy12044 335 FVCVAENQAGSTSSNYTIRIVLK 357 (767)
Q Consensus 335 Y~CvA~N~~G~s~~s~sL~V~~~ 357 (767)
|.|+++|..|.+.....+.+...
T Consensus 396 yQcvaen~~G~a~a~a~l~vv~~ 418 (1381)
T KOG4221|consen 396 YQCVAENDAGSAQAAAQLEVVPQ 418 (1381)
T ss_pred hhhhhccCcccccchhhheeccC
Confidence 99999999999999888866654
No 214
>cd04984 IgV_L_lambda Immunoglobulin (Ig) lambda light chain variable (V) domain. IgV_L_lambda: Immunoglobulin (Ig) light chain, lambda type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=93.44 E-value=0.12 Score=45.79 Aligned_cols=74 Identities=15% Similarity=0.270 Sum_probs=45.2
Q ss_pred eeccccccccccccccc--CCCcEEEeecC--eec---cCCC-ccccc-ccceeecccCcceeeeEEEEeeeccCCCCce
Q psy12044 265 EIQEGKNVSLLCKVSAI--PEAKITWLFDG--VPI---QNES-MSASE-SHAVYSTEEGTEIKKSELLIYNSNIDDNGTF 335 (767)
Q Consensus 265 ~v~~G~~vsL~C~a~g~--P~p~itW~~~g--~~l---~~~s-~~~~~-~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY 335 (767)
.+..|+.++|.|..... ....+.|++.. ... .... ..... ...+.... ......|.|.++..+|.|+|
T Consensus 2 ~v~~G~~v~l~C~~~~~~~~~~~i~Wy~q~~g~~~~~l~~~~~~~~~~~~~rf~~~~---~~~~~~L~I~~~~~~Dsg~Y 78 (98)
T cd04984 2 SVSPGETVTITCTGSSGNISGNYVNWYQQKPGSAPRYLIYEDSDRPSGIPDRFSGSK---SGNTASLTISGAQTEDEADY 78 (98)
T ss_pred ccCCCCCEEEEEEEcCCCcCCCCEEEEEECCCCCccEEEEeccccCCCCCCCEEEEc---cCCEEEEEECCCChhhCEEE
Confidence 45689999999988765 56679998722 111 1000 00000 01111111 11456799999999999999
Q ss_pred eEeecc
Q psy12044 336 VCVAEN 341 (767)
Q Consensus 336 ~CvA~N 341 (767)
.|.+.+
T Consensus 79 ~C~~~~ 84 (98)
T cd04984 79 YCQVWD 84 (98)
T ss_pred EEEEcc
Confidence 999864
No 215
>cd05846 Ig1_MRC-OX-2_like First immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200) and similar proteins. Ig1_ MRC-OX-2_like: domain similar to the first immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200). MRC OX-2 is a membrane glycoprotein expressed in a variety of lymphoid and non-lymphoid cells in rats. It has a similar broad distribution pattern in humans. MRC OX-2 may regulate myeloid cell activity. The protein has an extracellular portion containing two Ig-like domains, a transmembrane portion, and a cytoplasmic portion.
Probab=93.43 E-value=0.21 Score=44.18 Aligned_cols=83 Identities=23% Similarity=0.390 Sum_probs=45.6
Q ss_pred cccccccccccccCC-CcEEEeecCe----ecc------CCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeE
Q psy12044 269 GKNVSLLCKVSAIPE-AKITWLFDGV----PIQ------NESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVC 337 (767)
Q Consensus 269 G~~vsL~C~a~g~P~-p~itW~~~g~----~l~------~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~C 337 (767)
|+.++|.|....... ..+.|.+... .+. .............+. ........|.|.++..+|.|.|.|
T Consensus 1 G~~vtL~C~~~~~~~~~~v~W~k~~~~~~~~i~~~~~~~~~~~~~~~~~r~~~~--~~~~~~~sL~I~nv~~~D~G~Y~C 78 (97)
T cd05846 1 GGNVTLSCNLTLPEEVLQVTWQKIQGSSPENIATYSEKYGVKIQPSYFRRRSIT--SLGLNSTSITIWNVTLEDEGCYKC 78 (97)
T ss_pred CCcEEEEEEeCCCCeeEEEEEEEcCCCCceEEEEEcccCCcccCCCccCeEEEc--CCCCCccEEEEeCCceeeeEEEEE
Confidence 567889997554332 3689987321 110 001110111111111 122345789999999999999999
Q ss_pred eec-cCCCCcccceEEE
Q psy12044 338 VAE-NQAGSTSSNYTIR 353 (767)
Q Consensus 338 vA~-N~~G~s~~s~sL~ 353 (767)
... .+.|.....+.|+
T Consensus 79 ~~~~~p~g~~~~~~~L~ 95 (97)
T cd05846 79 IFNTFPDGSKSGTMCLT 95 (97)
T ss_pred EEEeCCCCCeeeEEEEE
Confidence 875 4445544444443
No 216
>cd04982 IgV_TCR_gamma Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) gamma chain. IgV_TCR_gamma: immunoglobulin (Ig) variable (V) domain of the gamma chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=93.24 E-value=0.12 Score=47.25 Aligned_cols=81 Identities=22% Similarity=0.381 Sum_probs=49.7
Q ss_pred Cccceeecccccccccccccc--cCCCcEEEeec--Cee---cc---CCCcc---cc-cccceeecccCcceeeeEEEEe
Q psy12044 260 STFYLEIQEGKNVSLLCKVSA--IPEAKITWLFD--GVP---IQ---NESMS---AS-ESHAVYSTEEGTEIKKSELLIY 325 (767)
Q Consensus 260 ~~~~~~v~~G~~vsL~C~a~g--~P~p~itW~~~--g~~---l~---~~s~~---~~-~~~~~~~~~~g~~~~~s~L~I~ 325 (767)
.+..+.+..|+.++|.|.+.+ .+.+.+.|++. +.. +. ..... .. ....+..... .......|.|.
T Consensus 4 ~p~~~~~~~G~~v~l~C~~~~~~~~~~~v~Wyrq~~g~~~~~l~~~~~~~~~~~~~~~~~~r~~~~~~-~~~~~~~L~I~ 82 (116)
T cd04982 4 PQLSITREESKSVTISCKVSGIDFSTTYIHWYRQKPGQALERLLYVSSTSTQRKLSGGTKNKFEARKD-VGKSTSTLTIQ 82 (116)
T ss_pred cCCeEEeCCCCCEEEEEEEeCCCccccEEEEEEECCCCCCEEEEEEecCCCcEEeCcccCCCEEEEEE-CCCCEEEEEEE
Confidence 344567889999999999877 67788999883 211 11 00000 00 0011111111 11135689999
Q ss_pred eeccCCCCceeEeecc
Q psy12044 326 NSNIDDNGTFVCVAEN 341 (767)
Q Consensus 326 nvs~sD~GtY~CvA~N 341 (767)
++..+|.|.|.|.+..
T Consensus 83 ~~~~~Dsg~Y~C~~~~ 98 (116)
T cd04982 83 NLEKEDSATYYCAYWE 98 (116)
T ss_pred ECCHHHCEEEEEEEec
Confidence 9999999999999864
No 217
>cd05761 Ig2_Necl-1-4_like Second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-4 (also known as cell adhesion molecules CADM3, CADM1, CADM2, and CADM4, respectively). Ig2_Necl-1-4_like: domain similar to the second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), Necl-3 (CADM2) and Necl-4 (CADM4). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cel
Probab=93.11 E-value=0.39 Score=41.09 Aligned_cols=69 Identities=22% Similarity=0.297 Sum_probs=43.4
Q ss_pred cccccccccc-CCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCCc
Q psy12044 272 VSLLCKVSAI-PEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGST 346 (767)
Q Consensus 272 vsL~C~a~g~-P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s 346 (767)
+.|.|.+.+. |.+.++|+.++..+.... ........+.....+.|.+......+.+.|+|.+.+.....
T Consensus 2 ~~L~C~~~~~~P~~~v~W~~~~~~l~~~~------~~~~~~~~~~~~~~s~l~~~~~~~d~g~~~~C~v~h~~l~~ 71 (82)
T cd05761 2 VELTCTSSGSKPAATIRWFKGDKELKGVK------LKEEDENGKTFTVTSSLRFQVDREDDGAPIICRVDHPALKS 71 (82)
T ss_pred EEEEEEecCcCcCCeEEEEECCEEccCce------eeEecCCCCEEEEEEEEEEEcchhhCCCEEEEEEeChhcCC
Confidence 4688988765 888999999987775322 01111122333345556664444455678999999876554
No 218
>cd05887 Ig1_Nectin-3_like First immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and similar proteins. Ig1_Nectin-3_like: domain similar to the first immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3). Nectin-3 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example, during spermatid development, the nectin-3,-2 trans-interaction is required for the formation of Sertoli cell-spermatid junctions in testis, and during morphogenesis of the ciliary body, the nectin-3,-1 trans-interaction is important for apex-apex adhesion between the pigment and non-pigment layers of the ciliary epithelia. Nectins also
Probab=93.09 E-value=0.27 Score=43.69 Aligned_cols=82 Identities=21% Similarity=0.356 Sum_probs=47.8
Q ss_pred ccccccccccc-CCCcEEEeecC----eecc------CCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEee
Q psy12044 271 NVSLLCKVSAI-PEAKITWLFDG----VPIQ------NESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVA 339 (767)
Q Consensus 271 ~vsL~C~a~g~-P~p~itW~~~g----~~l~------~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA 339 (767)
+++|.|..... ....+.|.+.. ..+. ...+......+..+.. ......+|.|.+++.+|.|.|.|..
T Consensus 2 ~vtL~C~~~~~~~~~qV~W~k~~~~~~~~ia~y~~~~g~~~~~~y~~Rv~~~~--~~~~d~sl~i~nv~~~D~G~Y~C~v 79 (96)
T cd05887 2 NVTLKCRIQVNETITQSSWEKIHGKGSVTLAVHHPMYGISIQPDYQGRVSFKN--YSLLDATIMLENVGFSDIGVYICKA 79 (96)
T ss_pred CEEEEEEecCCCcEEEEEEEEcCCCCcEEEEEEcccCCcccChhhCCcEEEcC--CCCCccEEEEeCCCccccEEEEEEE
Confidence 56778876532 33478998732 1111 0011111112233321 2234678999999999999999986
Q ss_pred -ccCCCCcccceEEEE
Q psy12044 340 -ENQAGSTSSNYTIRI 354 (767)
Q Consensus 340 -~N~~G~s~~s~sL~V 354 (767)
..+.|+..+...+.|
T Consensus 80 ~tfP~G~~~~~~~l~~ 95 (96)
T cd05887 80 VTFPLGNTQSSTTVTV 95 (96)
T ss_pred EeCCCCCeeEEEEEEE
Confidence 556777666665544
No 219
>KOG0663|consensus
Probab=92.74 E-value=0.042 Score=58.72 Aligned_cols=60 Identities=18% Similarity=0.295 Sum_probs=44.7
Q ss_pred cCCCCCCCCccccCCCCcceEEe--eCCceEEEec------cccCCCcchh---hhh-hhCCCCcccchhhc
Q psy12044 441 CMDKVNGGYIIADGHNDMMLYAT--DSGILVATNN------MNTYPSYSIS---YQI-EQNPDLVNDAESVD 500 (767)
Q Consensus 441 ~~nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~------~~~~~~~~~~---~~~-e~npdlin~~e~~~ 500 (767)
+.++|.--|.|++|.||.||||. .++++||-++ .+.++-.+++ -+. -++|.++|=-|+|-
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 34567777899999999999999 8999999999 3455544432 222 56899888767765
No 220
>cd00096 Ig Immunoglobulin domain. Ig: immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of this group are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as, T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as, butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=92.69 E-value=0.36 Score=37.60 Aligned_cols=65 Identities=37% Similarity=0.662 Sum_probs=44.3
Q ss_pred cccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCC
Q psy12044 273 SLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQA 343 (767)
Q Consensus 273 sL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~ 343 (767)
.+.|.+.+.+...+.|...+......... ..............|.+.++...|.|.|.|.+.+..
T Consensus 2 ~l~C~~~~~~~~~~~W~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~i~~~~~~d~g~y~C~~~~~~ 66 (74)
T cd00096 2 TLTCLASGPPPPTITWLKNGKPLPSSVLT------RVRSSRGTSSGSSTLTISNVTLEDSGTYTCVASNSA 66 (74)
T ss_pred EEEEEecCCCCCcEEEEECCEECCCcccE------EeccccCcceeEEEEEECccCcccCcEEEEEEecCc
Confidence 57788888778899999876544332211 111122233455678999999999999999987754
No 221
>PHA02987 Ig domain OX-2-like protein; Provisional
Probab=92.62 E-value=0.32 Score=48.18 Aligned_cols=91 Identities=18% Similarity=0.348 Sum_probs=55.1
Q ss_pred ceeeccccccccccccc-ccCCCcEEEeecCeeccCCCccc----cc-ccceeecccCcceeeeEEEEeeeccCCCCcee
Q psy12044 263 YLEIQEGKNVSLLCKVS-AIPEAKITWLFDGVPIQNESMSA----SE-SHAVYSTEEGTEIKKSELLIYNSNIDDNGTFV 336 (767)
Q Consensus 263 ~~~v~~G~~vsL~C~a~-g~P~p~itW~~~g~~l~~~s~~~----~~-~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~ 336 (767)
..++.+|++++|.|... +...+.+.|.+....+....... +. ..++.+ .......+.|.|.++..+|.|.|.
T Consensus 24 ~v~V~ege~VtLsCs~t~s~~~~qVtWkK~~~~IatY~~~g~~i~~~Fk~Rve~--mS~s~~~StItIknVt~sDeGcY~ 101 (189)
T PHA02987 24 KITVSEHVNVKISCNKTSSFNSILITWKKNNKTIAGYGPCGPVIVDKFKNKIEY--LSKSFNESTILIKNVSLKDNGCYT 101 (189)
T ss_pred EEEEcCCCCEEEEEecCCCCccceEEEEEcCCCEEEEecCCcEEChhhcCeEEE--eccCCCcceEEEEeCChhhCeEEE
Confidence 46788999999999985 55678899998543222111100 00 011111 111124578999999999999999
Q ss_pred EeeccC-CC-CcccceEEEEE
Q psy12044 337 CVAENQ-AG-STSSNYTIRIV 355 (767)
Q Consensus 337 CvA~N~-~G-~s~~s~sL~V~ 355 (767)
|..... .| .......+.|.
T Consensus 102 C~F~tfp~G~~~~gt~CLtVt 122 (189)
T PHA02987 102 CIFNTLLSKNNEKGVVCLNVT 122 (189)
T ss_pred EEEEecCCCCCceeEEEEEEE
Confidence 987543 34 34444444444
No 222
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=92.47 E-value=0.068 Score=55.91 Aligned_cols=36 Identities=11% Similarity=0.183 Sum_probs=31.1
Q ss_pred HHhcccCCCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 436 ATSATCMDKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 436 l~~AT~~nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+.-+| ++|+...+||+|+||.||+|. .++..||++.
T Consensus 3 ~~~~~--~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~ 40 (268)
T cd06624 3 YEYEY--DENGERVVLGKGTYGIVYAARDLSTQVRIAIKE 40 (268)
T ss_pred ccccc--ccCCceEEEecCCceEEEEeEecCCCcEEEEEE
Confidence 45567 899999999999999999999 6788899875
No 223
>cd05716 Ig_pIgR Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). Ig_pIgR: Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). pIgR delivers dimeric IgA and pentameric IgM to mucosal secretions. Polymeric immunoglobulin (pIgs) are the first defense against pathogens and toxins. IgA and IgM can form polymers via an 18-residue extension at their c-termini referred to as the tailpiece. pIgR transports pIgs across mucosal epithelia into mucosal secretions. Human pIgR is a glycosylated type I transmembrane protein, comprised of a 620 residue extracellular region, a 23 residue transmembrane region, and a 103 residue cytoplasmic tail. The extracellular region contains five domains that share sequence similarity with Ig variable (v) regions.
Probab=92.46 E-value=0.34 Score=42.75 Aligned_cols=78 Identities=15% Similarity=0.167 Sum_probs=46.9
Q ss_pred eeecccccccccccccc-cCCCcEEEeecCe-----eccCCCccc-ccccceeecccCcceeeeEEEEeeeccCCCCcee
Q psy12044 264 LEIQEGKNVSLLCKVSA-IPEAKITWLFDGV-----PIQNESMSA-SESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFV 336 (767)
Q Consensus 264 ~~v~~G~~vsL~C~a~g-~P~p~itW~~~g~-----~l~~~s~~~-~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~ 336 (767)
+.+..|+.++|.|.... .....+.|.+... .+....... .....+... .........|.|.++..+|+|.|.
T Consensus 2 v~~~~G~~vtl~C~~~~~~~~~~~~W~r~~~~~~~~~l~~~~~~~~~~~~r~~~~-~~~~~~~~~L~I~~v~~~DsG~Y~ 80 (98)
T cd05716 2 VTGELGGSVTIPCPYPPKNRSYEKYWCKWGSAGCCLIIVSEGSVQSQYEGRVSLT-DDPDNGVFTVTLNQLRKEDAGWYW 80 (98)
T ss_pred EEEEeCCeEEEEeeCCCCCCCcEeEeECCCCCCCCeEEECCCccccccCCCEEEE-ecCCCCEEEEEEcCCCHHHCEEEE
Confidence 35678999999998765 3566788987321 111000000 011112211 111234568999999999999999
Q ss_pred EeeccC
Q psy12044 337 CVAENQ 342 (767)
Q Consensus 337 CvA~N~ 342 (767)
|.+...
T Consensus 81 C~~~~~ 86 (98)
T cd05716 81 CGVGDD 86 (98)
T ss_pred EEcccC
Confidence 988754
No 224
>cd07706 IgV_TCR_delta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) delta chain. IgV_TCR_delta: immunoglobulin (Ig) variable (V) domain of the delta chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=92.09 E-value=0.18 Score=46.14 Aligned_cols=81 Identities=16% Similarity=0.258 Sum_probs=48.8
Q ss_pred ccceeeccccccccccccccc-CCCcEEEeec--Cee---c-cCCCccccc-ccceeecccCcceeeeEEEEeeeccCCC
Q psy12044 261 TFYLEIQEGKNVSLLCKVSAI-PEAKITWLFD--GVP---I-QNESMSASE-SHAVYSTEEGTEIKKSELLIYNSNIDDN 332 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~g~-P~p~itW~~~--g~~---l-~~~s~~~~~-~~~~~~~~~g~~~~~s~L~I~nvs~sD~ 332 (767)
+..+.+..|+.+.|.|..... ....+.|.+. +.. + ......... ..++.... ........|.|.++..+|.
T Consensus 6 ~~~v~~~~G~~v~L~C~~~~~~~~~~v~Wyrq~~~~~~~~l~~~~~~~~~~~~~R~~~~~-~~~~~~~sL~I~~~~~~Ds 84 (116)
T cd07706 6 QPDVSVQVGEEVTLNCRYETSWTNYYIFWYKQLPSGEMTFLIRQKSIYGNATKGRYSVNF-QKAQKSISLTISALQLEDS 84 (116)
T ss_pred CCceEEcCCCCEEEEEEEeCCCCceEEEEEEECCCCceEEEEEecCccCCccCCeEEEEE-eccCCEEEEEECCCCHHHC
Confidence 445678899999999987654 4567899873 211 1 111111111 11111110 1122356799999999999
Q ss_pred CceeEeeccC
Q psy12044 333 GTFVCVAENQ 342 (767)
Q Consensus 333 GtY~CvA~N~ 342 (767)
|.|.|.+...
T Consensus 85 g~Y~C~~~~~ 94 (116)
T cd07706 85 AKYFCALSTL 94 (116)
T ss_pred EEEEEEEECC
Confidence 9999998753
No 225
>PF07686 V-set: Immunoglobulin V-set domain; InterPro: IPR013106 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the V-set domains, which are Ig-like domains resembling the antibody variable domain. V-set domains are found in diverse protein families, including immunoglobulin light and heavy chains; in several T-cell receptors such as CD2 (Cluster of Differentiation 2), CD4, CD80, and CD86; in myelin membrane adhesion molecules; in junction adhesion molecules (JAM); in tyrosine-protein kinase receptors; and in the programmed cell death protein 1 (PD1).; PDB: 1PY9_A 2NXY_D 1U9K_B 3RNK_A 3BP6_A 3BIK_B 3SBW_A 1NPU_A 3BP5_A 3RNQ_A ....
Probab=91.78 E-value=0.096 Score=46.80 Aligned_cols=81 Identities=22% Similarity=0.305 Sum_probs=49.8
Q ss_pred ccceeeccccccccccccc-ccCCCcEEEeecCe-----ecc-C-CC----ccccc-ccceeecccCcceeeeEEEEeee
Q psy12044 261 TFYLEIQEGKNVSLLCKVS-AIPEAKITWLFDGV-----PIQ-N-ES----MSASE-SHAVYSTEEGTEIKKSELLIYNS 327 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~-g~P~p~itW~~~g~-----~l~-~-~s----~~~~~-~~~~~~~~~g~~~~~s~L~I~nv 327 (767)
+..+.+..|+.+.|.|... ......+.|.+... .+. . .. ..... .....+.. ........|.|.++
T Consensus 8 ~~~v~~~~G~~v~L~C~~~~~~~~~~v~W~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~r~~~~~-~~~~~~~sL~i~~l 86 (114)
T PF07686_consen 8 PSPVTVQEGESVTLPCSYSSSSNQSSVYWYRQSPGQGPQLIIRYSLSSTNETPTPSYSGRFTFSG-NGSQNNFSLTIKNL 86 (114)
T ss_dssp ESEEEEETTSEEEEEEEEESSSSGSEEEEEEEETTSEEEEEEEEETTEEEEEEETTETTTEEEEE-ETTTTEEEEEESSE
T ss_pred CCeEEEecCCCEEEEEEEeCCCCcceEEEEEECccccceeeeeeccceeeeccccceeeeeeeee-cccCCeEEEEECCC
Confidence 3456788999999999998 55667899998321 111 0 00 00000 00011111 11133567999999
Q ss_pred ccCCCCceeEeeccC
Q psy12044 328 NIDDNGTFVCVAENQ 342 (767)
Q Consensus 328 s~sD~GtY~CvA~N~ 342 (767)
..+|.|.|.|.....
T Consensus 87 ~~~DsG~Y~C~v~~~ 101 (114)
T PF07686_consen 87 QPSDSGTYFCQVSTS 101 (114)
T ss_dssp SGGGEEEEEEEEEES
T ss_pred CcCcCEEEEEEEEEC
Confidence 999999999998765
No 226
>cd07705 Ig2_Necl-1 Second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig2_Necl-1: second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue and is important to the formation of synapses, axon bundles, and myel
Probab=91.73 E-value=0.66 Score=39.93 Aligned_cols=69 Identities=19% Similarity=0.282 Sum_probs=43.9
Q ss_pred cccccccccc-CCCcEEEeecCeeccCCCcccccccceeeccc-CcceeeeEEEEeeeccCCCCceeEeeccCCCCc
Q psy12044 272 VSLLCKVSAI-PEAKITWLFDGVPIQNESMSASESHAVYSTEE-GTEIKKSELLIYNSNIDDNGTFVCVAENQAGST 346 (767)
Q Consensus 272 vsL~C~a~g~-P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~-g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~s 346 (767)
+.|.|.+.+. |.+.|+|.+++..+..... ....... +.....+.|.+......+...|.|.+.+.....
T Consensus 2 ~~LtC~a~g~~P~~~ItW~k~g~~l~~~~~------~~~~~~~~~t~~~~s~l~~~~~~~d~g~~~tC~v~h~~l~~ 72 (83)
T cd07705 2 AKLRCTSSGSKPAANIKWRKGDQELEGAPT------SVLEDGNGKTFTVSSSVEFQVTREDDGAEITCSVGHESLHD 72 (83)
T ss_pred EEEEEEecCccCCCEeEEEECCEECCCcce------eEEECCCCCEEEEEEEEEEEecchhCCCEEEEEEECcccCC
Confidence 4688998875 8889999999977654321 0111112 233344566665555556678999999876443
No 227
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=91.68 E-value=0.096 Score=60.74 Aligned_cols=21 Identities=10% Similarity=0.071 Sum_probs=19.9
Q ss_pred CCCCCCCccccCCCCcceEEe
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT 463 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~ 463 (767)
++|...++||+|+||.||||.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~ 165 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGL 165 (507)
T ss_pred cCceEeeEeecCCCeEEEEEE
Confidence 899999999999999999995
No 228
>PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region. The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway [].
Probab=91.64 E-value=0.093 Score=49.90 Aligned_cols=30 Identities=17% Similarity=0.195 Sum_probs=16.6
Q ss_pred eeEEEeeehhhHHHHHHHHHHHhh-hhhhhh
Q psy12044 372 VLIVSGIISVCSLVLIFLLVLCFL-CFRRKK 401 (767)
Q Consensus 372 ~~iIigivv~llvllllvvivi~~-~~rRrr 401 (767)
..+|+|+++|+.+.+++++++++| +|+|+|
T Consensus 48 knIVIGvVVGVGg~ill~il~lvf~~c~r~k 78 (154)
T PF04478_consen 48 KNIVIGVVVGVGGPILLGILALVFIFCIRRK 78 (154)
T ss_pred ccEEEEEEecccHHHHHHHHHhheeEEEecc
Confidence 357777777765555544444444 444433
No 229
>KOG0193|consensus
Probab=91.03 E-value=0.13 Score=59.00 Aligned_cols=57 Identities=14% Similarity=0.111 Sum_probs=37.2
Q ss_pred ccHHHHHhcccCCCCCCCCccccCCCCcceEEeeCCceEEEec--cccCCCcchhhhhhhCCCCcccchhhccccc
Q psy12044 431 YTSVNATSATCMDKVNGGYIIADGHNDMMLYATDSGILVATNN--MNTYPSYSISYQIEQNPDLVNDAESVDKDRR 504 (767)
Q Consensus 431 fs~~El~~AT~~nnFs~~nlIG~GgfG~VYKG~~dG~~VA~~~--~~~~~~~~~~~~~e~npdlin~~e~~~~~~~ 504 (767)
+.++|++.+. .||+|.||+||||.--|. ||+|- ++.-++..+.- |=|||-...|-|-
T Consensus 389 Ip~~ev~l~~---------rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~~qlqa-------FKnEVa~lkkTRH 447 (678)
T KOG0193|consen 389 IPPEEVLLGE---------RIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTPEQLQA-------FKNEVAVLKKTRH 447 (678)
T ss_pred cCHHHhhccc---------eeccccccceeecccccc-eEEEEEecCCCCHHHHHH-------HHHHHHHHhhcch
Confidence 4567777666 799999999999992222 88887 33333443333 4478866655443
No 230
>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane. Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.
Probab=90.96 E-value=0.075 Score=49.11 Aligned_cols=31 Identities=32% Similarity=0.410 Sum_probs=16.8
Q ss_pred EEEeeehhhHHHHHHHHHHHhhhhhhhhccc
Q psy12044 374 IVSGIISVCSLVLIFLLVLCFLCFRRKKKKL 404 (767)
Q Consensus 374 iIigivv~llvllllvvivi~~~~rRrrr~~ 404 (767)
.|++|++++++.+++++++++|++||+||+.
T Consensus 65 ~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk~ 95 (122)
T PF01102_consen 65 AIIGIIFGVMAGVIGIILLISYCIRRLRKKS 95 (122)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHS---
T ss_pred ceeehhHHHHHHHHHHHHHHHHHHHHHhccC
Confidence 4556665555555555566666666665554
No 231
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=90.56 E-value=0.17 Score=50.93 Aligned_cols=25 Identities=24% Similarity=0.178 Sum_probs=23.4
Q ss_pred ccccCCCCcceEEe-eCCceEEEecc
Q psy12044 450 IIADGHNDMMLYAT-DSGILVATNNM 474 (767)
Q Consensus 450 lIG~GgfG~VYKG~-~dG~~VA~~~~ 474 (767)
.||+|+||.||+|. .+|+.||+|..
T Consensus 4 ~ig~G~~~~Vy~a~~~~g~~vAvKv~ 29 (190)
T cd05147 4 CISTGKEANVYHATTANGEERAIKIY 29 (190)
T ss_pred ccccccceEEEEEECCCCCEEEEEEE
Confidence 79999999999999 99999999883
No 232
>KOG0595|consensus
Probab=90.14 E-value=0.17 Score=55.52 Aligned_cols=30 Identities=20% Similarity=0.128 Sum_probs=26.1
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.....||+|+||+||||. .+|..||+|.
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~ 42 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKC 42 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeee
Confidence 55555679999999999999 8999999977
No 233
>cd05711 Ig_FcalphaRI Immunoglobulin (IG)-like domain of of FcalphaRI. IG_FcalphaRI : immunoglobulin (IG)-like domain of of FcalphaRI. FcalphaRI (CD89) is an IgA-specific receptor that is expressed on monocytes, eosinophils, neutrophils and macrophages. FcalphaRI mediates IgA-induced immune effector responses such as phagocytosis, antibody-dependent cell-mediated cytotoxicity and respiratory burst. Both monomeric and dimeric IgA can bind to FcalphaRI, and monomeric or dimeric IgA immune complexes can activate phagocytosis and other immune responses through the clustering of FcalphaRI. The Fc RI ectodomain is comprised of two Ig-like domains oriented at about 90 degree to each another.
Probab=90.12 E-value=0.63 Score=41.03 Aligned_cols=66 Identities=15% Similarity=0.197 Sum_probs=44.3
Q ss_pred eeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeec
Q psy12044 264 LEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAE 340 (767)
Q Consensus 264 ~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~ 340 (767)
..+..|++++|.|.... ....+.|.+++........ ...........+.|..++..|.|.|.|...
T Consensus 10 ~vV~~G~~VTL~C~~~~-~~~~f~l~k~g~~~~~~~~----------~~~~~~~~~a~f~I~~~~~~~~G~Y~C~~~ 75 (94)
T cd05711 10 PVVPSGENVTLQCHSDI-RFDRFILYKEGRSKPVLHL----------YEKHHGGFQASFPLGPVTPAHAGTYRCYGS 75 (94)
T ss_pred CccCCCCeEEEEEecCC-CCCEEEEEECCCCCCceec----------ccccCCeEEEEEEecCCCcccCEEEEEEEE
Confidence 45678999999997765 5567888887643221100 000112234578999999999999999864
No 234
>KOG4222|consensus
Probab=90.07 E-value=0.36 Score=58.99 Aligned_cols=90 Identities=22% Similarity=0.327 Sum_probs=67.5
Q ss_pred CCCCCCccceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCc
Q psy12044 255 PQITPSTFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGT 334 (767)
Q Consensus 255 P~i~~~~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~Gt 334 (767)
|.+...+....+..|..+.+.|.+.+.|.|.+.|.+.+..+.-.+. +. ...+-+|.|..+++.|.|+
T Consensus 226 P~f~~rp~~~~v~~g~~~~f~c~v~GdP~P~Vrwkk~~~~~P~~ry--------~i-----~~d~qtl~i~r~tp~deg~ 292 (1281)
T KOG4222|consen 226 PWFWKRPKDLAVLVGAAAEFDCRVGGDPQPTVRWKKDDPSLPRSRY--------SI-----LDDTQTLRIDRVTPTDEGT 292 (1281)
T ss_pred CccccccccceeecccccccccccCCCCCCceeeeccCCCCCccce--------ee-----eeccccccccccCCCcccc
Confidence 3344445566788899999999999999999999985443322111 11 1122468889999999999
Q ss_pred eeEeeccCCCCcccceEEEEEee
Q psy12044 335 FVCVAENQAGSTSSNYTIRIVLK 357 (767)
Q Consensus 335 Y~CvA~N~~G~s~~s~sL~V~~~ 357 (767)
|.|.+.|..|...+...+.|...
T Consensus 293 y~C~a~n~vG~l~asa~ltV~ap 315 (1281)
T KOG4222|consen 293 YVCPAENLVGGLEASATLTVQAP 315 (1281)
T ss_pred eeeeccccccccccccceEEecC
Confidence 99999999999999988888764
No 235
>KOG0597|consensus
Probab=89.99 E-value=0.13 Score=58.51 Aligned_cols=30 Identities=13% Similarity=0.000 Sum_probs=24.8
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|---.+||+|.||.||||. .++++||.+-
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~ 34 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKF 34 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEE
Confidence 34434489999999999999 8899999866
No 236
>cd07694 Ig2_CD4 Second immunoglobulin (Ig) domain of CD4. Ig2_CD4; second immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=89.95 E-value=0.83 Score=39.74 Aligned_cols=61 Identities=21% Similarity=0.315 Sum_probs=43.1
Q ss_pred eecccccccccccccccCCC--cEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeecc
Q psy12044 265 EIQEGKNVSLLCKVSAIPEA--KITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAEN 341 (767)
Q Consensus 265 ~v~~G~~vsL~C~a~g~P~p--~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N 341 (767)
.+..|+.++|.|.....+.| .+.|...+...-.. ......+|.+..+...|.|+|+|.+..
T Consensus 10 ~lL~G~sLtLtl~~~s~s~p~~~i~w~~P~n~~~~~----------------~~~~~ktL~~~qv~~qdSG~WtC~V~~ 72 (88)
T cd07694 10 HVLSGTNLTLTLHGSSNSLPAFKVEWRGPGNKSKQI----------------LNQDKKTLNLVQLGPNDSGTWDCIVSV 72 (88)
T ss_pred eeecCCcEEEEEecCCCCCCCccEEEeCCCCcccee----------------ccCCccEEEeceeCcccCCEEEEEEEE
Confidence 46789999999998665555 99998754321100 011234688899999999999999863
No 237
>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]. This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].
Probab=89.94 E-value=0.36 Score=35.32 Aligned_cols=27 Identities=26% Similarity=0.562 Sum_probs=12.1
Q ss_pred eeEEEeeehhhHHHHHHHHHHHhhhhh
Q psy12044 372 VLIVSGIISVCSLVLIFLLVLCFLCFR 398 (767)
Q Consensus 372 ~~iIigivv~llvllllvvivi~~~~r 398 (767)
..+.+|+++.++++++++++++++++|
T Consensus 11 vaIa~~VvVPV~vI~~vl~~~l~~~~r 37 (40)
T PF08693_consen 11 VAIAVGVVVPVGVIIIVLGAFLFFWYR 37 (40)
T ss_pred EEEEEEEEechHHHHHHHHHHhheEEe
Confidence 344555555444444444443333333
No 238
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=89.64 E-value=0.17 Score=59.65 Aligned_cols=33 Identities=12% Similarity=0.092 Sum_probs=28.7
Q ss_pred CCCCCCCccccCCCCcceEEe--eC----CceEEEeccc
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DS----GILVATNNMN 475 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~d----G~~VA~~~~~ 475 (767)
++|.-.+.||+|+||.||||+ .+ |..||++...
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~ 170 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT 170 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEec
Confidence 788888999999999999999 56 7899988733
No 239
>cd05884 Ig2_Necl-3 Second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig2_Necl-3: second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-3 has been shown to accumulate in tissues of the central and peripheral nervous system, where it is expressed in ependymal cells and myelinated axons. It is observed at the interface between the axon shaft and the myelin sheath. Ig domains are likely to participate in ligand binding and recognition.
Probab=89.57 E-value=0.9 Score=39.12 Aligned_cols=69 Identities=22% Similarity=0.318 Sum_probs=42.6
Q ss_pred ccccccccc-cCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCC
Q psy12044 272 VSLLCKVSA-IPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGS 345 (767)
Q Consensus 272 vsL~C~a~g-~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~ 345 (767)
+.|.|.+.+ .|...++|.+++..+....... .....++.....+.|.+..-...+...|+|.+.+..-.
T Consensus 2 ~~LtC~a~gf~P~~~itW~kng~~l~~~~~~~-----~~~~~~~t~~~~s~L~~~~~~~d~g~~ytC~v~h~~l~ 71 (83)
T cd05884 2 MQLTCKTSGSKPAADIRWFKNDKEIKDVKYLK-----EEDANRKTFTVSSTLDFRVDRSDDGVAIICRVDHESLN 71 (83)
T ss_pred EEEEEEeCCccCCCEEEEEECCEECcCceeeE-----eeCCCCCEEEEEEEEEEEcccccCCCEEEEEEechhcC
Confidence 468898877 5678999999998864432110 11112233445566666544445566799999876543
No 240
>KOG0659|consensus
Probab=89.39 E-value=0.21 Score=51.99 Aligned_cols=24 Identities=21% Similarity=0.356 Sum_probs=23.0
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.||||.||.||||. ..|+.||++.
T Consensus 9 ~lGEG~~gvVyka~d~~t~~~VAIKK 34 (318)
T KOG0659|consen 9 KLGEGTYGVVYKARDTETGKRVAIKK 34 (318)
T ss_pred hhcCcceEEEEEEEecCCCcEEEEEE
Confidence 79999999999999 9999999988
No 241
>PF08374 Protocadherin: Protocadherin; InterPro: IPR013585 The structure of protocadherins is similar to that of classic cadherins (IPR002126 from INTERPRO), but they also have some unique features associated with the cytoplasmic domains. They are expressed in a variety of organisms and are found in high concentrations in the brain where they seem to be localised mainly at cell-cell contact sites. Their expression seems to be developmentally regulated [].
Probab=89.37 E-value=0.37 Score=48.41 Aligned_cols=28 Identities=18% Similarity=0.424 Sum_probs=20.6
Q ss_pred ceeeeEEEeeehhhHHHHHHHHHHHhhh
Q psy12044 369 LEYVLIVSGIISVCSLVLIFLLVLCFLC 396 (767)
Q Consensus 369 ~~~~~iIigivv~llvllllvvivi~~~ 396 (767)
..+..|++|||+|++.++|+++++++++
T Consensus 34 ~d~~~I~iaiVAG~~tVILVI~i~v~vR 61 (221)
T PF08374_consen 34 KDYVKIMIAIVAGIMTVILVIFIVVLVR 61 (221)
T ss_pred ccceeeeeeeecchhhhHHHHHHHHHHH
Confidence 4567788888888777777776666665
No 242
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=89.34 E-value=0.17 Score=53.77 Aligned_cols=31 Identities=26% Similarity=0.266 Sum_probs=27.1
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|...++||+|+||.||+|. .+|..||++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~ 33 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK 33 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEe
Confidence 356777899999999999999 7899999886
No 243
>cd05712 Ig_Siglec_N Immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Ig_Siglec_N: immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Siglec refers to a structurally related protein family that specifically recognizes sialic acid in oligosaccharide chains of glycoproteins and glycolipids. Siglecs are type I transmembrane proteins, organized as an extracellular module composed of Ig-like domains (an N-terminal variable set of Ig-like carbohydrate recognition domains, and 1 to 16 constant Ig-like domains), followed by transmembrane and short cytoplasmic domains. Human siglecs are classified into two subgroups, one subgroup is comprised of sialoadhesin (Siglec-1), CD22 (Siglec-2), and MAG, the other subgroup is comprised of CD33-related Siglecs which include CD33 (Siglec-3) and human Siglecs 5-11.
Probab=89.17 E-value=0.95 Score=41.67 Aligned_cols=80 Identities=21% Similarity=0.252 Sum_probs=47.0
Q ss_pred ccceeecccccccccccccccC------CCcEEEeecC--e---e-cc--CCCc-ccccc-cceeecccCcceeeeEEEE
Q psy12044 261 TFYLEIQEGKNVSLLCKVSAIP------EAKITWLFDG--V---P-IQ--NESM-SASES-HAVYSTEEGTEIKKSELLI 324 (767)
Q Consensus 261 ~~~~~v~~G~~vsL~C~a~g~P------~p~itW~~~g--~---~-l~--~~s~-~~~~~-~~~~~~~~g~~~~~s~L~I 324 (767)
+..+.+.+|+.++|.|...... ...+.|.+.. . . +. .... ..... .++... .........|.|
T Consensus 6 P~~v~~~~G~~VtL~C~f~~~~~~~~~~~~~~~Wykq~~g~~~~~~~~~~~~~~~~~~~f~gR~~~~-~~~~~~~~sL~I 84 (119)
T cd05712 6 PKSVSVQEGLCVLIPCSFSYPADWPVSNGVHGIWYKGHPYPKNRPPVATNNRSRLVHESTRGRFRLL-GDLGKKNCSLLI 84 (119)
T ss_pred CCEEEEeccccEEEEEEeeCcccccCCCceEEEEEeCCCCCCCCCcEEEcCCCccccccccccEEEe-cCCCCCEEEEEE
Confidence 3446788999999999764322 3458898732 1 1 11 0000 00011 111111 112344578999
Q ss_pred eeeccCCCCceeEeecc
Q psy12044 325 YNSNIDDNGTFVCVAEN 341 (767)
Q Consensus 325 ~nvs~sD~GtY~CvA~N 341 (767)
.++..+|+|+|.|....
T Consensus 85 ~~l~~~Dsg~Y~C~~~~ 101 (119)
T cd05712 85 SDAQPEDSGKYFFRVEL 101 (119)
T ss_pred ccCChhhCeEEEEEEEc
Confidence 99999999999998755
No 244
>PF08205 C2-set_2: CD80-like C2-set immunoglobulin domain ; InterPro: IPR013162 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the C2-set type domains found in the T-cell antigen CD80, as well as in related proteins. CD80 (B7-1) is a glycoprotein expressed on antigen-presenting cells []. The shared ligands on CD80 and CD86 (B7-2) deliver the co-stimulatory signal through CD28 and CTLA-4 on T-cells, where CD28 augments the T-cell response and CTLA-4 attenuates it [].; PDB: 3S58_A 3O3U_N 3CJJ_A 3S59_A 2PF6_B 2PET_A 3ALP_A 3SKU_D 3U83_A 3U82_B ....
Probab=89.04 E-value=0.45 Score=41.11 Aligned_cols=71 Identities=28% Similarity=0.488 Sum_probs=43.4
Q ss_pred cccccccccc-cccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCC
Q psy12044 269 GKNVSLLCKV-SAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAG 344 (767)
Q Consensus 269 G~~vsL~C~a-~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G 344 (767)
|..+.+.|.+ .+.|.+.++|..++..+.... .........+.....+.|.+..-...+...+.|.+.+..-
T Consensus 14 ~~~~~~~C~s~~~~P~~~i~W~~~~~~~~~~~-----~~~~~~~~~~~~~~~S~l~~~~~~~~~~~~~~C~~~~~~~ 85 (89)
T PF08205_consen 14 GEEVTLTCSSSGGYPPPQITWYLDGGPVVASN-----TTQSSSPDNGLFTVSSTLTLTPTREDHGKTLTCRASHPAL 85 (89)
T ss_dssp TEEEEEEEEEEEEBS-EEEEEEETTCEECEEE-----EEEEEETTTTTEEEEEEEEEETTGGGTTEEEEEEEEETTC
T ss_pred ceEEEEEEEeCCeECCeEEEEEECCCceeeee-----eeeeeccCCCcceEEEEEEEEcChHHCCeEEEEEEECCcc
Confidence 6789999955 668899999999876661100 1111222334444556777764444456679999987643
No 245
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=88.88 E-value=0.26 Score=53.98 Aligned_cols=43 Identities=12% Similarity=0.105 Sum_probs=32.8
Q ss_pred ccHHHHHhcc--cCCCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 431 YTSVNATSAT--CMDKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 431 fs~~El~~AT--~~nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|+.+|+.+++ --++|.....||+|+||.||+|+ .+|..||++.
T Consensus 1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~ 47 (342)
T cd07879 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKK 47 (342)
T ss_pred CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEE
Confidence 4556666653 01466667799999999999999 6899999886
No 246
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=88.77 E-value=0.23 Score=52.74 Aligned_cols=29 Identities=10% Similarity=0.113 Sum_probs=25.1
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|.....||+|+||.||+|. .+|..||++.
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~ 32 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKK 32 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEE
Confidence 4455689999999999998 7899999876
No 247
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=88.76 E-value=0.4 Score=48.18 Aligned_cols=29 Identities=24% Similarity=0.132 Sum_probs=25.5
Q ss_pred CCCCCccccCCCCcceEEe-eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
+.-.+.||+|+||.||+|. .+|+.||++.
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~ 46 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKF 46 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEE
Confidence 4455689999999999999 8999999986
No 248
>PTZ00382 Variant-specific surface protein (VSP); Provisional
Probab=88.72 E-value=0.25 Score=43.89 Aligned_cols=29 Identities=17% Similarity=0.073 Sum_probs=16.1
Q ss_pred eeEEEeeehhhHHHHHHHHHHHhhhhhhh
Q psy12044 372 VLIVSGIISVCSLVLIFLLVLCFLCFRRK 400 (767)
Q Consensus 372 ~~iIigivv~llvllllvvivi~~~~rRr 400 (767)
.++|+||++++++++.+++.+++|++.+|
T Consensus 65 ~gaiagi~vg~~~~v~~lv~~l~w~f~~r 93 (96)
T PTZ00382 65 TGAIAGISVAVVAVVGGLVGFLCWWFVCR 93 (96)
T ss_pred cccEEEEEeehhhHHHHHHHHHhheeEEe
Confidence 36778877766655544444444444333
No 249
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=88.66 E-value=0.22 Score=31.47 Aligned_cols=13 Identities=31% Similarity=0.317 Sum_probs=6.4
Q ss_pred ccEEeccCCCccc
Q psy12044 149 LVTLELSKCGIEV 161 (767)
Q Consensus 149 L~~L~Ls~N~L~~ 161 (767)
|+.|+|++|+|+.
T Consensus 2 L~~Ldls~n~l~~ 14 (22)
T PF00560_consen 2 LEYLDLSGNNLTS 14 (22)
T ss_dssp ESEEEETSSEESE
T ss_pred ccEEECCCCcCEe
Confidence 4445555555553
No 250
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D ....
Probab=88.48 E-value=0.27 Score=29.09 Aligned_cols=16 Identities=38% Similarity=0.648 Sum_probs=6.6
Q ss_pred CCCeeeccCCcccccc
Q psy12044 172 SLEWLKLDNNKITTIS 187 (767)
Q Consensus 172 ~L~~L~Ls~N~Lt~ip 187 (767)
+|+.|+|++|+|+.+|
T Consensus 2 ~L~~L~l~~n~L~~lP 17 (17)
T PF13504_consen 2 NLRTLDLSNNRLTSLP 17 (17)
T ss_dssp T-SEEEETSS--SSE-
T ss_pred ccCEEECCCCCCCCCc
Confidence 4555555555555443
No 251
>KOG0658|consensus
Probab=88.47 E-value=0.26 Score=53.36 Aligned_cols=29 Identities=17% Similarity=0.176 Sum_probs=25.5
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+...++||.|+||.||+|+ .++..||++.
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKK 56 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKK 56 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEE
Confidence 3356799999999999999 7789999988
No 252
>KOG0574|consensus
Probab=88.12 E-value=0.16 Score=53.51 Aligned_cols=25 Identities=20% Similarity=0.259 Sum_probs=23.3
Q ss_pred CccccCCCCcceEEe--eCCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
..||+|+||.||||. ..|.+||++-
T Consensus 39 ~KLGEGSYGSV~KAIH~EsG~v~AIK~ 65 (502)
T KOG0574|consen 39 GKLGEGSYGSVHKAIHRESGHVLAIKK 65 (502)
T ss_pred HHhcCCcchHHHHHHHhccCcEEEEEe
Confidence 469999999999999 9999999987
No 253
>cd05720 Ig_CD8_alpha Immunoglobulin (Ig) like domain of CD8 alpha chain. Ig_CD8_alpha: immunoglobulin (Ig)-like domain in CD8 alpha. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alphaalpha or alphabeta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a v-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain. The Ig domain of CD8 alpha binds to antibodies.
Probab=88.06 E-value=0.62 Score=41.84 Aligned_cols=75 Identities=20% Similarity=0.305 Sum_probs=44.1
Q ss_pred eecccccccccccccccCCCcEEEeecC----ee---ccCCCc-c-----cccccceeecccCcceeeeEEEEeeeccCC
Q psy12044 265 EIQEGKNVSLLCKVSAIPEAKITWLFDG----VP---IQNESM-S-----ASESHAVYSTEEGTEIKKSELLIYNSNIDD 331 (767)
Q Consensus 265 ~v~~G~~vsL~C~a~g~P~p~itW~~~g----~~---l~~~s~-~-----~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD 331 (767)
.+..|+.++|.|.........+.|++.. .. +..... . ........+... .......|.|.++..+|
T Consensus 2 ~v~~G~~vtL~C~~~~~~~~~v~Wyrq~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~rf~~~-~~~~~~~L~I~~~~~sD 80 (104)
T cd05720 2 DAELGQKVELKCEVLNSSPTGCSWLFQPPGSAPQPTFLVYLSGSSKITWDEEELSSKRFSGS-RSSNSFVLTLKNFQKEN 80 (104)
T ss_pred cccCCCeEEEEEEecCCCCCcEEEEEeCCCCCCCCEEEEEEeCCCCeeeccccCCCceEEEE-ecCCEEEEEECCCCHHH
Confidence 3567999999998866556679998832 11 110000 0 000000011100 11245579999999999
Q ss_pred CCceeEeec
Q psy12044 332 NGTFVCVAE 340 (767)
Q Consensus 332 ~GtY~CvA~ 340 (767)
.|+|.|...
T Consensus 81 sgtY~Ca~~ 89 (104)
T cd05720 81 EGYYFCSVA 89 (104)
T ss_pred CEEEEEEEc
Confidence 999999875
No 254
>PTZ00284 protein kinase; Provisional
Probab=88.06 E-value=0.18 Score=57.88 Aligned_cols=39 Identities=10% Similarity=0.042 Sum_probs=31.5
Q ss_pred HHHHhcccCCCCCCCCccccCCCCcceEEe--eCCceEEEecc
Q psy12044 434 VNATSATCMDKVNGGYIIADGHNDMMLYAT--DSGILVATNNM 474 (767)
Q Consensus 434 ~El~~AT~~nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~~ 474 (767)
+++...+ ++|.-..+||+|+||+||+|. .+|..||+|..
T Consensus 122 ~~~~~~~--~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i 162 (467)
T PTZ00284 122 EDIDVST--QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV 162 (467)
T ss_pred CccccCC--CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEE
Confidence 3444455 678878899999999999998 77899999873
No 255
>KOG0662|consensus
Probab=87.97 E-value=0.23 Score=48.64 Aligned_cols=25 Identities=20% Similarity=0.255 Sum_probs=23.2
Q ss_pred CccccCCCCcceEEe--eCCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
..||||.||+|+||. ..+++||-++
T Consensus 8 ekigegtygtvfkarn~~t~eivalkr 34 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKR 34 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEE
Confidence 469999999999999 8899999998
No 256
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=87.91 E-value=0.36 Score=48.31 Aligned_cols=24 Identities=21% Similarity=0.212 Sum_probs=22.9
Q ss_pred ccccCCCCcceEEe-eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
.||+|+||.||+|. .+|+.||+|.
T Consensus 4 ~ig~G~~~~Vy~a~~~~g~~vavKv 28 (190)
T cd05145 4 CISTGKEANVYHARTGDGEELAVKI 28 (190)
T ss_pred eeecCCCcEEEEEEcCCCCEEEEEE
Confidence 69999999999999 8999999988
No 257
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=87.71 E-value=0.32 Score=51.17 Aligned_cols=30 Identities=10% Similarity=0.096 Sum_probs=26.3
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||||+ .+|..||++.
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~ 33 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKR 33 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEE
Confidence 55666689999999999999 7899999987
No 258
>KOG0201|consensus
Probab=87.62 E-value=0.33 Score=53.82 Aligned_cols=30 Identities=17% Similarity=0.031 Sum_probs=26.0
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
-|...-+||+|.||.||||. ..+++||.|-
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKi 45 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKI 45 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEE
Confidence 35555689999999999999 8999999987
No 259
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=87.59 E-value=0.36 Score=47.63 Aligned_cols=25 Identities=24% Similarity=0.154 Sum_probs=22.9
Q ss_pred CccccCCCCcceEEe-eCCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
++||+|+||.||+|. .+|+.||++.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv 28 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKI 28 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEE
Confidence 479999999999999 8899999986
No 260
>PRK09188 serine/threonine protein kinase; Provisional
Probab=87.54 E-value=0.36 Score=53.66 Aligned_cols=31 Identities=6% Similarity=-0.017 Sum_probs=26.8
Q ss_pred CCCCCCCccccCCCCcceEEe--e-CCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--D-SGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~-dG~~VA~~~ 473 (767)
+.|.-...||+|+||+||+|. . +|++||++.
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~ 51 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRR 51 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEE
Confidence 567778899999999999997 3 788999976
No 261
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=87.43 E-value=0.33 Score=52.75 Aligned_cols=29 Identities=17% Similarity=0.133 Sum_probs=25.4
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|+-.++||+|+||.||+|. .+|..||++.
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~ 32 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKI 32 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEE
Confidence 5566789999999999998 7899999876
No 262
>cd05883 Ig2_Necl-2 Second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig2_Necl-2: second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Nectin-like molecules (Necls) have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is expressed in a wide variety of tissues, and is a putative tumour suppressor gene, which is downregulated in aggressive neuroblastoma. Ig domains are likely to participate in ligand binding and recognition.
Probab=87.30 E-value=1.8 Score=37.33 Aligned_cols=65 Identities=22% Similarity=0.349 Sum_probs=40.5
Q ss_pred ccccccccc-cCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCC-CceeEeeccCCC
Q psy12044 272 VSLLCKVSA-IPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDN-GTFVCVAENQAG 344 (767)
Q Consensus 272 vsL~C~a~g-~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~-GtY~CvA~N~~G 344 (767)
+.|.|.+.+ -|.+.|+|++++..+...... ...........++|.+. ...+|. ..|+|.|.|+.-
T Consensus 2 ~~L~C~s~gSkP~A~I~W~k~~~~l~~~~~~-------~~~~~~~~t~~S~L~~~-p~~eDdG~~~~C~a~~~~l 68 (82)
T cd05883 2 IELNCTAMASKPAATIRWFKGNKELTGKSTV-------EETWSRMFTVTSQLMLK-VTKEDDGVPVICLVDHPAV 68 (82)
T ss_pred EEEEEEecCCCCCCEEEEEECCEECcCcccc-------eeccCCCcEEEEEEEEE-CchhhCCCEEEEEEcCccc
Confidence 457887765 578899999998877543210 00111223445667774 445554 469999998763
No 263
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=87.30 E-value=0.25 Score=52.42 Aligned_cols=41 Identities=20% Similarity=0.072 Sum_probs=35.3
Q ss_pred ccHHHHHhcccCCCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 431 YTSVNATSATCMDKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 431 fs~~El~~AT~~nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++..++..++ ++|.-...||+|+||.||+++ .+|+.+|.+.
T Consensus 12 ~~~~~~~~~~--~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~ 54 (291)
T cd06639 12 LGLESLGDPT--DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKI 54 (291)
T ss_pred hhcccCCCCC--CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEE
Confidence 4456777788 889988999999999999999 7889999876
No 264
>cd05771 IgC_Tapasin_R Tapasin-R immunoglobulin-like domain. IgC_Tapasin_R: Immunoglobulin-like domain on Tapasin-R. Tapasin is a V-C1 (variable-constant) immunoglobulin superfamily molecule present in the endoplasmic reticulum (ER), where it links MHC class I molecules to the transporter associated with antigen processing (TAP). Tapasin-R is a tapasin-related protein that contains similar structural motifs to Tapasin, with some marked differences, especially in the V domain, transmembrane and cytoplasmic regions. The majority of Tapasin-R is located within the ER; however, there may be some expression of Tapasin-R at the cell surface. Tapasin-R lacks an obvious ER retention signal.
Probab=87.02 E-value=1.8 Score=40.96 Aligned_cols=77 Identities=17% Similarity=0.286 Sum_probs=45.2
Q ss_pred ccccccccccccccc-CC-CcEEEeecCeeccCCCcccccc--cceeecccCcceeeeEEEEeeeccCCCCceeEeeccC
Q psy12044 267 QEGKNVSLLCKVSAI-PE-AKITWLFDGVPIQNESMSASES--HAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQ 342 (767)
Q Consensus 267 ~~G~~vsL~C~a~g~-P~-p~itW~~~g~~l~~~s~~~~~~--~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~ 342 (767)
..|..+.|.|.+.+. |. ..+.|.+++............. .......++.....+.|.+..-...+...|+|.+...
T Consensus 51 ~~~~~~~L~C~a~g~~P~~~~i~W~~~g~~~~~~~~~~~~~~~~~~~~~~dgt~~~~s~L~v~~~~~~~g~~ytC~V~H~ 130 (139)
T cd05771 51 MIEEPQTLICHIAGYYPLDVQVEWTREPPGDSPPPVSLSNVSFSSHRQHQDGTYSLSSHLTLEPGTEDAGATYTCRVSHV 130 (139)
T ss_pred ecCCcEEEEEEECCCCCCCeEEEEEECCCCCccceeccCCeEecceEeCCCCCEEEEEEEEecCCccCCCCEEEEEEEcC
Confidence 367788999999996 43 4899999875322100000000 0122234455566677777644444566899999754
Q ss_pred C
Q psy12044 343 A 343 (767)
Q Consensus 343 ~ 343 (767)
.
T Consensus 131 ~ 131 (139)
T cd05771 131 S 131 (139)
T ss_pred C
Confidence 3
No 265
>PF15102 TMEM154: TMEM154 protein family
Probab=87.00 E-value=0.45 Score=45.09 Aligned_cols=23 Identities=26% Similarity=0.528 Sum_probs=9.7
Q ss_pred hhHHHHHHHHHHHhhhhhhhhcc
Q psy12044 381 VCSLVLIFLLVLCFLCFRRKKKK 403 (767)
Q Consensus 381 ~llvllllvvivi~~~~rRrrr~ 403 (767)
+++++++++++++++++||||.|
T Consensus 66 VLLvlLLl~vV~lv~~~kRkr~K 88 (146)
T PF15102_consen 66 VLLVLLLLSVVCLVIYYKRKRTK 88 (146)
T ss_pred HHHHHHHHHHHHheeEEeecccC
Confidence 33334444444444444444443
No 266
>KOG0594|consensus
Probab=86.96 E-value=0.4 Score=51.69 Aligned_cols=25 Identities=20% Similarity=0.312 Sum_probs=23.0
Q ss_pred CccccCCCCcceEEe--eCCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
..||+|.||+||||. .+|..||.+.
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKk 43 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKK 43 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEE
Confidence 369999999999999 8999999988
No 267
>cd05889 Ig1_DNAM-1_like First immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226) and similar proteins. Ig1_DNAM-1_like: domain similar to the first immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226). DNAM-1 is a transmembrane protein having two Ig-like domains. It is an adhesion molecule which plays a part in tumor-directed cytotoxicity and adhesion in natural killer (NK) cells and T lymphocytes. It has been shown to regulate the NK cell killing of several tumor types, including myeloma cells and ovarian carcinoma cells. DNAM-1 interacts specifically with poliovirus receptor (PVR; CD155) and nectin -2 (CD211), other members of the Ig superfamily. DNAM-1 is expressed in most peripheral T cells, NK cells, monocytes and a subset of B lymphocytes.
Probab=86.89 E-value=1.6 Score=38.88 Aligned_cols=29 Identities=24% Similarity=0.365 Sum_probs=23.5
Q ss_pred eeeEEEEeeeccCCCCceeEeeccC-CCCc
Q psy12044 318 KKSELLIYNSNIDDNGTFVCVAENQ-AGST 346 (767)
Q Consensus 318 ~~s~L~I~nvs~sD~GtY~CvA~N~-~G~s 346 (767)
...+|.|.+++.+|.|.|.|..... .|..
T Consensus 58 ~d~sI~i~nvt~~D~G~Y~C~~~t~P~g~~ 87 (96)
T cd05889 58 EDMSLSFNNATEEDVGLYCCSLVTYPQGSW 87 (96)
T ss_pred CccEEEEcCCCcccCEEEEEEEEeCCCCCe
Confidence 4578999999999999999988544 4443
No 268
>smart00407 IGc1 Immunoglobulin C-Type.
Probab=86.62 E-value=1.9 Score=36.04 Aligned_cols=67 Identities=24% Similarity=0.488 Sum_probs=41.7
Q ss_pred cccccccccc-C-CCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccC
Q psy12044 272 VSLLCKVSAI-P-EAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQ 342 (767)
Q Consensus 272 vsL~C~a~g~-P-~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~ 342 (767)
++|.|.+.+. | ...++|.+++..+...... .......++.....+.|.+......+...|+|.+...
T Consensus 2 ~~L~C~a~gf~P~~i~v~W~k~g~~~~~~~~~----~~~~~~~~gt~~~~s~L~v~~~~~~~~~~~tC~V~H~ 70 (75)
T smart00407 2 ATLVCLVSGFYPPDITVTWLRNGQEVTSGVST----TDPLKNSDGTYFLSSYLTVSASTWESGDTYTCQVTHE 70 (75)
T ss_pred eEEEEEEEeEeCCCCEEEEEECCEECCCCEEE----CceEECCCCCEEEEEEEEEccccCCCCCEEEEEEEEc
Confidence 4689999887 3 3589999988764322111 0011123455555667776655556677899998654
No 269
>KOG0600|consensus
Probab=86.61 E-value=0.37 Score=54.32 Aligned_cols=54 Identities=17% Similarity=0.206 Sum_probs=37.8
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec--ccc---CCCcc-------hhhhhhhCCCCcccchhhc
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN--MNT---YPSYS-------ISYQIEQNPDLVNDAESVD 500 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~--~~~---~~~~~-------~~~~~e~npdlin~~e~~~ 500 (767)
|..-..||+|-||.||||. .+|.+||-+. .+. =+|-. ++++. +|.+|+=-|.|-
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~--HpNIikL~eivt 186 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD--HPNIIKLEEIVT 186 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC--CCcccceeeEEE
Confidence 3333479999999999999 9999999988 221 12322 24444 888888776665
No 270
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=86.59 E-value=0.32 Score=51.27 Aligned_cols=42 Identities=12% Similarity=-0.010 Sum_probs=35.2
Q ss_pred cccHHHHHhcccCCCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 430 KYTSVNATSATCMDKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 430 ~fs~~El~~AT~~nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.+.+.++..++ ++|.-...||+|+||.|||+. .+|+.+|.+.
T Consensus 7 ~~~~~~~~~~~--~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~ 50 (286)
T cd06638 7 TIIFDSFPDPS--DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKI 50 (286)
T ss_pred eEEeecCCCcc--cceeeeeeeccCCCcEEEEEEECCCCceeEEEe
Confidence 34566677778 888888899999999999998 7888998875
No 271
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=86.55 E-value=0.48 Score=31.04 Aligned_cols=21 Identities=43% Similarity=0.765 Sum_probs=9.8
Q ss_pred CCCCEEEccCCCCCCCCCCCC
Q psy12044 99 TNLVDLDFSHNVLQTVPSDTF 119 (767)
Q Consensus 99 ~~L~~L~Ls~N~Lt~l~p~~f 119 (767)
++|+.|+|++|.|+.+++..|
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f 22 (26)
T smart00369 2 PNLRELDLSNNQLSSLPPGAF 22 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHc
Confidence 344455555555544444433
No 272
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=86.55 E-value=0.48 Score=31.04 Aligned_cols=21 Identities=43% Similarity=0.765 Sum_probs=9.8
Q ss_pred CCCCEEEccCCCCCCCCCCCC
Q psy12044 99 TNLVDLDFSHNVLQTVPSDTF 119 (767)
Q Consensus 99 ~~L~~L~Ls~N~Lt~l~p~~f 119 (767)
++|+.|+|++|.|+.+++..|
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f 22 (26)
T smart00370 2 PNLRELDLSNNQLSSLPPGAF 22 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHc
Confidence 344455555555544444433
No 273
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=86.07 E-value=0.41 Score=52.73 Aligned_cols=30 Identities=17% Similarity=0.209 Sum_probs=26.1
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||+|. .+|+.||++.
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~ 33 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKK 33 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEE
Confidence 45566789999999999999 7899999887
No 274
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=86.02 E-value=0.52 Score=52.21 Aligned_cols=30 Identities=23% Similarity=0.171 Sum_probs=26.2
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.....||+|+||.||+|. .+|+.||++.
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~ 32 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKK 32 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEe
Confidence 35666789999999999999 7899999987
No 275
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=85.77 E-value=0.43 Score=50.57 Aligned_cols=28 Identities=11% Similarity=0.114 Sum_probs=24.0
Q ss_pred CCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 446 NGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 446 s~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
....+||+|+||+||+|. .+|+.||++.
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~ 32 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKR 32 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEE
Confidence 344589999999999999 7899999876
No 276
>KOG4308|consensus
Probab=85.58 E-value=0.028 Score=64.54 Aligned_cols=134 Identities=26% Similarity=0.296 Sum_probs=61.4
Q ss_pred ccEEEeeCCCCCCCCchhhhc--cCCCCccEEEccCCCCCccCc----ccccCC-CCCCEEEccCCCCCCCCC----CCC
Q psy12044 51 TQVLDYTGNNLKTLHNEKFQK--MGLVNLQKIYLSRCRISVIDS----KAFRGL-TNLVDLDFSHNVLQTVPS----DTF 119 (767)
Q Consensus 51 L~~L~Ls~N~L~~l~~~~f~~--~~L~~L~~L~Ls~N~L~~i~p----~~f~~L-~~L~~L~Ls~N~Lt~l~p----~~f 119 (767)
+..|.|.+|.+..-....+.. ..+..|..|+++.|.+....- ..+... ..|+.|++..|.++.... ..+
T Consensus 89 l~~L~L~~~~l~~~~~~~l~~~l~t~~~L~~L~l~~n~l~~~g~~~l~~~l~~~~~~l~~L~l~~c~l~~~g~~~l~~~L 168 (478)
T KOG4308|consen 89 LLHLSLANNRLGDRGAEELAQALKTLPTLGQLDLSGNNLGDEGARLLCEGLRLPQCLLQTLELVSCSLTSEGAAPLAAVL 168 (478)
T ss_pred HHHhhhhhCccccchHHHHHHHhcccccHhHhhcccCCCccHhHHHHHhhcccchHHHHHHHhhcccccccchHHHHHHH
Confidence 556666666666544333321 134556666666666663221 112222 345555555555554321 223
Q ss_pred CCCCCCcEEECCCCcCccc----ccCC----cCCCCCccEEeccCCCccccc----hhhhcCCCC-CCeeeccCCccc
Q psy12044 120 PDYPSLMKLTLSGNPIKQI----KTGA----FQPLSYLVTLELSKCGIEVIE----DAAFVGLDS-LEWLKLDNNKIT 184 (767)
Q Consensus 120 ~~l~~L~~L~Ls~N~l~~l----~~~~----~~~l~~L~~L~Ls~N~L~~i~----~~~~~~l~~-L~~L~Ls~N~Lt 184 (767)
.....|+.++++.|.+... .... +....++++|.|++|.++... ...+....+ +..|++..|++.
T Consensus 169 ~~~~~l~~l~l~~n~l~~~g~~~l~~~l~~~~~~~~~le~L~L~~~~~t~~~c~~l~~~l~~~~~~~~el~l~~n~l~ 246 (478)
T KOG4308|consen 169 EKNEHLTELDLSLNGLIELGLLVLSQALESAASPLSSLETLKLSRCGVTSSSCALLDEVLASGESLLRELDLASNKLG 246 (478)
T ss_pred hcccchhHHHHHhcccchhhhHHHhhhhhhhhcccccHHHHhhhhcCcChHHHHHHHHHHhccchhhHHHHHHhcCcc
Confidence 3345556666666655311 1111 122445556666666554221 112222333 444555555554
No 277
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=85.56 E-value=0.31 Score=50.89 Aligned_cols=32 Identities=16% Similarity=0.174 Sum_probs=27.8
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEecc
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNNM 474 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~~ 474 (767)
+.|.....||+|+||.||+|. .++..||++..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~ 39 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM 39 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEE
Confidence 567777889999999999998 78899998873
No 278
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=85.36 E-value=0.56 Score=50.73 Aligned_cols=24 Identities=13% Similarity=0.270 Sum_probs=21.8
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||.||+|. .+|..||++.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~ 27 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKA 27 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEE
Confidence 69999999999998 7788999876
No 279
>KOG1166|consensus
Probab=85.22 E-value=0.39 Score=59.14 Aligned_cols=31 Identities=29% Similarity=0.266 Sum_probs=27.0
Q ss_pred CCCCCCCccccCCCCcceEEe-eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
..|.=..+||+|+||+||+|+ .+|.+||.+-
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~ 729 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKV 729 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEe
Confidence 445556799999999999999 8899999987
No 280
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=85.13 E-value=0.51 Score=51.17 Aligned_cols=29 Identities=17% Similarity=0.133 Sum_probs=24.3
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|.-...||+|+||.||+|. .+|..||++.
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~ 32 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKI 32 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEE
Confidence 4445689999999999998 6788999876
No 281
>KOG4222|consensus
Probab=85.12 E-value=1.6 Score=53.54 Aligned_cols=94 Identities=22% Similarity=0.324 Sum_probs=62.4
Q ss_pred CCCCccceeecccccccccccccccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCcee
Q psy12044 257 ITPSTFYLEIQEGKNVSLLCKVSAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFV 336 (767)
Q Consensus 257 i~~~~~~~~v~~G~~vsL~C~a~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~ 336 (767)
+...+....+..|..++|.|.+.+.|.|.++|.+.+....-....+...+ ..+.....+.|+|.++...|.|-|.
T Consensus 318 f~kkp~dq~v~lg~~vt~pc~~~gnP~PavfW~keg~q~llf~~~p~~~~-----~r~svs~~g~L~it~v~~~d~g~Yv 392 (1281)
T KOG4222|consen 318 FGKKPRDQKVALGGTVTFPCETLGNPPPAVFWLKEGSQDLLFSASPPSSN-----GRGSVSPTGTLTITNVRQSDEGYYV 392 (1281)
T ss_pred cccccCccccccCceEEeeeecCCCCCcceEEeccCcceecccCCCCCcC-----ccceecCCCCcccccccccccceEe
Confidence 33334445677888999999999999999999996643322111111111 0111122347999999999999999
Q ss_pred EeeccCCCCcccceEEEEE
Q psy12044 337 CVAENQAGSTSSNYTIRIV 355 (767)
Q Consensus 337 CvA~N~~G~s~~s~sL~V~ 355 (767)
|...+.+|.......+.++
T Consensus 393 cq~~~~~~ss~~~a~~~qt 411 (1281)
T KOG4222|consen 393 CQTQTSAGSSLTKAYLEQT 411 (1281)
T ss_pred ecccccccccccceeEEEE
Confidence 9998888877665444433
No 282
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=85.09 E-value=0.33 Score=51.09 Aligned_cols=30 Identities=20% Similarity=0.389 Sum_probs=25.4
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-.+.||+|+||.||+|. .+|..||++.
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~ 33 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKK 33 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEe
Confidence 45556789999999999999 5789999876
No 283
>KOG0661|consensus
Probab=84.98 E-value=0.38 Score=53.91 Aligned_cols=51 Identities=20% Similarity=0.275 Sum_probs=37.5
Q ss_pred ccccCCCCcceEEe--eCCceEEEec--cccCCCcchhhh------h--hhCCCCcccchhhc
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN--MNTYPSYSISYQ------I--EQNPDLVNDAESVD 500 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~--~~~~~~~~~~~~------~--e~npdlin~~e~~~ 500 (767)
.||.|.||.||+|+ .+|..||+++ ...|+-...+++ . -.||.+|+=-|++-
T Consensus 17 klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 17 KLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred HhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh
Confidence 69999999999999 9999999999 334442222222 2 34899998777775
No 284
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=84.89 E-value=0.56 Score=49.79 Aligned_cols=31 Identities=13% Similarity=0.056 Sum_probs=26.4
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+.|.-...||+|+||.||+|. .+|..||++.
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~ 37 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKE 37 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEE
Confidence 456666789999999999998 7889999876
No 285
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=84.72 E-value=0.63 Score=49.53 Aligned_cols=30 Identities=10% Similarity=-0.066 Sum_probs=25.6
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||+|. .+|+.||++.
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~ 33 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKV 33 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEE
Confidence 45556689999999999999 6899999876
No 286
>PHA02882 putative serine/threonine kinase; Provisional
Probab=84.71 E-value=0.57 Score=50.00 Aligned_cols=30 Identities=7% Similarity=-0.068 Sum_probs=21.6
Q ss_pred CCCCCCccccCCCCcceEEe--eC---CceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DS---GILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~d---G~~VA~~~ 473 (767)
.|.-..+||+||||+||||. .+ +..+|++.
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~ 47 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKI 47 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEe
Confidence 34445689999999999999 44 44566554
No 287
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=84.60 E-value=0.57 Score=50.47 Aligned_cols=31 Identities=13% Similarity=0.114 Sum_probs=25.3
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCce----EEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGIL----VATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~----VA~~~ 473 (767)
+.|...+.||+|+||.||||+ .+|.. ||++.
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~ 43 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE 43 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEe
Confidence 468888899999999999998 56665 67665
No 288
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=84.51 E-value=0.55 Score=52.32 Aligned_cols=29 Identities=17% Similarity=0.024 Sum_probs=24.9
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|..-..||+|+||+||+|. .+|..||+|.
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~ 33 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKT 33 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEE
Confidence 4445689999999999998 8899999876
No 289
>KOG4236|consensus
Probab=84.22 E-value=0.47 Score=53.65 Aligned_cols=54 Identities=15% Similarity=0.262 Sum_probs=38.9
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEeccc--cCCCcchhhhhhhCCCCcccchhhcccccc
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNNMN--TYPSYSISYQIEQNPDLVNDAESVDKDRRA 505 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~~~--~~~~~~~~~~~e~npdlin~~e~~~~~~~~ 505 (767)
-|.++ +||+|.||+||-|. .+|+-||++--| -++++ |.--|-|||-+.++..-+
T Consensus 566 if~de-vLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-------qesqlR~EVaILq~l~HP 623 (888)
T KOG4236|consen 566 IFADE-VLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-------QESQLRNEVAILQNLHHP 623 (888)
T ss_pred hhhHh-hccCCcceeeecceecccCceeeeeeeecccCCCc-------hHHHHHHHHHHHHhcCCC
Confidence 35566 99999999999999 999999998733 33333 224466777777765553
No 290
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=84.19 E-value=0.6 Score=50.05 Aligned_cols=32 Identities=22% Similarity=0.275 Sum_probs=28.5
Q ss_pred CCCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 442 MDKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 442 ~nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+++|.-.+.||+|+||.||+|. .+|..||++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~ 39 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKK 39 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEE
Confidence 3678888899999999999999 7899999876
No 291
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=83.97 E-value=0.84 Score=29.87 Aligned_cols=16 Identities=25% Similarity=0.343 Sum_probs=6.3
Q ss_pred ccEEeccCCCccccch
Q psy12044 149 LVTLELSKCGIEVIED 164 (767)
Q Consensus 149 L~~L~Ls~N~L~~i~~ 164 (767)
|+.|+|++|.|+.+++
T Consensus 4 L~~L~L~~N~l~~lp~ 19 (26)
T smart00370 4 LRELDLSNNQLSSLPP 19 (26)
T ss_pred CCEEECCCCcCCcCCH
Confidence 3334444444433333
No 292
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=83.97 E-value=0.84 Score=29.87 Aligned_cols=16 Identities=25% Similarity=0.343 Sum_probs=6.3
Q ss_pred ccEEeccCCCccccch
Q psy12044 149 LVTLELSKCGIEVIED 164 (767)
Q Consensus 149 L~~L~Ls~N~L~~i~~ 164 (767)
|+.|+|++|.|+.+++
T Consensus 4 L~~L~L~~N~l~~lp~ 19 (26)
T smart00369 4 LRELDLSNNQLSSLPP 19 (26)
T ss_pred CCEEECCCCcCCcCCH
Confidence 3334444444433333
No 293
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=83.92 E-value=0.5 Score=49.74 Aligned_cols=30 Identities=20% Similarity=0.193 Sum_probs=26.0
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
||.....||+|+||.||||+ .+|..||++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~ 32 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 32 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEE
Confidence 45666789999999999998 6899999876
No 294
>cd04981 IgV_H Immunoglobulin (Ig) heavy chain (H), variable (V) domain. IgV_H: Immunoglobulin (Ig) heavy chain (H), variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which can associate with any of the heavy chains. This family includes alpha, gamma, delta, epsilon, and mu heavy chains.
Probab=83.72 E-value=1.4 Score=40.48 Aligned_cols=78 Identities=18% Similarity=0.232 Sum_probs=44.8
Q ss_pred ceeecccccccccccccccC--CCcEEEeec--Cee---ccCC-Ccc-----cccc-cceeecccCcceeeeEEEEeeec
Q psy12044 263 YLEIQEGKNVSLLCKVSAIP--EAKITWLFD--GVP---IQNE-SMS-----ASES-HAVYSTEEGTEIKKSELLIYNSN 328 (767)
Q Consensus 263 ~~~v~~G~~vsL~C~a~g~P--~p~itW~~~--g~~---l~~~-s~~-----~~~~-~~~~~~~~g~~~~~s~L~I~nvs 328 (767)
...+..|+.++|.|...... ...+.|++. +.. +... ... .... .++... .........|.|.++.
T Consensus 6 ~~~v~~G~~vtL~C~~~~~~~~~~~~~WYkQ~~g~~p~~l~~~~~~~~~~~~~~~~~~rf~~~-~~~~~~~~~L~I~~~~ 84 (117)
T cd04981 6 PGLVKPGQSLKLSCKASGFTFTSYGVNWVRQAPGKGLEWIGFINPGGGETYYADSVKGRFTIT-RDTSKSTVYLQLNSLT 84 (117)
T ss_pred CeEEcCCCCEEEEEEEeCCCcccceEEEEEECCCCCcEEEEEEecCCCceEeCcccCCcEEEE-EEccCCEEEEEECCCC
Confidence 45678899999999875433 566899872 221 1100 000 0000 001110 0011123469999999
Q ss_pred cCCCCceeEeecc
Q psy12044 329 IDDNGTFVCVAEN 341 (767)
Q Consensus 329 ~sD~GtY~CvA~N 341 (767)
.+|.|+|.|....
T Consensus 85 ~~Dsa~YyCa~~~ 97 (117)
T cd04981 85 PEDTAVYYCARGL 97 (117)
T ss_pred HHHCEEEEEEEEc
Confidence 9999999998764
No 295
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=83.65 E-value=0.72 Score=49.90 Aligned_cols=24 Identities=13% Similarity=0.261 Sum_probs=21.8
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||.||+|. .+|..||++.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~ 27 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKA 27 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEE
Confidence 69999999999999 6788999876
No 296
>cd07700 IgV_CD8_beta Immunoglobulin (Ig) like domain of CD8 beta chain. IgV_CD8_beta: immunoglobulin (Ig)-like domain in CD8 beta. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alpha/alpha or alpha/beta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a V-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain.
Probab=83.56 E-value=1.4 Score=39.75 Aligned_cols=75 Identities=21% Similarity=0.316 Sum_probs=43.1
Q ss_pred eeccccccccccccccc-CCCcEEEeecCee-----cc---CCCcc-----cccc--cceeecccCcceeeeEEEEeeec
Q psy12044 265 EIQEGKNVSLLCKVSAI-PEAKITWLFDGVP-----IQ---NESMS-----ASES--HAVYSTEEGTEIKKSELLIYNSN 328 (767)
Q Consensus 265 ~v~~G~~vsL~C~a~g~-P~p~itW~~~g~~-----l~---~~s~~-----~~~~--~~~~~~~~g~~~~~s~L~I~nvs 328 (767)
.+..|+.++|.|..... ....+.|++...- +. ..... .... ..+... .........|.|.++.
T Consensus 2 ~v~~G~~vtL~C~~~~~~~~~~~~Wyrq~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~rf~~~-~~~~~~~~~L~I~~~~ 80 (107)
T cd07700 2 LVQTNNTVKLSCEAKGISENTRIYWLRWRQAPKDSHFEFLALWSPLGGATYGEEVSQEKFSIR-VTSDSSRYRLHINRVK 80 (107)
T ss_pred EEcCCCCEEEEEEEecCCCCCeEEEEEECCCCCCCccEEEEEEcCCCCeEEccccccCcEEEE-EECCCCEEEEEECCCC
Confidence 46789999999998654 3457899883211 00 00000 0000 001100 0111224579999999
Q ss_pred cCCCCceeEeec
Q psy12044 329 IDDNGTFVCVAE 340 (767)
Q Consensus 329 ~sD~GtY~CvA~ 340 (767)
.+|.|.|.|...
T Consensus 81 ~~Dsg~YyCa~~ 92 (107)
T cd07700 81 PEDSGTYFCMTV 92 (107)
T ss_pred HHHCEEEEEeEc
Confidence 999999999975
No 297
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=83.38 E-value=0.67 Score=49.13 Aligned_cols=29 Identities=10% Similarity=0.113 Sum_probs=24.3
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|.-..+||+|+||.||++. .+|..||++.
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~ 32 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKK 32 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEE
Confidence 3344589999999999999 7899999876
No 298
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=83.34 E-value=0.68 Score=48.85 Aligned_cols=30 Identities=17% Similarity=0.244 Sum_probs=25.6
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||+|. .+|..||++.
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~ 33 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKK 33 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEE
Confidence 45556689999999999999 6889999987
No 299
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=83.28 E-value=0.65 Score=50.38 Aligned_cols=30 Identities=13% Similarity=0.170 Sum_probs=26.0
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||++. .+|..||++.
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~ 33 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKV 33 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEE
Confidence 45566789999999999999 7899999887
No 300
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=83.26 E-value=0.78 Score=49.62 Aligned_cols=24 Identities=13% Similarity=0.220 Sum_probs=21.8
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||.||+|+ .+|..||++.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~ 27 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKV 27 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEE
Confidence 69999999999998 6788999876
No 301
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=83.12 E-value=0.79 Score=49.65 Aligned_cols=24 Identities=25% Similarity=0.346 Sum_probs=22.3
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||+||+|. .+|+.||++.
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~ 27 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKV 27 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEE
Confidence 69999999999999 7899999987
No 302
>PTZ00036 glycogen synthase kinase; Provisional
Probab=83.04 E-value=0.58 Score=53.43 Aligned_cols=31 Identities=26% Similarity=0.282 Sum_probs=26.7
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.+|.-..+||+|+||.||+|. .+|..||++.
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~ 98 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK 98 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEE
Confidence 456666789999999999999 7889999986
No 303
>smart00406 IGv Immunoglobulin V-Type.
Probab=82.97 E-value=1 Score=37.44 Aligned_cols=22 Identities=32% Similarity=0.620 Sum_probs=19.2
Q ss_pred eeeeEEEEeeeccCCCCceeEe
Q psy12044 317 IKKSELLIYNSNIDDNGTFVCV 338 (767)
Q Consensus 317 ~~~s~L~I~nvs~sD~GtY~Cv 338 (767)
.....|.|.+++.+|.|.|.|.
T Consensus 59 ~~~~~L~i~~~~~~D~G~Y~C~ 80 (81)
T smart00406 59 KNDVSLTISNLRVEDTGTYYCA 80 (81)
T ss_pred CCEEEEEEcCCCHHHCEEEEEc
Confidence 3456899999999999999995
No 304
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=82.92 E-value=0.81 Score=49.84 Aligned_cols=25 Identities=16% Similarity=0.204 Sum_probs=22.3
Q ss_pred CccccCCCCcceEEe--eCCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.+||+|+||.||+|. .+|+.||++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~ 27 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKV 27 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEE
Confidence 379999999999999 7889999876
No 305
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=82.92 E-value=0.81 Score=49.46 Aligned_cols=24 Identities=25% Similarity=0.361 Sum_probs=22.1
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||.||+|. .+|..||++.
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~ 27 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKV 27 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEE
Confidence 79999999999999 7899999876
No 306
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=82.77 E-value=0.83 Score=49.52 Aligned_cols=24 Identities=13% Similarity=0.241 Sum_probs=22.0
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||.||++. .+|..||++.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~ 27 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKI 27 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEE
Confidence 79999999999998 7899999876
No 307
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=82.77 E-value=0.98 Score=47.10 Aligned_cols=31 Identities=16% Similarity=0.221 Sum_probs=27.5
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||....+||+|+||.||+|. .+|..||++.
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~ 34 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQ 34 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEE
Confidence 478888899999999999998 6789999876
No 308
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D ....
Probab=82.66 E-value=0.77 Score=27.15 Aligned_cols=10 Identities=50% Similarity=0.597 Sum_probs=3.0
Q ss_pred CCEEEccCCC
Q psy12044 101 LVDLDFSHNV 110 (767)
Q Consensus 101 L~~L~Ls~N~ 110 (767)
|+.|+|++|+
T Consensus 3 L~~L~l~~n~ 12 (17)
T PF13504_consen 3 LRTLDLSNNR 12 (17)
T ss_dssp -SEEEETSS-
T ss_pred cCEEECCCCC
Confidence 3333333333
No 309
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=82.53 E-value=0.87 Score=49.36 Aligned_cols=24 Identities=25% Similarity=0.246 Sum_probs=22.2
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||.||+|. .+|..||++.
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~ 27 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKV 27 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEE
Confidence 69999999999998 7899999886
No 310
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=82.49 E-value=0.78 Score=50.95 Aligned_cols=30 Identities=17% Similarity=0.215 Sum_probs=25.6
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||++. .+|..||++.
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~ 33 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKT 33 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEE
Confidence 45555689999999999998 8999999876
No 311
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=82.47 E-value=0.87 Score=49.35 Aligned_cols=24 Identities=25% Similarity=0.397 Sum_probs=22.0
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||.||+|. .+|+.||++.
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~ 27 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKV 27 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEE
Confidence 79999999999999 7899999876
No 312
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=82.42 E-value=0.91 Score=46.68 Aligned_cols=24 Identities=17% Similarity=0.252 Sum_probs=22.2
Q ss_pred ccccCCCCcceEEe-eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
+||+|+||.||+|. .++..||.+.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~ 26 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKT 26 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEe
Confidence 79999999999999 8899999876
No 313
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=82.38 E-value=0.75 Score=50.12 Aligned_cols=30 Identities=10% Similarity=-0.017 Sum_probs=25.0
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||++. .+|..||++.
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~ 33 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKI 33 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEE
Confidence 34445689999999999999 7888999876
No 314
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=82.35 E-value=0.72 Score=50.37 Aligned_cols=30 Identities=17% Similarity=0.141 Sum_probs=25.3
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||+|. .+|..||++.
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~ 33 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKV 33 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEE
Confidence 34455689999999999999 6899999877
No 315
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=82.33 E-value=0.76 Score=49.82 Aligned_cols=29 Identities=17% Similarity=0.133 Sum_probs=23.9
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|.-...||+|+||.||+|. .+|..||++.
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~ 32 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKI 32 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEE
Confidence 3344589999999999998 6788999876
No 316
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=82.33 E-value=0.76 Score=49.30 Aligned_cols=31 Identities=13% Similarity=0.051 Sum_probs=26.0
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+.|.-...||+|+||.||+|+ .+|..||++.
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~ 38 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKE 38 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEE
Confidence 345556689999999999999 6888999886
No 317
>KOG0473|consensus
Probab=82.28 E-value=0.067 Score=54.54 Aligned_cols=83 Identities=18% Similarity=0.132 Sum_probs=47.6
Q ss_pred CCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCCCCeeeccCCccccccCCCCCCCCcccccCC
Q psy12044 123 PSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDSLEWLKLDNNKITTISGSNILPTGLHGIDLH 202 (767)
Q Consensus 123 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~L~~L~Ls~N~Lt~ip~~~~~~~~L~~L~Ls 202 (767)
...+.||++.|++-.+.. .|..++.|..|+|+.|.+.-.+. .+..+..+..+++..|.++..|......+.++.+++.
T Consensus 42 kr~tvld~~s~r~vn~~~-n~s~~t~~~rl~~sknq~~~~~~-d~~q~~e~~~~~~~~n~~~~~p~s~~k~~~~k~~e~k 119 (326)
T KOG0473|consen 42 KRVTVLDLSSNRLVNLGK-NFSILTRLVRLDLSKNQIKFLPK-DAKQQRETVNAASHKNNHSQQPKSQKKEPHPKKNEQK 119 (326)
T ss_pred ceeeeehhhhhHHHhhcc-chHHHHHHHHHhccHhhHhhChh-hHHHHHHHHHHHhhccchhhCCccccccCCcchhhhc
Confidence 344444555554443322 24445555556666665554433 3555556666666677777777666666677777777
Q ss_pred CCCCC
Q psy12044 203 HNPWT 207 (767)
Q Consensus 203 ~N~l~ 207 (767)
+|+|.
T Consensus 120 ~~~~~ 124 (326)
T KOG0473|consen 120 KTEFF 124 (326)
T ss_pred cCcch
Confidence 77754
No 318
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=82.21 E-value=0.89 Score=49.33 Aligned_cols=24 Identities=13% Similarity=0.236 Sum_probs=22.1
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||.||++. .+|..||++.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~ 27 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKI 27 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEE
Confidence 79999999999998 7899999876
No 319
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=82.20 E-value=0.66 Score=51.02 Aligned_cols=27 Identities=19% Similarity=0.116 Sum_probs=23.7
Q ss_pred CCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 447 GGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 447 ~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
....||+|+||.||+|+ .+|+.||+|.
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~ 106 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKV 106 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEE
Confidence 34479999999999999 7899999887
No 320
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=82.18 E-value=0.81 Score=50.54 Aligned_cols=30 Identities=17% Similarity=0.159 Sum_probs=26.0
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||+|+||+||++. .+|..||+|.
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~ 33 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKI 33 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEE
Confidence 56666789999999999998 7899999876
No 321
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=82.16 E-value=0.55 Score=54.53 Aligned_cols=31 Identities=19% Similarity=0.186 Sum_probs=27.2
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-..+||+|+||.||+|. .+|..||+|.
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~ 64 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKV 64 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEE
Confidence 556666799999999999998 7899999987
No 322
>KOG0577|consensus
Probab=82.02 E-value=0.43 Score=54.69 Aligned_cols=55 Identities=16% Similarity=0.164 Sum_probs=37.7
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEeccccCCCcchhhhhhhCCCCcccchhhcccc
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNNMNTYPSYSISYQIEQNPDLVNDAESVDKDR 503 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~~~ 503 (767)
|++-..||.|+||.||.|. .+..+||++-|.-..-+ -.|+=-|+|-||.-+.+.+
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQ----s~EKWqDIlKEVrFL~~l~ 84 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ----SNEKWQDILKEVRFLRQLR 84 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccc----cHHHHHHHHHHHHHHHhcc
Confidence 5556689999999999999 88899999875432222 2344556666665544443
No 323
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=81.90 E-value=0.75 Score=47.40 Aligned_cols=25 Identities=20% Similarity=0.149 Sum_probs=22.2
Q ss_pred CccccCCCCcceEEe--eCCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
..||+|+||+||++. .+|..+|++.
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~K~ 31 (260)
T PF00069_consen 5 KKLGSGGFGTVYKAKNKKNGQKVAVKI 31 (260)
T ss_dssp EEEEEESSEEEEEEEETTTTEEEEEEE
T ss_pred EEEEeCCCEEEEEEEECCCCeEEEEEE
Confidence 379999999999999 7777899887
No 324
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=81.74 E-value=0.97 Score=48.87 Aligned_cols=24 Identities=21% Similarity=0.333 Sum_probs=22.0
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||.||+|. .+|..||++.
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~ 27 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKA 27 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEE
Confidence 69999999999999 7899999876
No 325
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=81.66 E-value=0.97 Score=47.75 Aligned_cols=23 Identities=17% Similarity=0.203 Sum_probs=21.0
Q ss_pred cccCCCCcceEEe--eCCceEEEec
Q psy12044 451 IADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 451 IG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
||+|+||+||++. .+|..||++.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~ 25 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKK 25 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEe
Confidence 7999999999998 7899999876
No 326
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=81.61 E-value=0.91 Score=47.24 Aligned_cols=31 Identities=16% Similarity=0.219 Sum_probs=27.1
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-.++||+|+||.||+|. .+|..||++.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~ 34 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQ 34 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEE
Confidence 467777899999999999999 7799999876
No 327
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=81.58 E-value=1 Score=46.45 Aligned_cols=46 Identities=15% Similarity=0.224 Sum_probs=31.4
Q ss_pred ccccCCCCcceEEe--eCCceEEEeccc-cCCCcchhhhhhhCCCCcccchhhccc
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNNMN-TYPSYSISYQIEQNPDLVNDAESVDKD 502 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~~~-~~~~~~~~~~~e~npdlin~~e~~~~~ 502 (767)
.||+|+||.||+|+ .+|+.||.+... ..+ .+...++.+|++...+.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~-------~~~~~~~~~e~~~l~~l 50 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLP-------PDLKAKFLQEARILKQY 50 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCC-------HHHHHHHHHHHHHHHhC
Confidence 69999999999999 689999987521 111 12234566676665544
No 328
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=81.55 E-value=1.1 Score=47.45 Aligned_cols=29 Identities=21% Similarity=0.209 Sum_probs=23.4
Q ss_pred CCCCCccccCCCCcceEEe---eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT---DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~---~dG~~VA~~~ 473 (767)
|.-...||+|+||.||+|. .+|..||++.
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~ 34 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKR 34 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEE
Confidence 3344589999999999997 3578899886
No 329
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=81.54 E-value=0.8 Score=50.92 Aligned_cols=30 Identities=17% Similarity=0.015 Sum_probs=25.6
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.|.-...||+|+||.||+|. .+|..||++.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~ 33 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKT 33 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEE
Confidence 35556689999999999998 7899999876
No 330
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=81.53 E-value=0.87 Score=49.90 Aligned_cols=40 Identities=13% Similarity=0.110 Sum_probs=33.8
Q ss_pred cHHHHHhcccCCCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 432 TSVNATSATCMDKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 432 s~~El~~AT~~nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.-.++..++ ++|.....||+|+||.||+|. .+|..||++.
T Consensus 8 ~~~~~~~~~--~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~ 49 (345)
T cd07877 8 LNKTIWEVP--ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 49 (345)
T ss_pred HHHHHhhcc--CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEE
Confidence 345666677 888888899999999999998 7899999987
No 331
>PHA03376 BARF1; Provisional
Probab=81.50 E-value=4.7 Score=40.10 Aligned_cols=81 Identities=16% Similarity=0.183 Sum_probs=47.0
Q ss_pred ceeeccccccccccccc---ccCCCcEEEeecCe-----eccCC---Cccc-cccc-ceeecccCcceeeeEEEEeeecc
Q psy12044 263 YLEIQEGKNVSLLCKVS---AIPEAKITWLFDGV-----PIQNE---SMSA-SESH-AVYSTEEGTEIKKSELLIYNSNI 329 (767)
Q Consensus 263 ~~~v~~G~~vsL~C~a~---g~P~p~itW~~~g~-----~l~~~---s~~~-~~~~-~~~~~~~g~~~~~s~L~I~nvs~ 329 (767)
.+....|+.+.|.|.-. ......|.|++... .+.-. .... ...+ ...+... ..+.+|.|.++..
T Consensus 20 pVta~VGEda~LsC~lnp~ssa~~MrIrWqKs~p~~~~VvL~~~ggdVv~~QmEyRGrtD~~~~---~gnvsLvI~~l~l 96 (221)
T PHA03376 20 AVTAFLGERVTLTSYWRRVSLGPEIEVSWFKLGPGEEQVLIGRMHHDVIFIEWPFRGFFDIHRS---ANTFFLVVTAANI 96 (221)
T ss_pred chhheeCCcEEEEecccCccCCCceEEEEEecCCCCCCEEEEEcCCeeeeeeeccccEEEEEec---CCeEEEEEEeeee
Confidence 34566788999999654 23567899998321 11100 0000 0000 0111111 1466899999999
Q ss_pred CCCCceeEeeccCCCCc
Q psy12044 330 DDNGTFVCVAENQAGST 346 (767)
Q Consensus 330 sD~GtY~CvA~N~~G~s 346 (767)
+|+|+|.|..+......
T Consensus 97 SDdGtY~C~fQkge~~~ 113 (221)
T PHA03376 97 SHDGNYLCRMKLGETEV 113 (221)
T ss_pred cCCceEEEEEEcCCCce
Confidence 99999999987654333
No 332
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=81.47 E-value=1 Score=48.75 Aligned_cols=24 Identities=21% Similarity=0.275 Sum_probs=21.6
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||+||+|. .+|..||++.
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~ 27 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKV 27 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEE
Confidence 79999999999998 6788999876
No 333
>cd05755 Ig2_ICAM-1_like Second immunoglobulin (Ig)-like domain of intercellular cell adhesion molecule-1 (ICAM-1, CD54) and similar proteins. Ig2_ ICAM-1_like: domain similar to the second immunoglobulin (Ig)-like domain of intercellular cell adhesion molecule-1 (ICAM-1, CD54). During the inflammation process, these molecules recruit leukocytes onto the vascular endothelium before extravasation to the injured tissues. ICAM-1 may be involved in organ targeted tumor metastasis. The interaction of ICAM-1 with leukocyte function-associated antigen-1 (LFA-1) plays a part in leukocyte-endothelial cell recognition. This group also contains ICAM-2, which also interacts with LFA-1. Transmigration of immature dendritic cells across resting endothelium is dependent on the interaction of ICAM-2 with, yet unidentified, ligand(s) on the dendritic cells. ICAM-1 has five Ig-like domains and ICAM-2 has two. ICAM-1 may also act as host receptor for viruses and parasites.
Probab=81.46 E-value=3.9 Score=36.65 Aligned_cols=72 Identities=19% Similarity=0.357 Sum_probs=46.7
Q ss_pred eeccccccccccccccc-CCCc--EEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCC-ceeEeec
Q psy12044 265 EIQEGKNVSLLCKVSAI-PEAK--ITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNG-TFVCVAE 340 (767)
Q Consensus 265 ~v~~G~~vsL~C~a~g~-P~p~--itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~G-tY~CvA~ 340 (767)
.+.+|+.++|.|.+.+. |.+. |.|++.+..+....+... ........+++.+. ...+|.| .|+|.|.
T Consensus 12 ~~~eG~~~tL~C~v~g~~P~a~L~i~W~rG~~~l~~~~~~~~--------~~~~~~~~stlt~~-~~r~D~g~~~sC~A~ 82 (100)
T cd05755 12 WQPVGKNYTLQCDVPGVAPRQNLTVVLLRGNETLSRQPFGDN--------TKSPVNAPATITIT-VDREDHGANFSCETE 82 (100)
T ss_pred cccCCCcEEEEEEEcCcCCCCcEEEEEeeCCEEcccceeccc--------cCCCceeEEEEEEe-cchhhCCcEEEEEEE
Confidence 45789999999999774 5555 799998877754332210 01112234555554 4566766 6999998
Q ss_pred cCCCC
Q psy12044 341 NQAGS 345 (767)
Q Consensus 341 N~~G~ 345 (767)
+..+.
T Consensus 83 l~l~~ 87 (100)
T cd05755 83 LDLRP 87 (100)
T ss_pred eccCc
Confidence 87654
No 334
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=81.43 E-value=0.98 Score=49.04 Aligned_cols=23 Identities=17% Similarity=0.176 Sum_probs=21.2
Q ss_pred cccCCCCcceEEe--eCCceEEEec
Q psy12044 451 IADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 451 IG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
||+|+||.||+|. .+|..||++.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~ 25 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKV 25 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEE
Confidence 7999999999998 7899999886
No 335
>KOG0591|consensus
Probab=81.42 E-value=0.62 Score=49.03 Aligned_cols=124 Identities=19% Similarity=0.234 Sum_probs=65.9
Q ss_pred ccccCCCCcceEEe--eCCceEEEec-----cccC----------------CCcchhhhhhhCCCCcccchhhccccccC
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN-----MNTY----------------PSYSISYQIEQNPDLVNDAESVDKDRRAQ 506 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~-----~~~~----------------~~~~~~~~~e~npdlin~~e~~~~~~~~~ 506 (767)
.||.|+||.|||+. .||..||-+. +|+- .|.-.+++ +-+||-|+|++.=.---.
T Consensus 26 ~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy---~~~f~~~~evlnivmE~c 102 (375)
T KOG0591|consen 26 KIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYY---AHSFIEDNEVLNIVMELC 102 (375)
T ss_pred HHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHH---HHhhhccchhhHHHHHhh
Confidence 79999999999999 9999999877 2211 22222222 235667777666555544
Q ss_pred CCCCcch---hhcccc--cccccccccCCccccccccccccCCCccccccccCccCCCcccccCCccccCCCCcc--ccC
Q psy12044 507 GGEDTQD---TQDKAS--EAASVQYSDSGSQCQEWGNVCYNRMQPMQHIVLNNVYNQPADIHLTPEKFMDRDGYP--VDF 579 (767)
Q Consensus 507 ~~~~~~~---~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 579 (767)
+++|-.- +|++.. -+.+.-|--=---|.-+. .||. .+|||.+- ..||.+- --|+|..|-- =||
T Consensus 103 ~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~-~cH~------~~~r~~Vm--HRDIKPa-NIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 103 DAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALY-HCHS------KIPRGTVM--HRDIKPA-NIFLTANGVVKLGDF 172 (375)
T ss_pred cccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHH-HHhc------ccccccee--eccCcch-heEEcCCCceeeccc
Confidence 4444432 444331 111222211000011111 1222 34554432 2565443 2699999932 389
Q ss_pred CCCCCCC
Q psy12044 580 GLPKVPT 586 (767)
Q Consensus 580 ~~~~~~~ 586 (767)
||.+.=.
T Consensus 173 GL~r~l~ 179 (375)
T KOG0591|consen 173 GLGRFLS 179 (375)
T ss_pred hhHhHhc
Confidence 9998754
No 336
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=81.40 E-value=0.91 Score=47.75 Aligned_cols=40 Identities=10% Similarity=0.078 Sum_probs=33.0
Q ss_pred cHHHHHhcccCCCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 432 TSVNATSATCMDKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 432 s~~El~~AT~~nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++.++..+. +.|.-...||.|+||.||+|. .+|..||.+.
T Consensus 7 ~~~~~~~~~--~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~ 48 (282)
T cd06636 7 DLSALRDPA--GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKV 48 (282)
T ss_pred hhhhhcChh--hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEE
Confidence 456666666 677777799999999999999 7889999876
No 337
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=81.25 E-value=0.89 Score=49.52 Aligned_cols=29 Identities=14% Similarity=0.077 Sum_probs=24.6
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|.-...||+|+||.||++. .+|+.||+|.
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~ 33 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKI 33 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEE
Confidence 4444589999999999999 7899999877
No 338
>cd05771 IgC_Tapasin_R Tapasin-R immunoglobulin-like domain. IgC_Tapasin_R: Immunoglobulin-like domain on Tapasin-R. Tapasin is a V-C1 (variable-constant) immunoglobulin superfamily molecule present in the endoplasmic reticulum (ER), where it links MHC class I molecules to the transporter associated with antigen processing (TAP). Tapasin-R is a tapasin-related protein that contains similar structural motifs to Tapasin, with some marked differences, especially in the V domain, transmembrane and cytoplasmic regions. The majority of Tapasin-R is located within the ER; however, there may be some expression of Tapasin-R at the cell surface. Tapasin-R lacks an obvious ER retention signal.
Probab=81.23 E-value=1.1 Score=42.43 Aligned_cols=36 Identities=14% Similarity=0.348 Sum_probs=30.7
Q ss_pred EEEEeeeccCCCCceeEeeccCCCCcccceEEEEEe
Q psy12044 321 ELLIYNSNIDDNGTFVCVAENQAGSTSSNYTIRIVL 356 (767)
Q Consensus 321 ~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~sL~V~~ 356 (767)
.|.|.+++..|.|.|.|.+.+..|.....+.+.+..
T Consensus 2 sL~i~~v~~~D~G~Y~C~~~~~~~~~~~~~~l~v~~ 37 (139)
T cd05771 2 SLTLPGLTVHDEGTYICSVSTPPHQAQQIIQLSVSE 37 (139)
T ss_pred eEEECCCCHHHCEEEEEEEEccCcceeeEEEEEEec
Confidence 588999999999999999998888877777776654
No 339
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=81.20 E-value=0.96 Score=47.99 Aligned_cols=29 Identities=10% Similarity=0.117 Sum_probs=24.7
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|....+||+|+||.||++. .+|+.||++.
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~ 32 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKK 32 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEE
Confidence 4445689999999999999 7899999876
No 340
>KOG1006|consensus
Probab=81.06 E-value=0.64 Score=48.58 Aligned_cols=24 Identities=25% Similarity=0.221 Sum_probs=23.0
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.||.|.||+|+|-. +.|++.|+++
T Consensus 71 ~iG~G~fG~V~KM~hk~sg~~mAVKr 96 (361)
T KOG1006|consen 71 EIGNGAFGTVNKMLHKPSGKLMAVKR 96 (361)
T ss_pred HhcCCcchhhhhhhcCccCcEEEEEE
Confidence 79999999999998 9999999988
No 341
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=81.04 E-value=0.93 Score=47.79 Aligned_cols=27 Identities=26% Similarity=0.158 Sum_probs=23.5
Q ss_pred CCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 447 GGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 447 ~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
-...||+|+||.||+|. .+|+.||++.
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~ 32 (288)
T cd07863 4 PVAEIGVGAYGTVYKARDPHSGHFVALKS 32 (288)
T ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEE
Confidence 34579999999999998 7899999886
No 342
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=80.96 E-value=1 Score=48.45 Aligned_cols=23 Identities=17% Similarity=0.241 Sum_probs=20.9
Q ss_pred cccCCCCcceEEe--eCCceEEEec
Q psy12044 451 IADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 451 IG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
||+|+||.||+|. .+|..||++.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~ 25 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKT 25 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEE
Confidence 7999999999999 6788999876
No 343
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=80.92 E-value=0.9 Score=50.07 Aligned_cols=30 Identities=17% Similarity=0.170 Sum_probs=25.8
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.....||+|+||.||++. .+|..||++.
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~ 33 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKI 33 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEE
Confidence 45566789999999999998 7899999876
No 344
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=80.86 E-value=1.1 Score=48.84 Aligned_cols=24 Identities=17% Similarity=0.236 Sum_probs=22.0
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||.||+|. .+|..||+|.
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~ 27 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKV 27 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEE
Confidence 79999999999998 7899999876
No 345
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=80.77 E-value=1.1 Score=48.84 Aligned_cols=25 Identities=16% Similarity=0.212 Sum_probs=22.5
Q ss_pred CccccCCCCcceEEe--eCCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++||+|+||.||++. .+|..||++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~ 27 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKI 27 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEE
Confidence 379999999999998 7899999876
No 346
>cd05772 IgC_SIRP Signal-regulatory protein (SIRP) immunoglobulin-like domain. IgC_SIRP: Immunoglobulin-like domain of signal-regulatory proteins (SIRP); the signal-regulatory proteins (SIRP) are Ig-like cell surface receptors detected in hematopoietic and non-hematopoietic cells. While their extracellular domains are similar, SIRP are classified as alpha or beta based on the length of the intracytoplasmic domain. Those having a 110- to 113-amino acid tail are classified as SIRP-alpha, and those having a 5-amino acid tail as SIRP-beta. SIRP-alpha and SIRP-beta molecules are thought to have complementary roles in signal regulation: SIRP-alpha inhibit signalling via their immunoreceptor tyrosine (IT)-based inhibition motifs while SIRP-beta are activating. SIRP-beta lack the cytoplasmic domainof SIRP-alpha, and associate with at least one other transmembrane protein (DAP-12 or KARAP). The IT-based activation motifs within DAP-12's cytoplasmic domain may link SIRP-beta to the activating
Probab=80.76 E-value=7.4 Score=35.51 Aligned_cols=70 Identities=16% Similarity=0.338 Sum_probs=42.2
Q ss_pred cccccccccccccccCC--CcEEEeecCeeccCCCcccccccceeeccc-CcceeeeEEEEeeeccCCC-CceeEeeccC
Q psy12044 267 QEGKNVSLLCKVSAIPE--AKITWLFDGVPIQNESMSASESHAVYSTEE-GTEIKKSELLIYNSNIDDN-GTFVCVAENQ 342 (767)
Q Consensus 267 ~~G~~vsL~C~a~g~P~--p~itW~~~g~~l~~~s~~~~~~~~~~~~~~-g~~~~~s~L~I~nvs~sD~-GtY~CvA~N~ 342 (767)
..|+.++|.|.+.++.. ..++|.+++..+...... .....+ +.....+.|.+.. ...|. ..|+|.+...
T Consensus 19 ~~g~~~tL~C~a~gF~P~~i~v~W~kng~~~~~~~~~------~~p~~d~~ty~~~S~L~~~~-~~~d~~~~ytC~V~H~ 91 (111)
T cd05772 19 NPGQSVNFTCSAHGFSPRDITVKWLKNGNELSAEQPN------ITPEGDSVSYNVTSTVQVKL-TEDDVHSQVTCEVQHR 91 (111)
T ss_pred CCCCCEEEEEEEeeEeCCCCEEEEEECCEECcccccc------eeeCCCCCcEEEEEEEEEEC-ccccccCceEEEEEeC
Confidence 45777899999988644 488999999887532111 111112 2334455555553 33343 4599999765
Q ss_pred C
Q psy12044 343 A 343 (767)
Q Consensus 343 ~ 343 (767)
.
T Consensus 92 ~ 92 (111)
T cd05772 92 T 92 (111)
T ss_pred C
Confidence 4
No 347
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=80.74 E-value=1.1 Score=47.38 Aligned_cols=24 Identities=25% Similarity=0.272 Sum_probs=21.6
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||.||++. .+|+.||++.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~ 26 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKC 26 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEE
Confidence 58999999999999 6799999876
No 348
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=80.64 E-value=1.1 Score=47.23 Aligned_cols=23 Identities=13% Similarity=0.225 Sum_probs=21.0
Q ss_pred cccCCCCcceEEe--eCCceEEEec
Q psy12044 451 IADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 451 IG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
||+|+||.||++. .+|..+|.+.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~ 25 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKK 25 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEE
Confidence 7999999999998 7899999876
No 349
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=80.59 E-value=0.8 Score=48.14 Aligned_cols=53 Identities=11% Similarity=0.070 Sum_probs=34.3
Q ss_pred CCCccccCCCCcceEEe--eCCceEEEeccccCCCcchhhhhhhCCCCcccchhhccccc
Q psy12044 447 GGYIIADGHNDMMLYAT--DSGILVATNNMNTYPSYSISYQIEQNPDLVNDAESVDKDRR 504 (767)
Q Consensus 447 ~~nlIG~GgfG~VYKG~--~dG~~VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~~~~ 504 (767)
-...||+|++|.||||. .+|..||++....-. . -.+...+++||++.+.+.+.
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~--~~~~~~~~~~E~~~l~~l~~ 57 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET---E--DEGVPSTAIREISLLKELNH 57 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeeccc---c--cccchhHHHHHHHHHHhcCC
Confidence 34579999999999998 789999988721110 0 01223456667766665543
No 350
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=80.57 E-value=1.1 Score=46.30 Aligned_cols=58 Identities=12% Similarity=0.163 Sum_probs=37.6
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEeccccCCCcchhhhhhhCCCCcccchhhccccc
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNNMNTYPSYSISYQIEQNPDLVNDAESVDKDRR 504 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~~~~ 504 (767)
++|.-...||+|+||.||+|+ .+|..||++....+ .+.. .++..++.+|++...+...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~-~~~~~~~~~ei~~l~~~~~ 61 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIF---EMMD-AKARQDCLKEIDLLKQLDH 61 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecc---cccc-hhhHHHHHHHHHHHHhCCC
Confidence 566677789999999999999 58999998762211 0000 1123346677766665543
No 351
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=80.57 E-value=1.3 Score=48.30 Aligned_cols=31 Identities=13% Similarity=0.028 Sum_probs=26.4
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+.|.-...||+|+||.||+|. .+|..||++.
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~ 47 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKK 47 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEE
Confidence 456666789999999999998 7888999886
No 352
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=80.49 E-value=0.76 Score=51.11 Aligned_cols=37 Identities=8% Similarity=0.013 Sum_probs=30.1
Q ss_pred HHHhcccCCCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 435 NATSATCMDKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 435 El~~AT~~nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++..+. ++|.-...||+|+||.||++. .+|..||++.
T Consensus 37 ~~~~~~--~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~ 75 (371)
T cd05622 37 DLRMKA--EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 75 (371)
T ss_pred hcCcch--hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEE
Confidence 344444 677777899999999999999 7888999876
No 353
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=80.42 E-value=0.98 Score=49.15 Aligned_cols=30 Identities=10% Similarity=0.015 Sum_probs=24.7
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||++. .++..+|++.
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~ 33 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKI 33 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEE
Confidence 44555689999999999999 6788888876
No 354
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=80.28 E-value=1 Score=48.07 Aligned_cols=31 Identities=19% Similarity=0.154 Sum_probs=26.7
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||+|. .+|..||++.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~ 37 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKV 37 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEE
Confidence 456666789999999999999 6899999877
No 355
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=80.18 E-value=1.4 Score=45.31 Aligned_cols=28 Identities=18% Similarity=0.287 Sum_probs=24.0
Q ss_pred CCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 446 NGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 446 s~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.....||+|+||+||+|+ .+|..||.+.
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~ 32 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKE 32 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEE
Confidence 344589999999999999 5899999886
No 356
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=80.18 E-value=1.2 Score=45.99 Aligned_cols=31 Identities=19% Similarity=0.206 Sum_probs=26.0
Q ss_pred CCCCCCCccccCCCCcceEEeeCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYATDSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~~dG~~VA~~~ 473 (767)
++|.-...||.|+||.||+|...|..||++.
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~ 36 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKC 36 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEE
Confidence 4566667899999999999996688899877
No 357
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=80.14 E-value=1.1 Score=46.61 Aligned_cols=30 Identities=17% Similarity=0.062 Sum_probs=25.7
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||+|+ .+|..||++.
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~ 41 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKI 41 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEE
Confidence 45556689999999999999 7899999876
No 358
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=80.08 E-value=0.96 Score=49.16 Aligned_cols=29 Identities=21% Similarity=0.233 Sum_probs=24.5
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|.-...||+|+||.||+|+ .+|..||++.
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~ 33 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKR 33 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEE
Confidence 4445589999999999999 6799999876
No 359
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=79.80 E-value=1.1 Score=46.69 Aligned_cols=31 Identities=19% Similarity=0.108 Sum_probs=24.9
Q ss_pred CCCCCCCccccCCCCcceEEe-e-C---CceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT-D-S---GILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~-~-d---G~~VA~~~ 473 (767)
++|.-.+.||+|+||+||||. . + ...||++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~ 39 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT 39 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEE
Confidence 567788899999999999998 3 2 35788776
No 360
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=79.69 E-value=0.58 Score=51.97 Aligned_cols=31 Identities=13% Similarity=0.041 Sum_probs=27.1
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||++. .+|..||++.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~ 75 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL 75 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEE
Confidence 567677789999999999998 7899999876
No 361
>cd07698 IgC_MHC_I_alpha3 Class I major histocompatibility complex (MHC) alpha chain immunoglobulin domain. IgC_MHC_I_alpha3; Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class I alpha chain. Class I MHC proteins bind antigenic peptide fragments and present them to CD8+ T lymphocytes. Class I molecules consist of a transmembrane alpha chain and a small chain called the beta2 microglobulin. The alpha chain contains three extracellular domains, two of which fold together to form the peptide-binding cleft (alpha1 and alpha2), and one which has an Ig fold (alpha3). Peptide binding to class I molecules occurs in the endoplasmic reticulum (ER) and involves both chaperones and dedicated factors to assist in peptide loading. Class I MHC molecules are expressed on most nucleated cells.
Probab=79.64 E-value=4.7 Score=35.27 Aligned_cols=68 Identities=21% Similarity=0.382 Sum_probs=40.2
Q ss_pred cccccccccccccCCC--cEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCC
Q psy12044 269 GKNVSLLCKVSAIPEA--KITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQA 343 (767)
Q Consensus 269 G~~vsL~C~a~g~P~p--~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~ 343 (767)
++.+.|.|.+.+...+ .++|..++......... .......++.....+.|.+.. .+...|+|.+....
T Consensus 14 ~~~~~L~C~a~gF~P~~i~v~W~~~g~~~~~~~~~----~~~~~~~d~ty~~~s~l~v~~---~~~~~ytC~V~H~~ 83 (93)
T cd07698 14 DGSLTLSCHATGFYPRDIEVTWLRDGEDSVDDVES----GEILPNGDGTYQLWVTLEVPP---EDKARYSCRVEHSG 83 (93)
T ss_pred CCcEEEEEEEEEEeCCCcEEEEEECCEECcccccc----cceEECCCCeEEEEEEEEECC---CCCCEEEEEEEeCC
Confidence 5678999999996443 88999988532221111 011122233344444555443 47789999997543
No 362
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=79.63 E-value=1.2 Score=46.55 Aligned_cols=26 Identities=23% Similarity=0.404 Sum_probs=23.1
Q ss_pred CCccccCCCCcceEEe--eCCceEEEec
Q psy12044 448 GYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 448 ~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
...||+|+||+||+|. .+|..||++.
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~ 33 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQ 33 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeee
Confidence 3489999999999998 7899999886
No 363
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=79.62 E-value=0.8 Score=48.11 Aligned_cols=30 Identities=20% Similarity=0.309 Sum_probs=25.1
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||+|. .+|..||.+.
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~ 33 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK 33 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEE
Confidence 34445689999999999999 6899999886
No 364
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=79.55 E-value=0.89 Score=49.46 Aligned_cols=31 Identities=16% Similarity=0.144 Sum_probs=26.1
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||+|. .+|+.||++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~ 50 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKC 50 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEE
Confidence 455556689999999999999 7899999876
No 365
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=79.54 E-value=1.4 Score=45.88 Aligned_cols=58 Identities=14% Similarity=0.103 Sum_probs=38.2
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEeccccCCCcchhhhhhhCCCCcccchhhccccc
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNNMNTYPSYSISYQIEQNPDLVNDAESVDKDRR 504 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~~~~ 504 (767)
++|.-...||+|+||.||+|+ .+|..||++....+... -.+...++++|++...+.+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~~~e~~~l~~l~h 61 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM----DAKARQDCVKEIDLLKQLNH 61 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC----CHHHHHHHHHHHHHHHhCCC
Confidence 456666789999999999999 68999998752111000 01333456777776665543
No 366
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=79.50 E-value=1.3 Score=48.05 Aligned_cols=24 Identities=21% Similarity=0.235 Sum_probs=21.7
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.||+|+||.||+|. .+|..||++.
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~ 27 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKV 27 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEE
Confidence 69999999999999 7888899876
No 367
>KOG4250|consensus
Probab=79.44 E-value=0.66 Score=54.37 Aligned_cols=30 Identities=20% Similarity=0.265 Sum_probs=25.5
Q ss_pred CCCccccCCCCcceEEe--eCCceEEEeccccC
Q psy12044 447 GGYIIADGHNDMMLYAT--DSGILVATNNMNTY 477 (767)
Q Consensus 447 ~~nlIG~GgfG~VYKG~--~dG~~VA~~~~~~~ 477 (767)
++ .||+||||.||+|. ..|..||++.-+.+
T Consensus 18 ~e-~LG~Ga~g~V~rgrnketG~~vAvK~~~~~ 49 (732)
T KOG4250|consen 18 DE-RLGKGAFGNVYRGRNKETGRLVAVKTFNKE 49 (732)
T ss_pred hh-hhcCCccceeeeecccccccchhHHhhhhh
Confidence 44 89999999999999 99999998874433
No 368
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=79.21 E-value=0.88 Score=50.60 Aligned_cols=31 Identities=13% Similarity=0.040 Sum_probs=26.5
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||++. .+|..||++.
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~ 75 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL 75 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEE
Confidence 566666789999999999999 7788999876
No 369
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=78.97 E-value=1.2 Score=47.34 Aligned_cols=31 Identities=32% Similarity=0.307 Sum_probs=27.6
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||+|+ .+|+.||++.
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~ 39 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKK 39 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEE
Confidence 577778899999999999999 6899999877
No 370
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=78.86 E-value=1.1 Score=46.41 Aligned_cols=29 Identities=10% Similarity=0.016 Sum_probs=24.9
Q ss_pred CCCCCccccCCCCcceEEe-eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
|.-...||+|+||.||+|. .+|..||++.
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~ 37 (260)
T cd05067 8 LKLVKKLGAGQFGEVWMGYYNGHTKVAIKS 37 (260)
T ss_pred ceeeeeeccCccceEEeeecCCCceEEEEE
Confidence 3344589999999999999 8999999987
No 371
>KOG0575|consensus
Probab=78.85 E-value=1.3 Score=51.17 Aligned_cols=29 Identities=24% Similarity=0.269 Sum_probs=26.1
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|.-.++||+|||.+||+++ ..|.+||++.
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~Kv 50 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKV 50 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEE
Confidence 4456799999999999999 8999999988
No 372
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=78.76 E-value=1.4 Score=46.46 Aligned_cols=24 Identities=25% Similarity=0.272 Sum_probs=21.5
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||.||+|. .+|+.||.+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~ 26 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKC 26 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEE
Confidence 58999999999998 6789999876
No 373
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=78.68 E-value=1.3 Score=46.55 Aligned_cols=29 Identities=14% Similarity=0.016 Sum_probs=24.4
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|.....||+|+||.||+|. .+|..||++.
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~ 36 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI 36 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEE
Confidence 3445579999999999998 6889999876
No 374
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=78.66 E-value=1.4 Score=47.88 Aligned_cols=24 Identities=17% Similarity=0.249 Sum_probs=21.9
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||+||+|. .+|..||++.
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~ 27 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKV 27 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEE
Confidence 79999999999998 7888999877
No 375
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=78.63 E-value=1.2 Score=46.92 Aligned_cols=26 Identities=19% Similarity=0.193 Sum_probs=23.0
Q ss_pred CCccccCCCCcceEEe--eCCceEEEec
Q psy12044 448 GYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 448 ~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
...||+|+||.||+|. .+|..||.+.
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~ 32 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKR 32 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEE
Confidence 3479999999999999 7899999876
No 376
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=78.57 E-value=1.3 Score=46.44 Aligned_cols=30 Identities=13% Similarity=0.176 Sum_probs=25.8
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.....||+|+||.||||+ .+|..||++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~ 32 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKE 32 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEE
Confidence 35566789999999999999 6899999886
No 377
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=78.50 E-value=0.93 Score=47.85 Aligned_cols=30 Identities=17% Similarity=0.096 Sum_probs=24.8
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.....||+|+||.||++. .+|..||++.
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~ 36 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKR 36 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEE
Confidence 34444589999999999999 7889999876
No 378
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=78.38 E-value=1.1 Score=46.98 Aligned_cols=31 Identities=16% Similarity=0.208 Sum_probs=25.3
Q ss_pred CCCCCCCccccCCCCcceEEe-eC-----CceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT-DS-----GILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~-~d-----G~~VA~~~ 473 (767)
++|.-..+||+|+||.||+|. .+ +..||++.
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~ 42 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKT 42 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEE
Confidence 456666799999999999999 54 67888876
No 379
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=78.34 E-value=1.2 Score=46.48 Aligned_cols=31 Identities=16% Similarity=0.200 Sum_probs=25.0
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCc---eEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGI---LVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~---~VA~~~ 473 (767)
++|...+.||+|+||.||+|+ .+|. .||++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~ 40 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKT 40 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEe
Confidence 577788899999999999998 3443 677765
No 380
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=78.32 E-value=1.4 Score=47.67 Aligned_cols=24 Identities=13% Similarity=0.241 Sum_probs=21.9
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+||+|+||.||++. .+|..||++.
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~ 27 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKI 27 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEE
Confidence 69999999999998 7899999876
No 381
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=78.20 E-value=1.3 Score=46.89 Aligned_cols=31 Identities=16% Similarity=0.157 Sum_probs=26.8
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||+|. .+|+.||++.
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~ 37 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKE 37 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEE
Confidence 456666789999999999999 6899999987
No 382
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=78.20 E-value=1.3 Score=46.11 Aligned_cols=31 Identities=23% Similarity=0.147 Sum_probs=26.6
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-..+||+|+||.||+|. .+|..+|++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~ 34 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKK 34 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEe
Confidence 456666789999999999999 7999999875
No 383
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=78.17 E-value=1.2 Score=47.24 Aligned_cols=31 Identities=16% Similarity=0.063 Sum_probs=27.0
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||+|. .+|..||++.
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~ 37 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKV 37 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEE
Confidence 567777789999999999998 7899999876
No 384
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=78.15 E-value=0.94 Score=49.29 Aligned_cols=36 Identities=17% Similarity=0.052 Sum_probs=30.8
Q ss_pred HHhcccCCCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 436 ATSATCMDKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 436 l~~AT~~nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+..++ ++|.-...||+|+||.||+|. .+|..||++.
T Consensus 5 ~~~~~--~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~ 42 (328)
T cd07856 5 VFEIT--NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKK 42 (328)
T ss_pred eeccc--cceEEEEeecccCCeEEEEEEECCCCCEEEEEE
Confidence 34456 788888899999999999998 7899999886
No 385
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=77.72 E-value=1.7 Score=45.00 Aligned_cols=30 Identities=20% Similarity=0.221 Sum_probs=25.8
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|....+||+|+||.||+|. .+|..||.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~ 32 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQ 32 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEE
Confidence 35566799999999999998 8899999876
No 386
>cd05719 Ig2_PVR_like Second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig2_PVR_like: domain similar to the second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), these result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus
Probab=77.61 E-value=12 Score=33.11 Aligned_cols=67 Identities=18% Similarity=0.184 Sum_probs=38.8
Q ss_pred cccccccc-cccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCC
Q psy12044 271 NVSLLCKV-SAIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGS 345 (767)
Q Consensus 271 ~vsL~C~a-~g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~ 345 (767)
...+.|.+ .+.|.+.|+|+.+.... . ........++.....+.|.+.-....+...|+|.+.+..-.
T Consensus 17 ~~va~C~s~~gkP~a~ItW~~~~~~~----~----~~~~~~~~~g~~tv~S~l~~~p~~~d~G~~~tC~v~h~~l~ 84 (95)
T cd05719 17 VTVATCVSANGKPPATISWETTLGGE----A----ETQSKENPNGTVTVTSEYRLVPSREANGKELTCVVSHPTLQ 84 (95)
T ss_pred cEEEEEECCCCcCCCEEEEEeCCCCc----c----eeEeecCCCCCEEEEEEEEEecCHHHCCCEEEEEEeCcccC
Confidence 45678887 57899999999861100 0 00111222334445566666444444455699999887643
No 387
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=77.60 E-value=1.4 Score=46.39 Aligned_cols=31 Identities=13% Similarity=0.113 Sum_probs=24.5
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCce----EEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGIL----VATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~----VA~~~ 473 (767)
+.|.....||+|+||.||||+ ++|.. ||++.
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~ 43 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKV 43 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEE
Confidence 356666789999999999998 67774 67665
No 388
>PF01034 Syndecan: Syndecan domain; InterPro: IPR001050 The syndecans are transmembrane proteoglycans which are involved in the organisation of cytoskeleton and/or actin microfilaments, and have important roles as cell surface receptors during cell-cell and/or cell-matrix interactions [, ]. Structurally, these proteins consist of four separate domains: A signal sequence; An extracellular domain (ectodomain) of variable length whose sequence is not evolutionary conserved in the various forms of syndecans. The ectodomain contains the sites of attachment of the heparan sulphate glycosaminoglycan side chains; A transmembrane region; A highly conserved cytoplasmic domain of about 30 to 35 residues, which could interact with cytoskeletal proteins. The proteins known to belong to this family are: Syndecan 1. Syndecan 2 or fibroglycan. Syndecan 3 or neuroglycan or N-syndecan. Syndecan 4 or amphiglycan or ryudocan. Drosophila syndecan. Caenorhabditis elegans probable syndecan (F57C7.3). Syndecan-4, a transmembrane heparan sulphate proteoglycan, is a coreceptor with integrins in cell adhesion. It has been suggested to form a ternary signalling complex with protein kinase Calpha and phosphatidylinositol 4,5-bisphosphate (PIP2). Structural studies have demonstrated that the cytoplasmic domain undergoes a conformational transition and forms a symmetric dimer in the presence of phospholipid activator PIP2, and whose overall structure in solution exhibits a twisted clamp shape having a cavity in the centre of dimeric interface. In addition, it has been observed that the syndecan-4 variable domain interacts, strongly, not only with fatty acyl groups but also the anionic head group of PIP2. These findings indicate that PIP2 promotes oligomerisation of the syndecan-4 cytoplasmic domain for transmembrane signalling and cell-matrix adhesion [, ].; GO: 0008092 cytoskeletal protein binding, 0016020 membrane; PDB: 1EJQ_B 1EJP_B 1YBO_C 1OBY_Q.
Probab=77.55 E-value=0.73 Score=37.28 Aligned_cols=13 Identities=8% Similarity=0.143 Sum_probs=0.0
Q ss_pred eeEEEeeehhhHH
Q psy12044 372 VLIVSGIISVCSL 384 (767)
Q Consensus 372 ~~iIigivv~llv 384 (767)
.++|+|+++++++
T Consensus 12 aavIaG~Vvgll~ 24 (64)
T PF01034_consen 12 AAVIAGGVVGLLF 24 (64)
T ss_dssp -------------
T ss_pred HHHHHHHHHHHHH
Confidence 3455555544333
No 389
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=77.52 E-value=1.4 Score=45.55 Aligned_cols=31 Identities=13% Similarity=0.128 Sum_probs=25.9
Q ss_pred CCCCCCCccccCCCCcceEEe-eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||+|. .++..||++.
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~ 37 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKT 37 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEE
Confidence 456666789999999999999 7778888876
No 390
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=77.38 E-value=1.8 Score=44.75 Aligned_cols=31 Identities=16% Similarity=0.256 Sum_probs=27.5
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-.++||+|+||.||+|. .+|..||.+.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~ 34 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQ 34 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEE
Confidence 578888899999999999998 6789999876
No 391
>KOG0473|consensus
Probab=77.36 E-value=0.07 Score=54.42 Aligned_cols=89 Identities=17% Similarity=0.113 Sum_probs=59.6
Q ss_pred ccccCCCCCCEEEccCCCCCCCCCCCCCCCCCCcEEECCCCcCcccccCCcCCCCCccEEeccCCCccccchhhhcCCCC
Q psy12044 93 KAFRGLTNLVDLDFSHNVLQTVPSDTFPDYPSLMKLTLSGNPIKQIKTGAFQPLSYLVTLELSKCGIEVIEDAAFVGLDS 172 (767)
Q Consensus 93 ~~f~~L~~L~~L~Ls~N~Lt~l~p~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~l~~ 172 (767)
..+..+.....||++.|++-.+. ..|+-++.|..|+++.|.+..++. .++.+..+..+++..|.++..+ .++..++.
T Consensus 36 ~ei~~~kr~tvld~~s~r~vn~~-~n~s~~t~~~rl~~sknq~~~~~~-d~~q~~e~~~~~~~~n~~~~~p-~s~~k~~~ 112 (326)
T KOG0473|consen 36 REIASFKRVTVLDLSSNRLVNLG-KNFSILTRLVRLDLSKNQIKFLPK-DAKQQRETVNAASHKNNHSQQP-KSQKKEPH 112 (326)
T ss_pred hhhhccceeeeehhhhhHHHhhc-cchHHHHHHHHHhccHhhHhhChh-hHHHHHHHHHHHhhccchhhCC-ccccccCC
Confidence 34455566677777777766554 346666777777777777766654 3555666777777777776654 35777788
Q ss_pred CCeeeccCCccc
Q psy12044 173 LEWLKLDNNKIT 184 (767)
Q Consensus 173 L~~L~Ls~N~Lt 184 (767)
++.+++.+|.|+
T Consensus 113 ~k~~e~k~~~~~ 124 (326)
T KOG0473|consen 113 PKKNEQKKTEFF 124 (326)
T ss_pred cchhhhccCcch
Confidence 888888777654
No 392
>KOG0605|consensus
Probab=77.05 E-value=1.6 Score=49.74 Aligned_cols=33 Identities=21% Similarity=0.207 Sum_probs=29.2
Q ss_pred cCCCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 441 CMDKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 441 ~~nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++++|.--.+||+||||.||-+. ..|.+.|-+.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~ 173 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKI 173 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeec
Confidence 44788888899999999999998 8999999765
No 393
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=76.99 E-value=1.3 Score=48.20 Aligned_cols=32 Identities=25% Similarity=0.333 Sum_probs=27.4
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEecc
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNNM 474 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~~ 474 (767)
++|.-...||+|+||.||+|+ .+|+.||++..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~ 38 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI 38 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEe
Confidence 466666789999999999998 78999999873
No 394
>PHA02633 hypothetical protein; Provisional
Probab=76.98 E-value=3.5 Score=33.32 Aligned_cols=40 Identities=25% Similarity=0.532 Sum_probs=31.8
Q ss_pred eeEEEEeeeccCCCCceeEeeccCCCCcccceEEEEEeec
Q psy12044 319 KSELLIYNSNIDDNGTFVCVAENQAGSTSSNYTIRIVLKE 358 (767)
Q Consensus 319 ~s~L~I~nvs~sD~GtY~CvA~N~~G~s~~s~sL~V~~~~ 358 (767)
...|.|.++..+|.|.|.|+..|..-....++.+.|..+.
T Consensus 17 ~~nLwilpa~~sDSGiYiC~~rn~t~c~~~si~l~V~~~~ 56 (63)
T PHA02633 17 CNNMLILNPTQSDSGIYMCITKNETYSDMMKFDLCICLRI 56 (63)
T ss_pred cccEEEeccccccCcEEEEEEcCCCeeEEEEEEEEEeecc
Confidence 3468999999999999999999887777666766665543
No 395
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=76.87 E-value=1.5 Score=48.65 Aligned_cols=29 Identities=17% Similarity=0.036 Sum_probs=24.5
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|.-...||+|+||.||++. .+|..||++.
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~ 33 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKT 33 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEE
Confidence 4444589999999999998 7899999876
No 396
>KOG1163|consensus
Probab=76.79 E-value=1.1 Score=46.23 Aligned_cols=160 Identities=20% Similarity=0.205 Sum_probs=83.9
Q ss_pred HHHHHhcccCCCCCCCCccccCCCCcceEEe--eCCceEEEeccccCCCcchhhhhhhCCCCcccchhhccccccCCCCC
Q psy12044 433 SVNATSATCMDKVNGGYIIADGHNDMMLYAT--DSGILVATNNMNTYPSYSISYQIEQNPDLVNDAESVDKDRRAQGGED 510 (767)
Q Consensus 433 ~~El~~AT~~nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~~~~~~~~~~ 510 (767)
.+++..++ ++.--..||.|+||..|-|. .+|..||++- -+-.-++|-|+-|+.. =++.++++|--
T Consensus 8 ~~~~iv~g---ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~---------Es~~a~hpqL~yEskv-Y~iL~~g~GiP 74 (341)
T KOG1163|consen 8 LEELIVGG---KYKLVRKIGSGSFGDIYLGISITSGEEVAIKL---------ESSKAKHPQLLYESKV-YRILQGGVGIP 74 (341)
T ss_pred hhhheecc---ceEEEEeecCCchhheeeeeeccCCceEEEEe---------ecccCCCcchhHHHHH-HHHhccCCCCc
Confidence 45555555 44445679999999999999 9999999876 1123457888888743 44566555532
Q ss_pred cchhhcccccccccccccC-Cccccccccccc-------cCCCcccccccc-----CccCCCcccccCCccccCCCC---
Q psy12044 511 TQDTQDKASEAASVQYSDS-GSQCQEWGNVCY-------NRMQPMQHIVLN-----NVYNQPADIHLTPEKFMDRDG--- 574 (767)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--- 574 (767)
..-+|-+.. .-++.+-|= |-.--.+-+-|- +.|=+=|+|-|= ..|=| .|| -|..||=+=|
T Consensus 75 ~i~~y~~e~-~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiH-RDI--KPdNFLMGlgrh~ 150 (341)
T KOG1163|consen 75 HIRHYGTEK-DYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIH-RDI--KPDNFLMGLGRHC 150 (341)
T ss_pred hhhhhcccc-ccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhcccc-ccC--Cccceeecccccc
Confidence 222322111 112222220 000000000000 111111222111 22333 454 4668887666
Q ss_pred ---ccccCCCCCCCCCCCCCCCcccccccCCCCcccCCCCCCccc
Q psy12044 575 ---YPVDFGLPKVPTHFPALVPATAYYRTLPHRRHTAANPNNRYS 616 (767)
Q Consensus 575 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (767)
|=.||||.|-=-- .-.=+-.|+++.++-.-.+|||
T Consensus 151 ~kl~LIDFGLaKky~d-------~~t~~HIpyre~r~ltGTaRYA 188 (341)
T KOG1163|consen 151 NKLYLIDFGLAKKYRD-------IRTRQHIPYREDRNLTGTARYA 188 (341)
T ss_pred ceEEEEeccchhhhcc-------ccccccCccccCCccceeeeeh
Confidence 7789999984220 0122456777777766677887
No 397
>KOG1095|consensus
Probab=76.64 E-value=0.51 Score=58.22 Aligned_cols=50 Identities=18% Similarity=0.234 Sum_probs=32.1
Q ss_pred CccccCCCCcceEEe---eCCce----EEEeccccCCCcchhhhhhhCCCCcccchhhccccc
Q psy12044 449 YIIADGHNDMMLYAT---DSGIL----VATNNMNTYPSYSISYQIEQNPDLVNDAESVDKDRR 504 (767)
Q Consensus 449 nlIG~GgfG~VYKG~---~dG~~----VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~~~~ 504 (767)
..||+|+||.||+|+ .+|.. ||++...-.+. .+.--||..|+-.+++..-
T Consensus 698 ~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~------~~~~~~Fl~Ea~~m~~f~H 754 (1025)
T KOG1095|consen 698 RVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS------EQEVSDFLKEALLMSKFDH 754 (1025)
T ss_pred eeeccccccceEEEEEecCCCCccceEEEEEeccccCC------HHHHHHHHHHHHHHhcCCC
Confidence 579999999999999 56653 77655222211 1334567777766666554
No 398
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=76.60 E-value=1.8 Score=44.73 Aligned_cols=30 Identities=17% Similarity=0.050 Sum_probs=25.6
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-.+.||.|+||.||+|. .+|..||++.
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~ 33 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKR 33 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEE
Confidence 45566789999999999999 6888898876
No 399
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=76.55 E-value=1.5 Score=47.97 Aligned_cols=30 Identities=17% Similarity=0.131 Sum_probs=24.0
Q ss_pred CCCCCCccccCCCCcceEEe-------eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT-------DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~-------~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||+|. .+|+.||+|.
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~ 44 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM 44 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEE
Confidence 45455589999999999995 4578899887
No 400
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=76.53 E-value=1.5 Score=46.35 Aligned_cols=56 Identities=9% Similarity=0.071 Sum_probs=36.8
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEeccccCCCcchhhhhhhCCCCcccchhhcccc
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNNMNTYPSYSISYQIEQNPDLVNDAESVDKDR 503 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~~~ 503 (767)
++|.-...||+|+||.||||+ .+|+.||++....... -.+...++.+|++...+..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~e~~~l~~l~ 59 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-----DEGVPSTAIREISLLKEMQ 59 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-----cccchHHHHHHHHHHHhcc
Confidence 466667789999999999999 6899999876211100 0122234567776666554
No 401
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=76.50 E-value=1.7 Score=45.30 Aligned_cols=30 Identities=20% Similarity=0.217 Sum_probs=25.0
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||.|+||.||+|+ .+|..||++.
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~ 33 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKI 33 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEE
Confidence 34445589999999999999 6899999876
No 402
>PF12877 DUF3827: Domain of unknown function (DUF3827); InterPro: IPR024606 The function of the proteins in this entry is not currently known, but one of the human proteins (Q9HCM3 from SWISSPROT) has been implicated in pilocytic astrocytomas [, , ]. In the majority of cases of pilocytic astrocytomas a tandem duplication produces an in-frame fusion of the gene encoding this protein and the BRAF oncogene. The resulting fusion protein has constitutive BRAF kinase activity and is capable of transforming cells.
Probab=76.46 E-value=2 Score=49.88 Aligned_cols=33 Identities=21% Similarity=0.469 Sum_probs=19.7
Q ss_pred cccceeeeEEEeeehhhHHHHHHHHHHHhhhhh
Q psy12044 366 VFPLEYVLIVSGIISVCSLVLIFLLVLCFLCFR 398 (767)
Q Consensus 366 ~~~~~~~~iIigivv~llvllllvvivi~~~~r 398 (767)
..+.....||+|+++.+++++++++++++++||
T Consensus 263 ~s~~~NlWII~gVlvPv~vV~~Iiiil~~~LCR 295 (684)
T PF12877_consen 263 KSPPNNLWIIAGVLVPVLVVLLIIIILYWKLCR 295 (684)
T ss_pred CCCCCCeEEEehHhHHHHHHHHHHHHHHHHHhc
Confidence 344556778888876666665555555444443
No 403
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=76.40 E-value=2 Score=46.15 Aligned_cols=25 Identities=12% Similarity=0.037 Sum_probs=20.8
Q ss_pred CccccCCCCcceEEe-e---CCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT-D---SGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~-~---dG~~VA~~~ 473 (767)
..||+|+||.||+|. . ++..||++.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~ 35 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQ 35 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEE
Confidence 489999999999998 3 557788876
No 404
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=76.26 E-value=1.5 Score=47.49 Aligned_cols=25 Identities=28% Similarity=0.416 Sum_probs=22.7
Q ss_pred CccccCCCCcceEEe--eCCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.+||+|+||.||+|. .+|+.||++.
T Consensus 5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~ 31 (324)
T cd05589 5 AVLGRGHFGKVLLAEYKKTGELYAIKA 31 (324)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEE
Confidence 479999999999998 7899999887
No 405
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=76.10 E-value=1.8 Score=45.34 Aligned_cols=30 Identities=17% Similarity=0.112 Sum_probs=25.8
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.|...+.||+|+||.||+|+ .+|..||++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~ 33 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKI 33 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEE
Confidence 35556689999999999999 7899999886
No 406
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=76.09 E-value=1.3 Score=45.79 Aligned_cols=30 Identities=10% Similarity=0.059 Sum_probs=24.9
Q ss_pred CCCCCCccccCCCCcceEEe-eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||+|. .++..||++.
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~ 37 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKT 37 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEE
Confidence 44444589999999999999 8888899876
No 407
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=76.05 E-value=1.4 Score=46.57 Aligned_cols=31 Identities=23% Similarity=0.287 Sum_probs=26.5
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|...+.||+|+||.||+|+ .+|+.||++.
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~ 37 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKK 37 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEE
Confidence 456667789999999999999 6799999876
No 408
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=75.95 E-value=1.8 Score=47.17 Aligned_cols=31 Identities=16% Similarity=0.295 Sum_probs=26.6
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||+|. .+|..||.+.
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~ 37 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKL 37 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEE
Confidence 567777789999999999999 6889998865
No 409
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=75.71 E-value=1.7 Score=47.32 Aligned_cols=55 Identities=9% Similarity=0.148 Sum_probs=36.3
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEeccccCCCcchhhhhhhCCCCcccchhhcccc
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNNMNTYPSYSISYQIEQNPDLVNDAESVDKDR 503 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~~~ 503 (767)
++|.-...||+|+||.||++. .+|..||.+....-... +...++.+|++...+..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~------~~~~~~~~E~~~l~~l~ 61 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP------AIRNQIIRELQVLHECN 61 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH------HHHHHHHHHHHHHHHCC
Confidence 567777789999999999999 78899998762211000 11234666666665543
No 410
>KOG0192|consensus
Probab=75.71 E-value=1.8 Score=48.05 Aligned_cols=48 Identities=15% Similarity=0.191 Sum_probs=31.9
Q ss_pred ccccCCCCcceEEeeCCce-EEEeccc--cCCCcchhhhhhhCCCCcccchhhccccc
Q psy12044 450 IIADGHNDMMLYATDSGIL-VATNNMN--TYPSYSISYQIEQNPDLVNDAESVDKDRR 504 (767)
Q Consensus 450 lIG~GgfG~VYKG~~dG~~-VA~~~~~--~~~~~~~~~~~e~npdlin~~e~~~~~~~ 504 (767)
.||.|+||+||||.-.|+. ||++... -++... .-+|..|+....+.+-
T Consensus 48 ~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-------~~~f~~E~~il~~l~H 98 (362)
T KOG0192|consen 48 VLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-------RKAFRREASLLSRLRH 98 (362)
T ss_pred hcccCCceeEEEEEeCCceeEEEEEecchhcChHH-------HHHHHHHHHHHHhCCC
Confidence 5999999999999977777 9987711 111111 2356677776665544
No 411
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=75.69 E-value=1.1 Score=48.84 Aligned_cols=31 Identities=23% Similarity=0.253 Sum_probs=23.6
Q ss_pred CCCCCCCccccCCCCcceEEe-------eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT-------DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~-------~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||+|. .++..||+|.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~ 44 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKM 44 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheec
Confidence 344445689999999999995 3456888877
No 412
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=75.64 E-value=1.6 Score=44.84 Aligned_cols=29 Identities=10% Similarity=-0.011 Sum_probs=24.7
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|...+.||+|+||.||||. .+|..||.+.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~ 32 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKE 32 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEE
Confidence 4455689999999999999 7788898876
No 413
>PF13908 Shisa: Wnt and FGF inhibitory regulator
Probab=75.60 E-value=2.1 Score=42.63 Aligned_cols=14 Identities=21% Similarity=0.294 Sum_probs=6.9
Q ss_pred eeEEEeeehhhHHH
Q psy12044 372 VLIVSGIISVCSLV 385 (767)
Q Consensus 372 ~~iIigivv~llvl 385 (767)
+++|+||+++++++
T Consensus 78 ~~iivgvi~~Vi~I 91 (179)
T PF13908_consen 78 TGIIVGVICGVIAI 91 (179)
T ss_pred eeeeeehhhHHHHH
Confidence 44555555544433
No 414
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=75.53 E-value=1.9 Score=44.85 Aligned_cols=31 Identities=16% Similarity=0.172 Sum_probs=27.2
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-.++||+|+||.||+|. .+|..||.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~ 34 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQ 34 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEE
Confidence 467777899999999999999 7899999986
No 415
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=75.28 E-value=1.6 Score=45.23 Aligned_cols=31 Identities=10% Similarity=0.009 Sum_probs=26.1
Q ss_pred CCCCCCCccccCCCCcceEEe-eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
+.|.-...||+|+||.||+|. .++..||++.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~ 37 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKT 37 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEe
Confidence 356666789999999999999 7788899877
No 416
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=75.19 E-value=1.9 Score=46.24 Aligned_cols=30 Identities=13% Similarity=0.163 Sum_probs=25.6
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||+|. .+|..+|.+.
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~ 33 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKL 33 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEE
Confidence 56667789999999999998 7888888765
No 417
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=75.05 E-value=1.5 Score=48.85 Aligned_cols=31 Identities=23% Similarity=0.305 Sum_probs=24.1
Q ss_pred CCCCCCCccccCCCCcceEEe-------eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT-------DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~-------~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||+|+ .++..||++.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~ 72 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKM 72 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEe
Confidence 355556689999999999985 3456899887
No 418
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=75.05 E-value=2.3 Score=44.12 Aligned_cols=56 Identities=11% Similarity=0.227 Sum_probs=34.0
Q ss_pred CCccccCCCCcceEEe-eCCceEEEeccccCCCcchhhhhhhCCCCcccchhhccccc
Q psy12044 448 GYIIADGHNDMMLYAT-DSGILVATNNMNTYPSYSISYQIEQNPDLVNDAESVDKDRR 504 (767)
Q Consensus 448 ~nlIG~GgfG~VYKG~-~dG~~VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~~~~ 504 (767)
...||.|+||.||+|. .+|..||++....- ......-.++...+.+|++...+.+.
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~~~~~~e~~~l~~l~~ 61 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELD-TSNVLAAEKEYEKLQEEVDLLKSLKH 61 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecC-ccchhhHHHHHHHHHHHHHHHHhcCC
Confidence 3479999999999999 89999998762110 10001111222346666666655543
No 419
>KOG3864|consensus
Probab=74.98 E-value=0.54 Score=47.23 Aligned_cols=33 Identities=33% Similarity=0.351 Sum_probs=15.4
Q ss_pred CCccEEeccCC-CccccchhhhcCCCCCCeeecc
Q psy12044 147 SYLVTLELSKC-GIEVIEDAAFVGLDSLEWLKLD 179 (767)
Q Consensus 147 ~~L~~L~Ls~N-~L~~i~~~~~~~l~~L~~L~Ls 179 (767)
++|+.|+|++| +|+..--..+..+++|+.|.|.
T Consensus 151 ~~L~~L~lsgC~rIT~~GL~~L~~lknLr~L~l~ 184 (221)
T KOG3864|consen 151 PSLQDLDLSGCPRITDGGLACLLKLKNLRRLHLY 184 (221)
T ss_pred cchheeeccCCCeechhHHHHHHHhhhhHHHHhc
Confidence 44555555544 4444333334444555544443
No 420
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=74.82 E-value=2 Score=46.04 Aligned_cols=25 Identities=12% Similarity=0.045 Sum_probs=20.5
Q ss_pred CccccCCCCcceEEe-e---CCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT-D---SGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~-~---dG~~VA~~~ 473 (767)
..||+|+||.||||. . ++..||++.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~ 35 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQ 35 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEE
Confidence 489999999999998 4 446788776
No 421
>KOG1035|consensus
Probab=74.77 E-value=0.81 Score=56.71 Aligned_cols=31 Identities=10% Similarity=0.052 Sum_probs=27.8
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.+--+||+||||.|||+. -||+--|+|+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKK 511 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKK 511 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhh
Confidence 477777799999999999999 9999999888
No 422
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=74.75 E-value=2 Score=45.50 Aligned_cols=29 Identities=21% Similarity=0.381 Sum_probs=24.5
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|.-...||+|+||.||+|. .+|+.||++.
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~ 32 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKK 32 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEE
Confidence 3344589999999999999 6899999987
No 423
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=74.70 E-value=1.7 Score=47.57 Aligned_cols=31 Identities=19% Similarity=0.188 Sum_probs=27.0
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.....||+|+||.||+|. .+|..||++.
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~ 47 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKK 47 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEE
Confidence 456666789999999999998 7899999986
No 424
>PF02480 Herpes_gE: Alphaherpesvirus glycoprotein E; InterPro: IPR003404 Glycoprotein E (gE) of Alphaherpesvirus forms a complex with glycoprotein I (gI), functioning as an immunoglobulin G (IgG) Fc binding protein. gE is involved in virus spread but is not essential for propagation [].; GO: 0016020 membrane; PDB: 2GJ7_F 2GIY_B.
Probab=74.69 E-value=1.8 Score=49.29 Aligned_cols=20 Identities=25% Similarity=0.341 Sum_probs=13.8
Q ss_pred EEEEeeeccCCCCceeEeec
Q psy12044 321 ELLIYNSNIDDNGTFVCVAE 340 (767)
Q Consensus 321 ~L~I~nvs~sD~GtY~CvA~ 340 (767)
.|.+.|+...++|-|.|++.
T Consensus 270 ~l~f~~a~~~~sGLYv~V~~ 289 (439)
T PF02480_consen 270 DLQFTNAPESASGLYVFVVY 289 (439)
T ss_dssp SEEESS--GGG-EEEEEEEE
T ss_pred ceEecCCCcccCceEEEEEE
Confidence 47888888888999988774
No 425
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=74.63 E-value=1.5 Score=48.14 Aligned_cols=31 Identities=23% Similarity=0.162 Sum_probs=26.4
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+.|.-...||+|+||.||++. .+|..||++.
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~ 53 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKK 53 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEE
Confidence 455566689999999999998 7899999887
No 426
>KOG4308|consensus
Probab=74.62 E-value=0.09 Score=60.45 Aligned_cols=131 Identities=25% Similarity=0.232 Sum_probs=68.1
Q ss_pred ccEEEccCCCCCccC----cccccCCCCCCEEEccCCCCCCCCC----CCCCCC-CCCcEEECCCCcCccccc----CCc
Q psy12044 77 LQKIYLSRCRISVID----SKAFRGLTNLVDLDFSHNVLQTVPS----DTFPDY-PSLMKLTLSGNPIKQIKT----GAF 143 (767)
Q Consensus 77 L~~L~Ls~N~L~~i~----p~~f~~L~~L~~L~Ls~N~Lt~l~p----~~f~~l-~~L~~L~Ls~N~l~~l~~----~~~ 143 (767)
|..|.|.+|.+..-. ..++..+..|+.|++++|.+....- ..+... ..|+.|++..+.++.... ..+
T Consensus 89 l~~L~L~~~~l~~~~~~~l~~~l~t~~~L~~L~l~~n~l~~~g~~~l~~~l~~~~~~l~~L~l~~c~l~~~g~~~l~~~L 168 (478)
T KOG4308|consen 89 LLHLSLANNRLGDRGAEELAQALKTLPTLGQLDLSGNNLGDEGARLLCEGLRLPQCLLQTLELVSCSLTSEGAAPLAAVL 168 (478)
T ss_pred HHHhhhhhCccccchHHHHHHHhcccccHhHhhcccCCCccHhHHHHHhhcccchHHHHHHHhhcccccccchHHHHHHH
Confidence 566677777666533 3345566677777777777663211 112222 455666666666654332 223
Q ss_pred CCCCCccEEeccCCCcccc----chhhhc----CCCCCCeeeccCCccccccCC-----CCCCCC-cccccCCCCCCC
Q psy12044 144 QPLSYLVTLELSKCGIEVI----EDAAFV----GLDSLEWLKLDNNKITTISGS-----NILPTG-LHGIDLHHNPWT 207 (767)
Q Consensus 144 ~~l~~L~~L~Ls~N~L~~i----~~~~~~----~l~~L~~L~Ls~N~Lt~ip~~-----~~~~~~-L~~L~Ls~N~l~ 207 (767)
.....|+.++++.|.+... +...+. ...++++|+|++|.++..... +-.... +..|++..|.+.
T Consensus 169 ~~~~~l~~l~l~~n~l~~~g~~~l~~~l~~~~~~~~~le~L~L~~~~~t~~~c~~l~~~l~~~~~~~~el~l~~n~l~ 246 (478)
T KOG4308|consen 169 EKNEHLTELDLSLNGLIELGLLVLSQALESAASPLSSLETLKLSRCGVTSSSCALLDEVLASGESLLRELDLASNKLG 246 (478)
T ss_pred hcccchhHHHHHhcccchhhhHHHhhhhhhhhcccccHHHHhhhhcCcChHHHHHHHHHHhccchhhHHHHHHhcCcc
Confidence 3456667777777766311 122222 355667777777766522111 111122 445666666653
No 427
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=74.47 E-value=2 Score=45.32 Aligned_cols=25 Identities=8% Similarity=0.016 Sum_probs=20.1
Q ss_pred CCCCCCccccCCCCcceEEe--eCCce
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGIL 468 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~ 468 (767)
.|...+.||+|+||.||+|+ .+|..
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~ 34 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDS 34 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCc
Confidence 44455689999999999998 67765
No 428
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=74.40 E-value=1.8 Score=46.12 Aligned_cols=31 Identities=13% Similarity=0.038 Sum_probs=25.4
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+.|.....||+|+||.||+|. .+|..||.+.
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~ 38 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKE 38 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEE
Confidence 345555689999999999998 6788999876
No 429
>PF14575 EphA2_TM: Ephrin type-A receptor 2 transmembrane domain; PDB: 3KUL_A 2XVD_A 2VX1_A 2VWV_A 2VX0_A 2VWY_A 2VWZ_A 2VWW_A 2VWU_A 2VWX_A ....
Probab=74.26 E-value=0.68 Score=39.18 Aligned_cols=16 Identities=13% Similarity=0.025 Sum_probs=10.6
Q ss_pred cccHHHHHhcccCCCCCC
Q psy12044 430 KYTSVNATSATCMDKVNG 447 (767)
Q Consensus 430 ~fs~~El~~AT~~nnFs~ 447 (767)
-+||+|-.+|- ..|..
T Consensus 56 P~TYEDP~qAV--~eFAk 71 (75)
T PF14575_consen 56 PHTYEDPNQAV--REFAK 71 (75)
T ss_dssp GGGSSSHHHHH--HHCSS
T ss_pred cccccCHHHHH--HHHHh
Confidence 36788887776 55543
No 430
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=74.25 E-value=1.6 Score=46.34 Aligned_cols=31 Identities=19% Similarity=0.131 Sum_probs=26.8
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.....||+|+||.||+|. .+|..||++.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~ 44 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKK 44 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEE
Confidence 456666789999999999999 7899999886
No 431
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=74.24 E-value=2.1 Score=43.66 Aligned_cols=29 Identities=24% Similarity=0.359 Sum_probs=24.9
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|.....||+|+||.||+|+ .+|..|+++.
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~ 32 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKS 32 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEE
Confidence 4455689999999999999 5899999877
No 432
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=74.16 E-value=1.9 Score=42.91 Aligned_cols=24 Identities=17% Similarity=0.329 Sum_probs=19.5
Q ss_pred ccccCCCCcceEEeeCCceEEEec
Q psy12044 450 IIADGHNDMMLYATDSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~~dG~~VA~~~ 473 (767)
+||+|+||.||+|..+|..|+++.
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~ 24 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKE 24 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEE
Confidence 589999999999995566666655
No 433
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=74.15 E-value=2.2 Score=46.36 Aligned_cols=25 Identities=20% Similarity=0.189 Sum_probs=22.6
Q ss_pred CccccCCCCcceEEe--eCCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++||+|+||.||+|. .+|+.||++-
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~ 41 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIKK 41 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEEE
Confidence 479999999999999 6899999876
No 434
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=74.13 E-value=1.8 Score=53.59 Aligned_cols=31 Identities=16% Similarity=0.045 Sum_probs=26.5
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-..+||+|+||.||+|. .+|+.||+|.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~ 34 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKK 34 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEE
Confidence 355566789999999999999 6799999987
No 435
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=73.97 E-value=2.1 Score=44.79 Aligned_cols=30 Identities=17% Similarity=-0.010 Sum_probs=25.3
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||.|+||.||||. .+|..||.+.
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~ 33 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV 33 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEE
Confidence 34455689999999999999 6899999887
No 436
>KOG0580|consensus
Probab=73.91 E-value=2.6 Score=43.59 Aligned_cols=32 Identities=22% Similarity=0.226 Sum_probs=28.3
Q ss_pred CCCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 442 MDKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 442 ~nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+++|+=...||+|.||.||-|. .++-+||.+-
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKV 54 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKV 54 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEee
Confidence 3788888899999999999998 8888999765
No 437
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=73.85 E-value=2.1 Score=44.00 Aligned_cols=29 Identities=10% Similarity=0.013 Sum_probs=24.9
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|.-.+.||+|+||.||+|+ .+|..||.+.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~ 32 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQ 32 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEE
Confidence 4455689999999999999 7899999876
No 438
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=73.65 E-value=2.2 Score=46.17 Aligned_cols=25 Identities=24% Similarity=0.303 Sum_probs=22.8
Q ss_pred CccccCCCCcceEEe--eCCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
..||+|+||.||+|. .+|..||++.
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~ 32 (338)
T cd07859 6 EVIGKGSYGVVCSAIDTHTGEKVAIKK 32 (338)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEE
Confidence 479999999999999 7899999987
No 439
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=73.62 E-value=1.6 Score=45.79 Aligned_cols=53 Identities=13% Similarity=0.142 Sum_probs=32.2
Q ss_pred CCCCCccccCCCCcceEEe--eCCc----eEEEeccccCCCcchhhhhhhCCCCcccchhhcccc
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGI----LVATNNMNTYPSYSISYQIEQNPDLVNDAESVDKDR 503 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~----~VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~~~ 503 (767)
|.-...||+|+||.||+|+ .+|. .||.+....-+. .+...++.+|++...+..
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~------~~~~~~~~~e~~~l~~l~ 67 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS------PKANKEILDEAYVMASVD 67 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC------HHHHHHHHHHHHHHHhCC
Confidence 3344589999999999998 5564 467665221111 223345666766666543
No 440
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=73.31 E-value=2.3 Score=44.54 Aligned_cols=26 Identities=27% Similarity=0.311 Sum_probs=22.6
Q ss_pred CCccccCCCCcceEEe--eCCceEEEec
Q psy12044 448 GYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 448 ~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
...||+|+||.||+|+ .+|..||++.
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~ 31 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKK 31 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEE
Confidence 3579999999999999 5688899887
No 441
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=73.30 E-value=2 Score=47.36 Aligned_cols=31 Identities=16% Similarity=0.017 Sum_probs=26.6
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||++. ..|..||++.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~ 56 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKK 56 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEE
Confidence 456666789999999999998 7888999887
No 442
>cd05768 IgC_CH4 CH4 domain (fourth constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH4: The fourth immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=73.15 E-value=5.8 Score=35.55 Aligned_cols=74 Identities=16% Similarity=0.351 Sum_probs=41.2
Q ss_pred ccccccccccccccCCC--cEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccC
Q psy12044 268 EGKNVSLLCKVSAIPEA--KITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQ 342 (767)
Q Consensus 268 ~G~~vsL~C~a~g~P~p--~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~ 342 (767)
.+..++|.|.+.++... .++|.+++..+........... .....++.....+.|.+..-.-.+...|+|.+.-.
T Consensus 15 ~~~~~tL~C~a~gFyP~~i~v~W~k~g~~~~~~~~~~~~~~-~~~~~dgTy~~~s~L~v~~~~w~~~~~ytC~V~H~ 90 (102)
T cd05768 15 LQETATLTCLVKGFSPSDIFVKWLQNGQPLSKQKYVTTAPM-QEPGGNESYFLYSKLTVSAEDWNAGDVFTCVVGHE 90 (102)
T ss_pred cCCceEEEEEEeeEeCCCCEEEEEECCEECCcccccccCcc-cccCCCCeEEEEEEEEEcHHHhcCCCcEEEEeEeC
Confidence 46779999999997554 5699999877643321100000 00001244444555655322223456799998743
No 443
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=73.07 E-value=2.5 Score=43.60 Aligned_cols=31 Identities=10% Similarity=0.246 Sum_probs=26.5
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||+|+ .+|..||++.
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~ 33 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKK 33 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEE
Confidence 356667799999999999999 5699999876
No 444
>KOG0194|consensus
Probab=73.06 E-value=2.2 Score=48.79 Aligned_cols=49 Identities=14% Similarity=0.243 Sum_probs=32.0
Q ss_pred CccccCCCCcceEEe---eCC--ce-EEEeccccCCCcchhhhhhhCCCCcccchhhcc
Q psy12044 449 YIIADGHNDMMLYAT---DSG--IL-VATNNMNTYPSYSISYQIEQNPDLVNDAESVDK 501 (767)
Q Consensus 449 nlIG~GgfG~VYKG~---~dG--~~-VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~ 501 (767)
..||+|+||.||+|+ .++ .. ||++..-.- .....|+=-++.+||....+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~----~~~~~~~~~e~m~EArvMr~ 217 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS----SELTKEQIKEFMKEARVMRQ 217 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeeccc----ccccHHHHHHHHHHHHHHHh
Confidence 589999999999999 444 23 788773320 01123445578888876654
No 445
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=72.75 E-value=2.1 Score=44.47 Aligned_cols=30 Identities=17% Similarity=0.113 Sum_probs=24.9
Q ss_pred CCCCCCccccCCCCcceEEe-eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
.+.-.+.||+|+||.||+|. .++..||++.
T Consensus 7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~ 37 (260)
T cd05073 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKT 37 (260)
T ss_pred ceeEEeEecCccceEEEEEEecCCccEEEEe
Confidence 44556689999999999999 7788888865
No 446
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=72.74 E-value=2.6 Score=43.56 Aligned_cols=24 Identities=17% Similarity=0.070 Sum_probs=20.8
Q ss_pred ccccCCCCcceEEe----eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT----DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~----~dG~~VA~~~ 473 (767)
.||+|+||+||+|+ .++..||++.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~ 29 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKI 29 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEE
Confidence 69999999999995 4678899876
No 447
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=72.68 E-value=1.8 Score=44.78 Aligned_cols=29 Identities=14% Similarity=0.079 Sum_probs=23.8
Q ss_pred CCCCCccccCCCCcceEEe-eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
|.-...||+|+||.||+|. .++..+|.+.
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~ 35 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKA 35 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEe
Confidence 4444579999999999999 7887888875
No 448
>PHA03209 serine/threonine kinase US3; Provisional
Probab=72.64 E-value=2.1 Score=47.13 Aligned_cols=31 Identities=13% Similarity=-0.079 Sum_probs=26.3
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.+|.-...||+|+||.||+|. .++..||.|.
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~ 98 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI 98 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEe
Confidence 467777799999999999999 6778898875
No 449
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=72.60 E-value=2.5 Score=44.33 Aligned_cols=23 Identities=13% Similarity=0.195 Sum_probs=20.8
Q ss_pred cccCCCCcceEEe--eCCceEEEec
Q psy12044 451 IADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 451 IG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
||+|+||+||++. .+|..||.+.
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~ 25 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKK 25 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEE
Confidence 7999999999998 7899999875
No 450
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=72.57 E-value=1.8 Score=45.12 Aligned_cols=30 Identities=13% Similarity=0.144 Sum_probs=23.0
Q ss_pred CCCCCCccccCCCCcceEEe-e----CCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT-D----SGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~-~----dG~~VA~~~ 473 (767)
+|.-..+||+|+||.||+|. . .+..||.+.
T Consensus 6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~ 40 (266)
T cd05064 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHT 40 (266)
T ss_pred HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEe
Confidence 34455689999999999997 2 356788776
No 451
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=72.37 E-value=2.1 Score=45.76 Aligned_cols=31 Identities=19% Similarity=0.309 Sum_probs=24.1
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCce--EEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGIL--VATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~--VA~~~ 473 (767)
++|.-...||+|+||.||+|. .+|.. ||++.
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~ 41 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR 41 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEE
Confidence 566667789999999999998 56754 46555
No 452
>PF01034 Syndecan: Syndecan domain; InterPro: IPR001050 The syndecans are transmembrane proteoglycans which are involved in the organisation of cytoskeleton and/or actin microfilaments, and have important roles as cell surface receptors during cell-cell and/or cell-matrix interactions [, ]. Structurally, these proteins consist of four separate domains: A signal sequence; An extracellular domain (ectodomain) of variable length whose sequence is not evolutionary conserved in the various forms of syndecans. The ectodomain contains the sites of attachment of the heparan sulphate glycosaminoglycan side chains; A transmembrane region; A highly conserved cytoplasmic domain of about 30 to 35 residues, which could interact with cytoskeletal proteins. The proteins known to belong to this family are: Syndecan 1. Syndecan 2 or fibroglycan. Syndecan 3 or neuroglycan or N-syndecan. Syndecan 4 or amphiglycan or ryudocan. Drosophila syndecan. Caenorhabditis elegans probable syndecan (F57C7.3). Syndecan-4, a transmembrane heparan sulphate proteoglycan, is a coreceptor with integrins in cell adhesion. It has been suggested to form a ternary signalling complex with protein kinase Calpha and phosphatidylinositol 4,5-bisphosphate (PIP2). Structural studies have demonstrated that the cytoplasmic domain undergoes a conformational transition and forms a symmetric dimer in the presence of phospholipid activator PIP2, and whose overall structure in solution exhibits a twisted clamp shape having a cavity in the centre of dimeric interface. In addition, it has been observed that the syndecan-4 variable domain interacts, strongly, not only with fatty acyl groups but also the anionic head group of PIP2. These findings indicate that PIP2 promotes oligomerisation of the syndecan-4 cytoplasmic domain for transmembrane signalling and cell-matrix adhesion [, ].; GO: 0008092 cytoskeletal protein binding, 0016020 membrane; PDB: 1EJQ_B 1EJP_B 1YBO_C 1OBY_Q.
Probab=72.32 E-value=1.2 Score=36.17 Aligned_cols=33 Identities=21% Similarity=0.338 Sum_probs=0.5
Q ss_pred eeEEEeeehhhHHHHHHHHHHHhhhhhhhhccc
Q psy12044 372 VLIVSGIISVCSLVLIFLLVLCFLCFRRKKKKL 404 (767)
Q Consensus 372 ~~iIigivv~llvllllvvivi~~~~rRrrr~~ 404 (767)
..+++|+|+++++.++++++++++...|.|++.
T Consensus 8 ~~vlaavIaG~Vvgll~ailLIlf~iyR~rkkd 40 (64)
T PF01034_consen 8 SEVLAAVIAGGVVGLLFAILLILFLIYRMRKKD 40 (64)
T ss_dssp -----------------------------S---
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC
Confidence 357888888877777776666655555555544
No 453
>PHA02988 hypothetical protein; Provisional
Probab=72.30 E-value=3 Score=44.18 Aligned_cols=63 Identities=10% Similarity=0.054 Sum_probs=38.8
Q ss_pred ccHHHHHhcccCCCCCCCCccccCCCCcceEEeeCCceEEEeccccCCCcchhhhhhhCCCCcccchhhccccc
Q psy12044 431 YTSVNATSATCMDKVNGGYIIADGHNDMMLYATDSGILVATNNMNTYPSYSISYQIEQNPDLVNDAESVDKDRR 504 (767)
Q Consensus 431 fs~~El~~AT~~nnFs~~nlIG~GgfG~VYKG~~dG~~VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~~~~ 504 (767)
+..+|+...+ ...||+|++|.||||..+|..||++......... +.+. .++.+|++...+.+.
T Consensus 15 i~~~~i~~~~-------~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~-~~~~---~~~~~E~~~l~~l~h 77 (283)
T PHA02988 15 IESDDIDKYT-------SVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGH-KVLI---DITENEIKNLRRIDS 77 (283)
T ss_pred cCHHHcCCCC-------CeEEeeCCceEEEEEEECCEEEEEEecccccccc-HHHH---HHHHHHHHHHHhcCC
Confidence 4455554433 3589999999999999889999987722111110 0011 234577777766654
No 454
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=72.19 E-value=2.4 Score=44.51 Aligned_cols=27 Identities=19% Similarity=0.242 Sum_probs=23.4
Q ss_pred CCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 447 GGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 447 ~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
-...||+|+||.||+|+ .+|..||++.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~ 32 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKK 32 (285)
T ss_pred EeeEecccCceEEEEEEECCCCcEEEEEE
Confidence 34579999999999999 6899999876
No 455
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=72.09 E-value=3 Score=43.28 Aligned_cols=26 Identities=19% Similarity=0.368 Sum_probs=21.0
Q ss_pred CCccccCCCCcceEEe--eCC---ceEEEec
Q psy12044 448 GYIIADGHNDMMLYAT--DSG---ILVATNN 473 (767)
Q Consensus 448 ~nlIG~GgfG~VYKG~--~dG---~~VA~~~ 473 (767)
...||+|+||.||+|+ .++ ..||++.
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~ 34 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKT 34 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEE
Confidence 3579999999999998 333 6788876
No 456
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=71.98 E-value=2.1 Score=46.72 Aligned_cols=31 Identities=19% Similarity=0.179 Sum_probs=26.3
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.+|.-...||+|+||.||+|. .+|..||.+.
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~ 37 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKK 37 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEE
Confidence 355666789999999999999 7899999876
No 457
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=71.97 E-value=2.4 Score=44.65 Aligned_cols=28 Identities=11% Similarity=0.102 Sum_probs=23.4
Q ss_pred CCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 446 NGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 446 s~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.-...||+|+||.||+|. .+|..||.+.
T Consensus 8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~ 37 (284)
T cd06620 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKV 37 (284)
T ss_pred HHHHHcCCCCCeEEEEEEEcCCCcEEEEEE
Confidence 334579999999999999 6899999865
No 458
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=71.96 E-value=2.2 Score=44.74 Aligned_cols=30 Identities=20% Similarity=0.283 Sum_probs=25.2
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-...||+|+||.||+|+ .+|..||++.
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~ 33 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKK 33 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEeh
Confidence 45555689999999999999 6788999876
No 459
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=71.92 E-value=2 Score=47.08 Aligned_cols=31 Identities=16% Similarity=0.036 Sum_probs=26.4
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+.|.-...||+|+||.||++. ..|..||++.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~ 49 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK 49 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEE
Confidence 456566789999999999998 6889999887
No 460
>KOG1094|consensus
Probab=71.82 E-value=6.3 Score=45.66 Aligned_cols=25 Identities=16% Similarity=0.153 Sum_probs=22.3
Q ss_pred CccccCCCCcceEEe-eCCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
..||+|-||.|--.+ ..+..||++.
T Consensus 544 ekiGeGqFGEVhLCeveg~lkVAVK~ 569 (807)
T KOG1094|consen 544 EKIGEGQFGEVHLCEVEGPLKVAVKI 569 (807)
T ss_pred hhhcCcccceeEEEEecCceEEEEee
Confidence 359999999999999 7789999877
No 461
>PF07654 C1-set: Immunoglobulin C1-set domain; InterPro: IPR003597 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C1-set domains, which are classical Ig-like domains resembling the antibody constant domain. C1-set domains are found almost exclusively in molecules involved in the immune system, such as in immunoglobulin light and heavy chains, in the major histocompatibility complex (MHC) class I and II complex molecules [, ], and in various T-cell receptors.; PDB: 3BVN_D 3BXN_A 3PWV_E 3L9R_F 2XFX_B 1BMG_A 1K8I_A 3M1B_G 3M17_C 1EXU_A ....
Probab=71.72 E-value=11 Score=31.90 Aligned_cols=69 Identities=22% Similarity=0.391 Sum_probs=43.7
Q ss_pred ccccccccccccccCCC--cEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCC
Q psy12044 268 EGKNVSLLCKVSAIPEA--KITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQA 343 (767)
Q Consensus 268 ~G~~vsL~C~a~g~P~p--~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~ 343 (767)
.+..+.|.|.+.++... .+.|..++..+....... ......++.....+.|.+. ..+...|+|.+....
T Consensus 7 ~~~~~~L~C~v~~f~P~~i~v~W~~~~~~~~~~~~~~----~~~~~~dgty~~~s~l~v~---~~~~~~ysC~V~H~~ 77 (83)
T PF07654_consen 7 LGGSVTLTCLVSGFYPKDITVTWLKNGKEVTEGVETT----PPPPNSDGTYSVTSSLTVT---WNSGDEYSCRVTHES 77 (83)
T ss_dssp STSEEEEEEEEEEEBSSTEEEEEEETTEEETTTEEEE----EEEEETTSEEEEEEEEEEE---TTTTGGEEEEEEETT
T ss_pred CCCCEEEEEEEEEEECCCcEEEEEeccceeeeeeeec----ccccccccceeeeEEEEec---CCCCCEEEEEEEECC
Confidence 37788999999886443 689999887765432210 0111245555666667666 445557999987543
No 462
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=71.69 E-value=2 Score=45.65 Aligned_cols=31 Identities=16% Similarity=0.089 Sum_probs=27.1
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||+|+ .+|..||++.
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~ 40 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKK 40 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEE
Confidence 567777789999999999999 7889999876
No 463
>PHA03265 envelope glycoprotein D; Provisional
Probab=71.66 E-value=2 Score=46.10 Aligned_cols=32 Identities=28% Similarity=0.330 Sum_probs=16.9
Q ss_pred EEeeehhhHHHHHHHHHHHhhhhhhhhccccc
Q psy12044 375 VSGIISVCSLVLIFLLVLCFLCFRRKKKKLKK 406 (767)
Q Consensus 375 Iigivv~llvllllvvivi~~~~rRrrr~~k~ 406 (767)
.+|++++++++.++++.+++|.|+|||+..++
T Consensus 349 ~~g~~ig~~i~glv~vg~il~~~~rr~k~~~k 380 (402)
T PHA03265 349 FVGISVGLGIAGLVLVGVILYVCLRRKKELKK 380 (402)
T ss_pred ccceEEccchhhhhhhhHHHHHHhhhhhhhhh
Confidence 34444445555555555555655555554433
No 464
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=71.64 E-value=1.9 Score=44.80 Aligned_cols=30 Identities=10% Similarity=0.114 Sum_probs=25.5
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+|.-.+.||+|+||.||+|. .+|..||.+.
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~ 38 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT 38 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEE
Confidence 45566789999999999999 6788999876
No 465
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=71.57 E-value=2.7 Score=43.17 Aligned_cols=28 Identities=11% Similarity=0.042 Sum_probs=23.9
Q ss_pred CCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 446 NGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 446 s~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.-.+.||.|+||.||++. .+|..||.+.
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~ 32 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKE 32 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEE
Confidence 344689999999999998 7889999876
No 466
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=71.43 E-value=2.9 Score=42.86 Aligned_cols=24 Identities=17% Similarity=0.137 Sum_probs=22.0
Q ss_pred ccccCCCCcceEEe-eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
+||+|+||.||++. .+|..||.|.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~ 26 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKT 26 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEe
Confidence 69999999999999 6699999886
No 467
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=71.24 E-value=2.6 Score=44.02 Aligned_cols=26 Identities=27% Similarity=0.262 Sum_probs=22.8
Q ss_pred CCccccCCCCcceEEe--eCCceEEEec
Q psy12044 448 GYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 448 ~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
...||+|+||.||||+ .+|..||++.
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~ 31 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKK 31 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEE
Confidence 3479999999999999 6789999887
No 468
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=71.15 E-value=2.4 Score=43.90 Aligned_cols=27 Identities=15% Similarity=0.080 Sum_probs=23.1
Q ss_pred CCCccccCCCCcceEEe-eCCceEEEec
Q psy12044 447 GGYIIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 447 ~~nlIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
-...||+|+||.||+|. .++..||++.
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~ 37 (260)
T cd05070 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKT 37 (260)
T ss_pred hhheeccccCceEEEEEecCCceeEEEE
Confidence 34579999999999999 8888888876
No 469
>PF02009 Rifin_STEVOR: Rifin/stevor family; InterPro: IPR002858 Malaria is still a major cause of mortality in many areas of the world. Plasmodium falciparum causes the most severe human form of the disease and is responsible for most fatalities. Severe cases of malaria can occur when the parasite invades and then proliferates within red blood cell erythrocytes. The parasite produces many variant antigenic proteins, encoded by multigene families, which are present on the surface of the infected erythrocyte and play important roles in virulence. A crucial survival mechanism for the malaria parasite is its ability to evade the immune response by switching these variant surface antigens. The high virulence of P. falciparum relative to other malarial parasites is in large part due to the fact that in this organism many of these surface antigens mediate the binding of infected erythrocytes to the vascular endothelium (cytoadherence) and non-infected erythrocytes (rosetting). This can lead to the accumulation of infected cells in the vasculature of a variety of organs, blocking the blood flow and reducing the oxygen supply. Clinical symptoms of severe infection can include fever, progressive anaemia, multi-organ dysfunction and coma. For more information see []. Several multicopy gene families have been described in Plasmodium falciparum, including the stevor family of subtelomeric open reading frames and the rif interspersed repetitive elements. Both families contain three predicted transmembrane segments. It has been proposed that stevor and rif are members of a larger superfamily that code for variant surface antigens [].
Probab=71.08 E-value=1.4 Score=47.39 Aligned_cols=7 Identities=43% Similarity=0.752 Sum_probs=2.6
Q ss_pred Hhhhhhh
Q psy12044 393 CFLCFRR 399 (767)
Q Consensus 393 i~~~~rR 399 (767)
+++++||
T Consensus 277 LILRYRR 283 (299)
T PF02009_consen 277 LILRYRR 283 (299)
T ss_pred HHHHHHH
Confidence 3333333
No 470
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=71.06 E-value=2.6 Score=45.73 Aligned_cols=31 Identities=23% Similarity=0.147 Sum_probs=27.0
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||+|+ .+|..||+|.
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~ 37 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKK 37 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEE
Confidence 466666789999999999999 7899999987
No 471
>PHA03212 serine/threonine kinase US3; Provisional
Probab=70.85 E-value=2.4 Score=47.62 Aligned_cols=31 Identities=6% Similarity=-0.056 Sum_probs=26.0
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+.|.-...||+|+||.||++. .+|..||.+.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~ 124 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKA 124 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEec
Confidence 356666789999999999999 7889999864
No 472
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=70.73 E-value=2.5 Score=45.57 Aligned_cols=30 Identities=17% Similarity=0.154 Sum_probs=25.8
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.|...+.||+|+||.||+|. .+|..||.+.
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~ 57 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKK 57 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEE
Confidence 35666789999999999999 6889999876
No 473
>cd07699 IgC_L Immunoglobulin Constant domain. IgC_L: Immunoglobulin (Ig) light chain constant (C) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=70.69 E-value=11 Score=33.65 Aligned_cols=72 Identities=15% Similarity=0.338 Sum_probs=43.4
Q ss_pred ccccccccccccccC--CCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCC
Q psy12044 268 EGKNVSLLCKVSAIP--EAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQA 343 (767)
Q Consensus 268 ~G~~vsL~C~a~g~P--~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~ 343 (767)
.++.++|.|.+.+.. ...++|..++..+...... .......++.....+.|.+..-.-.+...|+|.+.-..
T Consensus 16 ~~~~~~L~C~~~gfyP~~i~v~W~~~g~~~~~~~~~----~~~~~~~dgty~~~s~L~v~~~~w~~~~~~sC~V~H~~ 89 (100)
T cd07699 16 KSGKATLVCLINDFYPGFATVQWKVDGATVSSGVQT----STTEQQSDNTYSLSSYLTLTKSDWNKHKVYTCEVTHEG 89 (100)
T ss_pred cCCCcEEEEEEEeEECCCCEEEEEECCEECcccEec----cccEECCCCCEEEEEEEEEcHHHhCCCCeEEEEEEecC
Confidence 466789999998864 3578999998877432111 00111224444555566554443334678999987543
No 474
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=70.68 E-value=3.1 Score=43.70 Aligned_cols=49 Identities=16% Similarity=0.183 Sum_probs=32.8
Q ss_pred CCccccCCCCcceEEe--eCCceEEEeccccCCCcchhhhhhhCCCCcccchhhccc
Q psy12044 448 GYIIADGHNDMMLYAT--DSGILVATNNMNTYPSYSISYQIEQNPDLVNDAESVDKD 502 (767)
Q Consensus 448 ~nlIG~GgfG~VYKG~--~dG~~VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~~ 502 (767)
-.+||+|+||.||+|. .+|..||.+....- . ..+...++.+|++...+.
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~----~--~~~~~~~~~~E~~~l~~l 56 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLD----I--TVELQKQIMSELEILYKC 56 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecC----C--ChHHHHHHHHHHHHHHhC
Confidence 3479999999999998 78899998762110 0 123344566777665543
No 475
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=70.60 E-value=1.6 Score=45.82 Aligned_cols=27 Identities=15% Similarity=-0.027 Sum_probs=22.9
Q ss_pred CCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 447 GGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 447 ~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
....||+|+||.||+|. .+|..||.+.
T Consensus 8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~ 36 (277)
T cd06642 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKI 36 (277)
T ss_pred HHHHhcCCCCeeEEEEEEcCCCeEEEEEE
Confidence 33479999999999998 6788999876
No 476
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=70.54 E-value=2.5 Score=46.03 Aligned_cols=31 Identities=19% Similarity=0.084 Sum_probs=26.7
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+.|.-...||+|+||.||+|. .+|..||++.
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~ 37 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKK 37 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEE
Confidence 456666789999999999999 7899999987
No 477
>cd05847 IgC_CH2_IgE CH2 domain (second constant Ig domain of the heavy chain) in immunoglobulin E (IgE). IgC_CH2_IgE: The second constant domain of the heavy chain of immunoglobulin E (IgE). The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma, and mu, all consisting of a variable domain (VH) and three (in alpha, delta, and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). The different classes of antibodies vary in their heavy chains; the IgE class has the epsilon type. This domain (Cepsilon2) of IgE is in place of the flexible hinge region found in IgG.
Probab=70.53 E-value=9 Score=33.80 Aligned_cols=72 Identities=25% Similarity=0.391 Sum_probs=41.2
Q ss_pred cccccccccccccCC--CcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCC
Q psy12044 269 GKNVSLLCKVSAIPE--AKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAG 344 (767)
Q Consensus 269 G~~vsL~C~a~g~P~--p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G 344 (767)
...+.|.|.+.++.. ..++|.+++..+....... .......+.....+.|.+..-.-.+...|.|.+.....
T Consensus 14 ~~~~~L~C~a~gFyP~~I~vtW~~dg~~~~~~~~~s----~~~~~~~~Ty~~~S~L~v~~~~w~~~~~ytC~V~H~~~ 87 (94)
T cd05847 14 SETIQLLCLISGYTPGTIEVEWLVDGQVATLVAAST----APQKEEGSTFSTTSELNVTQEDWKSGKTYTCKVTHQGT 87 (94)
T ss_pred CCCEEEEEEEEeEECCCCEEEEEECCEECcCceeec----ccEECCCCcEEEEEEEEEchHHhcCCCeEEEEEEECCe
Confidence 455789999998643 4779999887653221110 01111233344455565553333356789999976543
No 478
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=70.49 E-value=1.8 Score=44.61 Aligned_cols=29 Identities=31% Similarity=0.373 Sum_probs=23.9
Q ss_pred CCCCCccccCCCCcceEEeeCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYATDSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~~dG~~VA~~~ 473 (767)
|.-...||+|+||.||+|..+|..||++.
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~iK~ 36 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEYTGQKVAVKN 36 (254)
T ss_pred ceeeeeeccCCCCceEecccCCCceEEEe
Confidence 34456899999999999997777888876
No 479
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=70.46 E-value=2.9 Score=47.80 Aligned_cols=29 Identities=17% Similarity=0.021 Sum_probs=25.7
Q ss_pred CCCCCCccccCCCCcceEEe-eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
.|++ .-||+|++|.||||+ .+|+.||+|-
T Consensus 119 ~fd~-~plasaSigQVh~A~l~~G~~VaVKv 148 (437)
T TIGR01982 119 EFEE-KPLAAASIAQVHRARLVDGKEVAVKV 148 (437)
T ss_pred hCCC-cceeeeehhheEEEEecCCCEEEEEe
Confidence 4554 489999999999999 9999999988
No 480
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=70.44 E-value=2.5 Score=44.41 Aligned_cols=54 Identities=13% Similarity=0.050 Sum_probs=32.8
Q ss_pred CCCCCCccccCCCCcceEEe------eCCceEEEeccccCCCcchhhhhhhCCCCcccchhhcccc
Q psy12044 444 KVNGGYIIADGHNDMMLYAT------DSGILVATNNMNTYPSYSISYQIEQNPDLVNDAESVDKDR 503 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~------~dG~~VA~~~~~~~~~~~~~~~~e~npdlin~~e~~~~~~ 503 (767)
.|.-...||+|+||+||||+ .++..||++....-. ..+...++.+|++...+..
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~E~~~l~~l~ 65 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN------NPQQWGEFQQEASLMAELH 65 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC------CHHHHHHHHHHHHHHhhCC
Confidence 34444589999999999996 255788877622110 1122245556666665554
No 481
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=70.39 E-value=3 Score=43.06 Aligned_cols=25 Identities=24% Similarity=0.254 Sum_probs=20.1
Q ss_pred CccccCCCCcceEEe-e----CCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT-D----SGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~-~----dG~~VA~~~ 473 (767)
++||+|+||.||+|. . ++..||++.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~ 30 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKS 30 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEe
Confidence 479999999999998 3 345788876
No 482
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=70.22 E-value=3.1 Score=43.04 Aligned_cols=24 Identities=21% Similarity=0.194 Sum_probs=21.8
Q ss_pred ccccCCCCcceEEe--eCCceEEEec
Q psy12044 450 IIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 450 lIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.||+|+||.||+|+ .+|+.||++.
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~ 28 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKV 28 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEE
Confidence 58999999999998 6899999886
No 483
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=70.20 E-value=2.8 Score=44.64 Aligned_cols=30 Identities=23% Similarity=0.163 Sum_probs=25.8
Q ss_pred CCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 444 KVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 444 nFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
.|.-...||+|+||.||+|. .+|..||++.
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~ 51 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQ 51 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEE
Confidence 45556689999999999999 7899999886
No 484
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=69.95 E-value=2.7 Score=43.42 Aligned_cols=29 Identities=14% Similarity=0.077 Sum_probs=24.3
Q ss_pred CCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
|.-..+||.|+||.||+|. .+|..||.+.
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~ 32 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKY 32 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEE
Confidence 3445689999999999999 5799999876
No 485
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=69.79 E-value=2.8 Score=44.20 Aligned_cols=31 Identities=16% Similarity=0.065 Sum_probs=25.7
Q ss_pred CCCCCCCccccCCCCcceEEe-e------CCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT-D------SGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~-~------dG~~VA~~~ 473 (767)
++|.....||+|+||.||+|. . ++..||++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~ 42 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKM 42 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEe
Confidence 577778899999999999998 3 467888776
No 486
>cd05766 IgC_MHC_II_beta Class II major histocompatibility complex (MHC) beta chain immunoglobulin domain. IgC_MHC_II_beta: Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class II beta chain. MHC class II molecules play a key role in the initiation of the antigen-specific immune reponse. In both humans and in mice these molecules have been shown to be expressed constitutively on the cell surface of professional antigen-presenting cells (APCs), for example on B-lymphocytes, monocytes, and macrophages. The expression of these molecules has been shown to be induced in nonprofessional APCs such as keratinocyctes, and they are expressed on the surface of activated human T cells and on T cells from other species. The MHC II molecules present antigenic peptides to CD4(+) T-lymphocytes. These peptides derive mostly from protelytic processing via the endocytic pathway, of antigens internalized by the APC. These peptides bind to the MHC class II molecules in the endosome be
Probab=69.72 E-value=12 Score=32.95 Aligned_cols=69 Identities=17% Similarity=0.247 Sum_probs=42.0
Q ss_pred ccccccccccccccCCC--cEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCC
Q psy12044 268 EGKNVSLLCKVSAIPEA--KITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQA 343 (767)
Q Consensus 268 ~G~~vsL~C~a~g~P~p--~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~ 343 (767)
.+...+|.|.+.++..+ .++|..++..+...... .......++.....+.|.+ ...+...|+|.+.-..
T Consensus 13 ~~~~~~L~C~~~gFyP~~i~v~W~~~g~~~~~~~~~----~~~~~~~dgTy~~~s~L~~---~~~~~~~ysC~V~H~~ 83 (94)
T cd05766 13 LSHPHLLVCHVWGFYPPEITVKWFKNGQEETEGVVS----TELIPNGDWTYQILVMLET---TPSRGDTYTCVVEHSS 83 (94)
T ss_pred CCCCeEEEEEEeeecCCCCEEEEEECCeecCCCcee----cceEECCCCcEEEEEEEEE---cCCCCCEEEEEEEeCC
Confidence 46788999999986543 67999998876543111 0111222334444555544 3345668999987543
No 487
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=69.48 E-value=3.1 Score=43.42 Aligned_cols=25 Identities=24% Similarity=0.201 Sum_probs=22.6
Q ss_pred CccccCCCCcceEEe--eCCceEEEec
Q psy12044 449 YIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 449 nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
+.||+|+||.||+|+ .+|..||++.
T Consensus 5 ~~lg~g~~~~v~~~~~~~~~~~~aik~ 31 (282)
T cd07831 5 GKIGEGTFSEVLKAQSRKTGKYYAIKC 31 (282)
T ss_pred eeccccccceEEEEEEcCCCcEEEEEE
Confidence 479999999999999 7899999887
No 488
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=69.43 E-value=2.8 Score=43.83 Aligned_cols=27 Identities=22% Similarity=0.233 Sum_probs=23.5
Q ss_pred CCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 447 GGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 447 ~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
..+.||+|+||.||+|+ .+|..||++.
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~ 31 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKK 31 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEE
Confidence 34589999999999999 5699999987
No 489
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=69.41 E-value=2.6 Score=44.28 Aligned_cols=31 Identities=13% Similarity=0.065 Sum_probs=25.3
Q ss_pred CCCCCCCccccCCCCcceEEe-e------CCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT-D------SGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~-~------dG~~VA~~~ 473 (767)
++|.-.+.||+|+||.||+|. . .+..||.+.
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~ 43 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKT 43 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEE
Confidence 567777799999999999999 3 466788776
No 490
>KOG3864|consensus
Probab=69.29 E-value=0.46 Score=47.74 Aligned_cols=77 Identities=23% Similarity=0.257 Sum_probs=50.5
Q ss_pred CccEEEccCCCCCccCcccccCCCCCCEEEccCCC------CCCCCCCCCCCCCCCcEEECCCC-cCcccccCCcCCCCC
Q psy12044 76 NLQKIYLSRCRISVIDSKAFRGLTNLVDLDFSHNV------LQTVPSDTFPDYPSLMKLTLSGN-PIKQIKTGAFQPLSY 148 (767)
Q Consensus 76 ~L~~L~Ls~N~L~~i~p~~f~~L~~L~~L~Ls~N~------Lt~l~p~~f~~l~~L~~L~Ls~N-~l~~l~~~~~~~l~~ 148 (767)
.++.++-+++.|..+.-+-|.+++.|+.|.+.++. |..+.. -.++|+.|+|++| +|+.-.-..+..+++
T Consensus 102 ~IeaVDAsds~I~~eGle~L~~l~~i~~l~l~~ck~~dD~~L~~l~~----~~~~L~~L~lsgC~rIT~~GL~~L~~lkn 177 (221)
T KOG3864|consen 102 KIEAVDASDSSIMYEGLEHLRDLRSIKSLSLANCKYFDDWCLERLGG----LAPSLQDLDLSGCPRITDGGLACLLKLKN 177 (221)
T ss_pred eEEEEecCCchHHHHHHHHHhccchhhhheeccccchhhHHHHHhcc----cccchheeeccCCCeechhHHHHHHHhhh
Confidence 46677777777777666667777777777776664 222221 2378888898877 566544445566777
Q ss_pred ccEEeccC
Q psy12044 149 LVTLELSK 156 (767)
Q Consensus 149 L~~L~Ls~ 156 (767)
|+.|.|.+
T Consensus 178 Lr~L~l~~ 185 (221)
T KOG3864|consen 178 LRRLHLYD 185 (221)
T ss_pred hHHHHhcC
Confidence 77777654
No 491
>cd07703 Ig2_Nectin-2_like Second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112) and similar proteins. Ig2_Nectin-2_like: domain similar to the second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112). Nectin-2 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectin-2 and nectin-3 localize at Sertoli-spermatid junctions where they form heterophilic trans-interactions between the cells that are essential for the formation and maintenance of the junctions and for spermatid development.
Probab=69.27 E-value=23 Score=31.31 Aligned_cols=67 Identities=18% Similarity=0.198 Sum_probs=37.9
Q ss_pred ccccccccc-ccCCCcEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeeccCCCC
Q psy12044 271 NVSLLCKVS-AIPEAKITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAENQAGS 345 (767)
Q Consensus 271 ~vsL~C~a~-g~P~p~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N~~G~ 345 (767)
...+.|.+. +.|.+.|+|+.+...... .......++.....+.|.+.-....+...++|.+.+..-.
T Consensus 17 ~~va~C~s~~gkPaa~IsW~~~~~g~~~--------~~~~~~~~gt~tv~S~l~~~P~~~d~Gk~ltC~v~h~al~ 84 (95)
T cd07703 17 VPVAKCVSANGRPPARISWSSTLGGNAN--------TTSKENGDGTVTVTSEYSLVPTPEANGKEVTCKVEHETLQ 84 (95)
T ss_pred cEEEEEEcCCCCCCcEEEEEcCCCCCee--------EEEEeCCCCCEEEEEEEEEecCHHHCCCEEEEEEeCcccC
Confidence 567899665 778999999986211100 0011112233344556666443444455699999987644
No 492
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=69.22 E-value=2.7 Score=43.23 Aligned_cols=29 Identities=14% Similarity=-0.004 Sum_probs=23.6
Q ss_pred CCCCCccccCCCCcceEEe-eCCceEEEec
Q psy12044 445 VNGGYIIADGHNDMMLYAT-DSGILVATNN 473 (767)
Q Consensus 445 Fs~~nlIG~GgfG~VYKG~-~dG~~VA~~~ 473 (767)
|.-...||+|+||.||+|. .++..+|++.
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~ 35 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKT 35 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEE
Confidence 3334579999999999999 7788888876
No 493
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=69.20 E-value=3.2 Score=44.41 Aligned_cols=31 Identities=16% Similarity=0.155 Sum_probs=26.1
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
..|...+.||+|+||.||+|+ .+|..||.+.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~ 47 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKK 47 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEE
Confidence 345666789999999999999 6899999876
No 494
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=69.04 E-value=3.3 Score=43.99 Aligned_cols=31 Identities=13% Similarity=0.170 Sum_probs=26.2
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||+|+ .+|..||++.
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~ 47 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQ 47 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEE
Confidence 455666789999999999999 4599999877
No 495
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=68.97 E-value=3.1 Score=43.92 Aligned_cols=31 Identities=19% Similarity=0.177 Sum_probs=23.5
Q ss_pred CCCCCCCccccCCCCcceEEe-eC------CceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT-DS------GILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~-~d------G~~VA~~~ 473 (767)
++|.-...||+|+||.||+|. .+ ...||++.
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~ 49 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM 49 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEE
Confidence 455566689999999999998 32 25678776
No 496
>cd05770 IgC_beta2m Class I major histocompatibility complex (MHC) beta2-microglobulin. IgC_beta2m: Immunoglobulin-like domain in beta2-Microglobulin (beta2m). Beta2m is the non-covalently bound light chain of the human class I major histocompatibility complex (MHC-I). Beta2m is structured as a beta-sandwich domain composed of two facing beta-sheets (four stranded and three stranded), that is typical of the C-type immunoglobulin superfamily. This structure is stabilized by an intramolecular disulfide bridge connecting two Cys residues in the facing beta -sheets. In vivo, MHC-I continuously exposes beta2m on the cell surface, where it may be released to plasmatic fluids, transported to the kidneys, degraded and then excreted.
Probab=68.92 E-value=12 Score=32.96 Aligned_cols=66 Identities=18% Similarity=0.229 Sum_probs=40.1
Q ss_pred ccccccccccccccCCC--cEEEeecCeeccCCCcccccccceeecccCcceeeeEEEEeeeccCCCCceeEeecc
Q psy12044 268 EGKNVSLLCKVSAIPEA--KITWLFDGVPIQNESMSASESHAVYSTEEGTEIKKSELLIYNSNIDDNGTFVCVAEN 341 (767)
Q Consensus 268 ~G~~vsL~C~a~g~P~p--~itW~~~g~~l~~~s~~~~~~~~~~~~~~g~~~~~s~L~I~nvs~sD~GtY~CvA~N 341 (767)
.|...+|.|.+.++..+ .++|.++|..+. .... .......++.....+.|.+ ...+...|+|.+.-
T Consensus 14 ~g~~~~L~C~a~gFyP~~i~v~W~~dg~~~~-~~~~----~~~~p~~d~tyq~~s~l~~---~~~~~~~ysC~V~H 81 (93)
T cd05770 14 NGKPNVLNCYVTGFHPPDIEIRLLKNGVKIP-KVEQ----SDLSFSKDWTFYLLKSTEF---TPTKGDEYACRVRH 81 (93)
T ss_pred CCCceEEEEEEEEEeCCCCEEEEEECCEECC-CcEE----CcEEECCCCCEEEEEEEEE---CCCCCCeEEEEEEE
Confidence 35556899999997544 679999998765 2111 1122233343333444443 35667789999874
No 497
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=68.88 E-value=3.6 Score=42.90 Aligned_cols=24 Identities=13% Similarity=0.101 Sum_probs=0.0
Q ss_pred CccccCCCCcceEEe----eCCceEEEe
Q psy12044 449 YIIADGHNDMMLYAT----DSGILVATN 472 (767)
Q Consensus 449 nlIG~GgfG~VYKG~----~dG~~VA~~ 472 (767)
..||+|+||.||+|+ ..+..+|++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k 28 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVK 28 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEE
No 498
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=68.57 E-value=3 Score=44.74 Aligned_cols=30 Identities=13% Similarity=0.221 Sum_probs=0.0
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEe
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATN 472 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~ 472 (767)
++|.....||+|+||.||+|. .+|..||.+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK 32 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALK 32 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEE
No 499
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=68.48 E-value=3 Score=43.16 Aligned_cols=31 Identities=13% Similarity=0.172 Sum_probs=0.0
Q ss_pred CCCCCCCccccCCCCcceEEe--eCCceEEEec
Q psy12044 443 DKVNGGYIIADGHNDMMLYAT--DSGILVATNN 473 (767)
Q Consensus 443 nnFs~~nlIG~GgfG~VYKG~--~dG~~VA~~~ 473 (767)
++|.-...||+|+||.||++. .+|..||++.
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~ 33 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKT 33 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEE
No 500
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=68.48 E-value=2.9 Score=43.13 Aligned_cols=32 Identities=19% Similarity=0.126 Sum_probs=0.0
Q ss_pred cCCCCCCCCccccCCCCcceEEeeCCceEEEe
Q psy12044 441 CMDKVNGGYIIADGHNDMMLYATDSGILVATN 472 (767)
Q Consensus 441 ~~nnFs~~nlIG~GgfG~VYKG~~dG~~VA~~ 472 (767)
++++|.-...||+|+||.||+|...|..||.+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k 35 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK 35 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEcCCcEEEE
Done!